Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Carcinoma in situ of breast,A1BG,Alpha-1B-glycoprotein,7968,42,0.99 [0.18-5.46],0.9940551969101742
Chapter II Neoplasms,Carcinoma in situ of breast,AAMDC,Mth938 domain-containing protein,7776,44,0.81 [0.46-1.42],0.4582738577545221
Chapter II Neoplasms,Carcinoma in situ of breast,AARSD1,Alanyl-tRNA editing protein Aarsd1,9033,51,0.84 [0.53-1.32],0.4425243378734668
Chapter II Neoplasms,Carcinoma in situ of breast,ABCA2,ATP-binding cassette sub-family A member 2,7710,44,1.18 [0.55-2.53],0.6784811848217787
Chapter II Neoplasms,Carcinoma in situ of breast,ABHD14B,Protein ABHD14B,8977,49,0.88 [0.56-1.38],0.5821665739080076
Chapter II Neoplasms,Carcinoma in situ of breast,ABL1,Tyrosine-protein kinase ABL1,9033,51,0.81 [0.55-1.21],0.3025141085926899
Chapter II Neoplasms,Carcinoma in situ of breast,ABO,Histo-blood group ABO system transferase,7955,44,0.97 [0.79-1.18],0.7495130978877059
Chapter II Neoplasms,Carcinoma in situ of breast,ABRAXAS2,BRISC complex subunit Abraxas 2,7710,44,0.65 [0.41-1.04],0.0723575348554067
Chapter II Neoplasms,Carcinoma in situ of breast,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",8869,47,0.76 [0.54-1.07],0.111405699671361
Chapter II Neoplasms,Carcinoma in situ of breast,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",7824,45,0.88 [0.56-1.38],0.5813612275636659
Chapter II Neoplasms,Carcinoma in situ of breast,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",7948,45,0.86 [0.61-1.20],0.3616176075830536
Chapter II Neoplasms,Carcinoma in situ of breast,ACAN,Aggrecan core protein,8978,49,1.77 [0.72-4.37],0.2149410242011708
Chapter II Neoplasms,Carcinoma in situ of breast,ACE,Angiotensin-converting enzyme,7955,44,1.22 [0.42-3.57],0.7163143798555553
Chapter II Neoplasms,Carcinoma in situ of breast,ACE2,Angiotensin-converting enzyme 2,8895,49,0.84 [0.50-1.40],0.5063121827092709
Chapter II Neoplasms,Carcinoma in situ of breast,ACHE,Acetylcholinesterase,7807,44,1.27 [0.53-3.03],0.5853037129214023
Chapter II Neoplasms,Carcinoma in situ of breast,ACOT13,Acyl-coenzyme A thioesterase 13,7914,45,0.94 [0.72-1.21],0.6146505883389903
Chapter II Neoplasms,Carcinoma in situ of breast,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,9066,49,0.89 [0.53-1.49],0.6536058533169273
Chapter II Neoplasms,Carcinoma in situ of breast,ACP1,Low molecular weight phosphotyrosine protein phosphatase,7735,44,0.92 [0.47-1.80],0.8096184696802551
Chapter II Neoplasms,Carcinoma in situ of breast,ACP5,Tartrate-resistant acid phosphatase type 5,9129,48,0.68 [0.29-1.60],0.3765877658457256
Chapter II Neoplasms,Carcinoma in situ of breast,ACP6,Lysophosphatidic acid phosphatase type 6,9127,50,0.82 [0.60-1.12],0.2168592020503434
Chapter II Neoplasms,Carcinoma in situ of breast,ACRBP,Acrosin-binding protein,7924,45,0.85 [0.39-1.87],0.6888932388922127
Chapter II Neoplasms,Carcinoma in situ of breast,ACRV1,Acrosomal protein SP-10,7735,44,1.28 [0.58-2.85],0.5403153890894441
Chapter II Neoplasms,Carcinoma in situ of breast,ACSL1,Long-chain-fatty-acid--CoA ligase 1,7710,44,0.78 [0.32-1.87],0.5753067164285062
Chapter II Neoplasms,Carcinoma in situ of breast,ACTA2,"Actin, aortic smooth muscle",8895,49,1.84 [1.26-2.70],0.0017607004733311
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN2,Alpha-actinin-2,7710,44,0.92 [0.53-1.58],0.7535186512124253
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN4,Alpha-actinin-4,8903,49,1.20 [0.61-2.38],0.5972729542469812
Chapter II Neoplasms,Carcinoma in situ of breast,ACVRL1,Serine/threonine-protein kinase receptor R3,8991,49,1.80 [0.67-4.83],0.2400113737116056
Chapter II Neoplasms,Carcinoma in situ of breast,ACY1,Aminoacylase-1,9066,49,0.66 [0.42-1.02],0.063288355891221
Chapter II Neoplasms,Carcinoma in situ of breast,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,7710,44,0.88 [0.51-1.50],0.6330777799762968
Chapter II Neoplasms,Carcinoma in situ of breast,ACYP1,Acylphosphatase-1,7773,44,0.86 [0.55-1.35],0.5134753030510263
Chapter II Neoplasms,Carcinoma in situ of breast,ADA,Adenosine deaminase,9160,50,0.67 [0.31-1.47],0.320611352927887
Chapter II Neoplasms,Carcinoma in situ of breast,ADA2,Adenosine deaminase 2,9031,50,1.14 [0.63-2.04],0.6713183015156546
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,7735,44,1.50 [0.64-3.49],0.3504206385590132
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,8895,49,1.27 [0.55-2.90],0.5782436662030448
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,9005,49,1.84 [0.90-3.76],0.0937916769616195
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,9160,50,1.28 [0.61-2.68],0.516694432062876
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,9118,49,1.74 [0.71-4.26],0.22802585121511
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,7914,45,1.39 [0.55-3.51],0.4836179139312652
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,7735,44,1.26 [0.49-3.25],0.6280683759838335
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,9177,49,1.11 [0.37-3.33],0.8543947614400405
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,9033,51,0.75 [0.48-1.18],0.2130333081860626
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,8895,49,0.74 [0.29-1.88],0.5255355162994895
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,7735,44,1.49 [0.71-3.13],0.2974412911791005
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,9106,50,1.15 [0.65-2.04],0.625914216058437
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL2,ADAMTS-like protein 2,7965,46,0.97 [0.41-2.32],0.9522364573911178
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL4,ADAMTS-like protein 4,7776,44,2.11 [0.62-7.18],0.2334857070917046
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL5,ADAMTS-like protein 5,7948,45,0.57 [0.27-1.18],0.1299621010597815
Chapter II Neoplasms,Carcinoma in situ of breast,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,8869,47,0.82 [0.34-1.97],0.6591261956226684
Chapter II Neoplasms,Carcinoma in situ of breast,ADD1,Alpha-adducin,7807,44,0.68 [0.45-1.03],0.0676193342744992
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRB3,Adhesion G protein-coupled receptor B3,8991,49,1.21 [0.57-2.56],0.61762341785023
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRD1,Adhesion G-protein coupled receptor D1,7807,44,1.40 [0.65-3.00],0.3884147089064358
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE1,Adhesion G protein-coupled receptor E1,7914,45,1.03 [0.61-1.72],0.9244512357982514
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE2,Adhesion G protein-coupled receptor E2,9112,50,1.48 [0.60-3.65],0.3912074896101313
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE5,Adhesion G protein-coupled receptor E5,9148,49,1.00 [0.42-2.36],0.9910131322620632
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRF5,Adhesion G protein-coupled receptor F5,7948,45,0.47 [0.18-1.25],0.1309179606442883
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG1,Adhesion G-protein coupled receptor G1,9033,51,0.80 [0.52-1.24],0.3198870915596988
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG2,Adhesion G-protein coupled receptor G2,9066,49,0.93 [0.37-2.38],0.8849169504582246
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRV1,Adhesion G-protein coupled receptor V1,7686,45,0.85 [0.54-1.36],0.5038929574028432
Chapter II Neoplasms,Carcinoma in situ of breast,ADH1B,All-trans-retinol dehydrogenase,7807,44,0.81 [0.54-1.22],0.3103172846806858
Chapter II Neoplasms,Carcinoma in situ of breast,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,8895,49,0.91 [0.67-1.24],0.5586673027312845
Chapter II Neoplasms,Carcinoma in situ of breast,ADIPOQ,Adiponectin,7968,42,1.09 [0.70-1.69],0.6997302487394876
Chapter II Neoplasms,Carcinoma in situ of breast,ADM,Pro-adrenomedullin,9145,50,0.78 [0.30-2.04],0.6115780817138838
Chapter II Neoplasms,Carcinoma in situ of breast,ADRA2A,Alpha-2A adrenergic receptor,7710,44,0.97 [0.64-1.47],0.8781654149576518
Chapter II Neoplasms,Carcinoma in situ of breast,AFAP1,Actin filament-associated protein 1,7807,44,0.82 [0.57-1.18],0.2816876222437702
Chapter II Neoplasms,Carcinoma in situ of breast,AFM,Afamin,7968,42,0.49 [0.17-1.40],0.181611866662663
Chapter II Neoplasms,Carcinoma in situ of breast,AFP,Alpha-fetoprotein,8978,47,1.82 [1.27-2.62],0.0012080156374008
Chapter II Neoplasms,Carcinoma in situ of breast,AGBL2,Cytosolic carboxypeptidase 2,7686,45,1.06 [0.75-1.49],0.7535733177750268
Chapter II Neoplasms,Carcinoma in situ of breast,AGER,Advanced glycosylation end product-specific receptor,9049,50,1.31 [0.72-2.39],0.3758788084918621
Chapter II Neoplasms,Carcinoma in situ of breast,AGR2,Anterior gradient protein 2 homolog,8772,49,0.96 [0.75-1.24],0.7793293869337824
Chapter II Neoplasms,Carcinoma in situ of breast,AGR3,Anterior gradient protein 3,8849,47,0.83 [0.52-1.30],0.4090338569114871
Chapter II Neoplasms,Carcinoma in situ of breast,AGRN,Agrin,9112,50,0.62 [0.28-1.35],0.2303477015936942
Chapter II Neoplasms,Carcinoma in situ of breast,AGRP,Agouti-related protein,9160,50,1.52 [0.93-2.49],0.097097242692575
Chapter II Neoplasms,Carcinoma in situ of breast,AGT,Angiotensinogen,7955,44,1.07 [0.30-3.82],0.9145289882110736
Chapter II Neoplasms,Carcinoma in situ of breast,AGXT,Serine--pyruvate aminotransferase,9066,49,0.94 [0.67-1.32],0.725256449964133
Chapter II Neoplasms,Carcinoma in situ of breast,AHCY,Adenosylhomocysteinase,9066,49,0.91 [0.63-1.33],0.6281983922199322
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK,Neuroblast differentiation-associated protein AHNAK,7776,44,1.44 [0.61-3.36],0.4018347181049696
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK2,Protein AHNAK2,7776,44,1.79 [0.78-4.11],0.1702543332314154
Chapter II Neoplasms,Carcinoma in situ of breast,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,7924,45,0.98 [0.64-1.50],0.9377592331828314
Chapter II Neoplasms,Carcinoma in situ of breast,AHSG,Alpha-2-HS-glycoprotein,7955,44,0.63 [0.28-1.40],0.2554586785985503
Chapter II Neoplasms,Carcinoma in situ of breast,AHSP,Alpha-hemoglobin-stabilizing protein,9061,48,0.90 [0.67-1.20],0.462677546381376
Chapter II Neoplasms,Carcinoma in situ of breast,AIDA,"Axin interactor, dorsalization-associated protein",7742,44,1.08 [0.80-1.47],0.6063288691125968
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1,Allograft inflammatory factor 1,8869,47,0.88 [0.53-1.46],0.6137555063070863
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1L,Allograft inflammatory factor 1-like,7776,44,1.27 [0.89-1.81],0.1888920600746002
Chapter II Neoplasms,Carcinoma in situ of breast,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",9018,51,0.87 [0.68-1.11],0.2770919355718684
Chapter II Neoplasms,Carcinoma in situ of breast,AK1,Adenylate kinase isoenzyme 1,9066,49,0.77 [0.52-1.16],0.2123811874908925
Chapter II Neoplasms,Carcinoma in situ of breast,AK2,"Adenylate kinase 2, mitochondrial",7945,46,1.10 [0.84-1.44],0.5009582887360495
Chapter II Neoplasms,Carcinoma in situ of breast,AKAP12,A-kinase anchor protein 12,7807,44,1.08 [0.30-3.92],0.9074474556337024
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B1,Aldo-keto reductase family 1 member B1,8869,47,0.91 [0.64-1.28],0.5833215391889072
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B10,Aldo-keto reductase family 1 member B10,7742,44,0.78 [0.47-1.29],0.331688899239645
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1C4,Aldo-keto reductase family 1 member C4,8895,49,0.72 [0.40-1.28],0.2559624401482384
Chapter II Neoplasms,Carcinoma in situ of breast,AKR7L,Aflatoxin B1 aldehyde reductase member 4,7735,44,1.21 [0.86-1.72],0.2723411848722225
Chapter II Neoplasms,Carcinoma in situ of breast,AKT1S1,Proline-rich AKT1 substrate 1,8849,49,0.71 [0.48-1.04],0.0786348421382896
Chapter II Neoplasms,Carcinoma in situ of breast,AKT2,RAC-beta serine/threonine-protein kinase,7937,45,0.94 [0.75-1.19],0.6139073354478436
Chapter II Neoplasms,Carcinoma in situ of breast,AKT3,RAC-gamma serine/threonine-protein kinase,8828,47,0.77 [0.48-1.23],0.2734421769504206
Chapter II Neoplasms,Carcinoma in situ of breast,ALCAM,CD166 antigen,9177,49,3.66 [1.02-13.05],0.0457777286290144
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH1A1,Retinal dehydrogenase 1,9075,49,0.75 [0.47-1.20],0.2307602888394921
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH2,"Aldehyde dehydrogenase, mitochondrial",7924,45,1.14 [0.73-1.80],0.5636243394642202
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",9026,49,0.85 [0.57-1.26],0.4093187669657863
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",7937,45,1.15 [0.65-2.02],0.6291052467476309
Chapter II Neoplasms,Carcinoma in situ of breast,ALMS1,Alstrom syndrome protein 1,7824,45,1.20 [0.71-2.02],0.4994836599500328
Chapter II Neoplasms,Carcinoma in situ of breast,ALPI,Intestinal-type alkaline phosphatase,7735,44,1.08 [0.85-1.36],0.5281095675946315
Chapter II Neoplasms,Carcinoma in situ of breast,ALPP,"Alkaline phosphatase, placental type",9033,51,0.95 [0.74-1.22],0.699910069639688
Chapter II Neoplasms,Carcinoma in situ of breast,AMBN,Ameloblastin,8903,49,1.28 [0.61-2.69],0.5171718657942976
Chapter II Neoplasms,Carcinoma in situ of breast,AMBP,Protein AMBP,9128,50,2.13 [0.64-7.07],0.2150175860092707
Chapter II Neoplasms,Carcinoma in situ of breast,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,7965,46,0.72 [0.24-2.14],0.5553014753042038
Chapter II Neoplasms,Carcinoma in situ of breast,AMFR,E3 ubiquitin-protein ligase AMFR,8849,49,0.96 [0.63-1.47],0.8581590328956659
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO1,Amphoterin-induced protein 1,7742,44,0.64 [0.31-1.31],0.2248819923872008
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO2,Amphoterin-induced protein 2,9033,51,1.12 [0.37-3.35],0.838758786638101
Chapter II Neoplasms,Carcinoma in situ of breast,AMN,Protein amnionless,8903,49,1.41 [0.86-2.32],0.1722556435256238
Chapter II Neoplasms,Carcinoma in situ of breast,AMOT,Angiomotin,7807,44,0.97 [0.46-2.04],0.9440189012980418
Chapter II Neoplasms,Carcinoma in situ of breast,AMOTL2,Angiomotin-like protein 2,7893,45,0.73 [0.36-1.47],0.3805827898189374
Chapter II Neoplasms,Carcinoma in situ of breast,AMPD3,AMP deaminase 3,7945,46,0.78 [0.53-1.16],0.2186706504504733
Chapter II Neoplasms,Carcinoma in situ of breast,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,7428,41,0.76 [0.40-1.45],0.4110323648682006
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2A,Pancreatic alpha-amylase,8690,48,0.87 [0.50-1.51],0.6270906729341703
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2B,Alpha-amylase 2B,8448,47,0.87 [0.50-1.52],0.629824957802125
Chapter II Neoplasms,Carcinoma in situ of breast,ANG,Angiogenin,9064,50,0.90 [0.43-1.89],0.787588675561762
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT1,Angiopoietin-1,9030,49,0.88 [0.66-1.19],0.4111880838412022
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT2,Angiopoietin-2,9145,50,1.41 [0.72-2.75],0.311971089158602
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL1,Angiopoietin-related protein 1,8948,49,1.20 [0.50-2.90],0.6787401204786194
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL2,Angiopoietin-related protein 2,9083,50,1.31 [0.71-2.43],0.3826576890434546
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL3,Angiopoietin-related protein 3,9082,50,1.45 [0.72-2.91],0.3012104321956101
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL4,Angiopoietin-related protein 4,9094,50,0.80 [0.45-1.41],0.4328615509655458
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL7,Angiopoietin-related protein 7,9145,50,0.87 [0.44-1.75],0.6997780768044392
Chapter II Neoplasms,Carcinoma in situ of breast,ANK2,Ankyrin-2,7710,44,1.24 [0.91-1.69],0.1703652069915516
Chapter II Neoplasms,Carcinoma in situ of breast,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,7735,44,0.80 [0.55-1.17],0.2555004564981216
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRA2,Ankyrin repeat family A protein 2,7678,44,1.42 [1.02-1.99],0.038118970452692
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRD54,Ankyrin repeat domain-containing protein 54,8869,47,0.82 [0.50-1.35],0.4447127275732585
Chapter II Neoplasms,Carcinoma in situ of breast,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,7776,44,0.68 [0.27-1.69],0.4098652572064679
Chapter II Neoplasms,Carcinoma in situ of breast,ANPEP,Aminopeptidase N,9110,50,1.34 [0.56-3.22],0.5063360396876848
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA1,Annexin A1,7761,44,0.89 [0.45-1.79],0.748723779128125
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA10,Annexin A10,8849,49,0.79 [0.56-1.11],0.1687294573186841
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA11,Annexin A11,9032,49,0.94 [0.65-1.37],0.7539640975809938
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA2,Annexin A2,7659,44,0.86 [0.56-1.33],0.4985822490068808
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA3,Annexin A3,9118,49,1.08 [0.75-1.55],0.6709141977378128
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA4,Annexin A4,9022,48,0.83 [0.58-1.20],0.3295203687241029
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA5,Annexin A5,8827,49,0.77 [0.32-1.84],0.5541682821749647
Chapter II Neoplasms,Carcinoma in situ of breast,AOC1,Amiloride-sensitive amine oxidase [copper-containing],8903,49,1.02 [0.68-1.54],0.9293002281470608
Chapter II Neoplasms,Carcinoma in situ of breast,AOC3,Membrane primary amine oxidase,9120,50,1.85 [0.81-4.24],0.1468155922045359
Chapter II Neoplasms,Carcinoma in situ of breast,AP1G2,AP-1 complex subunit gamma-like 2,7924,45,0.82 [0.57-1.19],0.3039987653769905
Chapter II Neoplasms,Carcinoma in situ of breast,AP2B1,AP-2 complex subunit beta,7742,44,0.79 [0.41-1.50],0.464343822313915
Chapter II Neoplasms,Carcinoma in situ of breast,AP3B1,AP-3 complex subunit beta-1,7914,45,0.91 [0.62-1.33],0.6128918631257423
Chapter II Neoplasms,Carcinoma in situ of breast,AP3S2,AP-3 complex subunit sigma-2,7945,46,0.97 [0.53-1.79],0.9299328593788632
Chapter II Neoplasms,Carcinoma in situ of breast,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,9033,51,0.88 [0.49-1.61],0.6864774897560324
Chapter II Neoplasms,Carcinoma in situ of breast,APCS,Serum amyloid P-component,7888,41,0.74 [0.32-1.71],0.4784934943223353
Chapter II Neoplasms,Carcinoma in situ of breast,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,9112,50,1.14 [0.75-1.74],0.5358346974078037
Chapter II Neoplasms,Carcinoma in situ of breast,APLP1,Amyloid-like protein 1,9066,49,1.35 [0.85-2.14],0.2096058338683481
Chapter II Neoplasms,Carcinoma in situ of breast,APOA1,Apolipoprotein A-I,7968,42,1.19 [0.44-3.21],0.731378721348396
Chapter II Neoplasms,Carcinoma in situ of breast,APOA2,Apolipoprotein A-II,7955,44,1.13 [0.64-2.01],0.6674826444723454
Chapter II Neoplasms,Carcinoma in situ of breast,APOA4,Apolipoprotein A-IV,7968,42,1.43 [0.74-2.75],0.2850743959208085
Chapter II Neoplasms,Carcinoma in situ of breast,APOB,Apolipoprotein B-100,7955,44,0.89 [0.26-3.04],0.8576714017399321
Chapter II Neoplasms,Carcinoma in situ of breast,APOBR,Apolipoprotein B receptor,7776,44,1.06 [0.53-2.14],0.8667210337835927
Chapter II Neoplasms,Carcinoma in situ of breast,APOC1,Apolipoprotein C-I,7951,41,0.72 [0.29-1.79],0.4828872839531424
Chapter II Neoplasms,Carcinoma in situ of breast,APOD,Apolipoprotein D,7619,37,1.29 [0.74-2.25],0.3749423719441922
Chapter II Neoplasms,Carcinoma in situ of breast,APOE,Apolipoprotein E,7968,42,0.97 [0.63-1.50],0.8981484637251851
Chapter II Neoplasms,Carcinoma in situ of breast,APOF,Apolipoprotein F,7955,44,0.88 [0.32-2.40],0.800437048609364
Chapter II Neoplasms,Carcinoma in situ of breast,APOH,Beta-2-glycoprotein 1,9075,49,0.91 [0.44-1.89],0.8062529200333103
Chapter II Neoplasms,Carcinoma in situ of breast,APOL1,Apolipoprotein L1,7955,44,1.27 [0.86-1.86],0.224032263344569
Chapter II Neoplasms,Carcinoma in situ of breast,APOM,Apolipoprotein M,9101,50,1.86 [0.73-4.75],0.1950321877123356
Chapter II Neoplasms,Carcinoma in situ of breast,APP,Amyloid-beta precursor protein,9067,49,0.82 [0.55-1.21],0.3086651286214862
Chapter II Neoplasms,Carcinoma in situ of breast,APPL2,DCC-interacting protein 13-beta,7807,44,0.92 [0.71-1.20],0.55195108463826
Chapter II Neoplasms,Carcinoma in situ of breast,APRT,Adenine phosphoribosyltransferase,8993,49,0.90 [0.53-1.53],0.6972920890328795
Chapter II Neoplasms,Carcinoma in situ of breast,ARAF,Serine/threonine-protein kinase A-Raf,7824,45,0.84 [0.53-1.34],0.4736306697776197
Chapter II Neoplasms,Carcinoma in situ of breast,AREG,Amphiregulin,9033,51,2.18 [1.39-3.41],0.0006270928613779
Chapter II Neoplasms,Carcinoma in situ of breast,ARF6,ADP-ribosylation factor 6,7914,45,1.13 [0.85-1.50],0.3857603877871938
Chapter II Neoplasms,Carcinoma in situ of breast,ARFIP1,Arfaptin-1,7937,45,0.91 [0.60-1.39],0.6626478002338285
Chapter II Neoplasms,Carcinoma in situ of breast,ARG1,Arginase-1,9029,48,0.73 [0.45-1.18],0.1949816273621528
Chapter II Neoplasms,Carcinoma in situ of breast,ARG2,"Arginase-2, mitochondrial",7924,45,1.08 [0.59-1.99],0.8052382215604534
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP1,Rho GTPase-activating protein 1,8869,47,0.83 [0.47-1.46],0.5120326831505791
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP25,Rho GTPase-activating protein 25,8869,47,0.79 [0.49-1.28],0.3432941977607757
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP30,Rho GTPase-activating protein 30,7824,45,0.55 [0.19-1.55],0.2556246822912427
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP45,Rho GTPase-activating protein 45,7807,44,0.89 [0.62-1.27],0.5171242980707526
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP5,Rho GTPase-activating protein 5,7678,44,0.85 [0.56-1.28],0.4418195304099364
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF1,Rho guanine nucleotide exchange factor 1,7945,46,0.81 [0.59-1.11],0.1924186406386625
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF10,Rho guanine nucleotide exchange factor 10,7937,45,0.88 [0.64-1.20],0.4188772569594028
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF12,Rho guanine nucleotide exchange factor 12,9043,49,0.82 [0.64-1.05],0.1127514858096174
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF5,Rho guanine nucleotide exchange factor 5,7686,45,1.05 [0.71-1.53],0.821304652798287
Chapter II Neoplasms,Carcinoma in situ of breast,ARID3A,AT-rich interactive domain-containing protein 3A,7686,45,1.16 [0.58-2.34],0.6712504575004372
Chapter II Neoplasms,Carcinoma in situ of breast,ARID4B,AT-rich interactive domain-containing protein 4B,8849,49,1.14 [0.69-1.88],0.6168325258049413
Chapter II Neoplasms,Carcinoma in situ of breast,ARL13B,ADP-ribosylation factor-like protein 13B,7710,44,0.69 [0.43-1.10],0.1205704451119349
Chapter II Neoplasms,Carcinoma in situ of breast,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,7710,44,0.92 [0.44-1.90],0.8223132333232541
Chapter II Neoplasms,Carcinoma in situ of breast,ARMCX2,Armadillo repeat-containing X-linked protein 2,7686,45,1.01 [0.65-1.58],0.9619845264619874
Chapter II Neoplasms,Carcinoma in situ of breast,ARNT,Aryl hydrocarbon receptor nuclear translocator,8903,49,0.75 [0.35-1.63],0.4703920119459703
Chapter II Neoplasms,Carcinoma in situ of breast,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,7710,44,0.83 [0.44-1.58],0.5734807667663453
Chapter II Neoplasms,Carcinoma in situ of breast,ARSA,Arylsulfatase A,9075,49,0.96 [0.54-1.70],0.8952630618645909
Chapter II Neoplasms,Carcinoma in situ of breast,ARSB,Arylsulfatase B,9033,51,0.73 [0.46-1.18],0.2031662832218405
Chapter II Neoplasms,Carcinoma in situ of breast,ART3,Ecto-ADP-ribosyltransferase 3,9120,50,1.55 [0.75-3.21],0.2400406072805026
Chapter II Neoplasms,Carcinoma in situ of breast,ART5,Ecto-ADP-ribosyltransferase 5,7686,45,1.35 [1.02-1.78],0.034376599557602
Chapter II Neoplasms,Carcinoma in situ of breast,ARTN,Artemin,8903,49,1.00 [0.56-1.80],0.9888190144727786
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH1,Acid ceramidase,7877,46,1.04 [0.57-1.91],0.8914685388841496
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH2,Neutral ceramidase,9005,49,0.97 [0.60-1.55],0.8830710782464463
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR1,Asialoglycoprotein receptor 1,9005,49,0.75 [0.30-1.83],0.5218001796336604
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR2,Asialoglycoprotein receptor 2,7955,44,1.22 [0.42-3.59],0.7143243484573852
Chapter II Neoplasms,Carcinoma in situ of breast,ASPN,Asporin,7948,45,1.36 [0.50-3.71],0.5484211634432598
Chapter II Neoplasms,Carcinoma in situ of breast,ASPSCR1,Tether containing UBX domain for GLUT4,7937,45,0.80 [0.52-1.23],0.3041001946702704
Chapter II Neoplasms,Carcinoma in situ of breast,ASRGL1,Isoaspartyl peptidase/L-asparaginase,7776,44,0.94 [0.71-1.26],0.6965336633806625
Chapter II Neoplasms,Carcinoma in situ of breast,ASS1,Argininosuccinate synthase,7710,44,0.87 [0.60-1.26],0.4633950542124911
Chapter II Neoplasms,Carcinoma in situ of breast,ATF2,Cyclic AMP-dependent transcription factor ATF-2,8849,49,0.96 [0.64-1.45],0.8584195146588095
Chapter II Neoplasms,Carcinoma in situ of breast,ATF4,Cyclic AMP-dependent transcription factor ATF-4,7678,44,1.10 [0.51-2.37],0.8034353713077133
Chapter II Neoplasms,Carcinoma in situ of breast,ATG16L1,Autophagy-related protein 16-1,7914,45,0.85 [0.60-1.20],0.3630895770874485
Chapter II Neoplasms,Carcinoma in situ of breast,ATG4A,Cysteine protease ATG4A,8869,47,0.73 [0.46-1.16],0.1824463585222007
Chapter II Neoplasms,Carcinoma in situ of breast,ATOX1,Copper transport protein ATOX1,9106,50,0.99 [0.69-1.43],0.9667063267084456
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,7710,44,1.10 [0.66-1.83],0.7029717559636317
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,7710,44,1.23 [0.55-2.75],0.6122460059121357
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,7710,44,0.68 [0.29-1.60],0.3757241410091698
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B4,Protein ATP1B4,7678,44,0.54 [0.24-1.21],0.1361780914983172
Chapter II Neoplasms,Carcinoma in situ of breast,ATP2B4,Plasma membrane calcium-transporting ATPase 4,7710,44,0.88 [0.52-1.49],0.6460725855230681
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5F1D,"ATP synthase subunit delta, mitochondrial",7710,44,0.92 [0.51-1.69],0.7983032742169685
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5IF1,"ATPase inhibitor, mitochondrial",9112,50,0.86 [0.69-1.08],0.1865001306796156
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5PO,"ATP synthase subunit O, mitochondrial",8849,49,0.63 [0.33-1.23],0.1798762841897732
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6AP2,Renin receptor,8869,47,1.35 [0.83-2.20],0.2322721805997598
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1D,V-type proton ATPase subunit D,9033,51,0.49 [0.24-1.00],0.049437074752946
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1F,V-type proton ATPase subunit F,8830,49,1.00 [0.68-1.47],0.9933219001618364
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G1,V-type proton ATPase subunit G 1,7776,44,0.95 [0.63-1.43],0.7941604229968039
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G2,V-type proton ATPase subunit G 2,7710,44,1.05 [0.81-1.37],0.7183264343006366
Chapter II Neoplasms,Carcinoma in situ of breast,ATRAID,All-trans retinoic acid-induced differentiation factor,7914,45,1.90 [0.83-4.32],0.1273200893623674
Chapter II Neoplasms,Carcinoma in situ of breast,ATRN,"Attractin, Isoform 2",7968,42,0.45 [0.08-2.64],0.3771743641958238
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN10,Ataxin-10,8849,49,0.96 [0.67-1.37],0.8131643238521199
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2,Ataxin-2,7686,45,0.99 [0.77-1.28],0.9540449905875076
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2L,Ataxin-2-like protein,7937,45,0.65 [0.32-1.32],0.2318308698359949
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN3,Ataxin-3,7945,46,0.73 [0.46-1.17],0.1909180526049598
Chapter II Neoplasms,Carcinoma in situ of breast,AXIN1,Axin-1,9043,49,0.85 [0.65-1.12],0.2565154511862823
Chapter II Neoplasms,Carcinoma in situ of breast,AXL,Tyrosine-protein kinase receptor UFO,9120,50,3.21 [1.45-7.10],0.0039541053894092
Chapter II Neoplasms,Carcinoma in situ of breast,AZI2,5-azacytidine-induced protein 2,7937,45,0.75 [0.43-1.30],0.3013891938164008
Chapter II Neoplasms,Carcinoma in situ of breast,AZU1,Azurocidin,8786,47,1.12 [0.82-1.52],0.4882463863208691
Chapter II Neoplasms,Carcinoma in situ of breast,B2M,Beta-2-microglobulin,7968,42,0.77 [0.27-2.17],0.6173010154239245
Chapter II Neoplasms,Carcinoma in situ of breast,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,7710,44,1.90 [0.83-4.38],0.1311712274192623
Chapter II Neoplasms,Carcinoma in situ of breast,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",7776,44,1.18 [0.52-2.67],0.6948267717338289
Chapter II Neoplasms,Carcinoma in situ of breast,B4GALT1,"Beta-1,4-galactosyltransferase 1",9112,50,1.95 [0.80-4.77],0.1434652673462737
Chapter II Neoplasms,Carcinoma in situ of breast,B4GAT1,"Beta-1,4-glucuronyltransferase 1",9075,49,1.08 [0.37-3.14],0.8911727493300217
Chapter II Neoplasms,Carcinoma in situ of breast,BABAM1,BRISC and BRCA1-A complex member 1,7735,44,1.13 [0.46-2.76],0.7883359206982075
Chapter II Neoplasms,Carcinoma in situ of breast,BACH1,Transcription regulator protein BACH1,9043,49,0.77 [0.53-1.12],0.1741824864624715
Chapter II Neoplasms,Carcinoma in situ of breast,BAG3,BAG family molecular chaperone regulator 3,8991,49,1.46 [0.76-2.82],0.2537699865156489
Chapter II Neoplasms,Carcinoma in situ of breast,BAG4,BAG family molecular chaperone regulator 4,7735,44,1.12 [0.62-2.00],0.7099764692346018
Chapter II Neoplasms,Carcinoma in situ of breast,BAG6,Large proline-rich protein BAG6,8895,49,0.94 [0.45-1.95],0.8619138613206597
Chapter II Neoplasms,Carcinoma in situ of breast,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,8869,47,0.76 [0.50-1.17],0.2143967068313884
Chapter II Neoplasms,Carcinoma in situ of breast,BAMBI,BMP and activin membrane-bound inhibitor homolog,8869,47,0.84 [0.34-2.08],0.7067146554018506
Chapter II Neoplasms,Carcinoma in situ of breast,BANK1,B-cell scaffold protein with ankyrin repeats,9043,49,0.90 [0.71-1.15],0.3973668193869245
Chapter II Neoplasms,Carcinoma in situ of breast,BAP18,Chromatin complexes subunit BAP18,7945,46,1.07 [0.71-1.60],0.7584589311071224
Chapter II Neoplasms,Carcinoma in situ of breast,BATF,Basic leucine zipper transcriptional factor ATF-like,7742,44,0.85 [0.57-1.27],0.4253897993926636
Chapter II Neoplasms,Carcinoma in situ of breast,BAX,Apoptosis regulator BAX,8838,49,0.87 [0.64-1.17],0.3545464878631044
Chapter II Neoplasms,Carcinoma in situ of breast,BCAM,Basal cell adhesion molecule,9075,49,1.61 [0.58-4.43],0.3582621007261345
Chapter II Neoplasms,Carcinoma in situ of breast,BCAN,Brevican core protein,9005,49,1.50 [0.71-3.21],0.2902744786838218
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",7948,45,0.98 [0.38-2.55],0.9721856073653284
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",7686,45,1.56 [1.08-2.26],0.0184461170812122
Chapter II Neoplasms,Carcinoma in situ of breast,BCHE,Cholinesterase,7812,43,0.75 [0.30-1.86],0.5317626294943518
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2,Apoptosis regulator Bcl-2,7914,45,1.05 [0.62-1.78],0.8593796279930422
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L1,Bcl-2-like protein 1,7945,46,0.90 [0.67-1.19],0.4510987242302219
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",9043,49,0.73 [0.44-1.21],0.2208478676363474
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L15,Bcl-2-like protein 15,7735,44,1.15 [0.72-1.81],0.5597378058801741
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7A,B-cell CLL/lymphoma 7 protein family member A,7678,44,0.94 [0.59-1.49],0.7870904952093354
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7B,B-cell CLL/lymphoma 7 protein family member B,7924,45,0.50 [0.22-1.14],0.0971894438568884
Chapter II Neoplasms,Carcinoma in situ of breast,BCR,Breakpoint cluster region protein,9043,49,0.83 [0.62-1.10],0.1859051378392007
Chapter II Neoplasms,Carcinoma in situ of breast,BDNF,Brain-derived neurotrophic factor,7965,46,0.70 [0.51-0.96],0.0281511597387453
Chapter II Neoplasms,Carcinoma in situ of breast,BECN1,Beclin-1,7776,44,0.85 [0.51-1.40],0.518549059083471
Chapter II Neoplasms,Carcinoma in situ of breast,BEX3,Protein BEX3,7678,44,0.37 [0.16-0.85],0.0188833712193845
Chapter II Neoplasms,Carcinoma in situ of breast,BGLAP,Osteocalcin,7965,46,0.76 [0.57-1.02],0.0686739637651972
Chapter II Neoplasms,Carcinoma in situ of breast,BGN,Biglycan,8848,47,1.05 [0.85-1.30],0.6443721843451342
Chapter II Neoplasms,Carcinoma in situ of breast,BHLHE40,Class E basic helix-loop-helix protein 40,7686,45,1.33 [0.97-1.83],0.0768545788270884
Chapter II Neoplasms,Carcinoma in situ of breast,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,7710,44,0.76 [0.24-2.38],0.6346399186741976
Chapter II Neoplasms,Carcinoma in situ of breast,BID,BH3-interacting domain death agonist,9043,49,1.06 [0.74-1.53],0.7423193760096438
Chapter II Neoplasms,Carcinoma in situ of breast,BIN2,Bridging integrator 2,9075,49,0.84 [0.63-1.12],0.2384430752685308
Chapter II Neoplasms,Carcinoma in situ of breast,BIRC2,Baculoviral IAP repeat-containing protein 2,8869,47,0.77 [0.50-1.19],0.2424840903867552
Chapter II Neoplasms,Carcinoma in situ of breast,BLMH,Bleomycin hydrolase,9177,49,0.86 [0.39-1.89],0.7108488511594807
Chapter II Neoplasms,Carcinoma in situ of breast,BLNK,B-cell linker protein,7735,44,1.44 [0.81-2.56],0.2104966759447461
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,7686,45,0.81 [0.51-1.27],0.3598391340178295
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,7945,46,0.78 [0.37-1.64],0.5127932292638933
Chapter II Neoplasms,Carcinoma in situ of breast,BLVRB,Flavin reductase,9075,49,0.93 [0.64-1.35],0.6927539851648012
Chapter II Neoplasms,Carcinoma in situ of breast,BMP10,Bone morphogenetic protein 10,7807,44,1.59 [0.57-4.48],0.3783376652230134
Chapter II Neoplasms,Carcinoma in situ of breast,BMP4,Bone morphogenetic protein 4,8991,49,1.41 [0.85-2.35],0.1867259526646665
Chapter II Neoplasms,Carcinoma in situ of breast,BMP6,Bone morphogenetic protein 6,8886,49,0.91 [0.51-1.65],0.7626594918390677
Chapter II Neoplasms,Carcinoma in situ of breast,BMPER,BMP-binding endothelial regulator protein,7807,44,1.42 [0.39-5.17],0.5930342172817324
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,7948,45,1.02 [0.43-2.42],0.9699825648071132
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,7735,44,0.95 [0.48-1.88],0.8879987905421344
Chapter II Neoplasms,Carcinoma in situ of breast,BOC,Brother of CDO,8895,49,4.15 [1.47-11.74],0.0072765330476564
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA1,BolA-like protein 1,7686,45,0.64 [0.35-1.18],0.1566373474784965
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA2_BOLA2B,BolA-like protein 2,7776,44,0.80 [0.47-1.35],0.3938048530578677
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFA2,BPI fold-containing family A member 2,7500,40,1.46 [1.13-1.88],0.0038139076884884
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB1,BPI fold-containing family B member 1,9033,49,1.02 [0.68-1.54],0.9161239030364128
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB2,BPI fold-containing family B member 2,7933,45,0.74 [0.48-1.13],0.162241227755419
Chapter II Neoplasms,Carcinoma in situ of breast,BRAP,BRCA1-associated protein,7837,45,0.86 [0.66-1.12],0.2659368170981806
Chapter II Neoplasms,Carcinoma in situ of breast,BRD1,Bromodomain-containing protein 1,7824,45,0.71 [0.25-2.00],0.5112783790063861
Chapter II Neoplasms,Carcinoma in situ of breast,BRD2,Bromodomain-containing protein 2,7686,45,1.44 [0.81-2.56],0.2094793952913579
Chapter II Neoplasms,Carcinoma in situ of breast,BRD3,Bromodomain-containing protein 3,7710,44,1.07 [0.59-1.93],0.831900024309739
Chapter II Neoplasms,Carcinoma in situ of breast,BRDT,Bromodomain testis-specific protein,7710,44,0.90 [0.40-1.98],0.7858993713592144
Chapter II Neoplasms,Carcinoma in situ of breast,BRK1,Protein BRICK1,8849,49,0.77 [0.42-1.39],0.3803311040438233
Chapter II Neoplasms,Carcinoma in situ of breast,BRME1,Break repair meiotic recombinase recruitment factor 1,7686,45,1.23 [0.81-1.87],0.3352173766135294
Chapter II Neoplasms,Carcinoma in situ of breast,BRSK2,Serine/threonine-protein kinase BRSK2,7937,45,0.71 [0.33-1.54],0.3921488504913482
Chapter II Neoplasms,Carcinoma in situ of breast,BSG,Basigin,9147,50,2.64 [0.79-8.78],0.1145232895449639
Chapter II Neoplasms,Carcinoma in situ of breast,BSND,Barttin,7678,44,1.41 [0.68-2.90],0.3532776855466382
Chapter II Neoplasms,Carcinoma in situ of breast,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,9138,49,1.03 [0.60-1.78],0.914780037628248
Chapter II Neoplasms,Carcinoma in situ of breast,BST2,Bone marrow stromal antigen 2,9138,49,0.71 [0.40-1.25],0.2297010984002736
Chapter II Neoplasms,Carcinoma in situ of breast,BTC,Probetacellulin,8869,47,0.89 [0.62-1.29],0.5486193537349094
Chapter II Neoplasms,Carcinoma in situ of breast,BTD,Biotinidase,7968,42,0.68 [0.17-2.73],0.5869310577736562
Chapter II Neoplasms,Carcinoma in situ of breast,BTLA,B- and T-lymphocyte attenuator,7678,44,0.89 [0.59-1.33],0.5581305233686198
Chapter II Neoplasms,Carcinoma in situ of breast,BTN1A1,Butyrophilin subfamily 1 member A1,7909,45,1.13 [0.61-2.11],0.6939147890016282
Chapter II Neoplasms,Carcinoma in situ of breast,BTN2A1,Butyrophilin subfamily 2 member A1,9112,50,2.20 [0.94-5.16],0.0690565001555439
Chapter II Neoplasms,Carcinoma in situ of breast,BTN3A2,Butyrophilin subfamily 3 member A2,9043,49,0.92 [0.47-1.82],0.8138684150699307
Chapter II Neoplasms,Carcinoma in situ of breast,BTNL10,Butyrophilin-like protein 10,7678,44,0.65 [0.27-1.61],0.3537096290177397
Chapter II Neoplasms,Carcinoma in situ of breast,C19orf12,Protein C19orf12,8849,49,0.79 [0.50-1.24],0.3094687203274225
Chapter II Neoplasms,Carcinoma in situ of breast,C1GALT1C1,C1GALT1-specific chaperone 1,7710,44,0.86 [0.34-2.15],0.7427270951268286
Chapter II Neoplasms,Carcinoma in situ of breast,C1QA,Complement C1q subcomponent subunit A,9117,50,1.21 [0.39-3.82],0.7417923203047532
Chapter II Neoplasms,Carcinoma in situ of breast,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",7937,45,1.00 [0.67-1.49],0.9848732247946128
Chapter II Neoplasms,Carcinoma in situ of breast,C1QL2,Complement C1q-like protein 2,7735,44,1.08 [0.57-2.02],0.8208961411537158
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,9120,50,1.22 [0.69-2.15],0.4926983865300158
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,7807,44,0.93 [0.44-1.98],0.8570493534632028
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,7937,45,1.07 [0.44-2.60],0.8842859715709936
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,7790,44,1.05 [0.57-1.93],0.8860454122526886
Chapter II Neoplasms,Carcinoma in situ of breast,C1R,Complement C1r subcomponent,7968,42,0.42 [0.07-2.57],0.3506836165193132
Chapter II Neoplasms,Carcinoma in situ of breast,C1RL,Complement C1r subcomponent-like protein,7956,42,0.39 [0.10-1.49],0.1694493439996898
Chapter II Neoplasms,Carcinoma in situ of breast,C1S,Complement C1s subcomponent,7968,42,0.78 [0.22-2.84],0.7115219199007056
Chapter II Neoplasms,Carcinoma in situ of breast,C2,Complement C2,9101,50,5.01 [1.47-17.11],0.0101448425583746
Chapter II Neoplasms,Carcinoma in situ of breast,C2CD2L,Phospholipid transfer protein C2CD2L,8830,49,1.09 [0.61-1.95],0.7666152716926322
Chapter II Neoplasms,Carcinoma in situ of breast,C2orf69,UPF0565 protein C2orf69,7742,44,0.87 [0.49-1.52],0.6149095299650271
Chapter II Neoplasms,Carcinoma in situ of breast,C3,Complement C3,7563,40,1.44 [0.83-2.48],0.1918556962967597
Chapter II Neoplasms,Carcinoma in situ of breast,C4BPB,C4b-binding protein beta chain,9106,50,0.78 [0.42-1.46],0.4424381583553708
Chapter II Neoplasms,Carcinoma in situ of breast,C5,Complement C5,7968,42,0.48 [0.06-3.72],0.4813410444890224
Chapter II Neoplasms,Carcinoma in situ of breast,C7,Complement component C7,7763,40,1.06 [0.40-2.82],0.9071889728524096
Chapter II Neoplasms,Carcinoma in situ of breast,C7orf50,Uncharacterized protein C7orf50,7945,46,0.67 [0.15-3.08],0.6070384716891035
Chapter II Neoplasms,Carcinoma in situ of breast,C8B,Complement component C8 beta chain,7968,42,0.66 [0.25-1.74],0.4012698861963334
Chapter II Neoplasms,Carcinoma in situ of breast,C9,Complement component C9,7955,44,0.96 [0.54-1.71],0.8902176969742308
Chapter II Neoplasms,Carcinoma in situ of breast,C9orf40,Uncharacterized protein C9orf40,7914,45,0.77 [0.54-1.10],0.1525882193778385
Chapter II Neoplasms,Carcinoma in situ of breast,CA1,Carbonic anhydrase 1,8884,49,1.01 [0.68-1.49],0.9783025412755512
Chapter II Neoplasms,Carcinoma in situ of breast,CA11,Carbonic anhydrase-related protein 11,8869,47,1.13 [0.57-2.25],0.7273141980051854
Chapter II Neoplasms,Carcinoma in situ of breast,CA12,Carbonic anhydrase 12,9033,51,1.58 [0.76-3.25],0.2172338323563971
Chapter II Neoplasms,Carcinoma in situ of breast,CA13,Carbonic anhydrase 13,8989,49,0.88 [0.69-1.12],0.3133694224638083
Chapter II Neoplasms,Carcinoma in situ of breast,CA14,Carbonic anhydrase 14,9145,50,1.78 [0.89-3.56],0.1021666304427557
Chapter II Neoplasms,Carcinoma in situ of breast,CA2,Carbonic anhydrase 2,9041,48,0.84 [0.59-1.21],0.3494327058825212
Chapter II Neoplasms,Carcinoma in situ of breast,CA3,Carbonic anhydrase 3,9163,49,0.93 [0.61-1.41],0.73827886771406
Chapter II Neoplasms,Carcinoma in situ of breast,CA4,Carbonic anhydrase 4,9177,49,1.62 [0.54-4.83],0.3898661900205639
Chapter II Neoplasms,Carcinoma in situ of breast,CA5A,"Carbonic anhydrase 5A, mitochondrial",8895,49,1.02 [0.78-1.34],0.8981607989759244
Chapter II Neoplasms,Carcinoma in situ of breast,CA6,Carbonic anhydrase 6,9042,49,1.23 [0.82-1.85],0.3183256963473505
Chapter II Neoplasms,Carcinoma in situ of breast,CA7,Carbonic anhydrase 7,7824,45,0.86 [0.37-1.99],0.7234561607134746
Chapter II Neoplasms,Carcinoma in situ of breast,CA8,Carbonic anhydrase-related protein,7735,44,1.53 [0.80-2.93],0.20033385423318
Chapter II Neoplasms,Carcinoma in situ of breast,CA9,Carbonic anhydrase 9,9145,50,1.06 [0.63-1.78],0.8345084800742557
Chapter II Neoplasms,Carcinoma in situ of breast,CABP2,Calcium-binding protein 2,7742,44,0.86 [0.53-1.41],0.5572345030750852
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,7686,45,1.02 [0.43-2.42],0.9603667750598776
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,7710,44,0.89 [0.51-1.56],0.6894404953502382
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,7686,45,1.14 [0.73-1.77],0.5648665468124996
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,7937,45,0.87 [0.62-1.23],0.4291756011965509
Chapter II Neoplasms,Carcinoma in situ of breast,CACYBP,Calcyclin-binding protein,7793,44,0.97 [0.73-1.29],0.8362272235010108
Chapter II Neoplasms,Carcinoma in situ of breast,CADPS,Calcium-dependent secretion activator 1,7742,44,0.75 [0.34-1.65],0.4721623701403197
Chapter II Neoplasms,Carcinoma in situ of breast,CALB1,Calbindin,9033,51,0.99 [0.55-1.76],0.9631971373543636
Chapter II Neoplasms,Carcinoma in situ of breast,CALB2,Calretinin,8849,49,0.94 [0.43-2.05],0.8742786803726088
Chapter II Neoplasms,Carcinoma in situ of breast,CALCA,Calcitonin,8986,49,1.19 [0.78-1.81],0.4196891919451168
Chapter II Neoplasms,Carcinoma in situ of breast,CALCB,Calcitonin gene-related peptide 2,7945,46,1.37 [0.80-2.37],0.2517342746862386
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,9113,50,0.82 [0.64-1.05],0.114088526352262
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,7776,44,0.94 [0.64-1.38],0.7401168685723813
Chapter II Neoplasms,Carcinoma in situ of breast,CALY,Neuron-specific vesicular protein calcyon,7710,44,1.02 [0.50-2.09],0.9521895895452938
Chapter II Neoplasms,Carcinoma in situ of breast,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,8869,47,0.76 [0.40-1.46],0.4121516872605814
Chapter II Neoplasms,Carcinoma in situ of breast,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,7742,44,0.47 [0.24-0.93],0.0301544519382448
Chapter II Neoplasms,Carcinoma in situ of breast,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,7937,45,0.91 [0.70-1.20],0.5147200564818175
Chapter II Neoplasms,Carcinoma in situ of breast,CANT1,Soluble calcium-activated nucleotidase 1,9032,49,1.55 [0.44-5.48],0.4948371624634975
Chapter II Neoplasms,Carcinoma in situ of breast,CAPG,Macrophage-capping protein,8999,49,1.12 [0.72-1.73],0.6199856040463709
Chapter II Neoplasms,Carcinoma in situ of breast,CAPN3,Calpain-3,7924,45,0.54 [0.20-1.43],0.2137176732946438
Chapter II Neoplasms,Carcinoma in situ of breast,CAPS,Calcyphosin,7945,46,1.09 [0.85-1.39],0.4874142712498051
Chapter II Neoplasms,Carcinoma in situ of breast,CARHSP1,Calcium-regulated heat-stable protein 1,8849,49,0.83 [0.51-1.36],0.4538786821729573
Chapter II Neoplasms,Carcinoma in situ of breast,CASC3,Protein CASC3,7742,44,0.69 [0.33-1.46],0.3372065950356249
Chapter II Neoplasms,Carcinoma in situ of breast,CASP1,Caspase-1,8849,49,1.11 [0.79-1.58],0.546299753466704
Chapter II Neoplasms,Carcinoma in situ of breast,CASP10,Caspase-10,8849,49,0.92 [0.64-1.31],0.6450026759195344
Chapter II Neoplasms,Carcinoma in situ of breast,CASP2,Caspase-2,9043,49,1.24 [0.89-1.73],0.1998177505484709
Chapter II Neoplasms,Carcinoma in situ of breast,CASP3,Caspase-3,9177,49,0.80 [0.60-1.06],0.1219757267185981
Chapter II Neoplasms,Carcinoma in situ of breast,CASP4,Caspase-4,7824,45,1.09 [0.95-1.26],0.2338309481208784
Chapter II Neoplasms,Carcinoma in situ of breast,CASP7,Caspase-7,7945,46,0.89 [0.63-1.25],0.5025807676325824
Chapter II Neoplasms,Carcinoma in situ of breast,CASP8,Caspase-8,9110,50,1.01 [0.67-1.51],0.9668582552220576
Chapter II Neoplasms,Carcinoma in situ of breast,CASP9,Caspase-9,7735,44,0.67 [0.40-1.10],0.1138965278238796
Chapter II Neoplasms,Carcinoma in situ of breast,CASQ2,Calsequestrin-2,7710,44,1.17 [0.71-1.93],0.530156577599249
Chapter II Neoplasms,Carcinoma in situ of breast,CAT,Catalase,7840,43,0.67 [0.38-1.17],0.1572497990069573
Chapter II Neoplasms,Carcinoma in situ of breast,CBLIF,Cobalamin binding intrinsic factor,9050,49,0.91 [0.67-1.24],0.5414033901241533
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN1,Cerebellin-1,7686,45,0.84 [0.57-1.22],0.3469779475664784
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN4,Cerebellin-4,9145,50,0.91 [0.41-2.00],0.8099360838436495
Chapter II Neoplasms,Carcinoma in situ of breast,CBS,Cystathionine beta-synthase,7776,44,0.87 [0.48-1.59],0.6508240707949456
Chapter II Neoplasms,Carcinoma in situ of breast,CBX2,Chromobox protein homolog 2,7710,44,0.71 [0.30-1.71],0.4483841887667309
Chapter II Neoplasms,Carcinoma in situ of breast,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,9005,49,0.93 [0.65-1.32],0.6783894388776321
Chapter II Neoplasms,Carcinoma in situ of breast,CCAR2,Cell cycle and apoptosis regulator protein 2,7945,46,1.52 [1.15-2.01],0.0032379913835119
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC134,Coiled-coil domain-containing protein 134,7924,45,0.92 [0.50-1.66],0.772194936256487
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC28A,Coiled-coil domain-containing protein 28A,7742,44,0.68 [0.26-1.79],0.4311009651690127
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC50,Coiled-coil domain-containing protein 50,7937,45,1.12 [0.81-1.55],0.5046912543565791
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC80,Coiled-coil domain-containing protein 80,9066,49,1.30 [0.65-2.59],0.4595841928341442
Chapter II Neoplasms,Carcinoma in situ of breast,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,7776,44,0.86 [0.53-1.38],0.5302516796174475
Chapter II Neoplasms,Carcinoma in situ of breast,CCL11,Eotaxin,9160,50,0.70 [0.35-1.39],0.3086089293720283
Chapter II Neoplasms,Carcinoma in situ of breast,CCL13,C-C motif chemokine 13,9141,50,1.00 [0.70-1.44],0.9866787422337951
Chapter II Neoplasms,Carcinoma in situ of breast,CCL14,C-C motif chemokine 14,9064,50,0.82 [0.43-1.58],0.562483320678111
Chapter II Neoplasms,Carcinoma in situ of breast,CCL15,C-C motif chemokine 15,9177,49,0.84 [0.46-1.54],0.5766851196095418
Chapter II Neoplasms,Carcinoma in situ of breast,CCL16,C-C motif chemokine 16,9177,49,1.08 [0.66-1.76],0.7561039002656855
Chapter II Neoplasms,Carcinoma in situ of breast,CCL17,C-C motif chemokine 17,9064,50,1.00 [0.75-1.32],0.9815587453643698
Chapter II Neoplasms,Carcinoma in situ of breast,CCL18,C-C motif chemokine 18,8951,50,0.99 [0.69-1.42],0.9402760382263872
Chapter II Neoplasms,Carcinoma in situ of breast,CCL19,C-C motif chemokine 19,9138,49,0.97 [0.80-1.17],0.7327149002902738
Chapter II Neoplasms,Carcinoma in situ of breast,CCL2,C-C motif chemokine 2,8991,49,0.95 [0.59-1.54],0.8482337626262875
Chapter II Neoplasms,Carcinoma in situ of breast,CCL20,C-C motif chemokine 20,9160,50,0.97 [0.73-1.29],0.8289194748056032
Chapter II Neoplasms,Carcinoma in situ of breast,CCL21,C-C motif chemokine 21,9112,50,1.55 [1.07-2.24],0.0191786474551252
Chapter II Neoplasms,Carcinoma in situ of breast,CCL22,C-C motif chemokine 22,8997,50,1.10 [0.68-1.79],0.6886080490561345
Chapter II Neoplasms,Carcinoma in situ of breast,CCL23,C-C motif chemokine 23,9112,50,0.94 [0.51-1.72],0.8371400126814175
Chapter II Neoplasms,Carcinoma in situ of breast,CCL24,C-C motif chemokine 24,9094,50,1.18 [0.87-1.59],0.2846568729950889
Chapter II Neoplasms,Carcinoma in situ of breast,CCL25,C-C motif chemokine 25,9160,50,0.96 [0.57-1.64],0.8927732290128304
Chapter II Neoplasms,Carcinoma in situ of breast,CCL26,C-C motif chemokine 26,9043,49,1.10 [0.86-1.41],0.4425905324317104
Chapter II Neoplasms,Carcinoma in situ of breast,CCL27,C-C motif chemokine 27,9066,49,1.10 [0.71-1.70],0.6784298494198964
Chapter II Neoplasms,Carcinoma in situ of breast,CCL28,C-C motif chemokine 28,9008,49,0.55 [0.33-0.91],0.0200886783278988
Chapter II Neoplasms,Carcinoma in situ of breast,CCL3,C-C motif chemokine 3,9043,49,1.30 [0.98-1.74],0.0722962571220495
Chapter II Neoplasms,Carcinoma in situ of breast,CCL4,C-C motif chemokine 4,9094,50,1.00 [0.70-1.42],0.9967328621131564
Chapter II Neoplasms,Carcinoma in situ of breast,CCL5,C-C motif chemokine 5,9120,50,0.92 [0.72-1.18],0.511675265115531
Chapter II Neoplasms,Carcinoma in situ of breast,CCL7,C-C motif chemokine 7,9043,49,1.20 [0.82-1.77],0.3547529635918117
Chapter II Neoplasms,Carcinoma in situ of breast,CCL8,C-C motif chemokine 8,9128,50,0.91 [0.61-1.37],0.6589754737954563
Chapter II Neoplasms,Carcinoma in situ of breast,CCN1,CCN family member 1,9012,51,1.14 [0.81-1.59],0.4548323686503535
Chapter II Neoplasms,Carcinoma in situ of breast,CCN2,CCN family member 2,9056,49,0.71 [0.45-1.12],0.1416084693212965
Chapter II Neoplasms,Carcinoma in situ of breast,CCN3,CCN family member 3,9161,49,1.74 [0.91-3.32],0.0956224021743848
Chapter II Neoplasms,Carcinoma in situ of breast,CCN4,CCN family member 4,9145,50,1.02 [0.55-1.87],0.9556307936031744
Chapter II Neoplasms,Carcinoma in situ of breast,CCN5,CCN family member 5,9075,49,1.67 [0.89-3.14],0.1115888548627899
Chapter II Neoplasms,Carcinoma in situ of breast,CCND2,G1/S-specific cyclin-D2,7824,45,1.43 [0.64-3.19],0.3845343825170293
Chapter II Neoplasms,Carcinoma in situ of breast,CCNE1,G1/S-specific cyclin-E1,7735,44,0.79 [0.48-1.28],0.3337949043905285
Chapter II Neoplasms,Carcinoma in situ of breast,CCS,Copper chaperone for superoxide dismutase,9005,49,0.66 [0.38-1.14],0.1368886916561361
Chapter II Neoplasms,Carcinoma in situ of breast,CCT5,T-complex protein 1 subunit epsilon,8869,47,0.66 [0.34-1.26],0.2076800363197947
Chapter II Neoplasms,Carcinoma in situ of breast,CD101,Immunoglobulin superfamily member 2,7914,45,0.76 [0.40-1.46],0.4139882949649076
Chapter II Neoplasms,Carcinoma in situ of breast,CD109,CD109 antigen,9075,49,0.52 [0.24-1.12],0.0972627356688661
Chapter II Neoplasms,Carcinoma in situ of breast,CD14,Monocyte differentiation antigen CD14,8908,49,1.20 [0.65-2.21],0.5560301059661692
Chapter II Neoplasms,Carcinoma in situ of breast,CD160,CD160 antigen,9160,50,0.88 [0.51-1.50],0.6331476737965158
Chapter II Neoplasms,Carcinoma in situ of breast,CD163,Scavenger receptor cysteine-rich type 1 protein M130,9120,50,1.57 [0.90-2.76],0.113816975614774
Chapter II Neoplasms,Carcinoma in situ of breast,CD164,Sialomucin core protein 24,9075,49,1.58 [0.82-3.03],0.1686393050093692
Chapter II Neoplasms,Carcinoma in situ of breast,CD164L2,CD164 sialomucin-like 2 protein,7742,44,1.47 [0.82-2.64],0.1936179582675413
Chapter II Neoplasms,Carcinoma in situ of breast,CD177,CD177 antigen,9066,49,0.93 [0.77-1.11],0.4235001375870554
Chapter II Neoplasms,Carcinoma in situ of breast,CD1C,T-cell surface glycoprotein CD1c,9106,50,1.80 [0.62-5.18],0.2766008690807356
Chapter II Neoplasms,Carcinoma in situ of breast,CD2,T-cell surface antigen CD2,7710,44,0.94 [0.45-1.96],0.8658965776826446
Chapter II Neoplasms,Carcinoma in situ of breast,CD200,OX-2 membrane glycoprotein,9043,49,1.87 [0.70-4.97],0.2113292636859861
Chapter II Neoplasms,Carcinoma in situ of breast,CD200R1,Cell surface glycoprotein CD200 receptor 1,9012,49,0.86 [0.41-1.82],0.6949605640210176
Chapter II Neoplasms,Carcinoma in situ of breast,CD207,C-type lectin domain family 4 member K,8853,50,1.14 [0.59-2.22],0.69636059445556
Chapter II Neoplasms,Carcinoma in situ of breast,CD209,CD209 antigen,9097,49,1.83 [0.98-3.42],0.0568417468097654
Chapter II Neoplasms,Carcinoma in situ of breast,CD22,B-cell receptor CD22,9160,50,1.01 [0.54-1.87],0.9861943510566092
Chapter II Neoplasms,Carcinoma in situ of breast,CD226,CD226 antigen,7735,44,0.50 [0.24-1.04],0.0638444063366585
Chapter II Neoplasms,Carcinoma in situ of breast,CD244,Natural killer cell receptor 2B4,9160,50,0.88 [0.34-2.27],0.7922084438263854
Chapter II Neoplasms,Carcinoma in situ of breast,CD248,Endosialin,7965,46,1.76 [0.88-3.52],0.1118936321516679
Chapter II Neoplasms,Carcinoma in situ of breast,CD27,CD27 antigen,9106,50,1.53 [0.86-2.74],0.1507258051477545
Chapter II Neoplasms,Carcinoma in situ of breast,CD274,Programmed cell death 1 ligand 1,9005,49,1.97 [1.08-3.60],0.0264045783412014
Chapter II Neoplasms,Carcinoma in situ of breast,CD276,CD276 antigen,9065,50,1.76 [0.88-3.53],0.1119155770116555
Chapter II Neoplasms,Carcinoma in situ of breast,CD28,T-cell-specific surface glycoprotein CD28,8869,47,1.36 [0.70-2.65],0.3584129478905317
Chapter II Neoplasms,Carcinoma in situ of breast,CD2AP,CD2-associated protein,9066,49,0.60 [0.39-0.90],0.0145257334287895
Chapter II Neoplasms,Carcinoma in situ of breast,CD300A,CMRF35-like molecule 8,7807,44,0.89 [0.34-2.35],0.8206726284385206
Chapter II Neoplasms,Carcinoma in situ of breast,CD300C,CMRF35-like molecule 6,9138,49,1.07 [0.52-2.20],0.8545749916784722
Chapter II Neoplasms,Carcinoma in situ of breast,CD300E,CMRF35-like molecule 2,9110,50,1.23 [0.67-2.26],0.496249022356709
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LF,CMRF35-like molecule 1,9145,50,1.12 [0.73-1.71],0.6078832927545064
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LG,CMRF35-like molecule 9,9075,49,1.74 [0.89-3.40],0.1047204717902419
Chapter II Neoplasms,Carcinoma in situ of breast,CD302,CD302 antigen,9033,51,1.06 [0.47-2.38],0.8947871907978026
Chapter II Neoplasms,Carcinoma in situ of breast,CD33,Myeloid cell surface antigen CD33,9106,50,0.95 [0.70-1.29],0.756737898625693
Chapter II Neoplasms,Carcinoma in situ of breast,CD34,Hematopoietic progenitor cell antigen CD34,9114,49,0.87 [0.30-2.51],0.7944700150464934
Chapter II Neoplasms,Carcinoma in situ of breast,CD36,Platelet glycoprotein 4,7735,44,0.62 [0.31-1.26],0.1876240764432977
Chapter II Neoplasms,Carcinoma in situ of breast,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,9033,51,0.96 [0.43-2.14],0.91473264998808
Chapter II Neoplasms,Carcinoma in situ of breast,CD3D,T-cell surface glycoprotein CD3 delta chain,7686,45,1.94 [1.11-3.41],0.0206610368022731
Chapter II Neoplasms,Carcinoma in situ of breast,CD3E,T-cell surface glycoprotein CD3 epsilon chain,7824,45,0.97 [0.44-2.13],0.9347912998804566
Chapter II Neoplasms,Carcinoma in situ of breast,CD3G,T-cell surface glycoprotein CD3 gamma chain,7735,44,1.11 [0.84-1.46],0.4689549367246848
Chapter II Neoplasms,Carcinoma in situ of breast,CD4,T-cell surface glycoprotein CD4,9025,49,1.29 [0.61-2.76],0.5051466677595582
Chapter II Neoplasms,Carcinoma in situ of breast,CD40,Tumor necrosis factor receptor superfamily member 5,9076,50,0.97 [0.58-1.62],0.905635423620748
Chapter II Neoplasms,Carcinoma in situ of breast,CD40LG,CD40 ligand,9160,50,0.80 [0.58-1.11],0.1845533533460001
Chapter II Neoplasms,Carcinoma in situ of breast,CD46,Membrane cofactor protein,9038,50,2.13 [0.95-4.77],0.065676145081603
Chapter II Neoplasms,Carcinoma in situ of breast,CD48,CD48 antigen,9094,50,1.17 [0.49-2.75],0.7241204773630538
Chapter II Neoplasms,Carcinoma in situ of breast,CD5,T-cell surface glycoprotein CD5,9128,50,0.93 [0.43-2.02],0.8644495487205184
Chapter II Neoplasms,Carcinoma in situ of breast,CD55,Complement decay-accelerating factor,8769,49,2.40 [1.07-5.41],0.0338377350659165
Chapter II Neoplasms,Carcinoma in situ of breast,CD58,Lymphocyte function-associated antigen 3,9059,50,1.15 [0.28-4.76],0.8426213117228454
Chapter II Neoplasms,Carcinoma in situ of breast,CD59,CD59 glycoprotein,8756,46,1.39 [0.45-4.26],0.5692515923124972
Chapter II Neoplasms,Carcinoma in situ of breast,CD5L,CD5 antigen-like,7918,41,0.85 [0.44-1.64],0.6323667543751088
Chapter II Neoplasms,Carcinoma in situ of breast,CD6,T-cell differentiation antigen CD6,9147,50,1.02 [0.64-1.64],0.9228920389577516
Chapter II Neoplasms,Carcinoma in situ of breast,CD63,CD63 antigen,8991,49,0.83 [0.50-1.36],0.4477151824030227
Chapter II Neoplasms,Carcinoma in situ of breast,CD69,Early activation antigen CD69,9040,49,0.90 [0.67-1.20],0.4652912965648291
Chapter II Neoplasms,Carcinoma in situ of breast,CD7,T-cell antigen CD7,7716,44,2.03 [1.34-3.08],0.000839728675712
Chapter II Neoplasms,Carcinoma in situ of breast,CD70,CD70 antigen,9043,49,1.72 [0.95-3.13],0.072877057812629
Chapter II Neoplasms,Carcinoma in situ of breast,CD72,B-cell differentiation antigen CD72,7807,44,0.97 [0.48-1.95],0.9317081914533542
Chapter II Neoplasms,Carcinoma in situ of breast,CD74,HLA class II histocompatibility antigen gamma chain,9138,49,1.50 [0.75-3.00],0.255295604978655
Chapter II Neoplasms,Carcinoma in situ of breast,CD79B,B-cell antigen receptor complex-associated protein beta chain,9160,50,1.16 [0.66-2.05],0.6050110284445298
Chapter II Neoplasms,Carcinoma in situ of breast,CD80,T-lymphocyte activation antigen CD80,7948,45,1.25 [0.54-2.87],0.5995201143744229
Chapter II Neoplasms,Carcinoma in situ of breast,CD82,CD82 antigen,7824,45,1.41 [0.87-2.28],0.166679598947898
Chapter II Neoplasms,Carcinoma in situ of breast,CD83,CD83 antigen,9043,49,1.07 [0.51-2.28],0.8517630177316238
Chapter II Neoplasms,Carcinoma in situ of breast,CD84,SLAM family member 5,9043,49,0.78 [0.34-1.77],0.5478397133505115
Chapter II Neoplasms,Carcinoma in situ of breast,CD86,T-lymphocyte activation antigen CD86,7914,45,1.42 [0.52-3.86],0.4876427646954702
Chapter II Neoplasms,Carcinoma in situ of breast,CD8A,T-cell surface glycoprotein CD8 alpha chain,9138,49,0.68 [0.41-1.14],0.1460218573813248
Chapter II Neoplasms,Carcinoma in situ of breast,CD93,Complement component C1q receptor,8738,49,1.80 [0.84-3.87],0.1315392082786194
Chapter II Neoplasms,Carcinoma in situ of breast,CD99,CD99 antigen,9075,49,1.74 [0.48-6.33],0.3992081176676846
Chapter II Neoplasms,Carcinoma in situ of breast,CD99L2,CD99 antigen-like protein 2,9075,49,0.79 [0.26-2.36],0.6739869004575938
Chapter II Neoplasms,Carcinoma in situ of breast,CDA,Cytidine deaminase,7928,45,1.31 [0.75-2.28],0.3375395651039344
Chapter II Neoplasms,Carcinoma in situ of breast,CDAN1,Codanin-1,7945,46,0.96 [0.30-3.07],0.9429917337314836
Chapter II Neoplasms,Carcinoma in situ of breast,CDC123,Cell division cycle protein 123 homolog,7678,44,0.81 [0.48-1.37],0.435949642722257
Chapter II Neoplasms,Carcinoma in situ of breast,CDC25A,M-phase inducer phosphatase 1,7678,44,0.34 [0.14-0.81],0.0151715582979061
Chapter II Neoplasms,Carcinoma in situ of breast,CDC26,Anaphase-promoting complex subunit CDC26,7900,45,1.03 [0.68-1.56],0.8828610213012377
Chapter II Neoplasms,Carcinoma in situ of breast,CDC27,Cell division cycle protein 27 homolog,8869,47,0.85 [0.55-1.33],0.4841794480962559
Chapter II Neoplasms,Carcinoma in situ of breast,CDC37,Hsp90 co-chaperone Cdc37,9106,50,0.85 [0.62-1.15],0.2802560370457834
Chapter II Neoplasms,Carcinoma in situ of breast,CDC42BPB,Serine/threonine-protein kinase MRCK beta,7914,45,0.82 [0.61-1.09],0.1728901735713676
Chapter II Neoplasms,Carcinoma in situ of breast,CDCP1,CUB domain-containing protein 1,9005,49,1.08 [0.66-1.76],0.7599743977108403
Chapter II Neoplasms,Carcinoma in situ of breast,CDH1,Cadherin-1,8789,49,1.18 [0.65-2.14],0.5938239690674604
Chapter II Neoplasms,Carcinoma in situ of breast,CDH15,Cadherin-15,9119,49,0.95 [0.56-1.61],0.8520682935975711
Chapter II Neoplasms,Carcinoma in situ of breast,CDH17,Cadherin-17,9066,49,0.84 [0.57-1.24],0.3741480615686821
Chapter II Neoplasms,Carcinoma in situ of breast,CDH2,Cadherin-2,9066,49,0.50 [0.26-0.96],0.0379264316798624
Chapter II Neoplasms,Carcinoma in situ of breast,CDH22,Cadherin-22,7824,45,0.45 [0.14-1.41],0.1693105245031894
Chapter II Neoplasms,Carcinoma in situ of breast,CDH23,Cadherin-23,7945,46,0.92 [0.31-2.76],0.8879594944238431
Chapter II Neoplasms,Carcinoma in situ of breast,CDH3,Cadherin-3,9138,49,1.92 [1.00-3.67],0.0495730216499095
Chapter II Neoplasms,Carcinoma in situ of breast,CDH4,Cadherin-4,7686,45,1.10 [0.62-1.93],0.7528061554212501
Chapter II Neoplasms,Carcinoma in situ of breast,CDH5,Cadherin-5,9177,49,1.03 [0.45-2.36],0.9477253836760712
Chapter II Neoplasms,Carcinoma in situ of breast,CDH6,Cadherin-6,9066,49,1.47 [0.76-2.84],0.2477800436427161
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR1,Cadherin-related family member 1,8849,49,1.43 [0.87-2.34],0.1539803326609559
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR2,Cadherin-related family member 2,9033,51,0.60 [0.43-0.83],0.0020505108855342
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR5,Cadherin-related family member 5,9066,49,0.80 [0.43-1.50],0.4912701609337204
Chapter II Neoplasms,Carcinoma in situ of breast,CDK1,Cyclin-dependent kinase 1,7678,44,0.69 [0.31-1.55],0.3735314071772654
Chapter II Neoplasms,Carcinoma in situ of breast,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,7937,45,0.82 [0.48-1.40],0.4573224514009211
Chapter II Neoplasms,Carcinoma in situ of breast,CDKL5,Cyclin-dependent kinase-like 5,7686,45,1.40 [1.00-1.97],0.0523314049030272
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN1A,Cyclin-dependent kinase inhibitor 1,9033,51,0.92 [0.72-1.16],0.4657563910732828
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,9033,51,0.92 [0.71-1.20],0.5330100353188358
Chapter II Neoplasms,Carcinoma in situ of breast,CDNF,Cerebral dopamine neurotrophic factor,9033,51,0.84 [0.38-1.83],0.6556689664286783
Chapter II Neoplasms,Carcinoma in situ of breast,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,9082,50,1.41 [0.52-3.80],0.4944226274492468
Chapter II Neoplasms,Carcinoma in situ of breast,CDSN,Corneodesmosin,9124,50,1.49 [0.85-2.62],0.1653802360026506
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,9090,50,1.10 [0.36-3.35],0.8700383430791458
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,7914,45,1.42 [0.96-2.10],0.0784587539272393
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,7824,45,0.92 [0.59-1.45],0.726494211453089
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,7914,45,0.96 [0.47-1.94],0.9042682532913888
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,7824,45,0.62 [0.29-1.35],0.2283432616542611
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,9043,49,1.10 [0.83-1.46],0.5095216618739147
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,8869,47,0.57 [0.31-1.05],0.0701637491762771
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,8767,47,0.89 [0.60-1.34],0.5896654545611077
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,7965,46,1.24 [0.59-2.62],0.5674101927221317
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,8895,49,1.06 [0.63-1.78],0.8234941683409022
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPA,CCAAT/enhancer-binding protein alpha,7735,44,1.20 [0.65-2.21],0.5635592314769988
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPB,CCAAT/enhancer-binding protein beta,8895,49,0.92 [0.47-1.81],0.8092068183301804
Chapter II Neoplasms,Carcinoma in situ of breast,CELA2A,Chymotrypsin-like elastase family member 2A,7965,46,0.98 [0.61-1.57],0.9177784619877134
Chapter II Neoplasms,Carcinoma in situ of breast,CELA3A,Chymotrypsin-like elastase family member 3A,9162,49,0.83 [0.53-1.28],0.3893209411766032
Chapter II Neoplasms,Carcinoma in situ of breast,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,7807,44,0.43 [0.15-1.22],0.1120267798165121
Chapter II Neoplasms,Carcinoma in situ of breast,CEMIP2,Cell surface hyaluronidase,7735,44,0.65 [0.22-1.87],0.4216794260025157
Chapter II Neoplasms,Carcinoma in situ of breast,CEND1,Cell cycle exit and neuronal differentiation protein 1,7686,45,0.92 [0.54-1.56],0.752924334258763
Chapter II Neoplasms,Carcinoma in situ of breast,CENPF,Centromere protein F,7824,45,0.56 [0.31-1.01],0.055526919655442
Chapter II Neoplasms,Carcinoma in situ of breast,CENPJ,Centromere protein J,7824,45,1.44 [1.09-1.92],0.011476394848469
Chapter II Neoplasms,Carcinoma in situ of breast,CEP112,Centrosomal protein of 112 kDa,7710,44,1.35 [0.78-2.32],0.2850033381351045
Chapter II Neoplasms,Carcinoma in situ of breast,CEP152,Centrosomal protein of 152 kDa,7678,44,0.97 [0.48-1.98],0.9362508220937428
Chapter II Neoplasms,Carcinoma in situ of breast,CEP164,Centrosomal protein of 164 kDa,8903,49,1.26 [0.95-1.66],0.1036890651062425
Chapter II Neoplasms,Carcinoma in situ of breast,CEP170,Centrosomal protein of 170 kDa,7776,44,0.82 [0.54-1.23],0.3333976955324534
Chapter II Neoplasms,Carcinoma in situ of breast,CEP20,Centrosomal protein 20,8869,47,0.86 [0.60-1.23],0.4114744230910372
Chapter II Neoplasms,Carcinoma in situ of breast,CEP290,Centrosomal protein of 290 kDa,7824,45,0.58 [0.29-1.15],0.1157568570288107
Chapter II Neoplasms,Carcinoma in situ of breast,CEP350,Centrosome-associated protein 350,7678,44,0.48 [0.21-1.13],0.0925102054253539
Chapter II Neoplasms,Carcinoma in situ of breast,CEP43,Centrosomal protein 43,8828,49,0.93 [0.64-1.35],0.6975097022717467
Chapter II Neoplasms,Carcinoma in situ of breast,CEP85,Centrosomal protein of 85 kDa,8869,47,0.77 [0.50-1.18],0.2237083045248051
Chapter II Neoplasms,Carcinoma in situ of breast,CERT,Ceramide transfer protein,8849,49,0.87 [0.57-1.32],0.5110996638528176
Chapter II Neoplasms,Carcinoma in situ of breast,CES1,Liver carboxylesterase 1,9096,49,0.89 [0.65-1.23],0.485742683657288
Chapter II Neoplasms,Carcinoma in situ of breast,CES2,Cocaine esterase,9033,51,1.27 [0.83-1.94],0.2627240106778213
Chapter II Neoplasms,Carcinoma in situ of breast,CES3,Carboxylesterase 3,9033,51,0.96 [0.67-1.38],0.8416797487396952
Chapter II Neoplasms,Carcinoma in situ of breast,CETN2,Centrin-2,8849,49,1.00 [0.68-1.46],0.991112434264634
Chapter II Neoplasms,Carcinoma in situ of breast,CETN3,Centrin-3,7914,45,1.03 [0.70-1.50],0.8823398831314294
Chapter II Neoplasms,Carcinoma in situ of breast,CFB,Complement factor B,7822,41,0.84 [0.33-2.17],0.7253813847845194
Chapter II Neoplasms,Carcinoma in situ of breast,CFC1,Cryptic protein,8869,47,0.90 [0.48-1.69],0.7503531411115075
Chapter II Neoplasms,Carcinoma in situ of breast,CFD,Complement factor D,7968,42,1.26 [0.30-5.32],0.7531161576856289
Chapter II Neoplasms,Carcinoma in situ of breast,CFH,Complement factor H,7489,39,0.57 [0.15-2.17],0.4080067267854436
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR2,Complement factor H-related protein 2,7907,42,0.66 [0.43-1.00],0.0486773588874629
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR4,Complement factor H-related protein 4,7954,42,0.93 [0.63-1.37],0.7042041169175473
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR5,Complement factor H-related protein 5,7837,40,0.79 [0.41-1.54],0.4916185762440043
Chapter II Neoplasms,Carcinoma in situ of breast,CFI,Complement factor I,7968,42,0.53 [0.13-2.26],0.3920963375223161
Chapter II Neoplasms,Carcinoma in situ of breast,CFP,Properdin,7968,42,1.10 [0.29-4.16],0.8902193724741865
Chapter II Neoplasms,Carcinoma in situ of breast,CGA,Glycoprotein hormones alpha chain,9075,49,0.95 [0.63-1.46],0.8277378270353366
Chapter II Neoplasms,Carcinoma in situ of breast,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,7955,44,1.59 [0.75-3.36],0.2257867826032233
Chapter II Neoplasms,Carcinoma in situ of breast,CGN,Cingulin,7742,44,0.82 [0.38-1.78],0.611161891941364
Chapter II Neoplasms,Carcinoma in situ of breast,CGREF1,Cell growth regulator with EF hand domain protein 1,9066,49,1.15 [0.64-2.08],0.6396625881056562
Chapter II Neoplasms,Carcinoma in situ of breast,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,8869,47,1.07 [0.70-1.62],0.7605654086762046
Chapter II Neoplasms,Carcinoma in situ of breast,CHAD,Chondroadherin,7807,44,0.66 [0.40-1.11],0.1171433908938763
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",7945,46,1.22 [0.60-2.48],0.5842061929645942
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD6,MICOS complex subunit MIC25,7924,45,0.73 [0.24-2.25],0.582610484362307
Chapter II Neoplasms,Carcinoma in situ of breast,CHEK2,Serine/threonine-protein kinase Chk2,8895,49,1.57 [0.83-2.97],0.1620656252415477
Chapter II Neoplasms,Carcinoma in situ of breast,CHGA,Chromogranin-A,7965,46,0.79 [0.57-1.11],0.1766419461190803
Chapter II Neoplasms,Carcinoma in situ of breast,CHGB,Secretogranin-1,9104,49,1.24 [0.68-2.27],0.4831957616325203
Chapter II Neoplasms,Carcinoma in situ of breast,CHI3L1,Chitinase-3-like protein 1,8904,49,1.30 [0.96-1.74],0.0869457011902966
Chapter II Neoplasms,Carcinoma in situ of breast,CHIT1,Chitotriosidase-1,9114,48,1.17 [0.93-1.46],0.1846609398945571
Chapter II Neoplasms,Carcinoma in situ of breast,CHL1,Neural cell adhesion molecule L1-like protein,9108,50,1.48 [0.69-3.18],0.315775859584858
Chapter II Neoplasms,Carcinoma in situ of breast,CHM,Rab proteins geranylgeranyltransferase component A 1,7742,44,0.92 [0.57-1.50],0.74746060583085
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP1A,Charged multivesicular body protein 1a,9005,49,0.90 [0.65-1.24],0.5134406568694352
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP6,Charged multivesicular body protein 6,7948,45,0.81 [0.48-1.37],0.4254423097795304
Chapter II Neoplasms,Carcinoma in situ of breast,CHP1,Calcineurin B homologous protein 1,7686,45,0.93 [0.61-1.41],0.7379897656278813
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL1,Chordin-like protein 1,9094,50,1.31 [0.58-2.98],0.5164637916509707
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL2,Chordin-like protein 2,9066,49,1.73 [1.04-2.86],0.0346232845958673
Chapter II Neoplasms,Carcinoma in situ of breast,CHRM1,Muscarinic acetylcholine receptor M1,7742,44,0.63 [0.25-1.61],0.3348614265867131
Chapter II Neoplasms,Carcinoma in situ of breast,CIAPIN1,Anamorsin,9106,50,0.80 [0.54-1.20],0.2793304495698642
Chapter II Neoplasms,Carcinoma in situ of breast,CILP,Cartilage intermediate layer protein 1,7965,46,0.97 [0.58-1.64],0.9192747971829404
Chapter II Neoplasms,Carcinoma in situ of breast,CINP,Cyclin-dependent kinase 2-interacting protein,7824,45,0.85 [0.42-1.71],0.652913282723643
Chapter II Neoplasms,Carcinoma in situ of breast,CIRBP,Cold-inducible RNA-binding protein,7914,45,0.89 [0.65-1.20],0.4407063769200655
Chapter II Neoplasms,Carcinoma in situ of breast,CIT,Citron Rho-interacting kinase,7742,44,0.81 [0.41-1.60],0.5397870319486023
Chapter II Neoplasms,Carcinoma in situ of breast,CKAP4,Cytoskeleton-associated protein 4,9129,50,1.78 [0.83-3.80],0.1362439750313322
Chapter II Neoplasms,Carcinoma in situ of breast,CKB,Creatine kinase B-type,7965,46,0.97 [0.61-1.54],0.9033803349556012
Chapter II Neoplasms,Carcinoma in situ of breast,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",9053,50,0.86 [0.63-1.16],0.3174251165327686
Chapter II Neoplasms,Carcinoma in situ of breast,CLASP1,CLIP-associating protein 1,7678,44,0.77 [0.48-1.23],0.2695296499195398
Chapter II Neoplasms,Carcinoma in situ of breast,CLC,Galectin-10,9049,49,1.04 [0.71-1.53],0.8251622716285782
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC10A,C-type lectin domain family 10 member A,9005,49,1.47 [0.73-2.95],0.2804815527816785
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC11A,C-type lectin domain family 11 member A,9056,49,1.10 [0.65-1.86],0.7161865594876993
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC12A,C-type lectin domain family 12 member A,7735,44,2.45 [0.88-6.83],0.0862453440211432
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC14A,C-type lectin domain family 14 member A,9075,49,1.37 [0.63-2.98],0.4252579015621642
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1A,C-type lectin domain family 1 member A,8895,49,1.75 [0.84-3.62],0.1337682183887499
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1B,C-type lectin domain family 1 member B,9138,49,0.89 [0.68-1.16],0.3755936489266189
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC2L,C-type lectin domain family 2 member L,7742,44,1.04 [0.60-1.82],0.8878585567073899
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC3B,Tetranectin,7772,41,1.82 [0.52-6.43],0.3510739315606105
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4A,C-type lectin domain family 4 member A,9043,49,1.96 [0.90-4.26],0.0884532042811554
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4C,C-type lectin domain family 4 member C,9043,49,1.94 [1.21-3.13],0.0061828700804522
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4D,C-type lectin domain family 4 member D,9043,49,0.88 [0.58-1.33],0.5485305550355202
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4G,C-type lectin domain family 4 member G,9043,49,1.83 [0.85-3.95],0.1213699285108894
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4M,C-type lectin domain family 4 member M,7952,46,1.55 [0.88-2.74],0.1325600933243081
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC5A,C-type lectin domain family 5 member A,9049,49,2.13 [0.98-4.63],0.0575659327731773
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC6A,C-type lectin domain family 6 member A,8869,47,1.32 [0.79-2.23],0.2919926960126869
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC7A,C-type lectin domain family 7 member A,9160,50,1.05 [0.69-1.60],0.8246003900447224
Chapter II Neoplasms,Carcinoma in situ of breast,CLGN,Calmegin,7742,44,1.02 [0.53-1.95],0.9581551363025752
Chapter II Neoplasms,Carcinoma in situ of breast,CLIC5,Chloride intracellular channel protein 5,7742,44,1.13 [0.47-2.76],0.7810356241556169
Chapter II Neoplasms,Carcinoma in situ of breast,CLINT1,Clathrin interactor 1,7678,44,0.99 [0.52-1.88],0.9650670137835832
Chapter II Neoplasms,Carcinoma in situ of breast,CLIP2,CAP-Gly domain-containing linker protein 2,9043,49,0.92 [0.74-1.16],0.483888944468185
Chapter II Neoplasms,Carcinoma in situ of breast,CLMP,CXADR-like membrane protein,9145,50,2.94 [0.89-9.72],0.0767376896214944
Chapter II Neoplasms,Carcinoma in situ of breast,CLNS1A,Methylosome subunit pICln,7742,44,0.88 [0.36-2.17],0.783801913279115
Chapter II Neoplasms,Carcinoma in situ of breast,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",8986,49,0.90 [0.69-1.18],0.4597394569981956
Chapter II Neoplasms,Carcinoma in situ of breast,CLPS,Colipase,9061,48,1.02 [0.71-1.48],0.905052733770884
Chapter II Neoplasms,Carcinoma in situ of breast,CLSPN,Claspin,8830,49,1.72 [1.09-2.71],0.0192782916930828
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN1,Calsyntenin-1,8849,49,1.14 [0.75-1.73],0.5274872717025547
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN2,Calsyntenin-2,9160,50,0.91 [0.47-1.77],0.7722819146393602
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN3,Calsyntenin-3,7945,46,1.80 [0.74-4.40],0.1953478137631253
Chapter II Neoplasms,Carcinoma in situ of breast,CLTA,Clathrin light chain A,8895,49,1.56 [1.05-2.32],0.0285389226738013
Chapter II Neoplasms,Carcinoma in situ of breast,CLU,Clusterin,7968,42,1.03 [0.41-2.58],0.950883858435839
Chapter II Neoplasms,Carcinoma in situ of breast,CLUL1,Clusterin-like protein 1,9051,49,1.35 [0.81-2.26],0.2504500589491744
Chapter II Neoplasms,Carcinoma in situ of breast,CMC1,COX assembly mitochondrial protein homolog,7948,45,0.93 [0.68-1.28],0.661277093755526
Chapter II Neoplasms,Carcinoma in situ of breast,CMIP,C-Maf-inducing protein,7924,45,0.75 [0.53-1.07],0.1151851863943382
Chapter II Neoplasms,Carcinoma in situ of breast,CNDP1,Beta-Ala-His dipeptidase,9120,50,1.53 [0.84-2.78],0.1614005558460264
Chapter II Neoplasms,Carcinoma in situ of breast,CNGB3,Cyclic nucleotide-gated cation channel beta-3,7686,45,1.08 [0.68-1.72],0.7302403045673944
Chapter II Neoplasms,Carcinoma in situ of breast,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",7763,44,0.87 [0.60-1.26],0.4485727979752322
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY2,Protein canopy homolog 2,8895,49,1.20 [0.85-1.71],0.2973914551776209
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY4,Protein canopy homolog 4,9033,51,0.88 [0.63-1.23],0.4447523472955706
Chapter II Neoplasms,Carcinoma in situ of breast,CNST,Consortin,9066,49,0.84 [0.66-1.06],0.150040043033157
Chapter II Neoplasms,Carcinoma in situ of breast,CNTF,Ciliary neurotrophic factor,7686,45,1.33 [0.59-2.98],0.4955972923416669
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN1,Contactin-1,9177,49,1.15 [0.46-2.88],0.7693244394475125
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN2,Contactin-2,9145,50,0.86 [0.49-1.51],0.5996678411448183
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN3,Contactin-3,9075,49,0.56 [0.27-1.15],0.1148317028422758
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN4,Contactin-4,9075,49,1.43 [0.49-4.15],0.507207577840256
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN5,Contactin-5,9085,49,1.03 [0.52-2.04],0.9241450428990972
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP2,Contactin-associated protein-like 2,9043,49,1.40 [0.76-2.61],0.2809561402186968
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP4,Contactin-associated protein-like 4,7742,44,1.06 [0.82-1.37],0.6437413814663138
Chapter II Neoplasms,Carcinoma in situ of breast,COCH,Cochlin,7948,45,0.98 [0.53-1.81],0.9424096949749172
Chapter II Neoplasms,Carcinoma in situ of breast,COL15A1,Collagen alpha-1(XV) chain,7965,46,2.10 [0.76-5.78],0.1506894806579854
Chapter II Neoplasms,Carcinoma in situ of breast,COL18A1,Collagen alpha-1(XVIII) chain,9118,49,1.12 [0.38-3.37],0.8335108685145786
Chapter II Neoplasms,Carcinoma in situ of breast,COL1A1,Collagen alpha-1(I) chain,9177,49,1.20 [0.45-3.18],0.7191650996166703
Chapter II Neoplasms,Carcinoma in situ of breast,COL24A1,Collagen alpha-1(XXIV) chain,7914,45,0.74 [0.46-1.17],0.1950865895875978
Chapter II Neoplasms,Carcinoma in situ of breast,COL28A1,Collagen alpha-1(XXVIII) chain,7742,44,0.98 [0.66-1.45],0.921724954409651
Chapter II Neoplasms,Carcinoma in situ of breast,COL2A1,Collagen alpha-1(II) chain,7776,44,0.84 [0.58-1.21],0.3453371949542962
Chapter II Neoplasms,Carcinoma in situ of breast,COL3A1,Collagen alpha-1(III) chain,7965,46,2.61 [0.77-8.84],0.1219543806216471
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A1,Collagen alpha-1(IV) chain,9066,49,1.24 [0.66-2.31],0.5067281495390192
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A4,Collagen alpha-4(IV) chain,7810,45,0.97 [0.57-1.67],0.915611204822955
Chapter II Neoplasms,Carcinoma in situ of breast,COL5A1,Collagen alpha-1(V) chain,7807,44,0.50 [0.23-1.10],0.0835023638732459
Chapter II Neoplasms,Carcinoma in situ of breast,COL6A3,Collagen alpha-3(VI) chain,9177,49,1.72 [0.88-3.36],0.1127942659117256
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A1,Collagen alpha-1(IX) chain,9043,49,1.00 [0.60-1.64],0.9904835932612348
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A2,Collagen alpha-2(IX) chain,7824,45,1.24 [0.76-2.02],0.3944307460814475
Chapter II Neoplasms,Carcinoma in situ of breast,COLEC12,Collectin-12,9065,50,1.18 [0.44-3.16],0.738215117591426
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD1,COMM domain-containing protein 1,7776,44,1.12 [0.70-1.79],0.6413536795679637
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD9,COMM domain-containing protein 9,7924,45,1.24 [0.65-2.36],0.5156315712694155
Chapter II Neoplasms,Carcinoma in situ of breast,COMP,Cartilage oligomeric matrix protein,8978,50,2.56 [1.21-5.40],0.0139240729294135
Chapter II Neoplasms,Carcinoma in situ of breast,COMT,Catechol O-methyltransferase,8809,49,0.91 [0.67-1.24],0.5540527938371107
Chapter II Neoplasms,Carcinoma in situ of breast,COPB2,Coatomer subunit beta',7710,44,0.72 [0.35-1.47],0.3713811963379518
Chapter II Neoplasms,Carcinoma in situ of breast,COPE,Coatomer subunit epsilon,8849,49,0.68 [0.35-1.32],0.2561058698143332
Chapter II Neoplasms,Carcinoma in situ of breast,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",7776,44,0.91 [0.45-1.84],0.7932170853749764
Chapter II Neoplasms,Carcinoma in situ of breast,CORO1A,Coronin-1A,8876,47,0.96 [0.71-1.29],0.7755254479304727
Chapter II Neoplasms,Carcinoma in situ of breast,CORO6,Coronin-6,7686,45,1.35 [0.67-2.70],0.3997351132429479
Chapter II Neoplasms,Carcinoma in situ of breast,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",9033,51,1.06 [0.75-1.51],0.7243263599268326
Chapter II Neoplasms,Carcinoma in situ of breast,COX6B1,Cytochrome c oxidase subunit 6B1,7948,45,0.62 [0.25-1.55],0.3075684298289018
Chapter II Neoplasms,Carcinoma in situ of breast,CPA1,Carboxypeptidase A1,9177,49,0.68 [0.45-1.02],0.0639068634596369
Chapter II Neoplasms,Carcinoma in situ of breast,CPA2,Carboxypeptidase A2,9105,49,0.72 [0.48-1.08],0.1136772930709224
Chapter II Neoplasms,Carcinoma in situ of breast,CPA4,Carboxypeptidase A4,7657,43,0.73 [0.39-1.38],0.3329541442794663
Chapter II Neoplasms,Carcinoma in situ of breast,CPB1,Carboxypeptidase B,9177,49,0.74 [0.47-1.14],0.1736742228566416
Chapter II Neoplasms,Carcinoma in situ of breast,CPB2,Carboxypeptidase B2,7951,41,0.37 [0.10-1.41],0.1460588001395934
Chapter II Neoplasms,Carcinoma in situ of breast,CPE,Carboxypeptidase E,9071,49,0.81 [0.43-1.55],0.5306073521157152
Chapter II Neoplasms,Carcinoma in situ of breast,CPLX2,Complexin-2,7678,44,1.33 [0.62-2.89],0.4664703288570984
Chapter II Neoplasms,Carcinoma in situ of breast,CPM,Carboxypeptidase M,9090,49,0.69 [0.33-1.45],0.3243749753651012
Chapter II Neoplasms,Carcinoma in situ of breast,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",7735,44,1.41 [0.54-3.70],0.4850737705296214
Chapter II Neoplasms,Carcinoma in situ of breast,CPPED1,Serine/threonine-protein phosphatase CPPED1,9138,49,1.05 [0.72-1.53],0.7910222694696702
Chapter II Neoplasms,Carcinoma in situ of breast,CPQ,Carboxypeptidase Q,7943,46,1.01 [0.46-2.23],0.9811330521537952
Chapter II Neoplasms,Carcinoma in situ of breast,CPTP,Ceramide-1-phosphate transfer protein,7710,44,0.92 [0.42-2.00],0.8276772850708418
Chapter II Neoplasms,Carcinoma in situ of breast,CPVL,Probable serine carboxypeptidase CPVL,9136,50,0.86 [0.47-1.57],0.6202955057620896
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM1,Probable carboxypeptidase X1,9106,50,0.81 [0.56-1.16],0.2481009905699824
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM2,Inactive carboxypeptidase-like protein X2,7948,45,0.67 [0.21-2.11],0.4963766428541839
Chapter II Neoplasms,Carcinoma in situ of breast,CR1,Complement receptor type 1,7925,44,1.61 [0.72-3.62],0.2495557591062484
Chapter II Neoplasms,Carcinoma in situ of breast,CR2,Complement receptor type 2,9120,50,1.32 [0.77-2.26],0.3142937447438342
Chapter II Neoplasms,Carcinoma in situ of breast,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,8869,47,0.78 [0.56-1.08],0.1365160473823877
Chapter II Neoplasms,Carcinoma in situ of breast,CRADD,Death domain-containing protein CRADD,8986,49,0.88 [0.63-1.24],0.4710487389092571
Chapter II Neoplasms,Carcinoma in situ of breast,CREB3,Cyclic AMP-responsive element-binding protein 3,7678,44,1.26 [0.81-1.95],0.3042741590391
Chapter II Neoplasms,Carcinoma in situ of breast,CREBZF,CREB/ATF bZIP transcription factor,7678,44,0.95 [0.29-3.05],0.9272528769603648
Chapter II Neoplasms,Carcinoma in situ of breast,CREG1,Protein CREG1,8964,49,1.15 [0.57-2.30],0.6954727747776188
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD1,Protein disulfide isomerase CRELD1,7807,44,1.15 [0.53-2.49],0.71901749992413
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD2,Protein disulfide isomerase CRELD2,9094,50,0.96 [0.59-1.57],0.8753583268476773
Chapter II Neoplasms,Carcinoma in situ of breast,CRH,Corticoliberin,8852,47,1.24 [0.92-1.68],0.1537634281680657
Chapter II Neoplasms,Carcinoma in situ of breast,CRHBP,Corticotropin-releasing factor-binding protein,9065,50,0.88 [0.35-2.18],0.779506794626435
Chapter II Neoplasms,Carcinoma in situ of breast,CRHR1,Corticotropin-releasing factor receptor 1,8895,49,1.08 [0.74-1.58],0.6912968718000624
Chapter II Neoplasms,Carcinoma in situ of breast,CRIM1,Cysteine-rich motor neuron 1 protein,9112,50,1.98 [0.59-6.73],0.2713757799141321
Chapter II Neoplasms,Carcinoma in situ of breast,CRIP2,Cysteine-rich protein 2,9005,49,1.00 [0.49-2.01],0.991087787399466
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP2,Cysteine-rich secretory protein 2,9145,50,0.99 [0.67-1.46],0.9539349059719352
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP3,Cysteine-rich secretory protein 3,7891,44,1.31 [0.45-3.75],0.6213625454988063
Chapter II Neoplasms,Carcinoma in situ of breast,CRKL,Crk-like protein,9088,50,0.85 [0.67-1.07],0.1744205703679368
Chapter II Neoplasms,Carcinoma in situ of breast,CRLF1,Cytokine receptor-like factor 1,9112,50,2.12 [0.74-6.03],0.1596564816892723
Chapter II Neoplasms,Carcinoma in situ of breast,CRNN,Cornulin,8844,48,1.06 [0.72-1.54],0.778441483291289
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAC1,Cartilage acidic protein 1,9177,49,1.75 [0.71-4.29],0.2247998394510268
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAM,Cytotoxic and regulatory T-cell molecule,9005,49,0.86 [0.52-1.42],0.5585238617154247
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAP,Cartilage-associated protein,7742,44,0.85 [0.44-1.66],0.6405740160994007
Chapter II Neoplasms,Carcinoma in situ of breast,CRX,Cone-rod homeobox protein,8895,49,1.08 [0.88-1.32],0.4841346085893327
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB1,Beta-crystallin B1,7948,45,0.87 [0.55-1.37],0.5424468609864694
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB2,Beta-crystallin B2,7945,46,1.14 [0.85-1.53],0.382534699809277
Chapter II Neoplasms,Carcinoma in situ of breast,CRYGD,Gamma-crystallin D,7945,46,1.01 [0.75-1.36],0.9457853550915606
Chapter II Neoplasms,Carcinoma in situ of breast,CRYM,Ketimine reductase mu-crystallin,7686,45,1.37 [1.04-1.80],0.0233007996914225
Chapter II Neoplasms,Carcinoma in situ of breast,CRYZL1,Quinone oxidoreductase-like protein 1,7776,44,0.91 [0.66-1.26],0.5691888754737982
Chapter II Neoplasms,Carcinoma in situ of breast,CSDE1,Cold shock domain-containing protein E1,7710,44,0.93 [0.71-1.21],0.5993615909629246
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1,Macrophage colony-stimulating factor 1,9112,50,1.96 [0.83-4.63],0.1244913642499243
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1R,Macrophage colony-stimulating factor 1 receptor,7955,44,1.50 [0.76-2.98],0.243545238949645
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2,Granulocyte-macrophage colony-stimulating factor,7710,44,2.07 [1.00-4.28],0.0490518041557297
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,9005,49,1.05 [0.70-1.59],0.799070488944379
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RB,Cytokine receptor common subunit beta,7735,44,1.45 [0.73-2.88],0.2933295407139988
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3,Granulocyte colony-stimulating factor,8903,49,1.08 [0.64-1.83],0.7623985040794752
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3R,Granulocyte colony-stimulating factor receptor,7735,44,1.10 [0.43-2.83],0.8464797305820344
Chapter II Neoplasms,Carcinoma in situ of breast,CSH1,Chorionic somatomammotropin hormone 1,7955,44,1.05 [0.38-2.87],0.9316745313048092
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK1D,Casein kinase I isoform delta,7735,44,0.65 [0.38-1.10],0.1100237779207018
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK2A1,Casein kinase II subunit alpha,7937,45,0.62 [0.32-1.18],0.1423308476593361
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG4,Chondroitin sulfate proteoglycan 4,7965,46,1.62 [0.68-3.87],0.2765386595529747
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG5,Chondroitin sulfate proteoglycan 5,7686,45,1.45 [0.92-2.26],0.1073821122919737
Chapter II Neoplasms,Carcinoma in situ of breast,CSRP3,Cysteine and glycine-rich protein 3,7710,44,1.01 [0.75-1.37],0.9463283935329244
Chapter II Neoplasms,Carcinoma in situ of breast,CST1,Cystatin-SN,6931,37,1.15 [0.85-1.57],0.3583499967438531
Chapter II Neoplasms,Carcinoma in situ of breast,CST3,Cystatin-C,9106,50,2.74 [1.24-6.08],0.0129865602332696
Chapter II Neoplasms,Carcinoma in situ of breast,CST5,Cystatin-D,8912,49,2.03 [1.34-3.06],0.0007644687947458
Chapter II Neoplasms,Carcinoma in situ of breast,CST6,Cystatin-M,8835,44,1.33 [0.76-2.31],0.3224634696868036
Chapter II Neoplasms,Carcinoma in situ of breast,CST7,Cystatin-F,9094,50,0.81 [0.58-1.13],0.2091318573917553
Chapter II Neoplasms,Carcinoma in situ of breast,CSTB,Cystatin-B,8955,47,0.82 [0.43-1.57],0.5568365469942624
Chapter II Neoplasms,Carcinoma in situ of breast,CTAG1A_CTAG1B,Cancer/testis antigen 1,7807,45,0.94 [0.53-1.66],0.8245321483484955
Chapter II Neoplasms,Carcinoma in situ of breast,CTBS,Di-N-acetylchitobiase,7831,43,0.58 [0.24-1.36],0.2095072206648749
Chapter II Neoplasms,Carcinoma in situ of breast,CTF1,Cardiotrophin-1,8895,49,0.88 [0.64-1.20],0.4065364621765195
Chapter II Neoplasms,Carcinoma in situ of breast,CTHRC1,Collagen triple helix repeat-containing protein 1,7965,46,1.84 [0.76-4.45],0.1757702655370061
Chapter II Neoplasms,Carcinoma in situ of breast,CTLA4,Cytotoxic T-lymphocyte protein 4,7965,46,0.72 [0.27-1.93],0.5199551404188062
Chapter II Neoplasms,Carcinoma in situ of breast,CTNNA1,Catenin alpha-1,7686,45,1.40 [0.81-2.41],0.223648621548967
Chapter II Neoplasms,Carcinoma in situ of breast,CTRB1,Chymotrypsinogen B,9075,49,0.88 [0.56-1.40],0.5912649271229484
Chapter II Neoplasms,Carcinoma in situ of breast,CTRC,Chymotrypsin-C,9074,50,0.74 [0.51-1.08],0.1178994630958951
Chapter II Neoplasms,Carcinoma in situ of breast,CTRL,Chymotrypsin-like protease CTRL-1,7945,46,0.86 [0.56-1.31],0.4785508609181153
Chapter II Neoplasms,Carcinoma in situ of breast,CTSB,Cathepsin B,9095,49,1.39 [0.90-2.17],0.1403842596469018
Chapter II Neoplasms,Carcinoma in situ of breast,CTSC,Dipeptidyl peptidase 1,9056,49,0.89 [0.49-1.62],0.7120538649142713
Chapter II Neoplasms,Carcinoma in situ of breast,CTSD,Cathepsin D,8509,48,0.92 [0.48-1.76],0.7925165266203494
Chapter II Neoplasms,Carcinoma in situ of breast,CTSE,Cathepsin E,7807,44,0.86 [0.49-1.53],0.6106135080604096
Chapter II Neoplasms,Carcinoma in situ of breast,CTSF,Cathepsin F,9106,50,1.25 [0.67-2.35],0.4832699069181173
Chapter II Neoplasms,Carcinoma in situ of breast,CTSH,Pro-cathepsin H,8872,49,1.17 [0.83-1.66],0.3619074784464856
Chapter II Neoplasms,Carcinoma in situ of breast,CTSL,Cathepsin L1,9066,49,0.76 [0.26-2.24],0.615426483118433
Chapter II Neoplasms,Carcinoma in situ of breast,CTSO,Cathepsin O,9160,50,1.18 [0.52-2.66],0.6990426687655509
Chapter II Neoplasms,Carcinoma in situ of breast,CTSS,Cathepsin S,7059,42,1.51 [0.43-5.23],0.5190605692752759
Chapter II Neoplasms,Carcinoma in situ of breast,CTSV,Cathepsin L2,9119,49,0.86 [0.47-1.59],0.6364156045203031
Chapter II Neoplasms,Carcinoma in situ of breast,CTSZ,Cathepsin Z,9099,50,1.63 [0.75-3.51],0.2141905760650435
Chapter II Neoplasms,Carcinoma in situ of breast,CUZD1,CUB and zona pellucida-like domain-containing protein 1,7742,44,0.39 [0.14-1.12],0.0808681213333459
Chapter II Neoplasms,Carcinoma in situ of breast,CWC15,Spliceosome-associated protein CWC15 homolog,7860,45,0.90 [0.54-1.51],0.698270453825756
Chapter II Neoplasms,Carcinoma in situ of breast,CX3CL1,Fractalkine,9005,49,2.47 [1.26-4.86],0.0087154457177537
Chapter II Neoplasms,Carcinoma in situ of breast,CXADR,Coxsackievirus and adenovirus receptor,9043,49,0.87 [0.53-1.45],0.6017328182702171
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL1,Growth-regulated alpha protein,9069,50,0.92 [0.71-1.20],0.5551087429200807
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL10,C-X-C motif chemokine 10,9112,50,1.09 [0.77-1.55],0.634811561500974
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL11,C-X-C motif chemokine 11,9138,49,0.73 [0.52-1.04],0.0850464753124417
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL12,Stromal cell-derived factor 1,8903,49,0.84 [0.44-1.60],0.5902603035276477
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL13,C-X-C motif chemokine 13,9138,49,0.99 [0.66-1.49],0.974790195641518
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL14,C-X-C motif chemokine 14,8903,49,1.00 [0.67-1.49],0.99577547807912
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL16,C-X-C motif chemokine 16,9168,49,2.85 [1.02-7.94],0.0452536600943044
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL17,C-X-C motif chemokine 17,9160,50,0.89 [0.47-1.69],0.7231411331070484
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL3,C-X-C motif chemokine 3,9076,50,1.09 [0.83-1.43],0.549547210534131
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL5,C-X-C motif chemokine 5,9040,48,1.04 [0.83-1.30],0.7308584146263706
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL6,C-X-C motif chemokine 6,9160,50,1.04 [0.76-1.44],0.7911750255039741
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL8,Interleukin-8,9003,48,1.07 [0.75-1.51],0.7129898418913909
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL9,C-X-C motif chemokine 9,9112,50,1.00 [0.69-1.45],0.9821018495049292
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5A,Cytochrome b5,7678,44,1.16 [0.84-1.60],0.354635518621777
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5R2,NADH-cytochrome b5 reductase 2,7821,45,1.03 [0.62-1.71],0.8976977129081105
Chapter II Neoplasms,Carcinoma in situ of breast,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",7710,44,1.11 [0.82-1.49],0.5082739291929275
Chapter II Neoplasms,Carcinoma in situ of breast,CYTH3,Cytohesin-3,7678,44,0.68 [0.42-1.12],0.1278005834787036
Chapter II Neoplasms,Carcinoma in situ of breast,CYTL1,Cytokine-like protein 1,7965,46,2.43 [0.79-7.46],0.1209988840231731
Chapter II Neoplasms,Carcinoma in situ of breast,DAAM1,Disheveled-associated activator of morphogenesis 1,7807,44,0.77 [0.54-1.10],0.1566734361962416
Chapter II Neoplasms,Carcinoma in situ of breast,DAB2,Disabled homolog 2,9145,50,0.94 [0.75-1.17],0.5615769346848603
Chapter II Neoplasms,Carcinoma in situ of breast,DAG1,Dystroglycan,9112,50,0.78 [0.45-1.36],0.3872255017740859
Chapter II Neoplasms,Carcinoma in situ of breast,DAND5,DAN domain family member 5,7735,44,0.77 [0.45-1.33],0.3507507349724749
Chapter II Neoplasms,Carcinoma in situ of breast,DAPK2,Death-associated protein kinase 2,7735,44,1.62 [1.14-2.29],0.0067573839191878
Chapter II Neoplasms,Carcinoma in situ of breast,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,9043,49,0.98 [0.79-1.21],0.8700001015858243
Chapter II Neoplasms,Carcinoma in situ of breast,DARS1,"Aspartate--tRNA ligase, cytoplasmic",8986,49,0.94 [0.67-1.34],0.7459588235836327
Chapter II Neoplasms,Carcinoma in situ of breast,DBH,Dopamine beta-hydroxylase,7935,44,1.04 [0.78-1.38],0.7940368483027109
Chapter II Neoplasms,Carcinoma in situ of breast,DBI,Acyl-CoA-binding protein,9038,49,0.95 [0.68-1.33],0.7764608522502228
Chapter II Neoplasms,Carcinoma in situ of breast,DBN1,Drebrin,7735,44,0.64 [0.34-1.21],0.17182327170792
Chapter II Neoplasms,Carcinoma in situ of breast,DBNL,Drebrin-like protein,9112,50,0.86 [0.66-1.13],0.284433935145159
Chapter II Neoplasms,Carcinoma in situ of breast,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",9106,50,1.06 [0.52-2.17],0.8723674800185367
Chapter II Neoplasms,Carcinoma in situ of breast,DCC,Netrin receptor DCC,7742,44,0.60 [0.22-1.58],0.298383894396897
Chapter II Neoplasms,Carcinoma in situ of breast,DCDC2C,Doublecortin domain-containing protein 2C,7678,44,1.09 [0.72-1.64],0.6838737781410287
Chapter II Neoplasms,Carcinoma in situ of breast,DCLRE1C,Protein artemis,7678,44,0.60 [0.22-1.62],0.3136145554187138
Chapter II Neoplasms,Carcinoma in situ of breast,DCN,Decorin,8895,49,2.94 [1.06-8.16],0.0383461090774774
Chapter II Neoplasms,Carcinoma in situ of breast,DCTD,Deoxycytidylate deaminase,7807,44,0.91 [0.67-1.24],0.5444989175201866
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN1,Dynactin subunit 1,9145,50,0.70 [0.47-1.03],0.0673710383291582
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN2,Dynactin subunit 2,9033,51,1.00 [0.76-1.30],0.9793408181332424
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN6,Dynactin subunit 6,8849,49,1.00 [0.70-1.43],0.989154420831118
Chapter II Neoplasms,Carcinoma in situ of breast,DCTPP1,dCTP pyrophosphatase 1,9066,49,1.63 [0.73-3.66],0.235861816584223
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D1,DCN1-like protein 1,7686,45,1.23 [0.91-1.66],0.1829350116898715
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D2,DCN1-like protein 2,7678,44,1.01 [0.72-1.41],0.960260516346025
Chapter II Neoplasms,Carcinoma in situ of breast,DCXR,L-xylulose reductase,9106,50,0.67 [0.41-1.11],0.1193719047598771
Chapter II Neoplasms,Carcinoma in situ of breast,DDA1,DET1- and DDB1-associated protein 1,7710,44,1.26 [0.69-2.28],0.4536440566773515
Chapter II Neoplasms,Carcinoma in situ of breast,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",9033,51,0.85 [0.48-1.52],0.5886687908077917
Chapter II Neoplasms,Carcinoma in situ of breast,DDC,Aromatic-L-amino-acid decarboxylase,9050,49,0.91 [0.53-1.54],0.7119192963896925
Chapter II Neoplasms,Carcinoma in situ of breast,DDHD2,Phospholipase DDHD2,7937,45,0.78 [0.50-1.21],0.2712042238401053
Chapter II Neoplasms,Carcinoma in situ of breast,DDI2,Protein DDI1 homolog 2,7807,44,0.85 [0.59-1.22],0.3769539353436072
Chapter II Neoplasms,Carcinoma in situ of breast,DDR1,Epithelial discoidin domain-containing receptor 1,9138,49,1.63 [0.55-4.80],0.3794687473113561
Chapter II Neoplasms,Carcinoma in situ of breast,DDT,D-dopachrome decarboxylase,7965,46,0.52 [0.25-1.11],0.0924675346983772
Chapter II Neoplasms,Carcinoma in situ of breast,DDX1,ATP-dependent RNA helicase DDX1,7914,45,1.21 [0.73-1.98],0.4568202672807058
Chapter II Neoplasms,Carcinoma in situ of breast,DDX25,ATP-dependent RNA helicase DDX25,7742,44,1.72 [1.02-2.90],0.0425644279987724
Chapter II Neoplasms,Carcinoma in situ of breast,DDX39A,ATP-dependent RNA helicase DDX39A,7735,44,1.92 [0.63-5.87],0.2502745692891389
Chapter II Neoplasms,Carcinoma in situ of breast,DDX4,Probable ATP-dependent RNA helicase DDX4,7735,44,1.32 [0.87-1.99],0.187529792429499
Chapter II Neoplasms,Carcinoma in situ of breast,DDX53,Probable ATP-dependent RNA helicase DDX53,7742,44,1.05 [0.47-2.35],0.9108118047964088
Chapter II Neoplasms,Carcinoma in situ of breast,DDX58,Antiviral innate immune response receptor RIG-I,8869,47,0.70 [0.41-1.20],0.1987135988815667
Chapter II Neoplasms,Carcinoma in situ of breast,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",9043,49,1.00 [0.77-1.30],0.9961517444378843
Chapter II Neoplasms,Carcinoma in situ of breast,DEFA1_DEFA1B,Neutrophil defensin 1,8906,49,1.38 [0.93-2.04],0.1095389994291401
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB103A_DEFB103B,Beta-defensin 103,7668,44,0.76 [0.33-1.75],0.515254641187483
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB104A_DEFB104B,Beta-defensin 104,7686,45,1.58 [1.11-2.26],0.0120124979654803
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB116,Beta-defensin 116,7686,45,1.32 [1.03-1.70],0.0311453016603931
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB118,Beta-defensin 118,7686,45,0.93 [0.55-1.60],0.8022243113987284
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB4A_DEFB4B,Beta-defensin 4A,8959,51,1.05 [0.89-1.23],0.6013707735355277
Chapter II Neoplasms,Carcinoma in situ of breast,DENND2B,DENN domain-containing protein 2B,7710,44,0.73 [0.35-1.52],0.404541814071198
Chapter II Neoplasms,Carcinoma in situ of breast,DENR,Density-regulated protein,7735,44,0.58 [0.32-1.05],0.0726749015769017
Chapter II Neoplasms,Carcinoma in situ of breast,DFFA,DNA fragmentation factor subunit alpha,9160,50,0.85 [0.58-1.25],0.4191594687349209
Chapter II Neoplasms,Carcinoma in situ of breast,DGCR6,Protein DGCR6,7686,45,0.90 [0.45-1.82],0.7760282185614966
Chapter II Neoplasms,Carcinoma in situ of breast,DGKA,Diacylglycerol kinase alpha,7735,44,0.79 [0.45-1.38],0.4046784262493842
Chapter II Neoplasms,Carcinoma in situ of breast,DGKZ,Diacylglycerol kinase zeta,8903,49,1.08 [0.53-2.23],0.8268148870591374
Chapter II Neoplasms,Carcinoma in situ of breast,DHODH,Dihydroorotate dehydrogenase,7710,44,1.11 [0.65-1.90],0.7001474467815758
Chapter II Neoplasms,Carcinoma in situ of breast,DHPS,Deoxyhypusine synthase,7924,45,1.44 [0.91-2.29],0.1173739652566923
Chapter II Neoplasms,Carcinoma in situ of breast,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,7945,46,1.23 [0.69-2.20],0.4811779869393457
Chapter II Neoplasms,Carcinoma in situ of breast,DIABLO,"Diablo homolog, mitochondrial",9049,49,0.88 [0.70-1.11],0.2973140062907787
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK1C,Divergent protein kinase domain 1C,7742,44,0.54 [0.23-1.23],0.1409668249496297
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK2B,Divergent protein kinase domain 2B,7807,44,1.06 [0.36-3.16],0.9135900854583804
Chapter II Neoplasms,Carcinoma in situ of breast,DKK1,Dickkopf-related protein 1,9138,49,0.73 [0.48-1.12],0.1521943196517132
Chapter II Neoplasms,Carcinoma in situ of breast,DKK3,Dickkopf-related protein 3,9177,49,1.74 [0.76-3.97],0.1919281873804606
Chapter II Neoplasms,Carcinoma in situ of breast,DKK4,Dickkopf-related protein 4,8997,49,1.01 [0.57-1.77],0.9838356323971124
Chapter II Neoplasms,Carcinoma in situ of breast,DKKL1,Dickkopf-like protein 1,9033,51,1.33 [0.96-1.85],0.0820240517305719
Chapter II Neoplasms,Carcinoma in situ of breast,DLG4,Disks large homolog 4,7945,46,0.85 [0.56-1.29],0.4379030502648351
Chapter II Neoplasms,Carcinoma in situ of breast,DLGAP5,Disks large-associated protein 5,7937,45,0.77 [0.38-1.56],0.4719575931415924
Chapter II Neoplasms,Carcinoma in situ of breast,DLK1,Protein delta homolog 1,9177,49,0.92 [0.57-1.47],0.7169624570666567
Chapter II Neoplasms,Carcinoma in situ of breast,DLL1,Delta-like protein 1,9106,50,1.97 [0.89-4.35],0.0929896731367397
Chapter II Neoplasms,Carcinoma in situ of breast,DLL4,Delta-like protein 4,7776,44,0.93 [0.62-1.40],0.7269142070087876
Chapter II Neoplasms,Carcinoma in situ of breast,DMD,Dystrophin,7776,44,0.76 [0.40-1.46],0.4072066567621168
Chapter II Neoplasms,Carcinoma in situ of breast,DMP1,Dentin matrix acidic phosphoprotein 1,7776,44,0.74 [0.52-1.07],0.1143664618373713
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA1,DnaJ homolog subfamily A member 1,7678,44,0.67 [0.32-1.42],0.2990716516699691
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA2,DnaJ homolog subfamily A member 2,9142,50,0.86 [0.63-1.16],0.3236157264133678
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA4,DnaJ homolog subfamily A member 4,7945,46,0.90 [0.61-1.34],0.6105293390365533
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB1,DnaJ homolog subfamily B member 1,9033,51,0.87 [0.65-1.15],0.3273053279191337
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB14,DnaJ homolog subfamily B member 14,7914,45,0.84 [0.52-1.34],0.4661095703133081
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB2,DnaJ homolog subfamily B member 2,7807,44,0.70 [0.40-1.23],0.2118268288108109
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB6,DnaJ homolog subfamily B member 6,7733,44,1.01 [0.71-1.42],0.9758665462716968
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB8,DnaJ homolog subfamily B member 8,8895,49,1.33 [0.98-1.81],0.0690473094544512
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC21,DnaJ homolog subfamily C member 21,7945,46,0.91 [0.42-1.95],0.8058773982265411
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC6,Putative tyrosine-protein phosphatase auxilin,7776,44,0.79 [0.55-1.13],0.190515694757612
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC9,DnaJ homolog subfamily C member 9,7914,45,0.79 [0.54-1.16],0.2281314826123299
Chapter II Neoplasms,Carcinoma in situ of breast,DNER,Delta and Notch-like epidermal growth factor-related receptor,9054,50,1.16 [0.42-3.26],0.7721379987163657
Chapter II Neoplasms,Carcinoma in situ of breast,DNLZ,DNL-type zinc finger protein,7686,45,1.02 [0.76-1.36],0.886055071141626
Chapter II Neoplasms,Carcinoma in situ of breast,DNM1,Dynamin-1,7914,45,0.96 [0.75-1.24],0.758970445473383
Chapter II Neoplasms,Carcinoma in situ of breast,DNM3,Dynamin-3,7937,45,0.75 [0.42-1.33],0.3221520421781276
Chapter II Neoplasms,Carcinoma in situ of breast,DNMBP,Dynamin-binding protein,9005,49,0.92 [0.60-1.41],0.7026747598463731
Chapter II Neoplasms,Carcinoma in situ of breast,DNPEP,Aspartyl aminopeptidase,7945,46,1.03 [0.63-1.69],0.9101865063382704
Chapter II Neoplasms,Carcinoma in situ of breast,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,9106,50,0.79 [0.49-1.28],0.3371515276985732
Chapter II Neoplasms,Carcinoma in situ of breast,DOC2B,Double C2-like domain-containing protein beta,7742,44,0.99 [0.44-2.23],0.981426343530964
Chapter II Neoplasms,Carcinoma in situ of breast,DOCK9,Dedicator of cytokinesis protein 9,7686,45,1.06 [0.86-1.32],0.5643984585467866
Chapter II Neoplasms,Carcinoma in situ of breast,DOK1,Docking protein 1,7945,46,0.90 [0.73-1.11],0.314267750688037
Chapter II Neoplasms,Carcinoma in situ of breast,DOK2,Docking protein 2,9066,49,0.90 [0.73-1.11],0.3285155277985787
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP1,Dipeptidase 1,8986,49,1.17 [0.71-1.93],0.5346876447112716
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP2,Dipeptidase 2,9033,51,0.47 [0.19-1.16],0.102709587242091
Chapter II Neoplasms,Carcinoma in situ of breast,DPP10,Inactive dipeptidyl peptidase 10,9043,49,1.42 [0.72-2.77],0.3093340173967366
Chapter II Neoplasms,Carcinoma in situ of breast,DPP4,Dipeptidyl peptidase 4,8932,49,1.36 [0.54-3.44],0.5174737457179582
Chapter II Neoplasms,Carcinoma in situ of breast,DPP6,Dipeptidyl aminopeptidase-like protein 6,9033,51,1.12 [0.53-2.38],0.7632678823141512
Chapter II Neoplasms,Carcinoma in situ of breast,DPP7,Dipeptidyl peptidase 2,8993,49,1.05 [0.68-1.61],0.8389959805388967
Chapter II Neoplasms,Carcinoma in situ of breast,DPT,Dermatopontin,9177,49,0.93 [0.35-2.51],0.8916417183874997
Chapter II Neoplasms,Carcinoma in situ of breast,DPY30,Protein dpy-30 homolog,9112,50,1.07 [0.71-1.62],0.7449860788745293
Chapter II Neoplasms,Carcinoma in situ of breast,DRAXIN,Draxin,9005,49,1.09 [0.61-1.94],0.7665486429528141
Chapter II Neoplasms,Carcinoma in situ of breast,DRG2,Developmentally-regulated GTP-binding protein 2,9033,51,0.90 [0.57-1.42],0.6527333214543201
Chapter II Neoplasms,Carcinoma in situ of breast,DSC2,Desmocollin-2,8979,48,1.72 [0.86-3.44],0.1219038384723413
Chapter II Neoplasms,Carcinoma in situ of breast,DSCAM,Down syndrome cell adhesion molecule,7937,45,1.20 [0.54-2.70],0.6556082334980102
Chapter II Neoplasms,Carcinoma in situ of breast,DSG2,Desmoglein-2,9075,49,1.38 [0.55-3.48],0.4925101689868623
Chapter II Neoplasms,Carcinoma in situ of breast,DSG3,Desmoglein-3,9116,50,1.72 [0.82-3.61],0.1540233605439129
Chapter II Neoplasms,Carcinoma in situ of breast,DSG4,Desmoglein-4,9007,51,0.73 [0.46-1.17],0.1955495047869541
Chapter II Neoplasms,Carcinoma in situ of breast,DTD1,D-aminoacyl-tRNA deacylase 1,7807,44,0.94 [0.67-1.33],0.7355711919134953
Chapter II Neoplasms,Carcinoma in situ of breast,DTNB,Dystrobrevin beta,7910,45,0.77 [0.37-1.62],0.4949183177748378
Chapter II Neoplasms,Carcinoma in situ of breast,DTX2,Probable E3 ubiquitin-protein ligase DTX2,7742,44,0.66 [0.38-1.17],0.1534834896762521
Chapter II Neoplasms,Carcinoma in situ of breast,DTX3,Probable E3 ubiquitin-protein ligase DTX3,9033,51,0.66 [0.22-1.98],0.4629568134445893
Chapter II Neoplasms,Carcinoma in situ of breast,DTYMK,Thymidylate kinase,7948,45,0.80 [0.52-1.21],0.287153175028456
Chapter II Neoplasms,Carcinoma in situ of breast,DUOX2,Dual oxidase 2,8895,49,1.05 [0.75-1.48],0.7574669896209202
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP13,Dual specificity protein phosphatase 13 isoform A,7924,45,1.26 [0.66-2.39],0.4877568674215018
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP29,Dual specificity phosphatase 29,7742,44,0.64 [0.36-1.15],0.1333304424299495
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP3,Dual specificity protein phosphatase 3,8849,49,0.75 [0.52-1.08],0.1207761727330422
Chapter II Neoplasms,Carcinoma in situ of breast,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",7914,45,0.84 [0.63-1.13],0.248903703872144
Chapter II Neoplasms,Carcinoma in situ of breast,DXO,Decapping and exoribonuclease protein,7945,46,0.90 [0.48-1.71],0.7514114247621843
Chapter II Neoplasms,Carcinoma in situ of breast,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,7924,45,0.87 [0.45-1.69],0.6804262156563698
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT1,Dynein light chain Tctex-type 1,7742,44,1.13 [0.81-1.57],0.4829828723417996
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT3,Dynein light chain Tctex-type 3,7924,45,0.81 [0.42-1.57],0.5411919310008073
Chapter II Neoplasms,Carcinoma in situ of breast,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,9005,49,0.91 [0.69-1.20],0.5003662175839025
Chapter II Neoplasms,Carcinoma in situ of breast,EBI3_IL27,Interleukin-27,9127,50,1.61 [0.70-3.68],0.2626238559464112
Chapter II Neoplasms,Carcinoma in situ of breast,ECE1,Endothelin-converting enzyme 1,8849,49,0.79 [0.38-1.63],0.529314239209979
Chapter II Neoplasms,Carcinoma in situ of breast,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",7948,45,0.99 [0.68-1.46],0.977162327873542
Chapter II Neoplasms,Carcinoma in situ of breast,ECHS1,"Enoyl-CoA hydratase, mitochondrial",7776,44,0.80 [0.59-1.10],0.1733630255428065
Chapter II Neoplasms,Carcinoma in situ of breast,ECI2,Enoyl-CoA delta isomerase 2,7710,44,0.99 [0.61-1.59],0.963254209189534
Chapter II Neoplasms,Carcinoma in situ of breast,ECM1,Extracellular matrix protein 1,7750,40,0.69 [0.33-1.46],0.3312975035491235
Chapter II Neoplasms,Carcinoma in situ of breast,ECSCR,Endothelial cell-specific chemotaxis regulator,7686,45,1.07 [0.63-1.81],0.8013415517929687
Chapter II Neoplasms,Carcinoma in situ of breast,EDA2R,Tumor necrosis factor receptor superfamily member 27,9145,50,1.19 [0.60-2.34],0.6218066515876463
Chapter II Neoplasms,Carcinoma in situ of breast,EDAR,Tumor necrosis factor receptor superfamily member EDAR,9043,49,0.93 [0.71-1.23],0.6069389461579988
Chapter II Neoplasms,Carcinoma in situ of breast,EDDM3B,Epididymal secretory protein E3-beta,7924,45,1.07 [0.56-2.04],0.8346902986227582
Chapter II Neoplasms,Carcinoma in situ of breast,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,7710,44,1.18 [0.60-2.33],0.6251336744410034
Chapter II Neoplasms,Carcinoma in situ of breast,EDF1,Endothelial differentiation-related factor 1,7937,45,0.94 [0.61-1.45],0.770205897024314
Chapter II Neoplasms,Carcinoma in situ of breast,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,8895,49,1.28 [0.61-2.67],0.5130111499342633
Chapter II Neoplasms,Carcinoma in situ of breast,EDN1,Endothelin-1,7776,44,2.26 [0.85-5.99],0.1015986038457778
Chapter II Neoplasms,Carcinoma in situ of breast,EDNRB,Endothelin receptor type B,7735,44,0.83 [0.40-1.72],0.6155370504186644
Chapter II Neoplasms,Carcinoma in situ of breast,EEF1D,Elongation factor 1-delta,7948,45,0.95 [0.69-1.30],0.7510319219838791
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB14,EF-hand calcium-binding domain-containing protein 14,7914,45,1.29 [0.50-3.36],0.6014594513347438
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB2,Dynein regulatory complex protein 8,7824,45,0.62 [0.26-1.52],0.2991152509987076
Chapter II Neoplasms,Carcinoma in situ of breast,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,9111,50,3.52 [1.70-7.29],0.000699970933941
Chapter II Neoplasms,Carcinoma in situ of breast,EFHD1,EF-hand domain-containing protein D1,7937,45,0.83 [0.34-1.99],0.6696661235603036
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA1,Ephrin-A1,9064,49,1.16 [0.46-2.93],0.7524325804641174
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA4,Ephrin-A4,8991,49,1.37 [0.60-3.17],0.4575621956207368
Chapter II Neoplasms,Carcinoma in situ of breast,EFNB2,Ephrin-B2,7742,44,0.74 [0.41-1.35],0.3264486440078653
Chapter II Neoplasms,Carcinoma in situ of breast,EGF,Pro-epidermal growth factor,9061,50,0.82 [0.64-1.04],0.0950184470572854
Chapter II Neoplasms,Carcinoma in situ of breast,EGFL7,Epidermal growth factor-like protein 7,8869,47,1.30 [0.73-2.31],0.3660190800465613
Chapter II Neoplasms,Carcinoma in situ of breast,EGFLAM,Pikachurin,7914,45,1.92 [0.80-4.62],0.144639463861085
Chapter II Neoplasms,Carcinoma in situ of breast,EGFR,Epidermal growth factor receptor,9177,49,2.10 [0.44-10.00],0.3520292607486253
Chapter II Neoplasms,Carcinoma in situ of breast,EGLN1,Egl nine homolog 1,9043,49,0.99 [0.62-1.57],0.9713037309181126
Chapter II Neoplasms,Carcinoma in situ of breast,EHBP1,EH domain-binding protein 1,7948,45,0.91 [0.61-1.34],0.6282473587398391
Chapter II Neoplasms,Carcinoma in situ of breast,EHD3,EH domain-containing protein 3,7776,44,0.97 [0.75-1.25],0.7951621057447319
Chapter II Neoplasms,Carcinoma in situ of breast,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",7945,46,1.01 [0.61-1.69],0.9569785645196296
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",7877,44,0.91 [0.70-1.20],0.5201224796911899
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,7710,44,0.72 [0.44-1.17],0.186249810631061
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,7776,44,0.59 [0.27-1.33],0.205258152762658
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4B,Eukaryotic translation initiation factor 4B,9005,49,0.77 [0.51-1.18],0.2278281358461812
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4E,Eukaryotic translation initiation factor 4E,7735,44,0.88 [0.63-1.22],0.4261363358056033
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,9066,49,0.63 [0.42-0.96],0.0325259158718794
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,9160,50,0.86 [0.67-1.11],0.2536392477645074
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,7937,45,0.79 [0.50-1.25],0.3084740044582971
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5,Eukaryotic translation initiation factor 5,7710,44,1.05 [0.56-1.97],0.8715058086965526
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5A,Eukaryotic translation initiation factor 5A-1,8903,49,0.75 [0.29-1.93],0.5511978947996831
Chapter II Neoplasms,Carcinoma in situ of breast,ELAC1,Zinc phosphodiesterase ELAC protein 1,7937,45,0.93 [0.66-1.30],0.6589749797084876
Chapter II Neoplasms,Carcinoma in situ of breast,ELAVL4,ELAV-like protein 4,7686,45,1.08 [0.79-1.47],0.6444513823631856
Chapter II Neoplasms,Carcinoma in situ of breast,ELN,Elastin,7948,45,1.21 [0.56-2.65],0.6282495638208673
Chapter II Neoplasms,Carcinoma in situ of breast,ELOA,Elongin-A,9033,51,1.07 [0.68-1.68],0.7845712346562274
Chapter II Neoplasms,Carcinoma in situ of breast,ELOB,Elongin-B,7710,44,1.15 [0.56-2.34],0.7101022033101823
Chapter II Neoplasms,Carcinoma in situ of breast,ENAH,Protein enabled homolog,8903,49,1.00 [0.58-1.72],0.9957692581258664
Chapter II Neoplasms,Carcinoma in situ of breast,ENDOU,Poly(U)-specific endoribonuclease,7329,41,0.93 [0.51-1.72],0.8264380784754005
Chapter II Neoplasms,Carcinoma in situ of breast,ENG,Endoglin,9177,49,1.01 [0.23-4.39],0.9919818346636764
Chapter II Neoplasms,Carcinoma in situ of breast,ENO1,Alpha-enolase,9057,49,0.99 [0.71-1.37],0.9450884506705154
Chapter II Neoplasms,Carcinoma in situ of breast,ENO2,Gamma-enolase,9138,49,0.81 [0.55-1.20],0.3010370236334718
Chapter II Neoplasms,Carcinoma in situ of breast,ENO3,Beta-enolase,7776,44,0.59 [0.33-1.06],0.0771348741073755
Chapter II Neoplasms,Carcinoma in situ of breast,ENOPH1,Enolase-phosphatase E1,7924,45,0.67 [0.36-1.23],0.1919973214914268
Chapter II Neoplasms,Carcinoma in situ of breast,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,7710,44,1.18 [0.42-3.26],0.7544575575874131
Chapter II Neoplasms,Carcinoma in situ of breast,ENPEP,Glutamyl aminopeptidase,7710,44,1.02 [0.54-1.93],0.944024560810039
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,9177,49,1.70 [0.75-3.88],0.2069292037933107
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,9112,50,1.53 [0.75-3.15],0.2437905689772821
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,7776,44,1.03 [0.47-2.25],0.9366371444313766
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8762,49,0.85 [0.63-1.14],0.279955414499515
Chapter II Neoplasms,Carcinoma in situ of breast,ENSA,Alpha-endosulfine,7924,45,1.16 [0.69-1.95],0.5699828694787001
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,8869,47,0.78 [0.43-1.40],0.4043456692077395
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,8895,49,1.84 [0.53-6.41],0.3399120730277956
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,8895,49,1.29 [0.48-3.47],0.6158187246508737
Chapter II Neoplasms,Carcinoma in situ of breast,ENTR1,Endosome-associated-trafficking regulator 1,7776,44,1.07 [0.65-1.77],0.7800477105958857
Chapter II Neoplasms,Carcinoma in situ of breast,EP300,Histone acetyltransferase p300,7735,44,1.22 [0.52-2.88],0.6437745308356662
Chapter II Neoplasms,Carcinoma in situ of breast,EPB41L5,Band 4.1-like protein 5,7742,44,0.90 [0.54-1.49],0.681736238249046
Chapter II Neoplasms,Carcinoma in situ of breast,EPCAM,Epithelial cell adhesion molecule,9066,50,1.06 [0.83-1.36],0.6187472134655356
Chapter II Neoplasms,Carcinoma in situ of breast,EPGN,Epigen,7924,45,1.27 [0.81-1.98],0.304603589574876
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA1,Ephrin type-A receptor 1,9106,50,1.14 [0.54-2.41],0.7265438631081533
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA10,Ephrin type-A receptor 10,8849,49,1.09 [0.78-1.53],0.6011599655191613
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA2,Ephrin type-A receptor 2,8745,51,1.23 [0.55-2.74],0.6188467776337957
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA4,Ephrin type-A receptor 4,7807,44,0.88 [0.32-2.43],0.8076892513431583
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB4,Ephrin type-B receptor 4,9177,49,1.12 [0.40-3.17],0.8237589873290566
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB6,Ephrin type-B receptor 6,8986,49,1.98 [0.91-4.31],0.0852279544371132
Chapter II Neoplasms,Carcinoma in situ of breast,EPHX2,Bifunctional epoxide hydrolase 2,8895,49,0.83 [0.53-1.31],0.4258188317456221
Chapter II Neoplasms,Carcinoma in situ of breast,EPN1,Epsin-1,7824,45,0.98 [0.51-1.91],0.9567987738205108
Chapter II Neoplasms,Carcinoma in situ of breast,EPO,Erythropoietin,9043,49,1.13 [0.81-1.56],0.4822742194673394
Chapter II Neoplasms,Carcinoma in situ of breast,EPPK1,Epiplakin,7776,44,0.90 [0.60-1.36],0.6241020195383068
Chapter II Neoplasms,Carcinoma in situ of breast,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,9130,50,0.79 [0.33-1.87],0.5908513295471263
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB2,Receptor tyrosine-protein kinase erbB-2,9106,50,0.72 [0.25-2.09],0.5433388514541977
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB3,Receptor tyrosine-protein kinase erbB-3,9058,50,0.88 [0.22-3.54],0.8600985114904259
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB4,Receptor tyrosine-protein kinase erbB-4,9106,50,1.95 [0.71-5.34],0.1965958857408918
Chapter II Neoplasms,Carcinoma in situ of breast,ERBIN,Erbin,9033,51,0.85 [0.67-1.09],0.1991961274532532
Chapter II Neoplasms,Carcinoma in situ of breast,ERC2,ERC protein 2,7742,44,0.90 [0.58-1.38],0.6240248046638339
Chapter II Neoplasms,Carcinoma in situ of breast,ERCC1,DNA excision repair protein ERCC-1,7678,44,0.77 [0.29-2.07],0.6062625029366705
Chapter II Neoplasms,Carcinoma in situ of breast,EREG,Proepiregulin,8986,49,0.93 [0.67-1.29],0.6602428475395516
Chapter II Neoplasms,Carcinoma in situ of breast,ERI1,3'-5' exoribonuclease 1,7824,45,1.14 [0.51-2.54],0.7501472134769585
Chapter II Neoplasms,Carcinoma in situ of breast,ERMAP,Erythroid membrane-associated protein,7735,44,0.54 [0.27-1.06],0.0730083561383619
Chapter II Neoplasms,Carcinoma in situ of breast,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,7924,45,0.68 [0.31-1.48],0.3310299999644554
Chapter II Neoplasms,Carcinoma in situ of breast,ERP29,Endoplasmic reticulum resident protein 29,7807,44,0.93 [0.73-1.20],0.5956728799043407
Chapter II Neoplasms,Carcinoma in situ of breast,ERP44,Endoplasmic reticulum resident protein 44,9012,51,0.59 [0.22-1.56],0.2864053523188568
Chapter II Neoplasms,Carcinoma in situ of breast,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,7710,44,1.51 [0.88-2.59],0.1382894559093007
Chapter II Neoplasms,Carcinoma in situ of breast,ESAM,Endothelial cell-selective adhesion molecule,9177,49,0.92 [0.41-2.06],0.834868272140719
Chapter II Neoplasms,Carcinoma in situ of breast,ESM1,Endothelial cell-specific molecule 1,9065,50,1.10 [0.53-2.30],0.8017243334023394
Chapter II Neoplasms,Carcinoma in situ of breast,ESPL1,Separin,7678,44,0.63 [0.32-1.25],0.1864244830832398
Chapter II Neoplasms,Carcinoma in situ of breast,ESR1,Estrogen receptor,7735,44,0.90 [0.51-1.58],0.7083210342124735
Chapter II Neoplasms,Carcinoma in situ of breast,ESYT2,Extended synaptotagmin-2,7945,46,0.85 [0.59-1.22],0.3734674694139982
Chapter II Neoplasms,Carcinoma in situ of breast,EVI2B,Protein EVI2B,7678,44,0.64 [0.26-1.58],0.3368577780394912
Chapter II Neoplasms,Carcinoma in situ of breast,EVI5,Ecotropic viral integration site 5 protein homolog,7735,44,0.97 [0.70-1.35],0.8524885902495619
Chapter II Neoplasms,Carcinoma in situ of breast,EVPL,Envoplakin,7824,45,0.74 [0.30-1.82],0.5083047809037784
Chapter II Neoplasms,Carcinoma in situ of breast,EXOSC10,Exosome component 10,7710,44,1.11 [0.71-1.72],0.6563574030625925
Chapter II Neoplasms,Carcinoma in situ of breast,EXTL1,Exostosin-like 1,7710,44,1.33 [0.78-2.27],0.2996877065360065
Chapter II Neoplasms,Carcinoma in situ of breast,EZR,Ezrin,9138,49,0.71 [0.24-2.16],0.5510811976910155
Chapter II Neoplasms,Carcinoma in situ of breast,F10,Coagulation factor X,7955,44,1.10 [0.35-3.45],0.8704812707410781
Chapter II Neoplasms,Carcinoma in situ of breast,F11,Coagulation factor XI,7851,41,0.56 [0.19-1.70],0.3086277043696132
Chapter II Neoplasms,Carcinoma in situ of breast,F11R,Junctional adhesion molecule A,9075,49,0.84 [0.53-1.34],0.4624987739767789
Chapter II Neoplasms,Carcinoma in situ of breast,F12,Coagulation factor XII,7968,42,1.04 [0.52-2.10],0.9043886131032478
Chapter II Neoplasms,Carcinoma in situ of breast,F13B,Coagulation factor XIII B chain,7918,41,0.70 [0.22-2.25],0.5467291927719318
Chapter II Neoplasms,Carcinoma in situ of breast,F2,Prothrombin,7968,42,0.56 [0.09-3.46],0.5313953893475465
Chapter II Neoplasms,Carcinoma in situ of breast,F2R,Proteinase-activated receptor 1,9094,50,0.87 [0.56-1.37],0.5597879612682274
Chapter II Neoplasms,Carcinoma in situ of breast,F3,Tissue factor,9096,50,1.32 [0.55-3.16],0.5276188001408749
Chapter II Neoplasms,Carcinoma in situ of breast,F7,Coagulation factor VII,9111,50,1.75 [0.73-4.20],0.2075263056014456
Chapter II Neoplasms,Carcinoma in situ of breast,F9,Coagulation factor IX,9101,50,3.32 [0.89-12.33],0.0736770472851035
Chapter II Neoplasms,Carcinoma in situ of breast,FABP1,"Fatty acid-binding protein, liver",9065,50,1.09 [0.83-1.43],0.5302946380144573
Chapter II Neoplasms,Carcinoma in situ of breast,FABP2,"Fatty acid-binding protein, intestinal",9066,49,1.17 [0.85-1.61],0.3458492896717591
Chapter II Neoplasms,Carcinoma in situ of breast,FABP3,"Fatty acid-binding protein, heart",7948,45,0.95 [0.53-1.73],0.8727896010226552
Chapter II Neoplasms,Carcinoma in situ of breast,FABP4,"Fatty acid-binding protein, adipocyte",9177,49,1.22 [0.74-2.00],0.4331839948745501
Chapter II Neoplasms,Carcinoma in situ of breast,FABP5,Fatty acid-binding protein 5,9107,49,0.89 [0.61-1.30],0.5423649298509665
Chapter II Neoplasms,Carcinoma in situ of breast,FABP6,Gastrotropin,8879,49,1.33 [0.88-2.02],0.1794341210314403
Chapter II Neoplasms,Carcinoma in situ of breast,FABP9,Fatty acid-binding protein 9,9043,49,0.79 [0.50-1.24],0.3016505388083387
Chapter II Neoplasms,Carcinoma in situ of breast,FADD,FAS-associated death domain protein,9066,49,0.85 [0.61-1.19],0.3448208646013796
Chapter II Neoplasms,Carcinoma in situ of breast,FAM13A,Protein FAM13A,7914,45,0.71 [0.45-1.13],0.1536583447784007
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171A2,Protein FAM171A2,7937,45,1.07 [0.91-1.27],0.4137219656277527
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171B,Protein FAM171B,7924,45,0.71 [0.22-2.31],0.5742759993355369
Chapter II Neoplasms,Carcinoma in situ of breast,FAM172A,Cotranscriptional regulator FAM172A,7776,44,1.00 [0.62-1.62],0.996425711472131
Chapter II Neoplasms,Carcinoma in situ of breast,FAM20A,Pseudokinase FAM20A,7948,45,0.62 [0.21-1.77],0.3707158800526133
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3B,Protein FAM3B,9033,51,0.62 [0.32-1.20],0.152221287265957
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3C,Protein FAM3C,9050,49,1.51 [0.66-3.47],0.3293512844771887
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3D,Protein FAM3D,7914,45,0.97 [0.69-1.38],0.8687691305570269
Chapter II Neoplasms,Carcinoma in situ of breast,FAP,Prolyl endopeptidase FAP,9177,49,2.01 [0.78-5.21],0.1510491119610739
Chapter II Neoplasms,Carcinoma in situ of breast,FARSA,Phenylalanine--tRNA ligase alpha subunit,7742,44,1.14 [0.77-1.69],0.4975424571772983
Chapter II Neoplasms,Carcinoma in situ of breast,FAS,Tumor necrosis factor receptor superfamily member 6,9159,49,1.43 [0.81-2.52],0.2214647585420728
Chapter II Neoplasms,Carcinoma in situ of breast,FASLG,Tumor necrosis factor ligand superfamily member 6,9160,50,1.83 [0.94-3.58],0.0759326421774585
Chapter II Neoplasms,Carcinoma in situ of breast,FBLN2,Fibulin-2,7965,46,1.36 [0.57-3.24],0.4825949691778397
Chapter II Neoplasms,Carcinoma in situ of breast,FBN2,Fibrillin-2,7742,44,0.76 [0.50-1.17],0.2123306314021825
Chapter II Neoplasms,Carcinoma in situ of breast,FBP1,"Fructose-1,6-bisphosphatase 1",9066,49,1.03 [0.74-1.45],0.8446389744667312
Chapter II Neoplasms,Carcinoma in situ of breast,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,7948,45,0.87 [0.59-1.29],0.4916322333494693
Chapter II Neoplasms,Carcinoma in situ of breast,FCAR,Immunoglobulin alpha Fc receptor,9043,49,1.24 [0.73-2.11],0.4168490639617883
Chapter II Neoplasms,Carcinoma in situ of breast,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,7937,45,0.38 [0.12-1.18],0.0955874782127116
Chapter II Neoplasms,Carcinoma in situ of breast,FCER2,Low affinity immunoglobulin epsilon Fc receptor,9075,49,1.34 [0.78-2.29],0.2877789306151017
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,9049,50,1.61 [0.94-2.75],0.0812041984391123
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,8869,47,1.10 [0.72-1.68],0.6430067079688463
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,9096,50,1.09 [0.66-1.81],0.7381460741250978
Chapter II Neoplasms,Carcinoma in situ of breast,FCN1,Ficolin-1,7935,44,0.91 [0.56-1.47],0.6972702966208475
Chapter II Neoplasms,Carcinoma in situ of breast,FCN2,Ficolin-2,9037,50,1.54 [0.78-3.04],0.214299619492604
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL1,Fc receptor-like protein 1,9066,49,1.47 [0.83-2.60],0.1903071315952355
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL2,Fc receptor-like protein 2,9115,49,1.08 [0.64-1.81],0.776140926631876
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL3,Fc receptor-like protein 3,8903,49,1.25 [0.79-1.96],0.3418209209002612
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL5,Fc receptor-like protein 5,9075,49,1.27 [0.81-1.99],0.2947416193005124
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL6,Fc receptor-like protein 6,9043,49,0.79 [0.56-1.13],0.2008036554092148
Chapter II Neoplasms,Carcinoma in situ of breast,FCRLB,Fc receptor-like B,8869,47,0.90 [0.56-1.45],0.6735879464360972
Chapter II Neoplasms,Carcinoma in situ of breast,FDX1,"Adrenodoxin, mitochondrial",7710,44,1.23 [0.83-1.80],0.2999947905378228
Chapter II Neoplasms,Carcinoma in situ of breast,FDX2,"Ferredoxin-2, mitochondrial",7710,44,0.83 [0.47-1.45],0.5039537672520162
Chapter II Neoplasms,Carcinoma in situ of breast,FEN1,Flap endonuclease 1,8869,47,0.86 [0.54-1.37],0.5246358121283183
Chapter II Neoplasms,Carcinoma in situ of breast,FES,Tyrosine-protein kinase Fes/Fps,8869,47,0.74 [0.41-1.36],0.338177396872851
Chapter II Neoplasms,Carcinoma in situ of breast,FETUB,Fetuin-B,9101,50,1.25 [0.55-2.84],0.5892255155472762
Chapter II Neoplasms,Carcinoma in situ of breast,FGA,Fibrinogen alpha chain,7783,41,1.22 [0.45-3.33],0.7001172026780392
Chapter II Neoplasms,Carcinoma in situ of breast,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",7937,45,0.88 [0.61-1.26],0.4777128791443452
Chapter II Neoplasms,Carcinoma in situ of breast,FGF12,Fibroblast growth factor 12,7735,44,1.06 [0.60-1.88],0.8288511701509129
Chapter II Neoplasms,Carcinoma in situ of breast,FGF16,Fibroblast growth factor 16,7735,44,0.83 [0.43-1.60],0.5711945284013031
Chapter II Neoplasms,Carcinoma in situ of breast,FGF19,Fibroblast growth factor 19,9112,50,1.20 [0.87-1.66],0.2682342649830144
Chapter II Neoplasms,Carcinoma in situ of breast,FGF2,Fibroblast growth factor 2,9043,49,0.93 [0.63-1.38],0.7292451262238612
Chapter II Neoplasms,Carcinoma in situ of breast,FGF20,Fibroblast growth factor 20,7735,44,0.59 [0.24-1.44],0.2443317970857231
Chapter II Neoplasms,Carcinoma in situ of breast,FGF21,Fibroblast growth factor 21,9127,50,0.83 [0.67-1.04],0.1064078465728852
Chapter II Neoplasms,Carcinoma in situ of breast,FGF23,Fibroblast growth factor 23,9132,50,0.95 [0.58-1.56],0.8393541688328313
Chapter II Neoplasms,Carcinoma in situ of breast,FGF3,Fibroblast growth factor 3,7735,44,1.13 [0.46-2.79],0.7860382993792934
Chapter II Neoplasms,Carcinoma in situ of breast,FGF5,Fibroblast growth factor 5,8903,49,0.97 [0.44-2.13],0.9307236695334724
Chapter II Neoplasms,Carcinoma in situ of breast,FGF6,Fibroblast growth factor 6,7735,44,1.17 [0.63-2.15],0.6198745160965019
Chapter II Neoplasms,Carcinoma in situ of breast,FGF7,Fibroblast growth factor 7,7678,44,1.01 [0.71-1.44],0.9496768944944772
Chapter II Neoplasms,Carcinoma in situ of breast,FGF9,Fibroblast growth factor 9,7663,44,1.02 [0.51-2.05],0.9585737091698088
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP1,Fibroblast growth factor-binding protein 1,9106,50,0.99 [0.45-2.18],0.9764565653794828
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP2,Fibroblast growth factor-binding protein 2,7965,46,2.15 [1.28-3.61],0.0037663729692919
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP3,Fibroblast growth factor-binding protein 3,7945,46,0.56 [0.26-1.24],0.1526941969237771
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR2,Fibroblast growth factor receptor 2,9106,50,1.49 [0.48-4.67],0.4937305349243103
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR4,Fibroblast growth factor receptor 4,7807,44,0.83 [0.47-1.44],0.4966847926878714
Chapter II Neoplasms,Carcinoma in situ of breast,FGL1,Fibrinogen-like protein 1,7955,44,0.86 [0.56-1.34],0.5140826956724331
Chapter II Neoplasms,Carcinoma in situ of breast,FGR,Tyrosine-protein kinase Fgr,8849,49,1.07 [0.71-1.62],0.7485206821689919
Chapter II Neoplasms,Carcinoma in situ of breast,FH,"Fumarate hydratase, mitochondrial",7686,45,0.96 [0.67-1.37],0.8176678550995802
Chapter II Neoplasms,Carcinoma in situ of breast,FHIP2A,FHF complex subunit HOOK interacting protein 2A,7710,44,1.19 [0.71-2.00],0.5110546536697113
Chapter II Neoplasms,Carcinoma in situ of breast,FHIT,Bis(5'-adenosyl)-triphosphatase,8849,49,0.84 [0.60-1.19],0.3344427686531834
Chapter II Neoplasms,Carcinoma in situ of breast,FIS1,Mitochondrial fission 1 protein,9088,50,0.94 [0.67-1.30],0.6983494393255107
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,7937,45,0.89 [0.67-1.19],0.4453261123562104
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,9090,50,0.93 [0.74-1.17],0.5444632448791954
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,9005,49,0.78 [0.44-1.38],0.3857845732628373
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,9005,49,1.01 [0.77-1.32],0.9697607456206714
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,8830,49,1.17 [0.70-1.93],0.5515859301929013
Chapter II Neoplasms,Carcinoma in situ of breast,FKBPL,FK506-binding protein-like,7914,45,0.82 [0.50-1.37],0.4500889497601853
Chapter II Neoplasms,Carcinoma in situ of breast,FLI1,Friend leukemia integration 1 transcription factor,8869,47,0.88 [0.68-1.12],0.291983303195346
Chapter II Neoplasms,Carcinoma in situ of breast,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,9005,49,2.38 [1.10-5.18],0.0282157798463494
Chapter II Neoplasms,Carcinoma in situ of breast,FLT1,Vascular endothelial growth factor receptor 1,9021,51,0.75 [0.21-2.62],0.6520770433493739
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3,Receptor-type tyrosine-protein kinase FLT3,8869,47,1.53 [0.87-2.71],0.1414199219002809
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3LG,Fms-related tyrosine kinase 3 ligand,9160,50,1.03 [0.47-2.25],0.9365813620144062
Chapter II Neoplasms,Carcinoma in situ of breast,FLT4,Vascular endothelial growth factor receptor 3,9106,50,1.01 [0.47-2.17],0.9881266153424446
Chapter II Neoplasms,Carcinoma in situ of breast,FMNL1,Formin-like protein 1,8849,49,1.13 [0.80-1.60],0.4722553672458818
Chapter II Neoplasms,Carcinoma in situ of breast,FMR1,Synaptic functional regulator FMR1,8869,47,1.18 [0.57-2.45],0.6627599832739384
Chapter II Neoplasms,Carcinoma in situ of breast,FN1,Fibronectin,7968,42,1.35 [0.45-4.05],0.5896277463952775
Chapter II Neoplasms,Carcinoma in situ of breast,FNDC1,Fibronectin type III domain-containing protein 1,7945,46,0.63 [0.34-1.14],0.1270779631003175
Chapter II Neoplasms,Carcinoma in situ of breast,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,7924,45,0.80 [0.34-1.89],0.6175839146344129
Chapter II Neoplasms,Carcinoma in situ of breast,FOLH1,Glutamate carboxypeptidase 2,7735,44,0.71 [0.44-1.14],0.154472214031706
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR1,Folate receptor alpha,9069,49,1.61 [0.68-3.79],0.2763657302074982
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR2,Folate receptor beta,9138,49,1.78 [0.78-4.03],0.1678604034860348
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR3,Folate receptor gamma,9077,49,0.97 [0.84-1.12],0.7083372200989528
Chapter II Neoplasms,Carcinoma in situ of breast,FOS,Proto-oncogene c-Fos,7663,44,0.63 [0.28-1.41],0.2622637481872706
Chapter II Neoplasms,Carcinoma in situ of breast,FOSB,Protein fosB,8849,49,0.93 [0.47-1.85],0.838269774624277
Chapter II Neoplasms,Carcinoma in situ of breast,FOXJ3,Forkhead box protein J3,7735,44,0.86 [0.42-1.75],0.6741748607093349
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO1,Forkhead box protein O1,9043,49,0.85 [0.63-1.16],0.3158900563368174
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO3,Forkhead box protein O3,8869,47,0.81 [0.60-1.09],0.1605040171833521
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD4B,FERM domain-containing protein 4B,7710,44,0.71 [0.45-1.12],0.1411312414138491
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD7,FERM domain-containing protein 7,7742,44,0.68 [0.29-1.60],0.3771421874999173
Chapter II Neoplasms,Carcinoma in situ of breast,FRZB,Secreted frizzled-related protein 3,8975,49,1.09 [0.40-2.96],0.858734745914499
Chapter II Neoplasms,Carcinoma in situ of breast,FSHB,Follitropin subunit beta,7776,44,0.76 [0.47-1.22],0.2495592539142166
Chapter II Neoplasms,Carcinoma in situ of breast,FST,Follistatin,9094,50,1.06 [0.64-1.75],0.8210197531077315
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL1,Follistatin-related protein 1,7776,44,1.56 [0.45-5.43],0.4837028287997846
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL3,Follistatin-related protein 3,9053,50,1.92 [0.92-4.00],0.0835035908120497
Chapter II Neoplasms,Carcinoma in situ of breast,FTCD,Formimidoyltransferase-cyclodeaminase,7931,46,0.89 [0.64-1.24],0.4975030794219975
Chapter II Neoplasms,Carcinoma in situ of breast,FUCA1,Tissue alpha-L-fucosidase,9136,48,1.30 [0.91-1.85],0.1454403259629629
Chapter II Neoplasms,Carcinoma in situ of breast,FUOM,Fucose mutarotase,7807,44,0.86 [0.55-1.35],0.520454522824189
Chapter II Neoplasms,Carcinoma in situ of breast,FURIN,Furin,9106,50,1.06 [0.50-2.25],0.8788414069409521
Chapter II Neoplasms,Carcinoma in situ of breast,FUS,RNA-binding protein FUS,8857,47,0.87 [0.44-1.71],0.6827029440859271
Chapter II Neoplasms,Carcinoma in situ of breast,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",7803,45,1.16 [0.79-1.71],0.4492270040564046
Chapter II Neoplasms,Carcinoma in situ of breast,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,9138,49,0.89 [0.51-1.55],0.6802783815242148
Chapter II Neoplasms,Carcinoma in situ of breast,FUT8,"Alpha-(1,6)-fucosyltransferase",9005,49,0.72 [0.45-1.13],0.1546876960332576
Chapter II Neoplasms,Carcinoma in situ of breast,FXN,"Frataxin, mitochondrial",9145,50,0.96 [0.68-1.35],0.8166637194184704
Chapter II Neoplasms,Carcinoma in situ of breast,FXYD5,FXYD domain-containing ion transport regulator 5,8903,49,0.98 [0.66-1.45],0.9183215984389768
Chapter II Neoplasms,Carcinoma in situ of breast,FYB1,FYN-binding protein 1,9061,48,0.88 [0.66-1.16],0.3576943546756589
Chapter II Neoplasms,Carcinoma in situ of breast,FZD10,Frizzled-10,7742,44,1.20 [0.80-1.80],0.3839233654830613
Chapter II Neoplasms,Carcinoma in situ of breast,FZD8,Frizzled-8,7686,45,0.92 [0.46-1.86],0.8191188671929925
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAP,Gamma-aminobutyric acid receptor-associated protein,7924,45,0.67 [0.34-1.32],0.2442563829501931
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,7824,45,0.66 [0.36-1.20],0.1733010220821669
Chapter II Neoplasms,Carcinoma in situ of breast,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,7686,45,1.03 [0.66-1.61],0.8808989879605839
Chapter II Neoplasms,Carcinoma in situ of breast,GAD1,Glutamate decarboxylase 1,7678,44,0.87 [0.29-2.67],0.8131986364039809
Chapter II Neoplasms,Carcinoma in situ of breast,GAD2,Glutamate decarboxylase 2,7735,44,1.10 [0.61-1.98],0.747226930633658
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,7824,45,0.41 [0.16-1.07],0.0678365073507344
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,7776,44,1.04 [0.59-1.83],0.8841360029382253
Chapter II Neoplasms,Carcinoma in situ of breast,GAGE2A,G antigen 2A,7678,44,0.88 [0.53-1.45],0.6117231338645188
Chapter II Neoplasms,Carcinoma in situ of breast,GAL,Galanin peptides,9112,50,1.81 [1.23-2.67],0.0025383733373917
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,9033,51,0.74 [0.30-1.84],0.5175391824876001
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,9145,50,1.00 [0.39-2.57],0.9956809615624956
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,8903,49,1.15 [0.63-2.11],0.6396645134526369
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,7948,45,0.86 [0.31-2.35],0.770589329007208
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT7,N-acetylgalactosaminyltransferase 7,9033,51,1.10 [0.34-3.57],0.8699886638008105
Chapter II Neoplasms,Carcinoma in situ of breast,GAMT,Guanidinoacetate N-methyltransferase,7710,44,0.78 [0.32-1.87],0.5767945353337633
Chapter II Neoplasms,Carcinoma in situ of breast,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,7638,44,0.62 [0.29-1.33],0.2241838343888516
Chapter II Neoplasms,Carcinoma in situ of breast,GART,Trifunctional purine biosynthetic protein adenosine-3,7937,45,1.14 [0.40-3.25],0.8038190114007361
Chapter II Neoplasms,Carcinoma in situ of breast,GAS2,Growth arrest-specific protein 2,7824,45,1.04 [0.61-1.79],0.8835082338930812
Chapter II Neoplasms,Carcinoma in situ of breast,GAS6,Growth arrest-specific protein 6,9129,49,2.37 [0.89-6.31],0.0837903942192049
Chapter II Neoplasms,Carcinoma in situ of breast,GASK1A,Golgi-associated kinase 1A,7710,44,1.65 [0.87-3.15],0.1278165078221931
Chapter II Neoplasms,Carcinoma in situ of breast,GAST,Gastrin,7945,46,0.99 [0.81-1.21],0.9237176696689322
Chapter II Neoplasms,Carcinoma in situ of breast,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,7678,44,1.03 [0.35-3.03],0.9509554982418144
Chapter II Neoplasms,Carcinoma in situ of breast,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",7776,44,1.01 [0.69-1.48],0.9537854252515802
Chapter II Neoplasms,Carcinoma in situ of breast,GBA,Lysosomal acid glucosylceramidase,7742,44,1.20 [0.70-2.05],0.5065962828148147
Chapter II Neoplasms,Carcinoma in situ of breast,GBP1,Guanylate-binding protein 1,7931,46,1.52 [1.04-2.21],0.0288813125872928
Chapter II Neoplasms,Carcinoma in situ of breast,GBP2,Guanylate-binding protein 2,8903,49,1.08 [0.71-1.65],0.7265707730131301
Chapter II Neoplasms,Carcinoma in situ of breast,GBP4,Guanylate-binding protein 4,8849,49,0.90 [0.53-1.53],0.6962805609273843
Chapter II Neoplasms,Carcinoma in situ of breast,GBP6,Guanylate-binding protein 6,7710,44,1.39 [0.91-2.11],0.1258282213571859
Chapter II Neoplasms,Carcinoma in situ of breast,GC,Vitamin D-binding protein,7968,42,2.68 [0.90-8.00],0.0764833409729094
Chapter II Neoplasms,Carcinoma in situ of breast,GCC1,GRIP and coiled-coil domain-containing protein 1,7945,46,0.95 [0.72-1.23],0.680719325462668
Chapter II Neoplasms,Carcinoma in situ of breast,GCG,Pro-glucagon,8869,47,1.06 [0.86-1.31],0.569765802135763
Chapter II Neoplasms,Carcinoma in situ of breast,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,7629,44,0.72 [0.37-1.40],0.3318371046245035
Chapter II Neoplasms,Carcinoma in situ of breast,GCLM,Glutamate--cysteine ligase regulatory subunit,7710,44,0.91 [0.48-1.75],0.7820501667145878
Chapter II Neoplasms,Carcinoma in situ of breast,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",9033,51,0.78 [0.37-1.62],0.4990649980973622
Chapter II Neoplasms,Carcinoma in situ of breast,GDF15,Growth/differentiation factor 15,9177,49,0.80 [0.42-1.53],0.5065507091995056
Chapter II Neoplasms,Carcinoma in situ of breast,GDF2,Growth/differentiation factor 2,9066,49,1.45 [0.72-2.91],0.2977845220676552
Chapter II Neoplasms,Carcinoma in situ of breast,GDNF,Glial cell line-derived neurotrophic factor,8849,49,1.13 [0.59-2.16],0.7153200905625268
Chapter II Neoplasms,Carcinoma in situ of breast,GET3,ATPase GET3,7948,45,0.94 [0.56-1.59],0.827479532966207
Chapter II Neoplasms,Carcinoma in situ of breast,GFAP,Glial fibrillary acidic protein,8849,47,1.50 [0.89-2.53],0.1240561831443614
Chapter II Neoplasms,Carcinoma in situ of breast,GFER,FAD-linked sulfhydryl oxidase ALR,8869,47,0.85 [0.56-1.29],0.4432709046647741
Chapter II Neoplasms,Carcinoma in situ of breast,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,8869,47,0.97 [0.77-1.20],0.7601849706454296
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA1,GDNF family receptor alpha-1,9127,50,0.83 [0.34-2.06],0.688804311349533
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA2,GDNF family receptor alpha-2,9033,51,1.34 [0.40-4.45],0.6318465836545104
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA3,GDNF family receptor alpha-3,8980,47,1.88 [0.82-4.34],0.1385785296804263
Chapter II Neoplasms,Carcinoma in situ of breast,GFRAL,GDNF family receptor alpha-like,7704,45,1.05 [0.66-1.67],0.8456225861928685
Chapter II Neoplasms,Carcinoma in situ of breast,GGA1,ADP-ribosylation factor-binding protein GGA1,8849,49,1.43 [1.09-1.86],0.008510632821273
Chapter II Neoplasms,Carcinoma in situ of breast,GGACT,Gamma-glutamylaminecyclotransferase,7948,45,0.98 [0.65-1.47],0.9280558412499506
Chapter II Neoplasms,Carcinoma in situ of breast,GGCT,Gamma-glutamylcyclotransferase,7926,45,0.86 [0.46-1.58],0.6171627479231576
Chapter II Neoplasms,Carcinoma in situ of breast,GGH,Gamma-glutamyl hydrolase,8948,49,1.56 [0.78-3.11],0.2038380940315013
Chapter II Neoplasms,Carcinoma in situ of breast,GGT1,Glutathione hydrolase 1 proenzyme,9064,49,0.55 [0.30-0.98],0.0441415393892342
Chapter II Neoplasms,Carcinoma in situ of breast,GGT5,Glutathione hydrolase 5 proenzyme,9005,49,0.78 [0.25-2.47],0.6743888209434309
Chapter II Neoplasms,Carcinoma in situ of breast,GH1,Somatotropin,9050,49,1.06 [0.91-1.24],0.4293145239922428
Chapter II Neoplasms,Carcinoma in situ of breast,GH2,Growth hormone variant,8869,47,1.04 [0.90-1.20],0.6126867227286352
Chapter II Neoplasms,Carcinoma in situ of breast,GHR,Growth hormone receptor,7807,44,1.66 [0.58-4.74],0.3432499526631488
Chapter II Neoplasms,Carcinoma in situ of breast,GHRHR,Growth hormone-releasing hormone receptor,8849,49,0.98 [0.62-1.54],0.9262670637734268
Chapter II Neoplasms,Carcinoma in situ of breast,GHRL,Appetite-regulating hormone,9066,49,1.05 [0.77-1.43],0.7472588286101547
Chapter II Neoplasms,Carcinoma in situ of breast,GID8,Glucose-induced degradation protein 8 homolog,7937,45,1.09 [0.48-2.51],0.8316478339370946
Chapter II Neoplasms,Carcinoma in situ of breast,GIGYF2,GRB10-interacting GYF protein 2,7937,45,0.90 [0.61-1.33],0.5871659547766115
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP7,GTPase IMAP family member 7,7807,44,1.33 [0.61-2.90],0.4789841774306899
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP8,GTPase IMAP family member 8,7678,44,1.00 [0.57-1.73],0.9886498145415764
Chapter II Neoplasms,Carcinoma in situ of breast,GIP,Gastric inhibitory polypeptide,7776,44,0.97 [0.57-1.63],0.8982968767329023
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC2,PDZ domain-containing protein GIPC2,7945,46,0.77 [0.29-2.08],0.6071672161242623
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC3,PDZ domain-containing protein GIPC3,7914,45,0.90 [0.67-1.21],0.497320391190406
Chapter II Neoplasms,Carcinoma in situ of breast,GIPR,Gastric inhibitory polypeptide receptor,7735,44,1.02 [0.58-1.80],0.932363885332114
Chapter II Neoplasms,Carcinoma in situ of breast,GIT1,ARF GTPase-activating protein GIT1,7735,44,0.84 [0.62-1.14],0.2655940376223379
Chapter II Neoplasms,Carcinoma in situ of breast,GJA8,Gap junction alpha-8 protein,7678,44,0.82 [0.48-1.40],0.4660165626169396
Chapter II Neoplasms,Carcinoma in situ of breast,GKN1,Gastrokine-1,8682,49,1.76 [0.70-4.43],0.2276766765022846
Chapter II Neoplasms,Carcinoma in situ of breast,GLA,Alpha-galactosidase A,7793,44,0.99 [0.44-2.26],0.9827616836433276
Chapter II Neoplasms,Carcinoma in situ of breast,GLB1,Beta-galactosidase,9005,49,0.81 [0.43-1.54],0.5201740294495873
Chapter II Neoplasms,Carcinoma in situ of breast,GLI2,Zinc finger protein GLI2,7735,44,0.71 [0.26-1.97],0.512004304241664
Chapter II Neoplasms,Carcinoma in situ of breast,GLO1,Lactoylglutathione lyase,8895,49,0.95 [0.62-1.46],0.8117333668186841
Chapter II Neoplasms,Carcinoma in situ of breast,GLOD4,Glyoxalase domain-containing protein 4,9070,50,0.61 [0.30-1.24],0.1764820157313871
Chapter II Neoplasms,Carcinoma in situ of breast,GLP1R,Glucagon-like peptide 1 receptor,7686,45,1.56 [0.87-2.79],0.1348633963695043
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX,Glutaredoxin-1,8993,49,0.75 [0.47-1.18],0.21254216369718
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",7807,44,0.97 [0.70-1.36],0.8720122123695146
Chapter II Neoplasms,Carcinoma in situ of breast,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,8849,49,0.96 [0.55-1.66],0.8795428872758945
Chapter II Neoplasms,Carcinoma in situ of breast,GLYR1,Putative oxidoreductase GLYR1,7924,45,0.91 [0.54-1.55],0.7363634956608972
Chapter II Neoplasms,Carcinoma in situ of breast,GM2A,Ganglioside GM2 activator,7756,45,1.29 [0.74-2.25],0.3652896282583036
Chapter II Neoplasms,Carcinoma in situ of breast,GMFG,Glia maturation factor gamma,7948,45,0.86 [0.58-1.29],0.4794041197668992
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR,GMP reductase 1,9160,50,0.73 [0.46-1.15],0.1741076530205767
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR2,GMP reductase 2,7807,44,0.91 [0.59-1.41],0.6739035818327785
Chapter II Neoplasms,Carcinoma in situ of breast,GNAS,Neuroendocrine secretory protein 55,7937,45,1.00 [0.72-1.38],0.9929674987353362
Chapter II Neoplasms,Carcinoma in situ of breast,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,8869,47,0.83 [0.55-1.26],0.3815662072797965
Chapter II Neoplasms,Carcinoma in situ of breast,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,7742,44,0.83 [0.43-1.58],0.5632198270565946
Chapter II Neoplasms,Carcinoma in situ of breast,GNLY,Granulysin,9075,49,1.03 [0.63-1.68],0.9098317845852708
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA1,Glucosamine-6-phosphate isomerase 1,7776,44,0.66 [0.24-1.82],0.4180241109379516
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA2,Glucosamine-6-phosphate isomerase 2,7807,44,0.92 [0.41-2.07],0.8417687366390892
Chapter II Neoplasms,Carcinoma in situ of breast,GOLGA3,Golgin subfamily A member 3,7937,45,0.63 [0.42-0.94],0.0254118680590762
Chapter II Neoplasms,Carcinoma in situ of breast,GOLM2,Protein GOLM2,9138,49,0.60 [0.19-1.94],0.3982044603005527
Chapter II Neoplasms,Carcinoma in situ of breast,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,9043,49,0.90 [0.70-1.16],0.4287796641759973
Chapter II Neoplasms,Carcinoma in situ of breast,GORASP2,Golgi reassembly-stacking protein 2,7914,45,0.80 [0.42-1.51],0.4934316482927103
Chapter II Neoplasms,Carcinoma in situ of breast,GOT1,"Aspartate aminotransferase, cytoplasmic",7965,46,0.61 [0.29-1.29],0.1952933790463788
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BA,Platelet glycoprotein Ib alpha chain,9031,50,1.43 [0.66-3.09],0.3675849822184923
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BB,Platelet glycoprotein Ib beta chain,7710,44,1.21 [0.79-1.87],0.377810316174069
Chapter II Neoplasms,Carcinoma in situ of breast,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,8794,49,1.11 [0.84-1.46],0.4557269805244353
Chapter II Neoplasms,Carcinoma in situ of breast,GP5,Platelet glycoprotein V,7807,44,0.68 [0.31-1.49],0.3370785698331488
Chapter II Neoplasms,Carcinoma in situ of breast,GP6,Platelet glycoprotein VI,9061,48,0.88 [0.65-1.19],0.4017940537299306
Chapter II Neoplasms,Carcinoma in situ of breast,GPA33,Cell surface A33 antigen,9033,51,1.02 [0.85-1.22],0.8422252052189233
Chapter II Neoplasms,Carcinoma in situ of breast,GPC1,Glypican-1,9145,50,2.75 [1.17-6.44],0.0201641138665235
Chapter II Neoplasms,Carcinoma in situ of breast,GPC5,Glypican-5,9005,49,0.87 [0.55-1.37],0.5427127096032065
Chapter II Neoplasms,Carcinoma in situ of breast,GPD1,Glycerol-3-phosphate dehydrogenase,7924,45,1.23 [0.73-2.06],0.4434312894872505
Chapter II Neoplasms,Carcinoma in situ of breast,GPHA2,Glycoprotein hormone alpha-2,7914,45,1.39 [0.86-2.24],0.1821662123184544
Chapter II Neoplasms,Carcinoma in situ of breast,GPI,Glucose-6-phosphate isomerase,7955,44,0.98 [0.53-1.82],0.9487312867359944
Chapter II Neoplasms,Carcinoma in situ of breast,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,7914,45,1.43 [0.94-2.18],0.0960079196246671
Chapter II Neoplasms,Carcinoma in situ of breast,GPKOW,G-patch domain and KOW motifs-containing protein,8849,49,1.07 [0.45-2.53],0.8865811027745769
Chapter II Neoplasms,Carcinoma in situ of breast,GPNMB,Transmembrane glycoprotein NMB,8811,48,1.61 [0.64-4.02],0.3124727599598892
Chapter II Neoplasms,Carcinoma in situ of breast,GPR101,Probable G-protein coupled receptor 101,7686,45,1.32 [0.92-1.90],0.1327431180110709
Chapter II Neoplasms,Carcinoma in situ of breast,GPR158,Probable G-protein coupled receptor 158,7937,45,1.47 [0.76-2.84],0.2476172692535347
Chapter II Neoplasms,Carcinoma in situ of breast,GPR15L,Protein GPR15L,7914,45,0.85 [0.53-1.39],0.5275420555114397
Chapter II Neoplasms,Carcinoma in situ of breast,GPR37,Prosaposin receptor GPR37,8895,49,1.14 [0.78-1.67],0.4831914132536679
Chapter II Neoplasms,Carcinoma in situ of breast,GPRC5C,G-protein coupled receptor family C group 5 member C,7924,45,0.55 [0.29-1.06],0.0721972288830419
Chapter II Neoplasms,Carcinoma in situ of breast,GRAP2,GRB2-related adapter protein 2,9066,49,0.89 [0.73-1.09],0.2628956951321978
Chapter II Neoplasms,Carcinoma in situ of breast,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,7948,45,0.92 [0.59-1.45],0.7198069071560979
Chapter II Neoplasms,Carcinoma in situ of breast,GRIK2,"Glutamate receptor ionotropic, kainate 2",7937,45,0.83 [0.40-1.70],0.6089204142477129
Chapter II Neoplasms,Carcinoma in situ of breast,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",7686,45,1.28 [0.91-1.79],0.1513239904605545
Chapter II Neoplasms,Carcinoma in situ of breast,GRK5,G protein-coupled receptor kinase 5,8895,49,0.76 [0.42-1.37],0.3630098492155529
Chapter II Neoplasms,Carcinoma in situ of breast,GRN,Progranulin,9041,49,2.59 [0.93-7.23],0.0687814374069044
Chapter II Neoplasms,Carcinoma in situ of breast,GRP,Gastrin-releasing peptide,7776,44,1.51 [0.91-2.51],0.1135752705921675
Chapter II Neoplasms,Carcinoma in situ of breast,GRPEL1,"GrpE protein homolog 1, mitochondrial",9033,51,0.88 [0.57-1.37],0.5835026089991759
Chapter II Neoplasms,Carcinoma in situ of breast,GRSF1,G-rich sequence factor 1,7632,44,0.85 [0.58-1.25],0.4135207433696797
Chapter II Neoplasms,Carcinoma in situ of breast,GSAP,Gamma-secretase-activating protein,8869,47,1.07 [0.82-1.40],0.634842566324821
Chapter II Neoplasms,Carcinoma in situ of breast,GSN,Gelsolin,7930,44,1.21 [0.26-5.67],0.8131769032461486
Chapter II Neoplasms,Carcinoma in situ of breast,GSR,"Glutathione reductase, mitochondrial",7911,44,0.79 [0.22-2.82],0.7209737766114266
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA1,Glutathione S-transferase A1,9049,49,0.83 [0.61-1.13],0.2310867073040959
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA3,Glutathione S-transferase A3,8869,47,0.92 [0.66-1.29],0.6395931714853941
Chapter II Neoplasms,Carcinoma in situ of breast,GSTM4,Glutathione S-transferase Mu 4,7710,44,1.12 [0.80-1.57],0.5141022514214488
Chapter II Neoplasms,Carcinoma in situ of breast,GSTP1,Glutathione S-transferase P,8795,49,0.95 [0.65-1.39],0.7896062951334815
Chapter II Neoplasms,Carcinoma in situ of breast,GSTT2B,Glutathione S-transferase theta-2B,7945,46,1.04 [0.92-1.17],0.5182952835996772
Chapter II Neoplasms,Carcinoma in situ of breast,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,7824,45,1.13 [0.80-1.58],0.4937840411319395
Chapter II Neoplasms,Carcinoma in situ of breast,GTPBP2,GTP-binding protein 2,7742,44,1.01 [0.70-1.46],0.9443757584310276
Chapter II Neoplasms,Carcinoma in situ of breast,GUCA2A,Guanylin,9030,48,1.29 [0.60-2.76],0.5111378285947239
Chapter II Neoplasms,Carcinoma in situ of breast,GUCY2C,Heat-stable enterotoxin receptor,7824,45,1.00 [0.70-1.42],0.9849061125245584
Chapter II Neoplasms,Carcinoma in situ of breast,GUK1,Guanylate kinase,7710,44,0.63 [0.25-1.58],0.3229056549044874
Chapter II Neoplasms,Carcinoma in situ of breast,GUSB,Beta-glucuronidase,9129,48,0.86 [0.57-1.30],0.4726242671338344
Chapter II Neoplasms,Carcinoma in situ of breast,GYS1,"Glycogen [starch] synthase, muscle",8895,49,0.84 [0.64-1.12],0.2384906082320436
Chapter II Neoplasms,Carcinoma in situ of breast,GZMA,Granzyme A,9160,50,0.74 [0.36-1.53],0.41616872123479
Chapter II Neoplasms,Carcinoma in situ of breast,GZMB,Granzyme B,9043,49,0.89 [0.58-1.36],0.5836936533389553
Chapter II Neoplasms,Carcinoma in situ of breast,GZMH,Granzyme H,8895,49,0.69 [0.47-1.02],0.0630165097782557
Chapter II Neoplasms,Carcinoma in situ of breast,H2AP,Huntingtin-interacting protein M,7678,44,0.73 [0.34-1.55],0.4062225693167628
Chapter II Neoplasms,Carcinoma in situ of breast,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",7710,44,1.01 [0.67-1.53],0.9530012359387792
Chapter II Neoplasms,Carcinoma in situ of breast,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",9110,50,0.86 [0.61-1.22],0.4009059626770979
Chapter II Neoplasms,Carcinoma in situ of breast,HAO1,Hydroxyacid oxidase 1,9145,50,1.00 [0.83-1.21],0.9770478017058766
Chapter II Neoplasms,Carcinoma in situ of breast,HARS1,"Histidine--tRNA ligase, cytoplasmic",9075,49,0.89 [0.64-1.24],0.506747915439983
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR1,Hepatitis A virus cellular receptor 1,9128,50,0.88 [0.58-1.33],0.5408742233375334
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR2,Hepatitis A virus cellular receptor 2,9075,49,1.78 [0.89-3.58],0.104425339770142
Chapter II Neoplasms,Carcinoma in situ of breast,HBEGF,Proheparin-binding EGF-like growth factor,9110,50,0.76 [0.54-1.07],0.1187318826655773
Chapter II Neoplasms,Carcinoma in situ of breast,HBQ1,Hemoglobin subunit theta-1,9145,50,0.76 [0.50-1.17],0.2131531918205884
Chapter II Neoplasms,Carcinoma in situ of breast,HBZ,Hemoglobin subunit zeta,7948,45,1.06 [0.82-1.38],0.6437534115575774
Chapter II Neoplasms,Carcinoma in situ of breast,HCG22,Protein PBMUCL2,7710,44,0.62 [0.27-1.38],0.2398835510470088
Chapter II Neoplasms,Carcinoma in situ of breast,HCLS1,Hematopoietic lineage cell-specific protein,9160,50,0.83 [0.53-1.30],0.4203266199091398
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC8,Histone deacetylase 8,7735,44,0.82 [0.45-1.50],0.5204450817647297
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC9,Histone deacetylase 9,7686,45,1.16 [0.80-1.66],0.4340729276808334
Chapter II Neoplasms,Carcinoma in situ of breast,HDDC2,5'-deoxynucleotidase HDDC2,7914,45,0.71 [0.36-1.39],0.318764987973149
Chapter II Neoplasms,Carcinoma in situ of breast,HDGF,Hepatoma-derived growth factor,9132,50,1.13 [0.87-1.46],0.3572594734023149
Chapter II Neoplasms,Carcinoma in situ of breast,HDGFL2,Hepatoma-derived growth factor-related protein 2,7945,46,1.09 [0.70-1.69],0.702335533152803
Chapter II Neoplasms,Carcinoma in situ of breast,HEBP1,Heme-binding protein 1,8895,49,1.16 [0.79-1.70],0.4498356299063366
Chapter II Neoplasms,Carcinoma in situ of breast,HEG1,Protein HEG homolog 1,7807,44,0.54 [0.18-1.58],0.2588596877401331
Chapter II Neoplasms,Carcinoma in situ of breast,HEPACAM2,HEPACAM family member 2,7945,46,1.12 [0.56-2.27],0.7417410624170804
Chapter II Neoplasms,Carcinoma in situ of breast,HEPH,Hephaestin,7948,45,1.59 [0.50-5.02],0.4324597689949283
Chapter II Neoplasms,Carcinoma in situ of breast,HEXIM1,Protein HEXIM1,9043,49,0.82 [0.59-1.13],0.2201220049456091
Chapter II Neoplasms,Carcinoma in situ of breast,HGF,Hepatocyte growth factor,9160,50,0.94 [0.45-1.98],0.8769247839841741
Chapter II Neoplasms,Carcinoma in situ of breast,HGFAC,Hepatocyte growth factor activator,7874,43,0.74 [0.37-1.47],0.38848112828227
Chapter II Neoplasms,Carcinoma in situ of breast,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,8869,47,0.78 [0.55-1.11],0.1684640991484131
Chapter II Neoplasms,Carcinoma in situ of breast,HHEX,Hematopoietically-expressed homeobox protein HHEX,7945,46,1.01 [0.69-1.48],0.96109373198804
Chapter II Neoplasms,Carcinoma in situ of breast,HIF1A,Hypoxia-inducible factor 1-alpha,7735,44,0.90 [0.55-1.49],0.6908707602356723
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1,Huntingtin-interacting protein 1,7710,44,1.27 [0.61-2.64],0.5181670043898705
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1R,Huntingtin-interacting protein 1-related protein,7927,46,0.99 [0.51-1.90],0.9668339075925888
Chapter II Neoplasms,Carcinoma in situ of breast,HJV,Hemojuvelin,7937,45,1.30 [0.81-2.10],0.2790809194929119
Chapter II Neoplasms,Carcinoma in situ of breast,HK2,Hexokinase-2,8895,49,1.87 [0.88-3.97],0.1017508330055045
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",7937,45,1.53 [0.63-3.73],0.3515870759736161
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",9020,49,1.41 [0.73-2.75],0.3083812780589188
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",9043,49,0.98 [0.41-2.33],0.9613016423109444
Chapter II Neoplasms,Carcinoma in situ of breast,HMBS,Porphobilinogen deaminase,9145,50,0.72 [0.42-1.24],0.2357190467673444
Chapter II Neoplasms,Carcinoma in situ of breast,HMCN2,Hemicentin-2,7794,44,1.03 [0.62-1.71],0.911243567227526
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",7776,44,1.40 [0.82-2.40],0.2224319762867765
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",7710,44,0.90 [0.45-1.81],0.7762998001300176
Chapter II Neoplasms,Carcinoma in situ of breast,HMMR,Hyaluronan mediated motility receptor,7664,44,0.86 [0.45-1.65],0.6419571367759956
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX1,Heme oxygenase 1,8966,49,1.08 [0.63-1.86],0.7805827782877672
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX2,Heme oxygenase 2,8849,49,1.25 [0.76-2.07],0.3788732744590437
Chapter II Neoplasms,Carcinoma in situ of breast,HNF1A,Hepatocyte nuclear factor 1-alpha,7742,44,1.04 [0.70-1.54],0.8345816730031304
Chapter II Neoplasms,Carcinoma in situ of breast,HNMT,Histamine N-methyltransferase,8959,49,1.00 [0.59-1.70],0.9992643340700734
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,8874,49,0.88 [0.62-1.24],0.4539333603291843
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,7937,45,1.05 [0.58-1.89],0.8733353723386429
Chapter II Neoplasms,Carcinoma in situ of breast,HPCAL1,Hippocalcin-like protein 1,9160,50,0.90 [0.64-1.27],0.5470068361737531
Chapter II Neoplasms,Carcinoma in situ of breast,HPGDS,Hematopoietic prostaglandin D synthase,8869,47,1.27 [0.65-2.47],0.4903283386472266
Chapter II Neoplasms,Carcinoma in situ of breast,HPSE,Heparanase,7856,46,0.85 [0.62-1.14],0.2767059441620815
Chapter II Neoplasms,Carcinoma in situ of breast,HRAS,GTPase Hras,7804,44,1.13 [0.91-1.42],0.267483725735367
Chapter II Neoplasms,Carcinoma in situ of breast,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,7776,44,0.97 [0.42-2.24],0.9432126788934092
Chapter II Neoplasms,Carcinoma in situ of breast,HRG,Histidine-rich glycoprotein,7918,41,0.51 [0.20-1.31],0.1622351795100678
Chapter II Neoplasms,Carcinoma in situ of breast,HS1BP3,HCLS1-binding protein 3,7776,44,0.90 [0.64-1.27],0.550385272302928
Chapter II Neoplasms,Carcinoma in situ of breast,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,9033,51,1.08 [0.56-2.08],0.8143118837176817
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,9145,50,0.83 [0.40-1.73],0.6138958135422048
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,7735,44,1.35 [0.53-3.42],0.5291678644604543
Chapter II Neoplasms,Carcinoma in situ of breast,HSBP1,Heat shock factor-binding protein 1,7776,44,0.83 [0.61-1.14],0.2569679403180079
Chapter II Neoplasms,Carcinoma in situ of breast,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,9043,49,1.59 [0.84-3.00],0.1525315824754191
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,7945,46,1.25 [0.81-1.92],0.3153853430978934
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B3,Testosterone 17-beta-dehydrogenase 3,7710,44,1.18 [0.69-2.00],0.5494921803556063
Chapter II Neoplasms,Carcinoma in situ of breast,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,7776,44,0.59 [0.30-1.14],0.1154462429211771
Chapter II Neoplasms,Carcinoma in situ of breast,HSP90B1,Endoplasmin,8808,49,1.01 [0.71-1.45],0.9422326434047906
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA1A,Heat shock 70 kDa protein 1A,9106,50,0.93 [0.65-1.32],0.674535718041724
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA2,Heat shock-related 70 kDa protein 2,7924,45,0.96 [0.40-2.32],0.9304816755234758
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB1,Heat shock protein beta-1,8931,48,0.69 [0.49-0.97],0.031881818629905
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB6,Heat shock protein beta-6,9145,50,1.15 [0.59-2.27],0.6787859031581218
Chapter II Neoplasms,Carcinoma in situ of breast,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,9022,50,2.11 [0.89-4.97],0.0889426757123112
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1A,5-hydroxytryptamine receptor 1A,7686,45,0.93 [0.64-1.36],0.7234665566910952
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1B,5-hydroxytryptamine receptor 1B,7686,45,1.14 [0.62-2.11],0.6697407666728032
Chapter II Neoplasms,Carcinoma in situ of breast,HTRA2,"Serine protease HTRA2, mitochondrial",9106,50,0.83 [0.54-1.25],0.371036411215244
Chapter II Neoplasms,Carcinoma in situ of breast,HYAL1,Hyaluronidase-1,9030,50,3.64 [1.57-8.44],0.0026083501242479
Chapter II Neoplasms,Carcinoma in situ of breast,HYOU1,Hypoxia up-regulated protein 1,9177,49,1.36 [0.43-4.30],0.5993580370447504
Chapter II Neoplasms,Carcinoma in situ of breast,ICA1,Islet cell autoantigen 1,8903,49,0.84 [0.60-1.17],0.3029900013995559
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM1,Intercellular adhesion molecule 1,9041,50,1.57 [0.66-3.71],0.3033673271839888
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM2,Intercellular adhesion molecule 2,9177,49,0.96 [0.43-2.15],0.9299310445669824
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM3,Intercellular adhesion molecule 3,9177,49,1.90 [0.71-5.13],0.2025682037843481
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM4,Intercellular adhesion molecule 4,9043,49,0.96 [0.59-1.54],0.8566445538761513
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM5,Intercellular adhesion molecule 5,9066,49,1.10 [0.62-1.94],0.7420540236949447
Chapter II Neoplasms,Carcinoma in situ of breast,ICOSLG,ICOS ligand,9033,51,2.49 [0.72-8.56],0.1489387030064701
Chapter II Neoplasms,Carcinoma in situ of breast,ID4,DNA-binding protein inhibitor ID-4,7824,45,1.14 [0.62-2.07],0.6783541377847001
Chapter II Neoplasms,Carcinoma in situ of breast,IDI2,Isopentenyl-diphosphate delta-isomerase 2,8849,49,0.85 [0.48-1.51],0.574690220279534
Chapter II Neoplasms,Carcinoma in situ of breast,IDO1,"Indoleamine 2,3-dioxygenase 1",7776,44,0.91 [0.58-1.43],0.6801108954255253
Chapter II Neoplasms,Carcinoma in situ of breast,IDS,Iduronate 2-sulfatase,9160,50,0.46 [0.03-8.13],0.5976304513906188
Chapter II Neoplasms,Carcinoma in situ of breast,IDUA,Alpha-L-iduronidase,9145,50,1.03 [0.60-1.77],0.9022307943448906
Chapter II Neoplasms,Carcinoma in situ of breast,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,7707,44,1.06 [0.50-2.26],0.8766353738045388
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,7824,45,0.73 [0.40-1.31],0.287733449275937
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,7824,45,0.85 [0.39-1.88],0.6957872572371817
Chapter II Neoplasms,Carcinoma in situ of breast,IFNAR1,Interferon alpha/beta receptor 1,7914,45,1.29 [0.47-3.57],0.6171259366793292
Chapter II Neoplasms,Carcinoma in situ of breast,IFNG,Interferon gamma,8903,49,0.87 [0.70-1.08],0.2183436156188976
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR1,Interferon gamma receptor 1,9112,50,2.86 [0.89-9.20],0.0771110554489138
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR2,Interferon gamma receptor 2,9005,49,0.94 [0.57-1.53],0.7946521663575413
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL1,Interferon lambda-1,8849,49,1.39 [0.83-2.31],0.2108463075195708
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL2,Interferon lambda-2,7686,45,1.43 [1.05-1.95],0.0238149851070735
Chapter II Neoplasms,Carcinoma in situ of breast,IFNLR1,Interferon lambda receptor 1,9043,49,0.73 [0.35-1.55],0.4179505217385701
Chapter II Neoplasms,Carcinoma in situ of breast,IFNW1,Interferon omega-1,7710,44,1.16 [0.56-2.39],0.6900448413059665
Chapter II Neoplasms,Carcinoma in situ of breast,IFT20,Intraflagellar transport protein 20 homolog,7742,44,1.02 [0.52-2.00],0.9494459898435872
Chapter II Neoplasms,Carcinoma in situ of breast,IGBP1,Immunoglobulin-binding protein 1,7937,45,0.73 [0.45-1.18],0.1988210983056003
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,7686,45,1.30 [0.82-2.07],0.2630717558873465
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,7965,46,1.19 [0.40-3.59],0.7541112674209831
Chapter II Neoplasms,Carcinoma in situ of breast,IGF1R,Insulin-like growth factor 1 receptor,9033,51,1.62 [0.51-5.20],0.4153041709093055
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,7710,44,0.73 [0.34-1.54],0.405969956467731
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2R,Cation-independent mannose-6-phosphate receptor,9075,49,1.07 [0.35-3.29],0.9094032613490954
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP1,Insulin-like growth factor-binding protein 1,9163,49,1.12 [0.91-1.39],0.2904153944454642
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP2,Insulin-like growth factor-binding protein 2,9166,49,1.06 [0.71-1.57],0.7798317191174258
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP3,Insulin-like growth factor-binding protein 3,9120,50,1.68 [0.68-4.18],0.264445275875435
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP4,Insulin-like growth factor-binding protein 4,8969,49,1.60 [0.94-2.72],0.0865714498696343
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP6,Insulin-like growth factor-binding protein 6,9044,50,2.34 [1.12-4.87],0.0232497619960961
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP7,Insulin-like growth factor-binding protein 7,9177,49,1.99 [0.94-4.21],0.0722528257637128
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBPL1,Insulin-like growth factor-binding protein-like 1,9066,49,0.89 [0.42-1.88],0.7573805137192322
Chapter II Neoplasms,Carcinoma in situ of breast,IGFL4,Insulin growth factor-like family member 4,7735,44,1.04 [0.73-1.49],0.817482160330065
Chapter II Neoplasms,Carcinoma in situ of breast,IGHMBP2,DNA-binding protein SMUBP-2,7710,44,1.04 [0.62-1.75],0.8818003360236109
Chapter II Neoplasms,Carcinoma in situ of breast,IGLC2,Immunoglobulin lambda constant 2,7948,42,0.75 [0.18-3.10],0.686867900248515
Chapter II Neoplasms,Carcinoma in situ of breast,IGLON5,IgLON family member 5,7678,44,0.73 [0.46-1.16],0.1823924214048979
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF21,Immunoglobulin superfamily member 21,7776,44,0.73 [0.31-1.69],0.4602104422358256
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF3,Immunoglobulin superfamily member 3,9033,51,0.60 [0.27-1.31],0.2014681732956609
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF8,Immunoglobulin superfamily member 8,9066,49,0.56 [0.23-1.38],0.2112402379389095
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF9,Protein turtle homolog A,7948,45,0.87 [0.61-1.24],0.453329230460628
Chapter II Neoplasms,Carcinoma in situ of breast,IKBKG,NF-kappa-B essential modulator,9043,49,0.89 [0.67-1.18],0.4312536763574748
Chapter II Neoplasms,Carcinoma in situ of breast,IKZF2,Zinc finger protein Helios,8869,47,0.89 [0.63-1.26],0.5102991419671699
Chapter II Neoplasms,Carcinoma in situ of breast,IL10,Interleukin-10,8903,49,1.25 [1.00-1.55],0.0478154068665382
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RA,Interleukin-10 receptor subunit alpha,8903,49,1.24 [0.90-1.70],0.1847090018715174
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RB,Interleukin-10 receptor subunit beta,9112,50,1.28 [0.55-2.97],0.5645602083419305
Chapter II Neoplasms,Carcinoma in situ of breast,IL11,Interleukin-11,8903,49,1.15 [0.83-1.59],0.400982069516015
Chapter II Neoplasms,Carcinoma in situ of breast,IL12A_IL12B,Interleukin-12,9033,51,0.90 [0.66-1.24],0.5335040336081902
Chapter II Neoplasms,Carcinoma in situ of breast,IL12B,Interleukin-12 subunit beta,9160,50,0.95 [0.60-1.49],0.8210390115953865
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB1,Interleukin-12 receptor subunit beta-1,8903,49,1.09 [0.55-2.13],0.805879408483715
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB2,Interleukin-12 receptor subunit beta-2,7735,44,0.96 [0.47-1.98],0.9131552932445066
Chapter II Neoplasms,Carcinoma in situ of breast,IL13,Interleukin-13,8903,49,1.24 [0.83-1.85],0.2908827367597516
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA1,Interleukin-13 receptor subunit alpha-1,8965,48,1.43 [0.41-4.99],0.5717359935050568
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA2,Interleukin-13 receptor subunit alpha-2,7686,45,0.63 [0.23-1.72],0.3667350579954166
Chapter II Neoplasms,Carcinoma in situ of breast,IL15,Interleukin-15,9043,49,0.94 [0.44-2.00],0.8767050489708863
Chapter II Neoplasms,Carcinoma in situ of breast,IL15RA,Interleukin-15 receptor subunit alpha,8903,49,1.62 [0.80-3.30],0.1834319149661694
Chapter II Neoplasms,Carcinoma in situ of breast,IL16,Pro-interleukin-16,9160,50,1.13 [0.63-2.03],0.6797201179734034
Chapter II Neoplasms,Carcinoma in situ of breast,IL17A,Interleukin-17A,8894,49,0.94 [0.52-1.70],0.8313887136417177
Chapter II Neoplasms,Carcinoma in situ of breast,IL17C,Interleukin-17C,8903,49,1.07 [0.76-1.51],0.6894728768686011
Chapter II Neoplasms,Carcinoma in situ of breast,IL17D,Interleukin-17D,8903,49,1.04 [0.49-2.18],0.926654143758392
Chapter II Neoplasms,Carcinoma in situ of breast,IL17F,Interleukin-17F,8903,49,1.14 [0.86-1.51],0.3476484423468385
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RA,Interleukin-17 receptor A,9075,49,1.04 [0.58-1.85],0.90473889034383
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RB,Interleukin-17 receptor B,8929,49,1.13 [0.70-1.83],0.624529284825079
Chapter II Neoplasms,Carcinoma in situ of breast,IL18,Interleukin-18,9039,50,0.95 [0.56-1.60],0.83816012093701
Chapter II Neoplasms,Carcinoma in situ of breast,IL18BP,Interleukin-18-binding protein,9120,50,2.35 [1.18-4.69],0.0155598345818553
Chapter II Neoplasms,Carcinoma in situ of breast,IL18R1,Interleukin-18 receptor 1,9160,50,0.67 [0.31-1.45],0.3118776044974944
Chapter II Neoplasms,Carcinoma in situ of breast,IL18RAP,Interleukin-18 receptor accessory protein,8945,49,0.97 [0.84-1.13],0.7156373109894565
Chapter II Neoplasms,Carcinoma in situ of breast,IL19,Interleukin-19,8839,48,0.97 [0.66-1.41],0.8614331363149331
Chapter II Neoplasms,Carcinoma in situ of breast,IL1A,Interleukin-1 alpha,8903,49,0.89 [0.54-1.47],0.652660190402795
Chapter II Neoplasms,Carcinoma in situ of breast,IL1B,Interleukin-1 beta,8865,49,0.75 [0.46-1.25],0.2701245053258218
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R1,Interleukin-1 receptor type 1,9064,49,1.11 [0.37-3.35],0.8472930762683146
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R2,Interleukin-1 receptor type 2,9056,50,1.56 [0.43-5.73],0.5005521811971687
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RAP,Interleukin-1 receptor accessory protein,9075,49,1.02 [0.57-1.82],0.9544267320471558
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL1,Interleukin-1 receptor-like 1,9159,49,1.34 [0.75-2.40],0.327853791942245
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL2,Interleukin-1 receptor-like 2,8903,49,1.11 [0.57-2.15],0.7690694275911476
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RN,Interleukin-1 receptor antagonist protein,9068,50,1.14 [0.75-1.71],0.5389132797721282
Chapter II Neoplasms,Carcinoma in situ of breast,IL2,Interleukin-2,8903,49,0.44 [0.20-0.95],0.0371213060547792
Chapter II Neoplasms,Carcinoma in situ of breast,IL20,Interleukin-20,8903,49,1.18 [0.80-1.75],0.406998147546758
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RA,Interleukin-20 receptor subunit alpha,8903,49,0.96 [0.54-1.70],0.8788746881558572
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RB,Interleukin-20 receptor subunit beta,7735,44,1.16 [0.59-2.27],0.6632320567320009
Chapter II Neoplasms,Carcinoma in situ of breast,IL21R,Interleukin-21 receptor,7735,44,1.02 [0.62-1.68],0.9329363852937504
Chapter II Neoplasms,Carcinoma in situ of breast,IL22,Interleukin-22,7924,45,1.05 [0.70-1.60],0.8021582953544799
Chapter II Neoplasms,Carcinoma in situ of breast,IL22RA1,Interleukin-22 receptor subunit alpha-1,8903,49,1.12 [0.66-1.90],0.684524505588906
Chapter II Neoplasms,Carcinoma in situ of breast,IL24,Interleukin-24,8903,49,1.06 [0.64-1.76],0.8144770622409602
Chapter II Neoplasms,Carcinoma in situ of breast,IL25,Interleukin-25,7649,44,0.79 [0.34-1.84],0.5901370073272257
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RA,Interleukin-2 receptor subunit alpha,9003,47,1.82 [1.00-3.30],0.0483789955447994
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RB,Interleukin-2 receptor subunit beta,8903,49,1.04 [0.55-1.98],0.8947778146081771
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RG,Cytokine receptor common subunit gamma,7924,45,0.93 [0.42-2.04],0.8532115054390377
Chapter II Neoplasms,Carcinoma in situ of breast,IL3,Interleukin-3,7678,44,0.83 [0.53-1.30],0.4210858118006254
Chapter II Neoplasms,Carcinoma in situ of breast,IL31,Interleukin-31,7735,44,0.53 [0.26-1.08],0.081839915164229
Chapter II Neoplasms,Carcinoma in situ of breast,IL31RA,Interleukin-31 receptor subunit alpha,7702,44,0.93 [0.45-1.94],0.8512077292049115
Chapter II Neoplasms,Carcinoma in situ of breast,IL32,Interleukin-32,9043,49,0.90 [0.49-1.63],0.7203050351328142
Chapter II Neoplasms,Carcinoma in situ of breast,IL33,Interleukin-33,8903,49,1.06 [0.55-2.05],0.8687451396160086
Chapter II Neoplasms,Carcinoma in situ of breast,IL34,Interleukin-34,8838,49,0.71 [0.36-1.41],0.3296550393213529
Chapter II Neoplasms,Carcinoma in situ of breast,IL36A,Interleukin-36 alpha,7735,44,0.54 [0.27-1.09],0.0860038424829983
Chapter II Neoplasms,Carcinoma in situ of breast,IL36G,Interleukin-36 gamma,7696,44,0.80 [0.49-1.32],0.3905453897658946
Chapter II Neoplasms,Carcinoma in situ of breast,IL3RA,Interleukin-3 receptor subunit alpha,8903,49,1.45 [0.70-3.01],0.3121261658807953
Chapter II Neoplasms,Carcinoma in situ of breast,IL4,Interleukin-4,8903,49,1.04 [0.78-1.40],0.7733179692710198
Chapter II Neoplasms,Carcinoma in situ of breast,IL4R,Interleukin-4 receptor subunit alpha,9043,49,1.25 [0.63-2.49],0.5217200651019267
Chapter II Neoplasms,Carcinoma in situ of breast,IL5,Interleukin-5,8903,49,1.04 [0.88-1.23],0.6563922615218436
Chapter II Neoplasms,Carcinoma in situ of breast,IL5RA,Interleukin-5 receptor subunit alpha,9043,49,1.38 [0.89-2.15],0.1529064503424773
Chapter II Neoplasms,Carcinoma in situ of breast,IL6,Interleukin-6,9033,51,0.85 [0.58-1.24],0.3944145695935628
Chapter II Neoplasms,Carcinoma in situ of breast,IL6R,Interleukin-6 receptor subunit alpha,9026,50,1.88 [0.91-3.91],0.0899215958308571
Chapter II Neoplasms,Carcinoma in situ of breast,IL6ST,Interleukin-6 receptor subunit beta,9066,49,0.82 [0.18-3.66],0.7954339356534968
Chapter II Neoplasms,Carcinoma in situ of breast,IL7,Interleukin-7,9043,49,0.87 [0.58-1.29],0.4856906477015544
Chapter II Neoplasms,Carcinoma in situ of breast,IL7R,Interleukin-7 receptor subunit alpha,9075,49,1.28 [0.78-2.10],0.3341600073350983
Chapter II Neoplasms,Carcinoma in situ of breast,IL9,Interleukin-9,7824,45,1.26 [0.85-1.86],0.252595063978955
Chapter II Neoplasms,Carcinoma in situ of breast,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,8838,47,0.61 [0.37-1.01],0.0556632263318063
Chapter II Neoplasms,Carcinoma in situ of breast,IMMT,MICOS complex subunit MIC60,7924,45,0.77 [0.37-1.58],0.470073779188472
Chapter II Neoplasms,Carcinoma in situ of breast,IMPA1,Inositol monophosphatase 1,9005,49,0.93 [0.61-1.42],0.7335109379648274
Chapter II Neoplasms,Carcinoma in situ of breast,IMPACT,Protein IMPACT,7945,46,0.69 [0.42-1.15],0.1592581098396183
Chapter II Neoplasms,Carcinoma in situ of breast,IMPG1,Interphotoreceptor matrix proteoglycan 1,7686,45,0.85 [0.32-2.29],0.7457035635361855
Chapter II Neoplasms,Carcinoma in situ of breast,ING1,Inhibitor of growth protein 1,8830,49,1.12 [0.65-1.92],0.6874391485871991
Chapter II Neoplasms,Carcinoma in situ of breast,INHBB,Inhibin beta B chain,7807,44,1.10 [0.63-1.89],0.7437002570059931
Chapter II Neoplasms,Carcinoma in situ of breast,INHBC,Inhibin beta C chain,9075,49,0.67 [0.38-1.19],0.1713580269898658
Chapter II Neoplasms,Carcinoma in situ of breast,INPP1,Inositol polyphosphate 1-phosphatase,9033,51,1.19 [0.75-1.87],0.4626225150689234
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",7776,44,0.52 [0.30-0.91],0.0207338049382935
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",7937,45,0.70 [0.33-1.48],0.3493678959785961
Chapter II Neoplasms,Carcinoma in situ of breast,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",9033,51,0.81 [0.63-1.06],0.1228834679289637
Chapter II Neoplasms,Carcinoma in situ of breast,INSL3,Insulin-like 3,7945,46,0.78 [0.51-1.19],0.2525146753721797
Chapter II Neoplasms,Carcinoma in situ of breast,INSL4,Early placenta insulin-like peptide,7924,45,1.06 [0.60-1.87],0.8517423122577719
Chapter II Neoplasms,Carcinoma in situ of breast,INSL5,Insulin-like peptide INSL5,7914,45,1.02 [0.75-1.38],0.9058806375406316
Chapter II Neoplasms,Carcinoma in situ of breast,INSR,Insulin receptor,7735,44,1.67 [0.29-9.50],0.563977063895124
Chapter II Neoplasms,Carcinoma in situ of breast,IPCEF1,Interactor protein for cytohesin exchange factors 1,8991,49,0.86 [0.65-1.14],0.298666622422535
Chapter II Neoplasms,Carcinoma in situ of breast,IQGAP2,Ras GTPase-activating-like protein IQGAP2,9033,51,0.92 [0.58-1.46],0.7105271413210934
Chapter II Neoplasms,Carcinoma in situ of breast,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",8895,49,1.02 [0.76-1.36],0.9146337098407312
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK1,Interleukin-1 receptor-associated kinase 1,8903,49,0.86 [0.58-1.27],0.4422687437831714
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK4,Interleukin-1 receptor-associated kinase 4,9043,49,0.94 [0.74-1.20],0.6111733178662321
Chapter II Neoplasms,Carcinoma in situ of breast,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8733,49,0.81 [0.41-1.62],0.5594833206551262
Chapter II Neoplasms,Carcinoma in situ of breast,ISM1,Isthmin-1,9043,49,0.90 [0.47-1.72],0.7484259337336011
Chapter II Neoplasms,Carcinoma in situ of breast,ISM2,Isthmin-2,7965,46,0.85 [0.43-1.67],0.6331698742805121
Chapter II Neoplasms,Carcinoma in situ of breast,IST1,IST1 homolog,7851,44,0.87 [0.65-1.17],0.3524701663114263
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA11,Integrin alpha-11,9043,49,1.66 [0.86-3.22],0.1305193937519408
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA2,Integrin alpha-2,7807,44,0.72 [0.31-1.69],0.4498698871663416
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA5,Integrin alpha-5,9075,49,1.17 [0.42-3.20],0.7651197093217057
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA6,Integrin alpha-6,9043,49,1.29 [0.83-1.98],0.2551806340123143
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAL,Integrin alpha-L,7735,44,1.17 [0.59-2.32],0.6627005581331264
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAM,Integrin alpha-M,9075,49,1.81 [0.84-3.93],0.1324448553543565
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAV,Integrin alpha-V,9145,50,2.37 [0.47-11.92],0.2948618149456116
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAX,Integrin alpha-X,7824,45,0.73 [0.39-1.35],0.3173122567899079
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1,Integrin beta-1,9081,50,2.71 [1.01-7.27],0.0468443810689291
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP1,Integrin beta-1-binding protein 1,8869,47,0.73 [0.41-1.32],0.3017130777279118
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP2,Integrin beta-1-binding protein 2,8895,49,0.86 [0.68-1.08],0.1907894344875403
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB2,Integrin beta-2,9016,48,2.28 [0.96-5.42],0.0621716771507791
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB5,Integrin beta-5,9106,50,0.93 [0.48-1.82],0.8343277720650589
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB6,Integrin beta-6,8903,49,1.35 [0.58-3.18],0.4857850311451397
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB7,Integrin beta-7,9145,50,0.92 [0.52-1.62],0.7595787396392916
Chapter II Neoplasms,Carcinoma in situ of breast,ITGBL1,Integrin beta-like protein 1,7965,46,0.72 [0.31-1.65],0.4365069302109434
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,7968,42,0.92 [0.19-4.44],0.9204057767387848
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,9120,50,2.40 [1.19-4.84],0.014108375575277
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,7968,42,2.54 [1.03-6.28],0.0427942554321141
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,7924,45,1.47 [0.98-2.22],0.0653668676317277
Chapter II Neoplasms,Carcinoma in situ of breast,ITM2A,Integral membrane protein 2A,9043,49,1.00 [0.65-1.54],0.9885427280945452
Chapter II Neoplasms,Carcinoma in situ of breast,ITPA,Inosine triphosphate pyrophosphatase,7710,44,0.94 [0.61-1.46],0.7946708651853733
Chapter II Neoplasms,Carcinoma in situ of breast,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",7776,44,0.85 [0.53-1.34],0.4766738239121911
Chapter II Neoplasms,Carcinoma in situ of breast,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",7686,45,1.17 [0.64-2.15],0.6057620156772529
Chapter II Neoplasms,Carcinoma in situ of breast,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",8849,49,1.26 [0.80-1.98],0.3170958621304641
Chapter II Neoplasms,Carcinoma in situ of breast,IZUMO1,Izumo sperm-egg fusion protein 1,7678,44,1.21 [0.67-2.17],0.5239431696840879
Chapter II Neoplasms,Carcinoma in situ of breast,JAM2,Junctional adhesion molecule B,9138,49,0.67 [0.24-1.86],0.4466884302592142
Chapter II Neoplasms,Carcinoma in situ of breast,JAM3,Junctional adhesion molecule C,7807,44,1.24 [0.71-2.16],0.4567664685550402
Chapter II Neoplasms,Carcinoma in situ of breast,JCHAIN,Immunoglobulin J chain,8903,49,1.28 [0.86-1.91],0.2227742117231256
Chapter II Neoplasms,Carcinoma in situ of breast,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,7678,44,0.78 [0.44-1.39],0.4058932873639403
Chapter II Neoplasms,Carcinoma in situ of breast,JPT2,Jupiter microtubule associated homolog 2,7914,45,0.85 [0.61-1.19],0.3436326067673291
Chapter II Neoplasms,Carcinoma in situ of breast,JUN,Transcription factor AP-1,8903,49,0.92 [0.52-1.62],0.7695845603998875
Chapter II Neoplasms,Carcinoma in situ of breast,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,9033,51,1.84 [1.00-3.40],0.049946853484891
Chapter II Neoplasms,Carcinoma in situ of breast,KAZN,Kazrin,7914,45,0.80 [0.60-1.05],0.1044750330847681
Chapter II Neoplasms,Carcinoma in situ of breast,KCNC4,Potassium voltage-gated channel subfamily C member 4,7686,45,0.86 [0.48-1.55],0.6213454165797607
Chapter II Neoplasms,Carcinoma in situ of breast,KCNH2,Potassium voltage-gated channel subfamily H member 2,7742,44,0.96 [0.65-1.42],0.8466412428143171
Chapter II Neoplasms,Carcinoma in situ of breast,KCNIP4,Kv channel-interacting protein 4,8849,49,1.20 [0.78-1.83],0.4016418762714269
Chapter II Neoplasms,Carcinoma in situ of breast,KCTD5,BTB/POZ domain-containing protein KCTD5,7804,45,1.00 [0.51-1.95],0.9995914530958108
Chapter II Neoplasms,Carcinoma in situ of breast,KDM3A,Lysine-specific demethylase 3A,7735,44,0.96 [0.68-1.36],0.8117836333589743
Chapter II Neoplasms,Carcinoma in situ of breast,KDR,Vascular endothelial growth factor receptor 2,9106,50,0.52 [0.19-1.42],0.2030327150233576
Chapter II Neoplasms,Carcinoma in situ of breast,KEL,Kell blood group glycoprotein,8849,49,0.84 [0.42-1.70],0.6289333229130286
Chapter II Neoplasms,Carcinoma in situ of breast,KHDC3L,KH domain-containing protein 3,7678,44,1.08 [0.73-1.59],0.6959420322811622
Chapter II Neoplasms,Carcinoma in situ of breast,KHK,Ketohexokinase,7776,44,0.97 [0.62-1.53],0.9112793312984244
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA0319,Dyslexia-associated protein KIAA0319,7945,46,2.15 [1.12-4.14],0.0218716841305092
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549,UPF0606 protein KIAA1549,7824,45,0.93 [0.62-1.39],0.7222618352795632
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549L,UPF0606 protein KIAA1549L,7824,45,0.69 [0.24-1.96],0.483815597622843
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA2013,Uncharacterized protein KIAA2013,7924,45,0.86 [0.48-1.55],0.6236005926710437
Chapter II Neoplasms,Carcinoma in situ of breast,KIF1C,Kinesin-like protein KIF1C,7710,44,1.13 [0.50-2.56],0.7723236149410986
Chapter II Neoplasms,Carcinoma in situ of breast,KIF20B,Kinesin-like protein KIF20B,7686,45,0.98 [0.68-1.43],0.9294221034450876
Chapter II Neoplasms,Carcinoma in situ of breast,KIF22,Kinesin-like protein KIF22,7710,44,0.89 [0.70-1.13],0.3454275512592172
Chapter II Neoplasms,Carcinoma in situ of breast,KIFBP,KIF-binding protein,9033,51,0.99 [0.73-1.34],0.929070351482032
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,7924,45,1.00 [0.73-1.38],0.987438740811048
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,8869,47,0.92 [0.66-1.28],0.6164936523095131
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,7914,45,1.08 [0.92-1.26],0.3693004434847685
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,8869,47,0.98 [0.80-1.21],0.8832043913249429
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,7678,44,1.15 [0.87-1.51],0.338639941743877
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL1,Kin of IRRE-like protein 1,7686,45,0.57 [0.27-1.22],0.146215990136162
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL2,Kin of IRRE-like protein 2,8849,49,0.60 [0.31-1.16],0.1261227885345181
Chapter II Neoplasms,Carcinoma in situ of breast,KIT,Mast/stem cell growth factor receptor Kit,9101,50,3.27 [1.54-6.94],0.0020830741771837
Chapter II Neoplasms,Carcinoma in situ of breast,KITLG,Kit ligand,9066,49,2.16 [1.05-4.43],0.0363862885375166
Chapter II Neoplasms,Carcinoma in situ of breast,KLB,Beta-klotho,8849,49,1.17 [0.83-1.66],0.358779559606615
Chapter II Neoplasms,Carcinoma in situ of breast,KLF4,Krueppel-like factor 4,7686,45,1.15 [0.57-2.33],0.6878417516280844
Chapter II Neoplasms,Carcinoma in situ of breast,KLHL41,Kelch-like protein 41,7937,45,0.78 [0.39-1.53],0.4665423351762562
Chapter II Neoplasms,Carcinoma in situ of breast,KLK1,Kallikrein-1,8975,49,0.98 [0.80-1.19],0.8141154572032804
Chapter II Neoplasms,Carcinoma in situ of breast,KLK10,Kallikrein-10,9072,50,0.71 [0.37-1.35],0.2985402282037578
Chapter II Neoplasms,Carcinoma in situ of breast,KLK11,Kallikrein-11,9021,50,1.43 [0.70-2.93],0.322544160504105
Chapter II Neoplasms,Carcinoma in situ of breast,KLK12,Kallikrein-12,8869,47,1.04 [0.86-1.25],0.6729633364646939
Chapter II Neoplasms,Carcinoma in situ of breast,KLK13,Kallikrein-13,8871,51,1.09 [0.62-1.89],0.772345903935405
Chapter II Neoplasms,Carcinoma in situ of breast,KLK14,Kallikrein-14,9145,50,1.86 [1.10-3.13],0.0196999511922925
Chapter II Neoplasms,Carcinoma in situ of breast,KLK15,Kallikrein-15,7915,45,1.00 [0.58-1.74],0.9933955005966713
Chapter II Neoplasms,Carcinoma in situ of breast,KLK3,Prostate-specific antigen,7965,46,1.10 [0.69-1.75],0.6829897267368965
Chapter II Neoplasms,Carcinoma in situ of breast,KLK4,Kallikrein-4,9145,50,1.39 [0.95-2.04],0.0939767894741802
Chapter II Neoplasms,Carcinoma in situ of breast,KLK6,Kallikrein-6,9090,50,2.28 [1.01-5.12],0.0461076600213658
Chapter II Neoplasms,Carcinoma in situ of breast,KLK7,Kallikrein-7,7618,44,0.88 [0.41-1.88],0.7398619231686219
Chapter II Neoplasms,Carcinoma in situ of breast,KLK8,Kallikrein-8,8774,49,1.83 [0.98-3.41],0.0588961812677401
Chapter II Neoplasms,Carcinoma in situ of breast,KLKB1,Plasma kallikrein,7795,40,0.46 [0.14-1.47],0.1896457578006842
Chapter II Neoplasms,Carcinoma in situ of breast,KLRB1,Killer cell lectin-like receptor subfamily B member 1,9160,50,0.84 [0.43-1.65],0.6152160099344384
Chapter II Neoplasms,Carcinoma in situ of breast,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,7686,45,0.73 [0.40-1.34],0.3138829987580263
Chapter II Neoplasms,Carcinoma in situ of breast,KLRD1,Natural killer cells antigen CD94,9160,50,0.88 [0.50-1.53],0.6452699024939542
Chapter II Neoplasms,Carcinoma in situ of breast,KLRF1,Killer cell lectin-like receptor subfamily F member 1,7735,44,1.12 [0.66-1.91],0.6818061179367798
Chapter II Neoplasms,Carcinoma in situ of breast,KLRK1,NKG2-D type II integral membrane protein,7945,46,0.59 [0.34-1.04],0.0663333058973049
Chapter II Neoplasms,Carcinoma in situ of breast,KRT14,"Keratin, type I cytoskeletal 14",8559,46,0.53 [0.18-1.55],0.248117927311431
Chapter II Neoplasms,Carcinoma in situ of breast,KRT17,"Keratin, type I cytoskeletal 17",7710,44,0.96 [0.43-2.14],0.915462040187832
Chapter II Neoplasms,Carcinoma in situ of breast,KRT18,"Keratin, type I cytoskeletal 18",9033,51,0.83 [0.60-1.14],0.2574945568699892
Chapter II Neoplasms,Carcinoma in situ of breast,KRT19,"Keratin, type I cytoskeletal 19",9026,49,1.40 [1.01-1.95],0.046037122156667
Chapter II Neoplasms,Carcinoma in situ of breast,KRT5,"Keratin, type II cytoskeletal 5",8849,49,1.05 [0.62-1.78],0.865533329132802
Chapter II Neoplasms,Carcinoma in situ of breast,KRT6C,"Keratin, type II cytoskeletal 6C",7710,44,1.23 [0.64-2.36],0.5293725508044619
Chapter II Neoplasms,Carcinoma in situ of breast,KRT8,"Keratin, type II cytoskeletal 8",7686,45,0.84 [0.53-1.34],0.4641498252985916
Chapter II Neoplasms,Carcinoma in situ of breast,KYAT1,Kynurenine--oxoglutarate transaminase 1,9057,49,0.74 [0.46-1.17],0.1936399544506364
Chapter II Neoplasms,Carcinoma in situ of breast,KYNU,Kynureninase,9160,50,0.76 [0.44-1.33],0.3409458849181074
Chapter II Neoplasms,Carcinoma in situ of breast,L1CAM,Neural cell adhesion molecule L1,9106,50,1.31 [0.55-3.12],0.5404771001128581
Chapter II Neoplasms,Carcinoma in situ of breast,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,7948,45,0.94 [0.68-1.29],0.6967364816628538
Chapter II Neoplasms,Carcinoma in situ of breast,LACRT,Extracellular glycoprotein lacritin,7903,44,1.18 [0.75-1.86],0.4646708868172379
Chapter II Neoplasms,Carcinoma in situ of breast,LACTB2,Endoribonuclease LACTB2,9066,49,0.74 [0.50-1.11],0.1424215468196234
Chapter II Neoplasms,Carcinoma in situ of breast,LAG3,Lymphocyte activation gene 3 protein,9033,51,1.20 [0.67-2.17],0.5410165893342744
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,9065,50,1.65 [0.96-2.84],0.0722814724386136
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,9005,49,0.86 [0.70-1.06],0.1617981348086175
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA1,Laminin subunit alpha-1,7710,44,1.14 [0.72-1.81],0.5685177601878688
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA4,Laminin subunit alpha-4,9112,50,0.81 [0.37-1.78],0.5971904923741134
Chapter II Neoplasms,Carcinoma in situ of breast,LAMB1,Laminin subunit beta-1,7776,44,1.44 [0.53-3.89],0.4696073557565338
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP1,Lysosome-associated membrane glycoprotein 1,7725,46,1.06 [0.41-2.72],0.9099868200016848
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP2,Lysosome-associated membrane glycoprotein 2,8794,48,0.56 [0.14-2.19],0.4025147475214434
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP3,Lysosome-associated membrane glycoprotein 3,9147,50,1.17 [0.72-1.89],0.5326409242066825
Chapter II Neoplasms,Carcinoma in situ of breast,LAMTOR5,Ragulator complex protein LAMTOR5,7924,45,1.40 [0.82-2.41],0.2203961494461067
Chapter II Neoplasms,Carcinoma in situ of breast,LAP3,Cytosol aminopeptidase,8903,49,1.15 [0.67-1.95],0.6106182849011772
Chapter II Neoplasms,Carcinoma in situ of breast,LARP1,La-related protein 1,7924,45,0.77 [0.46-1.29],0.3241227309709538
Chapter II Neoplasms,Carcinoma in situ of breast,LAT,Linker for activation of T-cells family member 1,9160,50,0.85 [0.62-1.18],0.3332937401117857
Chapter II Neoplasms,Carcinoma in situ of breast,LAT2,Linker for activation of T-cells family member 2,9033,51,0.94 [0.76-1.15],0.5240740470696137
Chapter II Neoplasms,Carcinoma in situ of breast,LATS1,Serine/threonine-protein kinase LATS1,7735,44,0.93 [0.65-1.32],0.6736067763256228
Chapter II Neoplasms,Carcinoma in situ of breast,LAYN,Layilin,8986,49,1.13 [0.54-2.34],0.745229660029074
Chapter II Neoplasms,Carcinoma in situ of breast,LBP,Lipopolysaccharide-binding protein,9120,50,1.19 [0.77-1.82],0.4329420043748896
Chapter II Neoplasms,Carcinoma in situ of breast,LBR,Delta(14)-sterol reductase LBR,9138,49,1.11 [0.78-1.58],0.5647367152680831
Chapter II Neoplasms,Carcinoma in situ of breast,LCAT,Phosphatidylcholine-sterol acyltransferase,7955,44,1.30 [0.32-5.25],0.7106730436528848
Chapter II Neoplasms,Carcinoma in situ of breast,LCN15,Lipocalin-15,7937,45,1.04 [0.65-1.65],0.8769417415960608
Chapter II Neoplasms,Carcinoma in situ of breast,LCN2,Neutrophil gelatinase-associated lipocalin,8832,50,1.41 [0.77-2.56],0.2648857508679703
Chapter II Neoplasms,Carcinoma in situ of breast,LCP1,Plastin-2,7965,46,1.06 [0.58-1.92],0.8509922634424143
Chapter II Neoplasms,Carcinoma in situ of breast,LDLR,Low-density lipoprotein receptor,9092,48,0.89 [0.54-1.47],0.6600295052232792
Chapter II Neoplasms,Carcinoma in situ of breast,LDLRAP1,Low density lipoprotein receptor adapter protein 1,7937,45,0.90 [0.66-1.21],0.4659778253241917
Chapter II Neoplasms,Carcinoma in situ of breast,LECT2,Leukocyte cell-derived chemotaxin-2,7948,45,1.16 [0.76-1.76],0.490969432086584
Chapter II Neoplasms,Carcinoma in situ of breast,LEFTY2,Left-right determination factor 2,9127,50,1.24 [0.73-2.10],0.4204220177520024
Chapter II Neoplasms,Carcinoma in situ of breast,LEG1,Protein LEG1 homolog,7546,42,0.95 [0.62-1.46],0.829476016841115
Chapter II Neoplasms,Carcinoma in situ of breast,LELP1,Late cornified envelope-like proline-rich protein 1,7686,45,1.01 [0.69-1.49],0.9443311820299252
Chapter II Neoplasms,Carcinoma in situ of breast,LEO1,RNA polymerase-associated protein LEO1,7937,45,0.56 [0.17-1.83],0.3386024764838334
Chapter II Neoplasms,Carcinoma in situ of breast,LEP,Leptin,9066,49,0.99 [0.65-1.49],0.9445814950323926
Chapter II Neoplasms,Carcinoma in situ of breast,LEPR,Leptin receptor,9066,49,1.18 [0.52-2.66],0.6966501377021508
Chapter II Neoplasms,Carcinoma in situ of breast,LETM1,Mitochondrial proton/calcium exchanger protein,7937,45,0.83 [0.47-1.49],0.5390386926709843
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS1,Galectin-1,9066,49,1.29 [0.62-2.70],0.4981685667136549
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3,Galectin-3,9089,48,1.90 [0.80-4.51],0.1473079358838064
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3BP,Galectin-3-binding protein,7968,42,0.33 [0.11-1.02],0.0537537098570036
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS4,Galectin-4,9065,50,1.09 [0.69-1.74],0.7096053791983461
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS7_LGALS7B,Galectin-7,9043,49,1.46 [0.84-2.53],0.1797581996361346
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS8,Galectin-8,9138,49,0.86 [0.56-1.33],0.4953626044695741
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS9,Galectin-9,9076,50,1.07 [0.49-2.35],0.865027188975825
Chapter II Neoplasms,Carcinoma in situ of breast,LGMN,Legumain,9112,50,0.57 [0.28-1.18],0.1277203043217765
Chapter II Neoplasms,Carcinoma in situ of breast,LHB,Lutropin subunit beta,8869,47,1.00 [0.72-1.39],0.9933408832575072
Chapter II Neoplasms,Carcinoma in situ of breast,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,9086,50,0.75 [0.48-1.17],0.2083262410447528
Chapter II Neoplasms,Carcinoma in situ of breast,LIF,Leukemia inhibitory factor,8849,49,1.10 [0.71-1.68],0.6764548529801917
Chapter II Neoplasms,Carcinoma in situ of breast,LIFR,Leukemia inhibitory factor receptor,9043,49,1.36 [0.48-3.80],0.5623079750645595
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,9075,49,1.33 [0.64-2.77],0.4425100774748272
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,7965,46,1.03 [0.83-1.26],0.8077045852326036
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,7710,44,0.86 [0.45-1.63],0.6385755120026044
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,9050,49,1.24 [0.56-2.78],0.5925677551180855
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,7948,45,0.97 [0.66-1.42],0.8816106324991736
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,9177,49,1.69 [0.66-4.29],0.270430490149924
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,9148,49,1.43 [0.67-3.03],0.350673656545591
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,8903,49,1.29 [0.73-2.26],0.3799124498672906
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,9177,49,0.87 [0.62-1.22],0.4225350240032997
Chapter II Neoplasms,Carcinoma in situ of breast,LIPF,Gastric triacylglycerol lipase,7776,44,1.14 [0.71-1.83],0.5855698726320111
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB1,Lamin-B1,7896,45,1.57 [1.18-2.07],0.0016764290144645
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB2,Lamin-B2,7945,46,1.29 [0.48-3.46],0.6153231036144287
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD1,Leiomodin-1,7937,45,0.97 [0.42-2.21],0.9330510619728334
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD2,Leiomodin-2,7686,45,1.02 [0.64-1.62],0.9316272774078732
Chapter II Neoplasms,Carcinoma in situ of breast,LONP1,"Lon protease homolog, mitochondrial",7776,44,0.88 [0.62-1.25],0.4637319162835271
Chapter II Neoplasms,Carcinoma in situ of breast,LPA,Apolipoprotein(a),7778,40,1.00 [0.84-1.19],0.9850409650884456
Chapter II Neoplasms,Carcinoma in situ of breast,LPCAT2,Lysophosphatidylcholine acyltransferase 2,9033,51,1.50 [1.05-2.14],0.0244397724814059
Chapter II Neoplasms,Carcinoma in situ of breast,LPL,Lipoprotein lipase,9066,49,1.11 [0.64-1.93],0.7130711320969222
Chapter II Neoplasms,Carcinoma in situ of breast,LPO,Lactoperoxidase,8779,48,1.07 [0.71-1.63],0.7429726782956836
Chapter II Neoplasms,Carcinoma in situ of breast,LPP,Lipoma-preferred partner,7710,44,0.83 [0.53-1.30],0.4160217206352464
Chapter II Neoplasms,Carcinoma in situ of breast,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,7710,44,0.75 [0.48-1.19],0.2290165365889555
Chapter II Neoplasms,Carcinoma in situ of breast,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,7742,44,1.31 [0.81-2.12],0.2742089452623718
Chapter II Neoplasms,Carcinoma in situ of breast,LRG1,Leucine-rich alpha-2-glycoprotein,7968,42,2.04 [0.67-6.21],0.2097444190966053
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,9110,50,1.70 [0.83-3.49],0.1485205647934933
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,7703,43,1.41 [0.65-3.05],0.3778888173171932
Chapter II Neoplasms,Carcinoma in situ of breast,LRP1,Prolow-density lipoprotein receptor-related protein 1,9033,51,1.50 [0.60-3.72],0.3845448799997567
Chapter II Neoplasms,Carcinoma in situ of breast,LRP11,Low-density lipoprotein receptor-related protein 11,9066,49,0.96 [0.47-1.95],0.9052108356782942
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2,Low-density lipoprotein receptor-related protein 2,7742,44,0.49 [0.20-1.20],0.1183900863875453
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2BP,LRP2-binding protein,7742,44,1.05 [0.77-1.42],0.7744409760516875
Chapter II Neoplasms,Carcinoma in situ of breast,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,9138,49,1.06 [0.70-1.59],0.7927563668662669
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC25,Leucine-rich repeat-containing protein 25,9033,51,0.87 [0.45-1.69],0.6808919824968482
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC37A2,Leucine-rich repeat-containing protein 37A2,7914,45,1.18 [0.60-2.34],0.6346344739798264
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC38,Leucine-rich repeat-containing protein 38,7742,44,0.97 [0.53-1.77],0.9253686175812446
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC59,Leucine-rich repeat-containing protein 59,7948,45,0.78 [0.41-1.48],0.4498056189132364
Chapter II Neoplasms,Carcinoma in situ of breast,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,7924,45,0.75 [0.40-1.42],0.3755968426812778
Chapter II Neoplasms,Carcinoma in situ of breast,LRRN1,Leucine-rich repeat neuronal protein 1,8903,49,1.53 [0.77-3.02],0.2206667526344401
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,7742,44,0.95 [0.45-2.00],0.8928767295898449
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,7937,45,1.01 [0.35-2.90],0.987914843228227
Chapter II Neoplasms,Carcinoma in situ of breast,LSM1,U6 snRNA-associated Sm-like protein LSm1,8869,47,1.01 [0.64-1.60],0.9684238518872972
Chapter II Neoplasms,Carcinoma in situ of breast,LSM8,U6 snRNA-associated Sm-like protein LSm8,7824,45,1.00 [0.72-1.37],0.9773423420763168
Chapter II Neoplasms,Carcinoma in situ of breast,LSP1,Lymphocyte-specific protein 1,9043,49,1.07 [0.57-2.03],0.8330181572376285
Chapter II Neoplasms,Carcinoma in situ of breast,LTA,Lymphotoxin-alpha,9043,49,1.24 [0.68-2.27],0.4837922987342752
Chapter II Neoplasms,Carcinoma in situ of breast,LTA4H,Leukotriene A-4 hydrolase,9145,50,1.33 [0.87-2.03],0.1866513868219136
Chapter II Neoplasms,Carcinoma in situ of breast,LTB,Lymphotoxin-beta,7924,45,1.10 [0.53-2.28],0.7941202881513069
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP2,Latent-transforming growth factor beta-binding protein 2,9177,49,1.57 [0.73-3.36],0.2463616293445166
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP3,Latent-transforming growth factor beta-binding protein 3,8869,47,1.40 [0.95-2.06],0.0860880373347766
Chapter II Neoplasms,Carcinoma in situ of breast,LTBR,Tumor necrosis factor receptor superfamily member 3,9041,50,1.47 [0.62-3.47],0.3770141160773989
Chapter II Neoplasms,Carcinoma in situ of breast,LTO1,Protein LTO1 homolog,8903,49,1.34 [0.83-2.19],0.2348176927531646
Chapter II Neoplasms,Carcinoma in situ of breast,LUZP2,Leucine zipper protein 2,7924,45,0.85 [0.43-1.67],0.6305440462948564
Chapter II Neoplasms,Carcinoma in situ of breast,LXN,Latexin,8967,49,0.98 [0.67-1.45],0.931879380005397
Chapter II Neoplasms,Carcinoma in situ of breast,LY6D,Lymphocyte antigen 6D,9049,50,1.13 [0.59-2.16],0.7163649674881876
Chapter II Neoplasms,Carcinoma in situ of breast,LY75,Lymphocyte antigen 75,9043,49,2.79 [1.37-5.70],0.0047450242781381
Chapter II Neoplasms,Carcinoma in situ of breast,LY9,T-lymphocyte surface antigen Ly-9,8974,48,1.50 [0.62-3.64],0.3727054463214762
Chapter II Neoplasms,Carcinoma in situ of breast,LY96,Lymphocyte antigen 96,9005,49,1.69 [0.86-3.34],0.1276848892355853
Chapter II Neoplasms,Carcinoma in situ of breast,LYAR,Cell growth-regulating nucleolar protein,8869,47,0.87 [0.50-1.50],0.6149705404469011
Chapter II Neoplasms,Carcinoma in situ of breast,LYN,Tyrosine-protein kinase Lyn,9033,51,0.96 [0.71-1.29],0.7683528489098662
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD1,Ly6/PLAUR domain-containing protein 1,8849,49,0.75 [0.44-1.30],0.3108660241519312
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD3,Ly6/PLAUR domain-containing protein 3,9022,50,1.01 [0.47-2.15],0.984059432780238
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD8,Ly6/PLAUR domain-containing protein 8,8869,47,0.56 [0.33-0.96],0.0339300101771471
Chapter II Neoplasms,Carcinoma in situ of breast,LYPLA2,Acyl-protein thioesterase 2,7686,45,1.03 [0.80-1.32],0.8253716727367298
Chapter II Neoplasms,Carcinoma in situ of breast,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,7742,44,0.85 [0.62-1.16],0.301782460799339
Chapter II Neoplasms,Carcinoma in situ of breast,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,7968,42,0.99 [0.23-4.32],0.992351877260968
Chapter II Neoplasms,Carcinoma in situ of breast,LYZL2,Lysozyme-like protein 2,7678,44,0.98 [0.41-2.33],0.9660638508527528
Chapter II Neoplasms,Carcinoma in situ of breast,LZTFL1,Leucine zipper transcription factor-like protein 1,7807,44,0.94 [0.62-1.42],0.7585684081294473
Chapter II Neoplasms,Carcinoma in situ of breast,M6PR,Cation-dependent mannose-6-phosphate receptor,7776,44,1.28 [0.70-2.33],0.4181535249642726
Chapter II Neoplasms,Carcinoma in situ of breast,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,8967,48,1.29 [0.84-1.98],0.2460635318845493
Chapter II Neoplasms,Carcinoma in situ of breast,MAEA,E3 ubiquitin-protein transferase MAEA,8869,47,0.76 [0.37-1.54],0.4392011155007699
Chapter II Neoplasms,Carcinoma in situ of breast,MAG,Myelin-associated glycoprotein,7742,44,1.76 [0.98-3.15],0.0564730967831571
Chapter II Neoplasms,Carcinoma in situ of breast,MAGEA3,Melanoma-associated antigen 3,7824,45,0.72 [0.58-0.88],0.0015176556333369
Chapter II Neoplasms,Carcinoma in situ of breast,MAGED1,Melanoma-associated antigen D1,8869,47,0.79 [0.45-1.40],0.4252067841944651
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC2,MAM domain-containing protein 2,7948,45,1.28 [0.57-2.89],0.5447460654928515
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC4,Apical endosomal glycoprotein,7924,45,1.40 [0.84-2.32],0.1918853587087378
Chapter II Neoplasms,Carcinoma in situ of breast,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",7776,44,1.75 [0.54-5.73],0.3532338979377281
Chapter II Neoplasms,Carcinoma in situ of breast,MAN2B2,Epididymis-specific alpha-mannosidase,7948,45,1.39 [0.86-2.25],0.1786044447055929
Chapter II Neoplasms,Carcinoma in situ of breast,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",7678,44,0.84 [0.46-1.53],0.5753620092238455
Chapter II Neoplasms,Carcinoma in situ of breast,MANF,Mesencephalic astrocyte-derived neurotrophic factor,9112,50,0.88 [0.72-1.08],0.2217353841987513
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC1,MANSC domain-containing protein 1,9106,50,1.41 [0.56-3.53],0.4613329773866681
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC4,MANSC domain-containing protein 4,7710,44,0.78 [0.50-1.23],0.2915628425646225
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,7686,45,1.12 [0.45-2.81],0.810516155928872
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,7710,44,1.00 [0.65-1.54],0.9995741084227452
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2,Microtubule-associated protein 2,7945,46,0.67 [0.33-1.35],0.2584756561464215
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,7914,45,0.89 [0.56-1.41],0.6301471319512542
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,9043,49,0.95 [0.74-1.22],0.6771294569461173
Chapter II Neoplasms,Carcinoma in situ of breast,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,8869,47,0.75 [0.56-1.00],0.0535188476054585
Chapter II Neoplasms,Carcinoma in situ of breast,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,8986,49,0.93 [0.74-1.17],0.527027538808881
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK13,Mitogen-activated protein kinase 13,7678,44,1.28 [0.73-2.25],0.3911146082418048
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK9,Mitogen-activated protein kinase 9,9043,49,1.00 [0.55-1.81],0.9936261519142108
Chapter II Neoplasms,Carcinoma in situ of breast,MAPKAPK2,MAP kinase-activated protein kinase 2,7824,45,0.84 [0.56-1.26],0.3993642080366988
Chapter II Neoplasms,Carcinoma in situ of breast,MAPRE3,Microtubule-associated protein RP/EB family member 3,7678,44,0.94 [0.75-1.17],0.5685750852120777
Chapter II Neoplasms,Carcinoma in situ of breast,MAPT,Microtubule-associated protein tau,8849,49,1.30 [0.80-2.11],0.2917510173241216
Chapter II Neoplasms,Carcinoma in situ of breast,MARCO,Macrophage receptor MARCO,9066,49,1.36 [0.52-3.55],0.5348367490026565
Chapter II Neoplasms,Carcinoma in situ of breast,MARS1,"Methionine--tRNA ligase, cytoplasmic",7793,44,0.97 [0.69-1.37],0.8678134765661142
Chapter II Neoplasms,Carcinoma in situ of breast,MASP1,Mannan-binding lectin serine protease 1,8986,49,1.59 [0.53-4.76],0.4107906080735424
Chapter II Neoplasms,Carcinoma in situ of breast,MATN2,Matrilin-2,9082,50,1.90 [0.82-4.43],0.136781157562339
Chapter II Neoplasms,Carcinoma in situ of breast,MATN3,Matrilin-3,8991,49,1.52 [0.68-3.36],0.3044955821775746
Chapter II Neoplasms,Carcinoma in situ of breast,MAVS,Mitochondrial antiviral-signaling protein,8869,47,0.90 [0.67-1.20],0.4578853395975019
Chapter II Neoplasms,Carcinoma in situ of breast,MAX,Protein max,8849,49,0.98 [0.76-1.26],0.8707393481256414
Chapter II Neoplasms,Carcinoma in situ of breast,MB,Myoglobin,9177,49,1.14 [0.70-1.86],0.6078692520232587
Chapter II Neoplasms,Carcinoma in situ of breast,MBL2,Mannose-binding protein C,7854,41,1.04 [0.78-1.37],0.8103737684883332
Chapter II Neoplasms,Carcinoma in situ of breast,MCAM,Cell surface glycoprotein MUC18,9120,50,2.65 [1.47-4.75],0.0011390801887359
Chapter II Neoplasms,Carcinoma in situ of breast,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",7937,45,1.21 [0.67-2.20],0.5304148361008096
Chapter II Neoplasms,Carcinoma in situ of breast,MCEMP1,Mast cell-expressed membrane protein 1,7735,44,0.79 [0.56-1.11],0.1720282467746279
Chapter II Neoplasms,Carcinoma in situ of breast,MCFD2,Multiple coagulation factor deficiency protein 2,9017,49,0.97 [0.53-1.75],0.9086649303569256
Chapter II Neoplasms,Carcinoma in situ of breast,MCTS1,Malignant T-cell-amplified sequence 1,7914,45,0.59 [0.16-2.10],0.414781025501764
Chapter II Neoplasms,Carcinoma in situ of breast,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,9005,49,1.11 [0.77-1.61],0.5697759175613153
Chapter II Neoplasms,Carcinoma in situ of breast,MDH1,"Malate dehydrogenase, cytoplasmic",7908,44,0.66 [0.31-1.40],0.2760988351426512
Chapter II Neoplasms,Carcinoma in situ of breast,MDK,Midkine,9088,49,0.79 [0.47-1.34],0.382809015182352
Chapter II Neoplasms,Carcinoma in situ of breast,MDM1,Nuclear protein MDM1,7742,44,0.76 [0.29-2.01],0.574943207103846
Chapter II Neoplasms,Carcinoma in situ of breast,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",7776,44,0.98 [0.71-1.36],0.9014692826649952
Chapter II Neoplasms,Carcinoma in situ of breast,MED18,Mediator of RNA polymerase II transcription subunit 18,8869,47,0.91 [0.64-1.28],0.5741997697183576
Chapter II Neoplasms,Carcinoma in situ of breast,MED21,Mediator of RNA polymerase II transcription subunit 21,7710,44,1.42 [0.95-2.14],0.0898501254737279
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF10,Multiple epidermal growth factor-like domains protein 10,9065,50,1.53 [0.78-3.01],0.2158168519794028
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF11,Multiple epidermal growth factor-like domains protein 11,7710,44,1.02 [0.43-2.37],0.9716864691259248
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF9,Multiple epidermal growth factor-like domains protein 9,9159,49,3.18 [0.88-11.52],0.0776141921244151
Chapter II Neoplasms,Carcinoma in situ of breast,MELTF,Melanotransferrin,7948,45,0.87 [0.32-2.33],0.7821777399779105
Chapter II Neoplasms,Carcinoma in situ of breast,MENT,Protein MENT,7807,44,1.37 [0.37-5.07],0.6331836783841017
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1A,Meprin A subunit alpha,7914,45,0.89 [0.59-1.34],0.5777053143502561
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1B,Meprin A subunit beta,9066,49,0.92 [0.76-1.13],0.4468659012679634
Chapter II Neoplasms,Carcinoma in situ of breast,MEPE,Matrix extracellular phosphoglycoprotein,9065,50,0.80 [0.33-1.94],0.6142407013210451
Chapter II Neoplasms,Carcinoma in situ of breast,MERTK,Tyrosine-protein kinase Mer,9160,50,0.97 [0.36-2.62],0.945538380045364
Chapter II Neoplasms,Carcinoma in situ of breast,MESD,LRP chaperone MESD,9075,49,0.93 [0.75-1.15],0.4944351964502914
Chapter II Neoplasms,Carcinoma in situ of breast,MET,Hepatocyte growth factor receptor,9093,48,1.20 [0.33-4.33],0.779169545171364
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1,Methionine aminopeptidase 1,8849,49,0.66 [0.26-1.63],0.3644891986562015
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",9043,49,1.09 [0.80-1.48],0.5945848915320635
Chapter II Neoplasms,Carcinoma in situ of breast,METAP2,Methionine aminopeptidase 2,9127,50,0.81 [0.53-1.24],0.3250654251117768
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3,Microfibril-associated glycoprotein 3,8895,49,0.95 [0.56-1.61],0.8497505544787175
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3L,Microfibrillar-associated protein 3-like,7742,44,0.91 [0.57-1.47],0.7059054172662913
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP4,Microfibril-associated glycoprotein 4,7807,44,1.43 [0.58-3.57],0.4388115299766602
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP5,Microfibrillar-associated protein 5,9177,49,2.10 [1.12-3.93],0.0206185256282219
Chapter II Neoplasms,Carcinoma in situ of breast,MFGE8,Lactadherin,9075,49,0.85 [0.47-1.55],0.5936198765106604
Chapter II Neoplasms,Carcinoma in situ of breast,MGLL,Monoglyceride lipase,9094,50,0.91 [0.68-1.21],0.5216522314000719
Chapter II Neoplasms,Carcinoma in situ of breast,MGMT,Methylated-DNA--protein-cysteine methyltransferase,9043,49,0.93 [0.76-1.14],0.4786714082280114
Chapter II Neoplasms,Carcinoma in situ of breast,MIA,Melanoma-derived growth regulatory protein,9106,50,1.23 [0.63-2.41],0.5422451516997808
Chapter II Neoplasms,Carcinoma in situ of breast,MICALL2,MICAL-like protein 2,7742,44,0.56 [0.33-0.96],0.0334122519352257
Chapter II Neoplasms,Carcinoma in situ of breast,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,9043,49,0.90 [0.78-1.04],0.1556119113824411
Chapter II Neoplasms,Carcinoma in situ of breast,MIF,Macrophage migration inhibitory factor,9066,49,0.81 [0.56-1.17],0.254482106172851
Chapter II Neoplasms,Carcinoma in situ of breast,MILR1,Allergin-1,8903,49,1.20 [0.73-1.96],0.4729335242192247
Chapter II Neoplasms,Carcinoma in situ of breast,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,7924,45,0.88 [0.68-1.14],0.3375500704989528
Chapter II Neoplasms,Carcinoma in situ of breast,MINK1,Misshapen-like kinase 1,7945,46,0.94 [0.69-1.27],0.6787146681891595
Chapter II Neoplasms,Carcinoma in situ of breast,MITD1,MIT domain-containing protein 1,9005,49,0.93 [0.72-1.21],0.5892734397588673
Chapter II Neoplasms,Carcinoma in situ of breast,MKI67,Proliferation marker protein Ki-67,7735,44,1.26 [0.68-2.36],0.4640857878544709
Chapter II Neoplasms,Carcinoma in situ of breast,MLLT1,Protein ENL,7678,44,0.78 [0.47-1.29],0.3268133299632191
Chapter II Neoplasms,Carcinoma in situ of breast,MLN,Promotilin,9043,49,1.00 [0.75-1.33],0.9933750685658193
Chapter II Neoplasms,Carcinoma in situ of breast,MME,Neprilysin,9033,51,0.95 [0.71-1.29],0.761914020519378
Chapter II Neoplasms,Carcinoma in situ of breast,MMP1,Interstitial collagenase,8715,48,0.77 [0.58-1.01],0.0572286306519853
Chapter II Neoplasms,Carcinoma in situ of breast,MMP10,Stromelysin-2,9044,49,1.13 [0.74-1.74],0.5635523379349845
Chapter II Neoplasms,Carcinoma in situ of breast,MMP12,Macrophage metalloelastase,9067,50,0.90 [0.55-1.48],0.6729427694298445
Chapter II Neoplasms,Carcinoma in situ of breast,MMP13,Collagenase 3,8849,49,2.04 [1.00-4.14],0.0495401539329002
Chapter II Neoplasms,Carcinoma in situ of breast,MMP15,Matrix metalloproteinase-15,7948,45,1.30 [0.88-1.93],0.1902775906262745
Chapter II Neoplasms,Carcinoma in situ of breast,MMP3,Stromelysin-1,9075,49,1.63 [1.03-2.59],0.0364037386190836
Chapter II Neoplasms,Carcinoma in situ of breast,MMP7,Matrilysin,8880,49,0.99 [0.58-1.68],0.959335440279234
Chapter II Neoplasms,Carcinoma in situ of breast,MMP8,Neutrophil collagenase,9118,49,1.13 [0.81-1.59],0.4713243522593376
Chapter II Neoplasms,Carcinoma in situ of breast,MMP9,Matrix metalloproteinase-9,9055,49,1.49 [0.98-2.27],0.0652568449232862
Chapter II Neoplasms,Carcinoma in situ of breast,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",7710,44,1.38 [0.83-2.31],0.218335437016806
Chapter II Neoplasms,Carcinoma in situ of breast,MN1,Transcriptional activator MN1,7742,44,0.86 [0.51-1.48],0.5954274586846072
Chapter II Neoplasms,Carcinoma in situ of breast,MNAT1,CDK-activating kinase assembly factor MAT1,7824,45,1.17 [0.63-2.16],0.6239876550274588
Chapter II Neoplasms,Carcinoma in situ of breast,MNDA,Myeloid cell nuclear differentiation antigen,9049,49,1.05 [0.82-1.33],0.7047889092210183
Chapter II Neoplasms,Carcinoma in situ of breast,MOCS2,Molybdopterin synthase catalytic subunit,7807,44,0.79 [0.50-1.26],0.3186777772898218
Chapter II Neoplasms,Carcinoma in situ of breast,MOG,Myelin-oligodendrocyte glycoprotein,9145,50,1.33 [0.62-2.86],0.4666240104657919
Chapter II Neoplasms,Carcinoma in situ of breast,MORC3,MORC family CW-type zinc finger protein 3,7945,46,1.34 [0.54-3.32],0.5296069716478036
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L1,Mortality factor 4-like protein 1,7824,45,0.67 [0.29-1.57],0.3552587557090801
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L2,Mortality factor 4-like protein 2,7678,44,0.74 [0.31-1.78],0.4969468407650108
Chapter II Neoplasms,Carcinoma in situ of breast,MORN4,MORN repeat-containing protein 4,7678,44,0.72 [0.44-1.18],0.1948397626324978
Chapter II Neoplasms,Carcinoma in situ of breast,MPHOSPH8,M-phase phosphoprotein 8,8895,49,1.01 [0.72-1.41],0.9720421642835184
Chapter II Neoplasms,Carcinoma in situ of breast,MPI,Mannose-6-phosphate isomerase,9033,51,0.85 [0.63-1.15],0.284777831210255
Chapter II Neoplasms,Carcinoma in situ of breast,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,9094,50,0.78 [0.57-1.06],0.1067326843053654
Chapter II Neoplasms,Carcinoma in situ of breast,MPO,Myeloperoxidase,9075,49,1.08 [0.64-1.84],0.7671178214533765
Chapter II Neoplasms,Carcinoma in situ of breast,MPRIP,Myosin phosphatase Rho-interacting protein,7903,45,0.93 [0.47-1.82],0.8238417985629745
Chapter II Neoplasms,Carcinoma in situ of breast,MRC1,Macrophage mannose receptor 1,7955,44,1.68 [0.64-4.42],0.2940006029052713
Chapter II Neoplasms,Carcinoma in situ of breast,MRI1,Methylthioribose-1-phosphate isomerase,7742,44,0.79 [0.52-1.20],0.2658913127301985
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL24,"39S ribosomal protein L24, mitochondrial",7710,44,1.30 [0.66-2.55],0.442469055657729
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL28,"39S ribosomal protein L28, mitochondrial",7937,45,1.33 [0.76-2.33],0.3196332701906018
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL46,"39S ribosomal protein L46, mitochondrial",8849,49,1.96 [0.94-4.10],0.0732011797111138
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL52,"39S ribosomal protein L52, mitochondrial",7664,44,0.92 [0.29-2.94],0.8813840107207835
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",7937,45,0.75 [0.46-1.23],0.2540044558500374
Chapter II Neoplasms,Carcinoma in situ of breast,MRPS16,"28S ribosomal protein S16, mitochondrial",7735,44,1.18 [0.50-2.80],0.7022775617692589
Chapter II Neoplasms,Carcinoma in situ of breast,MSLN,Mesothelin,9016,51,1.13 [0.73-1.74],0.5793313074809547
Chapter II Neoplasms,Carcinoma in situ of breast,MSLNL,Mesothelin-like protein,7742,44,0.72 [0.32-1.63],0.4298098873061196
Chapter II Neoplasms,Carcinoma in situ of breast,MSMB,Beta-microseminoprotein,9034,49,1.03 [0.72-1.47],0.8739647911713693
Chapter II Neoplasms,Carcinoma in situ of breast,MSR1,Macrophage scavenger receptor types I and II,9138,49,1.69 [0.97-2.95],0.062898042194885
Chapter II Neoplasms,Carcinoma in situ of breast,MSRA,Mitochondrial peptide methionine sulfoxide reductase,9106,50,0.91 [0.64-1.29],0.5931156578239023
Chapter II Neoplasms,Carcinoma in situ of breast,MST1,Hepatocyte growth factor-like protein,7822,42,0.83 [0.58-1.19],0.3080458061325896
Chapter II Neoplasms,Carcinoma in situ of breast,MSTN,Growth/differentiation factor 8,8895,49,0.98 [0.59-1.62],0.9456896556732396
Chapter II Neoplasms,Carcinoma in situ of breast,MTDH,Protein LYRIC,7735,44,0.99 [0.71-1.36],0.9380486413495432
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",7945,46,1.24 [0.48-3.24],0.6564269435289812
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,7824,45,0.98 [0.75-1.26],0.8504857109967401
Chapter II Neoplasms,Carcinoma in situ of breast,MTIF3,"Translation initiation factor IF-3, mitochondrial",7914,45,0.95 [0.68-1.32],0.7506867573379628
Chapter II Neoplasms,Carcinoma in situ of breast,MTPN,Myotrophin,8895,49,0.81 [0.34-1.88],0.6179593899058072
Chapter II Neoplasms,Carcinoma in situ of breast,MTR,Methionine synthase,7710,44,1.08 [0.72-1.61],0.7107842289469862
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS1,Protein MTSS 1,7914,45,0.81 [0.62-1.05],0.1096831114377615
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS2,Protein MTSS 2,7924,45,0.96 [0.71-1.29],0.7643923611146681
Chapter II Neoplasms,Carcinoma in situ of breast,MTUS1,Microtubule-associated tumor suppressor 1,7824,45,0.88 [0.51-1.53],0.6608789206419925
Chapter II Neoplasms,Carcinoma in situ of breast,MUC13,Mucin-13,8849,49,1.03 [0.61-1.75],0.9021685431295556
Chapter II Neoplasms,Carcinoma in situ of breast,MUC16,Mucin-16,9033,51,0.94 [0.84-1.07],0.3469007708716839
Chapter II Neoplasms,Carcinoma in situ of breast,MUC2,Mucin-2,7965,46,0.89 [0.66-1.22],0.4740713755936172
Chapter II Neoplasms,Carcinoma in situ of breast,MUCL3,Mucin-like protein 3,7678,44,1.24 [0.72-2.13],0.4408868333822213
Chapter II Neoplasms,Carcinoma in situ of breast,MVK,Mevalonate kinase,8903,49,0.83 [0.60-1.17],0.2934677437228115
Chapter II Neoplasms,Carcinoma in situ of breast,MXRA8,Matrix remodeling-associated protein 8,7807,44,1.82 [0.73-4.54],0.1982474184040389
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC1,"Myosin-binding protein C, slow-type",7948,45,0.90 [0.58-1.42],0.6628563917787624
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC2,"Myosin-binding protein C, fast-type",7776,44,0.94 [0.65-1.36],0.7439989686603798
Chapter II Neoplasms,Carcinoma in situ of breast,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,7937,45,0.96 [0.61-1.49],0.8424694917919856
Chapter II Neoplasms,Carcinoma in situ of breast,MYDGF,Myeloid-derived growth factor,7948,45,0.97 [0.72-1.30],0.8366792985197604
Chapter II Neoplasms,Carcinoma in situ of breast,MYH4,Myosin-4,7710,44,1.08 [0.60-1.95],0.7863323251362345
Chapter II Neoplasms,Carcinoma in situ of breast,MYH7B,Myosin-7B,7678,44,1.37 [0.79-2.35],0.2600550346566772
Chapter II Neoplasms,Carcinoma in situ of breast,MYH9,Myosin-9,7965,46,0.97 [0.76-1.25],0.8240064319972995
Chapter II Neoplasms,Carcinoma in situ of breast,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",7710,44,1.35 [0.84-2.17],0.2196360715257201
Chapter II Neoplasms,Carcinoma in situ of breast,MYL3,Myosin light chain 3,7776,44,1.09 [0.72-1.66],0.6695342215390532
Chapter II Neoplasms,Carcinoma in situ of breast,MYL4,Myosin light chain 4,7776,44,0.96 [0.55-1.68],0.8930014595688937
Chapter II Neoplasms,Carcinoma in situ of breast,MYL6B,Myosin light chain 6B,7742,44,1.08 [0.81-1.44],0.6094917679327291
Chapter II Neoplasms,Carcinoma in situ of breast,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",7742,44,0.77 [0.34-1.70],0.5118913618804249
Chapter II Neoplasms,Carcinoma in situ of breast,MYO6,Unconventional myosin-VI,7937,45,0.96 [0.43-2.16],0.928510138296142
Chapter II Neoplasms,Carcinoma in situ of breast,MYO9B,Unconventional myosin-IXb,8903,49,1.03 [0.70-1.50],0.8889479229064695
Chapter II Neoplasms,Carcinoma in situ of breast,MYOC,Myocilin,9075,49,1.57 [0.89-2.76],0.1172426948480208
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM1,Myomesin-1,7686,45,1.14 [0.68-1.92],0.6209987517795026
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM2,Myomesin-2,7710,44,1.32 [0.74-2.39],0.3492467720286355
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM3,Myomesin-3,7807,44,1.16 [0.84-1.58],0.3706117324308138
Chapter II Neoplasms,Carcinoma in situ of breast,MZB1,Marginal zone B- and B1-cell-specific protein,9100,50,0.91 [0.56-1.49],0.7125060118809325
Chapter II Neoplasms,Carcinoma in situ of breast,MZT1,Mitotic-spindle organizing protein 1,8869,47,1.01 [0.61-1.67],0.9575314893380804
Chapter II Neoplasms,Carcinoma in situ of breast,NAA10,N-alpha-acetyltransferase 10,7710,44,0.76 [0.43-1.33],0.3290706510959753
Chapter II Neoplasms,Carcinoma in situ of breast,NAA80,N-alpha-acetyltransferase 80,7742,44,0.90 [0.70-1.16],0.4196904812202899
Chapter II Neoplasms,Carcinoma in situ of breast,NAAA,N-acylethanolamine-hydrolyzing acid amidase,8962,48,1.13 [0.73-1.75],0.5793402734869004
Chapter II Neoplasms,Carcinoma in situ of breast,NACC1,Nucleus accumbens-associated protein 1,7924,45,0.87 [0.50-1.50],0.6097009824071382
Chapter II Neoplasms,Carcinoma in situ of breast,NADK,NAD kinase,9066,49,1.08 [0.70-1.67],0.7181804696634375
Chapter II Neoplasms,Carcinoma in situ of breast,NAGA,Alpha-N-acetylgalactosaminidase,7716,44,0.81 [0.43-1.50],0.4981828383157203
Chapter II Neoplasms,Carcinoma in situ of breast,NAGK,N-acetyl-D-glucosamine kinase,7763,44,1.02 [0.60-1.73],0.9497681542334206
Chapter II Neoplasms,Carcinoma in situ of breast,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,7807,44,1.11 [0.28-4.33],0.8824913586536041
Chapter II Neoplasms,Carcinoma in situ of breast,NAMPT,Nicotinamide phosphoribosyltransferase,8869,47,0.85 [0.49-1.47],0.5624763085375664
Chapter II Neoplasms,Carcinoma in situ of breast,NAP1L4,Nucleosome assembly protein 1-like 4,7900,45,0.78 [0.40-1.54],0.4785628049098993
Chapter II Neoplasms,Carcinoma in situ of breast,NAPRT,Nicotinate phosphoribosyltransferase,7945,46,0.95 [0.40-2.26],0.9074984512927132
Chapter II Neoplasms,Carcinoma in situ of breast,NARS1,"Asparagine--tRNA ligase, cytoplasmic",7937,45,0.77 [0.43-1.40],0.3933770372719176
Chapter II Neoplasms,Carcinoma in situ of breast,NBL1,Neuroblastoma suppressor of tumorigenicity 1,9106,50,2.26 [0.92-5.54],0.0738973963515481
Chapter II Neoplasms,Carcinoma in situ of breast,NBN,Nibrin,8903,49,1.05 [0.66-1.66],0.84512028077668
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM1,Neural cell adhesion molecule 1,9120,50,3.70 [1.93-7.08],8.158477551086594e-05
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM2,Neural cell adhesion molecule 2,9075,49,1.51 [0.60-3.83],0.3815366495318751
Chapter II Neoplasms,Carcinoma in situ of breast,NCAN,Neurocan core protein,9138,49,1.07 [0.55-2.10],0.8336741344096843
Chapter II Neoplasms,Carcinoma in situ of breast,NCF2,Neutrophil cytosol factor 2,9031,49,1.00 [0.74-1.35],0.9809947358269212
Chapter II Neoplasms,Carcinoma in situ of breast,NCK2,Cytoplasmic protein NCK2,9112,50,0.89 [0.70-1.13],0.3190684266072173
Chapter II Neoplasms,Carcinoma in situ of breast,NCLN,Nicalin,8903,49,0.93 [0.54-1.61],0.8016358290313776
Chapter II Neoplasms,Carcinoma in situ of breast,NCR1,Natural cytotoxicity triggering receptor 1,9030,49,1.52 [0.77-2.98],0.2262410274163287
Chapter II Neoplasms,Carcinoma in situ of breast,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,7914,45,1.47 [0.62-3.51],0.3804401957826526
Chapter II Neoplasms,Carcinoma in situ of breast,NCS1,Neuronal calcium sensor 1,9145,50,0.90 [0.36-2.21],0.8111655447114087
Chapter II Neoplasms,Carcinoma in situ of breast,NDRG1,Protein NDRG1,8849,49,1.14 [0.84-1.54],0.4118564251159023
Chapter II Neoplasms,Carcinoma in situ of breast,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,7924,45,1.20 [0.85-1.70],0.2898626122023082
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,7724,44,2.01 [0.96-4.21],0.0634433893955994
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,7914,45,0.86 [0.62-1.19],0.3621657362761887
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",8869,47,1.02 [0.73-1.41],0.9142347144972556
Chapter II Neoplasms,Carcinoma in situ of breast,NEB,Nebulin,7710,44,0.58 [0.22-1.53],0.271714641575188
Chapter II Neoplasms,Carcinoma in situ of breast,NECAP2,Adaptin ear-binding coat-associated protein 2,7710,44,0.77 [0.48-1.24],0.2775685924108143
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN1,Nectin-1,7735,44,1.15 [0.48-2.74],0.7481812872989777
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN2,Nectin-2,9050,49,1.08 [0.45-2.57],0.8675228213433703
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN4,Nectin-4,9106,50,1.99 [1.07-3.74],0.030985848257001
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,7735,44,0.88 [0.50-1.57],0.6715255838705317
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD9,Enhancer of filamentation 1,7735,44,1.74 [0.95-3.18],0.0724497582211952
Chapter II Neoplasms,Carcinoma in situ of breast,NEFL,Neurofilament light polypeptide,8814,49,1.58 [0.89-2.81],0.114691222773528
Chapter II Neoplasms,Carcinoma in situ of breast,NEK7,Serine/threonine-protein kinase Nek7,7824,45,1.04 [0.74-1.47],0.8213460374826294
Chapter II Neoplasms,Carcinoma in situ of breast,NELL1,Protein kinase C-binding protein NELL1,9106,50,1.16 [0.65-2.09],0.6112726277868754
Chapter II Neoplasms,Carcinoma in situ of breast,NELL2,Protein kinase C-binding protein NELL2,9112,50,0.58 [0.23-1.45],0.2425639321701328
Chapter II Neoplasms,Carcinoma in situ of breast,NENF,Neudesin,7924,45,0.76 [0.53-1.08],0.1277727562554302
Chapter II Neoplasms,Carcinoma in situ of breast,NEO1,Neogenin,7937,45,4.44 [1.94-10.20],0.0004362539521657
Chapter II Neoplasms,Carcinoma in situ of breast,NEXN,Nexilin,7955,44,1.02 [0.67-1.55],0.935284329282892
Chapter II Neoplasms,Carcinoma in situ of breast,NFASC,Neurofascin,9160,50,0.76 [0.30-1.90],0.5560008708004716
Chapter II Neoplasms,Carcinoma in situ of breast,NFAT5,Nuclear factor of activated T-cells 5,7735,44,0.90 [0.63-1.28],0.545553369545373
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",9043,49,0.88 [0.67-1.16],0.365482413588057
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",8903,49,0.87 [0.55-1.37],0.5446553736021212
Chapter II Neoplasms,Carcinoma in situ of breast,NFE2,Transcription factor NF-E2 45 kDa subunit,7776,44,0.82 [0.55-1.24],0.3506109654673551
Chapter II Neoplasms,Carcinoma in situ of breast,NFIC,Nuclear factor 1 C-type,7937,45,1.13 [0.66-1.92],0.6632335166198586
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB1,Nuclear factor NF-kappa-B p105 subunit,7710,44,0.79 [0.52-1.19],0.2567112503215865
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB2,Nuclear factor NF-kappa-B p100 subunit,7824,45,1.01 [0.60-1.70],0.9683487276969166
Chapter II Neoplasms,Carcinoma in situ of breast,NFKBIE,NF-kappa-B inhibitor epsilon,8869,47,0.62 [0.35-1.11],0.1082325953019895
Chapter II Neoplasms,Carcinoma in situ of breast,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",7914,45,0.95 [0.72-1.27],0.7444025475586636
Chapter II Neoplasms,Carcinoma in situ of breast,NFX1,Transcriptional repressor NF-X1,7710,44,0.90 [0.57-1.40],0.6309203196736506
Chapter II Neoplasms,Carcinoma in situ of breast,NFYA,Nuclear transcription factor Y subunit alpha,7710,44,1.56 [0.98-2.46],0.058619676434952
Chapter II Neoplasms,Carcinoma in situ of breast,NGF,Beta-nerve growth factor,9005,49,2.37 [0.27-20.49],0.4344719568127737
Chapter II Neoplasms,Carcinoma in situ of breast,NGFR,Tumor necrosis factor receptor superfamily member 16,7948,45,1.39 [0.58-3.34],0.4634197805586961
Chapter II Neoplasms,Carcinoma in situ of breast,NGRN,Neugrin,7945,46,0.90 [0.24-3.32],0.8704862616467195
Chapter II Neoplasms,Carcinoma in situ of breast,NHLRC3,NHL repeat-containing protein 3,7618,44,1.67 [0.64-4.32],0.2932417684946388
Chapter II Neoplasms,Carcinoma in situ of breast,NID1,Nidogen-1,9082,50,0.89 [0.47-1.68],0.7138225800521297
Chapter II Neoplasms,Carcinoma in situ of breast,NID2,Nidogen-2,9075,49,0.85 [0.60-1.20],0.3458059221008255
Chapter II Neoplasms,Carcinoma in situ of breast,NINJ1,Ninjurin-1,8869,47,0.58 [0.29-1.15],0.1174863101492763
Chapter II Neoplasms,Carcinoma in situ of breast,NIT1,Deaminated glutathione amidase,7776,44,0.95 [0.52-1.75],0.8816110105858264
Chapter II Neoplasms,Carcinoma in situ of breast,NIT2,Omega-amidase NIT2,7914,45,0.94 [0.63-1.40],0.7633430009309204
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN1,Neuroligin-1,7742,44,1.18 [0.85-1.64],0.3197668409629518
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN2,Neuroligin-2,7686,45,1.37 [0.90-2.09],0.1380581958456458
Chapter II Neoplasms,Carcinoma in situ of breast,NME1,Nucleoside diphosphate kinase A,7735,44,1.50 [0.44-5.10],0.5184318479892452
Chapter II Neoplasms,Carcinoma in situ of breast,NME3,Nucleoside diphosphate kinase 3,9082,50,0.52 [0.18-1.55],0.2432450212262679
Chapter II Neoplasms,Carcinoma in situ of breast,NMI,N-myc-interactor,7895,45,1.02 [0.68-1.53],0.9071623807478646
Chapter II Neoplasms,Carcinoma in situ of breast,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,9005,49,1.15 [0.85-1.57],0.3578760743302823
Chapter II Neoplasms,Carcinoma in situ of breast,NMRK2,Nicotinamide riboside kinase 2,7678,44,1.18 [0.64-2.17],0.6043266992092622
Chapter II Neoplasms,Carcinoma in situ of breast,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,7937,45,0.98 [0.62-1.53],0.9175999933769554
Chapter II Neoplasms,Carcinoma in situ of breast,NOMO1,Nodal modulator 1,9075,49,2.19 [0.76-6.32],0.1470159790702077
Chapter II Neoplasms,Carcinoma in situ of breast,NOP56,Nucleolar protein 56,7710,44,1.12 [0.90-1.41],0.3113782522738911
Chapter II Neoplasms,Carcinoma in situ of breast,NOS1,"Nitric oxide synthase, brain",8849,49,1.25 [0.75-2.07],0.3868766270818152
Chapter II Neoplasms,Carcinoma in situ of breast,NOS2,"Nitric oxide synthase, inducible",7710,44,1.27 [0.64-2.55],0.4959414222906733
Chapter II Neoplasms,Carcinoma in situ of breast,NOS3,"Nitric oxide synthase, endothelial",8849,49,1.08 [0.68-1.71],0.7587800808116174
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH1,Neurogenic locus notch homolog protein 1,9177,49,1.74 [0.35-8.68],0.5017357919787913
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH2,Neurogenic locus notch homolog protein 2,7965,46,4.58 [1.51-13.85],0.0070691380394434
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH3,Neurogenic locus notch homolog protein 3,9177,49,2.12 [1.03-4.37],0.0409862933697935
Chapter II Neoplasms,Carcinoma in situ of breast,NPC2,NPC intracellular cholesterol transporter 2,7819,45,1.33 [0.57-3.10],0.5086029133299943
Chapter II Neoplasms,Carcinoma in situ of breast,NPDC1,Neural proliferation differentiation and control protein 1,9066,49,1.64 [0.78-3.44],0.1888789404882319
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS1,Nephrin,7735,44,0.88 [0.36-2.16],0.7764389463756514
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS2,Podocin,7735,44,0.92 [0.69-1.25],0.6052626905549564
Chapter II Neoplasms,Carcinoma in situ of breast,NPL,N-acetylneuraminate lyase,7948,45,0.83 [0.44-1.57],0.5613436084493639
Chapter II Neoplasms,Carcinoma in situ of breast,NPPB,Natriuretic peptides B,8895,49,1.10 [0.90-1.34],0.3467547213776798
Chapter II Neoplasms,Carcinoma in situ of breast,NPPC,C-type natriuretic peptide,9043,49,0.89 [0.49-1.62],0.7049186835364478
Chapter II Neoplasms,Carcinoma in situ of breast,NPR1,Atrial natriuretic peptide receptor 1,7710,44,1.00 [0.47-2.11],0.9954775196619806
Chapter II Neoplasms,Carcinoma in situ of breast,NPTN,Neuroplastin,8869,47,1.17 [0.91-1.51],0.2268459426968417
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX1,Neuronal pentraxin-1,9075,49,0.97 [0.50-1.89],0.9280600938059436
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX2,Neuronal pentraxin-2,7965,46,1.17 [0.48-2.85],0.7311608323403331
Chapter II Neoplasms,Carcinoma in situ of breast,NPTXR,Neuronal pentraxin receptor,9066,49,1.41 [0.72-2.77],0.3227939090068899
Chapter II Neoplasms,Carcinoma in situ of breast,NPY,Pro-neuropeptide Y,9145,50,1.37 [0.92-2.05],0.1185710710579237
Chapter II Neoplasms,Carcinoma in situ of breast,NRCAM,Neuronal cell adhesion molecule,9066,49,1.26 [0.53-2.97],0.6006202969126099
Chapter II Neoplasms,Carcinoma in situ of breast,NRGN,Neurogranin,7955,44,0.86 [0.62-1.19],0.3579915275815922
Chapter II Neoplasms,Carcinoma in situ of breast,NRN1,Neuritin,7937,45,1.18 [0.57-2.44],0.6592294496501148
Chapter II Neoplasms,Carcinoma in situ of breast,NRP1,Neuropilin-1,9134,50,1.77 [0.75-4.19],0.1911586081399332
Chapter II Neoplasms,Carcinoma in situ of breast,NRP2,Neuropilin-2,9075,49,1.90 [0.90-4.03],0.0931954289483008
Chapter II Neoplasms,Carcinoma in situ of breast,NRTN,Neurturin,8903,49,0.98 [0.59-1.60],0.9255584282723726
Chapter II Neoplasms,Carcinoma in situ of breast,NRXN3,Neurexin-3,7742,44,1.40 [0.74-2.64],0.3021879568268075
Chapter II Neoplasms,Carcinoma in situ of breast,NSFL1C,NSFL1 cofactor p47,9138,49,0.79 [0.54-1.17],0.2401093738662889
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",7948,45,0.84 [0.57-1.24],0.378373324383556
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C1A,Cytosolic 5'-nucleotidase 1A,7945,46,1.34 [0.67-2.71],0.4079884196918741
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C3A,Cytosolic 5'-nucleotidase 3A,9032,49,0.88 [0.66-1.18],0.3951469641515454
Chapter II Neoplasms,Carcinoma in situ of breast,NT5E,5'-nucleotidase,9106,50,0.81 [0.51-1.28],0.3667517297339806
Chapter II Neoplasms,Carcinoma in situ of breast,NTF3,Neurotrophin-3,9043,49,0.69 [0.34-1.43],0.3218479556779466
Chapter II Neoplasms,Carcinoma in situ of breast,NTF4,Neurotrophin-4,8869,47,1.12 [0.65-1.92],0.6788692544297165
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK2,BDNF/NT-3 growth factors receptor,9066,49,0.89 [0.33-2.41],0.8164989628116817
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK3,NT-3 growth factor receptor,9138,49,1.30 [0.43-3.97],0.6437065649764475
Chapter II Neoplasms,Carcinoma in situ of breast,NTproBNP,N-terminal prohormone of brain natriuretic peptide,9066,49,1.19 [0.94-1.51],0.1421862237060421
Chapter II Neoplasms,Carcinoma in situ of breast,NUB1,NEDD8 ultimate buster 1,9043,49,0.91 [0.67-1.24],0.5553422480111762
Chapter II Neoplasms,Carcinoma in situ of breast,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,7924,45,0.91 [0.67-1.25],0.5641668595150937
Chapter II Neoplasms,Carcinoma in situ of breast,NUCB2,Nucleobindin-2,9129,50,0.96 [0.48-1.91],0.9013095547359072
Chapter II Neoplasms,Carcinoma in situ of breast,NUDC,Nuclear migration protein nudC,9160,50,0.94 [0.63-1.41],0.7698096764820465
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,7776,44,1.95 [0.94-4.05],0.073874332693844
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,7710,44,0.87 [0.47-1.61],0.656727321532234
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT16,U8 snoRNA-decapping enzyme,7897,45,0.87 [0.62-1.22],0.4229505328896886
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],9033,51,0.95 [0.61-1.49],0.8324658788106266
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT5,ADP-sugar pyrophosphatase,9075,49,0.91 [0.55-1.51],0.7218198307249646
Chapter II Neoplasms,Carcinoma in situ of breast,NUMB,Protein numb homolog,7735,44,0.85 [0.59-1.21],0.3669442366794893
Chapter II Neoplasms,Carcinoma in situ of breast,NUP50,Nuclear pore complex protein Nup50,7710,44,0.67 [0.23-1.95],0.4661832628701979
Chapter II Neoplasms,Carcinoma in situ of breast,NXPE4,NXPE family member 4,7710,44,1.55 [0.96-2.51],0.0699984036009891
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH1,Neurexophilin-1,8849,49,1.21 [0.65-2.23],0.5456995316499214
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH3,Neurexophilin-3,7735,44,0.74 [0.28-1.97],0.5526584206338778
Chapter II Neoplasms,Carcinoma in situ of breast,OBP2B,Odorant-binding protein 2b,8978,49,0.94 [0.64-1.39],0.7669705943200966
Chapter II Neoplasms,Carcinoma in situ of breast,OCLN,Occludin,7937,45,1.36 [0.73-2.54],0.3341127287522215
Chapter II Neoplasms,Carcinoma in situ of breast,ODAM,Odontogenic ameloblast-associated protein,8838,49,1.28 [0.91-1.80],0.1638443237283292
Chapter II Neoplasms,Carcinoma in situ of breast,OFD1,Oral-facial-digital syndrome 1 protein,7824,45,0.63 [0.35-1.15],0.1352892678134161
Chapter II Neoplasms,Carcinoma in situ of breast,OGA,Protein O-GlcNAcase,7914,45,0.80 [0.52-1.22],0.2989270146933938
Chapter II Neoplasms,Carcinoma in situ of breast,OGFR,Opioid growth factor receptor,9033,51,0.76 [0.35-1.64],0.4829958802489754
Chapter II Neoplasms,Carcinoma in situ of breast,OGN,Mimecan,9075,49,1.34 [0.73-2.44],0.3446053223971035
Chapter II Neoplasms,Carcinoma in situ of breast,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,7824,45,0.63 [0.35-1.15],0.1316140075252078
Chapter II Neoplasms,Carcinoma in situ of breast,OLFM4,Olfactomedin-4,7508,42,1.10 [0.86-1.41],0.4354312892058303
Chapter II Neoplasms,Carcinoma in situ of breast,OLR1,Oxidized low-density lipoprotein receptor 1,8992,49,1.25 [0.84-1.85],0.2652654901812311
Chapter II Neoplasms,Carcinoma in situ of breast,OMD,Osteomodulin,9112,50,0.72 [0.43-1.23],0.2331026433410162
Chapter II Neoplasms,Carcinoma in situ of breast,OMG,Oligodendrocyte-myelin glycoprotein,9033,51,1.21 [0.82-1.78],0.3393770869556991
Chapter II Neoplasms,Carcinoma in situ of breast,OMP,Olfactory marker protein,7686,45,1.08 [0.63-1.83],0.7834116867509066
Chapter II Neoplasms,Carcinoma in situ of breast,OPHN1,Oligophrenin-1,7945,46,0.85 [0.65-1.12],0.2492485848992295
Chapter II Neoplasms,Carcinoma in situ of breast,OPLAH,5-oxoprolinase,7776,44,1.06 [0.69-1.62],0.8029056738792724
Chapter II Neoplasms,Carcinoma in situ of breast,OPTC,Opticin,9033,51,1.05 [0.62-1.78],0.8623739411891789
Chapter II Neoplasms,Carcinoma in situ of breast,ORM1,Alpha-1-acid glycoprotein 1,7940,42,0.62 [0.14-2.85],0.54297765254699
Chapter II Neoplasms,Carcinoma in situ of breast,OSBPL2,Oxysterol-binding protein-related protein 2,7945,46,1.53 [0.95-2.47],0.0802565792678798
Chapter II Neoplasms,Carcinoma in situ of breast,OSCAR,Osteoclast-associated immunoglobulin-like receptor,9082,50,1.22 [0.58-2.60],0.5981486508348246
Chapter II Neoplasms,Carcinoma in situ of breast,OSM,Oncostatin-M,9013,49,1.08 [0.76-1.54],0.6738104536711826
Chapter II Neoplasms,Carcinoma in situ of breast,OSMR,Oncostatin-M-specific receptor subunit beta,9134,50,3.15 [1.02-9.69],0.0459024235882488
Chapter II Neoplasms,Carcinoma in situ of breast,OSTN,Osteocrin,7742,44,0.42 [0.16-1.09],0.0736370466944714
Chapter II Neoplasms,Carcinoma in situ of breast,OTOA,Otoancorin,7686,45,0.80 [0.43-1.46],0.4612360776136602
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD6B,Deubiquitinase OTUD6B,7914,45,0.70 [0.42-1.16],0.1638581101585388
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD7B,OTU domain-containing protein 7B,7937,45,0.80 [0.50-1.29],0.36691840780316
Chapter II Neoplasms,Carcinoma in situ of breast,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",7776,44,0.96 [0.62-1.49],0.8703081743061624
Chapter II Neoplasms,Carcinoma in situ of breast,OXT,Oxytocin-neurophysin 1,9138,49,0.99 [0.81-1.20],0.898485763808064
Chapter II Neoplasms,Carcinoma in situ of breast,P4HB,Protein disulfide-isomerase,9029,49,0.84 [0.43-1.66],0.6205991127179774
Chapter II Neoplasms,Carcinoma in situ of breast,PACS2,Phosphofurin acidic cluster sorting protein 2,7710,44,0.74 [0.45-1.22],0.2340114903695392
Chapter II Neoplasms,Carcinoma in situ of breast,PADI2,Protein-arginine deiminase type-2,8903,49,1.10 [0.73-1.67],0.6495704571596834
Chapter II Neoplasms,Carcinoma in situ of breast,PADI4,Protein-arginine deiminase type-4,8838,49,1.07 [0.78-1.48],0.6755374772241107
Chapter II Neoplasms,Carcinoma in situ of breast,PAEP,Glycodelin,9005,49,1.33 [1.02-1.74],0.0330283506358363
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,7937,45,0.96 [0.74-1.24],0.7427050058927154
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",7824,45,0.81 [0.44-1.51],0.5127906770292809
Chapter II Neoplasms,Carcinoma in situ of breast,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,8895,49,0.92 [0.58-1.48],0.7404384862026283
Chapter II Neoplasms,Carcinoma in situ of breast,PAGR1,PAXIP1-associated glutamate-rich protein 1,7776,44,1.04 [0.55-1.95],0.9090046117771692
Chapter II Neoplasms,Carcinoma in situ of breast,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,7663,44,1.07 [0.62-1.84],0.8145961302035727
Chapter II Neoplasms,Carcinoma in situ of breast,PAK4,Serine/threonine-protein kinase PAK 4,8849,49,0.79 [0.50-1.25],0.3092871595070496
Chapter II Neoplasms,Carcinoma in situ of breast,PALLD,Palladin,7735,44,0.98 [0.48-2.03],0.960866729253808
Chapter II Neoplasms,Carcinoma in situ of breast,PALM,Paralemmin-1,7868,45,1.76 [0.75-4.13],0.1901905477695309
Chapter II Neoplasms,Carcinoma in situ of breast,PALM2,Paralemmin-2,7945,46,0.79 [0.36-1.77],0.5704923495879093
Chapter II Neoplasms,Carcinoma in situ of breast,PALM3,Paralemmin-3,7710,44,0.95 [0.63-1.46],0.8283554210998343
Chapter II Neoplasms,Carcinoma in situ of breast,PAM,Peptidyl-glycine alpha-amidating monooxygenase,9125,49,2.78 [1.03-7.48],0.0428315880382342
Chapter II Neoplasms,Carcinoma in situ of breast,PAMR1,Inactive serine protease PAMR1,9075,49,1.60 [0.62-4.14],0.3347363487581699
Chapter II Neoplasms,Carcinoma in situ of breast,PAPPA,Pappalysin-1,8903,49,0.78 [0.45-1.37],0.3900359556498243
Chapter II Neoplasms,Carcinoma in situ of breast,PARD3,Partitioning defective 3 homolog,7824,45,0.85 [0.55-1.31],0.4552724498286975
Chapter II Neoplasms,Carcinoma in situ of breast,PARK7,Parkinson disease protein 7,9075,49,0.80 [0.49-1.30],0.3698843955189999
Chapter II Neoplasms,Carcinoma in situ of breast,PARP1,Poly [ADP-ribose] polymerase 1,9043,49,0.69 [0.38-1.23],0.2038911535108692
Chapter II Neoplasms,Carcinoma in situ of breast,PAXX,Protein PAXX,7807,44,0.84 [0.44-1.59],0.5864605245247994
Chapter II Neoplasms,Carcinoma in situ of breast,PBK,Lymphokine-activated killer T-cell-originated protein kinase,7678,44,0.86 [0.32-2.31],0.7686288691433176
Chapter II Neoplasms,Carcinoma in situ of breast,PBLD,Phenazine biosynthesis-like domain-containing protein,8849,49,0.92 [0.55-1.52],0.7369115654746633
Chapter II Neoplasms,Carcinoma in situ of breast,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,7914,45,0.75 [0.26-2.15],0.5867750278628404
Chapter II Neoplasms,Carcinoma in situ of breast,PCARE,Photoreceptor cilium actin regulator,7686,45,0.93 [0.65-1.34],0.6945844148432625
Chapter II Neoplasms,Carcinoma in situ of breast,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,7797,44,0.77 [0.41-1.47],0.4341425407074742
Chapter II Neoplasms,Carcinoma in situ of breast,PCBP2,Poly(rC)-binding protein 2,7937,45,0.83 [0.55-1.24],0.3585768619398964
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH1,Protocadherin-1,9132,50,2.41 [1.19-4.91],0.0151213694931042
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH12,Protocadherin-12,7937,45,0.81 [0.27-2.44],0.7034483427029004
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH17,Protocadherin-17,9066,49,1.25 [0.62-2.53],0.5340301588333958
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH7,Protocadherin-7,7914,45,1.17 [0.55-2.48],0.6751171238082494
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH9,Protocadherin-9,7914,45,0.66 [0.28-1.54],0.3318864536296493
Chapter II Neoplasms,Carcinoma in situ of breast,PCDHB15,Protocadherin beta-15,7924,45,1.21 [0.60-2.45],0.5943529087207179
Chapter II Neoplasms,Carcinoma in situ of breast,PCNA,Proliferating cell nuclear antigen,7678,44,0.64 [0.33-1.26],0.2001002665164017
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK7,Proprotein convertase subtilisin/kexin type 7,7924,45,1.05 [0.57-1.92],0.8777739472543515
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK9,Proprotein convertase subtilisin/kexin type 9,9177,49,1.76 [0.92-3.36],0.0856927862149638
Chapter II Neoplasms,Carcinoma in situ of breast,PCYT2,Ethanolamine-phosphate cytidylyltransferase,7914,45,0.97 [0.66-1.42],0.8677721183205134
Chapter II Neoplasms,Carcinoma in situ of breast,PDAP1,28 kDa heat- and acid-stable phosphoprotein,7948,45,0.91 [0.67-1.23],0.53198791566953
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1,Programmed cell death protein 1,9130,50,0.83 [0.46-1.49],0.5324940527359907
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1LG2,Programmed cell death 1 ligand 2,9033,51,1.18 [0.53-2.64],0.683051739943958
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD5,Programmed cell death protein 5,9138,49,0.89 [0.57-1.38],0.5916840231502676
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD6,Programmed cell death protein 6,9066,49,1.16 [0.76-1.77],0.4951703437638327
Chapter II Neoplasms,Carcinoma in situ of breast,PDCL2,Phosducin-like protein 2,7678,44,0.77 [0.41-1.45],0.4234753303093553
Chapter II Neoplasms,Carcinoma in situ of breast,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",7678,44,1.01 [0.60-1.69],0.976933857205588
Chapter II Neoplasms,Carcinoma in situ of breast,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",7710,44,1.19 [0.80-1.76],0.3895774351458849
Chapter II Neoplasms,Carcinoma in situ of breast,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",7807,44,0.83 [0.63-1.09],0.1796710477444648
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFA,Platelet-derived growth factor subunit A,9177,49,0.83 [0.58-1.17],0.2833497612236343
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFB,Platelet-derived growth factor subunit B,9112,50,0.84 [0.63-1.12],0.246366672642513
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFC,Platelet-derived growth factor C,8869,47,0.47 [0.19-1.17],0.1039322588459779
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRA,Platelet-derived growth factor receptor alpha,9066,49,1.19 [0.50-2.81],0.6982577808981165
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRB,Platelet-derived growth factor receptor beta,9177,49,1.10 [0.53-2.30],0.7919061888571233
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA2,Protein disulfide-isomerase A2,7678,44,0.93 [0.45-1.90],0.8349365484483864
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA3,Protein disulfide-isomerase A3,7807,44,0.65 [0.19-2.18],0.4834052269038258
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA4,Protein disulfide-isomerase A4,7965,46,0.90 [0.55-1.45],0.6528266892007428
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA5,Protein disulfide-isomerase A5,7678,44,0.83 [0.48-1.42],0.489396417010197
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM5,PDZ and LIM domain protein 5,7937,45,0.85 [0.67-1.08],0.1793382559402678
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM7,PDZ and LIM domain protein 7,9112,50,0.90 [0.73-1.10],0.2864636198694082
Chapter II Neoplasms,Carcinoma in situ of breast,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",8869,47,0.72 [0.39-1.34],0.3019733138050414
Chapter II Neoplasms,Carcinoma in situ of breast,PDRG1,p53 and DNA damage-regulated protein 1,7742,44,1.18 [0.81-1.71],0.3807832366427128
Chapter II Neoplasms,Carcinoma in situ of breast,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,7678,44,0.87 [0.47-1.62],0.6701697136048879
Chapter II Neoplasms,Carcinoma in situ of breast,PDZD2,PDZ domain-containing protein 2,7710,44,0.67 [0.39-1.17],0.1605103963822876
Chapter II Neoplasms,Carcinoma in situ of breast,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,7735,44,0.80 [0.39-1.65],0.5465250366816838
Chapter II Neoplasms,Carcinoma in situ of breast,PEAR1,Platelet endothelial aggregation receptor 1,9177,49,0.89 [0.29-2.74],0.8439412004797804
Chapter II Neoplasms,Carcinoma in situ of breast,PEBP1,Phosphatidylethanolamine-binding protein 1,9075,49,0.80 [0.51-1.25],0.318096474531344
Chapter II Neoplasms,Carcinoma in situ of breast,PECAM1,Platelet endothelial cell adhesion molecule,9075,49,1.10 [0.48-2.52],0.8191576831658318
Chapter II Neoplasms,Carcinoma in situ of breast,PECR,Peroxisomal trans-2-enoyl-CoA reductase,7776,44,0.41 [0.13-1.30],0.1293306717322465
Chapter II Neoplasms,Carcinoma in situ of breast,PENK,Proenkephalin-A,7807,44,0.77 [0.30-2.03],0.6008063264493544
Chapter II Neoplasms,Carcinoma in situ of breast,PEPD,Xaa-Pro dipeptidase,7955,44,0.98 [0.33-2.93],0.9739514800793284
Chapter II Neoplasms,Carcinoma in situ of breast,PER3,Period circadian protein homolog 3,7735,44,0.86 [0.67-1.11],0.2469517116622982
Chapter II Neoplasms,Carcinoma in situ of breast,PF4,Platelet factor 4,7915,41,0.77 [0.57-1.06],0.1059447104927473
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN2,Prefoldin subunit 2,8849,49,0.98 [0.61-1.57],0.9367791152751336
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN4,Prefoldin subunit 4,7678,44,0.49 [0.25-0.98],0.0423499112342618
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN6,Prefoldin subunit 6,7742,44,0.63 [0.34-1.17],0.1404577392520436
Chapter II Neoplasms,Carcinoma in situ of breast,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",9012,51,1.02 [0.74-1.41],0.8938724981952859
Chapter II Neoplasms,Carcinoma in situ of breast,PGA4,Pepsin A-4,7955,44,0.98 [0.66-1.44],0.9096330750406196
Chapter II Neoplasms,Carcinoma in situ of breast,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",7948,45,1.05 [0.61-1.79],0.8688375713440678
Chapter II Neoplasms,Carcinoma in situ of breast,PGF,Placenta growth factor,9160,50,0.97 [0.34-2.78],0.9528434963058804
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP1,Peptidoglycan recognition protein 1,9148,49,0.80 [0.43-1.49],0.4816246820562976
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,7868,41,0.91 [0.34-2.45],0.8499325201767594
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP4,Peptidoglycan recognition protein 4,7710,44,1.00 [0.63-1.58],0.9857045718103996
Chapter II Neoplasms,Carcinoma in situ of breast,PGM2,Phosphoglucomutase-2,7742,44,0.86 [0.48-1.55],0.6147444046199888
Chapter II Neoplasms,Carcinoma in situ of breast,PGR,Progesterone receptor,7735,44,0.83 [0.56-1.23],0.3522139179143908
Chapter II Neoplasms,Carcinoma in situ of breast,PHACTR2,Phosphatase and actin regulator 2,7937,45,0.92 [0.71-1.19],0.5203546515417277
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB1,Pleckstrin homology-like domain family B member 1,7914,45,0.83 [0.47-1.46],0.5189973458867052
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB2,Pleckstrin homology-like domain family B member 2,7678,44,1.14 [0.88-1.49],0.326823165422998
Chapter II Neoplasms,Carcinoma in situ of breast,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,9005,49,2.82 [1.24-6.43],0.0136218956932548
Chapter II Neoplasms,Carcinoma in situ of breast,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,7807,44,1.12 [0.55-2.28],0.7491456314018147
Chapter II Neoplasms,Carcinoma in situ of breast,PI16,Peptidase inhibitor 16,7955,44,1.46 [0.47-4.53],0.5091098357849513
Chapter II Neoplasms,Carcinoma in situ of breast,PI3,Elafin,8959,46,1.05 [0.65-1.70],0.8509764103368763
Chapter II Neoplasms,Carcinoma in situ of breast,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",7937,45,0.97 [0.67-1.41],0.8670508344453277
Chapter II Neoplasms,Carcinoma in situ of breast,PIGR,Polymeric immunoglobulin receptor,8956,49,0.95 [0.45-1.98],0.8840528915202166
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,9043,49,0.85 [0.56-1.30],0.4553615987252352
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,9075,49,1.86 [0.78-4.44],0.1645292412064611
Chapter II Neoplasms,Carcinoma in situ of breast,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,7735,44,0.76 [0.42-1.38],0.3639843539924846
Chapter II Neoplasms,Carcinoma in situ of breast,PILRA,Paired immunoglobulin-like type 2 receptor alpha,9075,49,1.67 [0.91-3.08],0.0994976188567319
Chapter II Neoplasms,Carcinoma in situ of breast,PILRB,Paired immunoglobulin-like type 2 receptor beta,9066,49,1.36 [0.85-2.17],0.2034713046028388
Chapter II Neoplasms,Carcinoma in situ of breast,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,7807,44,0.93 [0.61-1.42],0.7491233421096855
Chapter II Neoplasms,Carcinoma in situ of breast,PITHD1,PITH domain-containing protein 1,7663,44,0.83 [0.54-1.27],0.3883623153297504
Chapter II Neoplasms,Carcinoma in situ of breast,PKD1,Polycystin-1,7948,45,0.68 [0.22-2.05],0.4907508553210252
Chapter II Neoplasms,Carcinoma in situ of breast,PKD2,Polycystin-2,7710,44,1.08 [0.66-1.76],0.7584702467161395
Chapter II Neoplasms,Carcinoma in situ of breast,PKLR,Pyruvate kinase PKLR,9088,50,0.93 [0.64-1.35],0.7079291333353007
Chapter II Neoplasms,Carcinoma in situ of breast,PKN3,Serine/threonine-protein kinase N3,7824,45,0.76 [0.51-1.14],0.1811417152130532
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G10,Group 10 secretory phospholipase A2,9005,49,1.23 [0.81-1.86],0.3339601188137407
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G15,Phospholipase A2 group XV,9106,50,1.17 [0.46-3.00],0.743125207532338
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G1B,Phospholipase A2,9165,48,0.86 [0.48-1.53],0.5998680320155645
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G2A,"Phospholipase A2, membrane associated",9036,48,1.42 [1.03-1.98],0.0344783495488456
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G4A,Cytosolic phospholipase A2,9112,50,0.88 [0.66-1.18],0.3994932419955638
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G7,Platelet-activating factor acetylhydrolase,9075,49,0.91 [0.42-1.96],0.8058495543957304
Chapter II Neoplasms,Carcinoma in situ of breast,PLAT,Tissue-type plasminogen activator,9159,49,0.94 [0.57-1.55],0.794105260041101
Chapter II Neoplasms,Carcinoma in situ of breast,PLAU,Urokinase-type plasminogen activator,9075,49,1.11 [0.48-2.59],0.8058154945845047
Chapter II Neoplasms,Carcinoma in situ of breast,PLAUR,Urokinase plasminogen activator surface receptor,9013,50,1.14 [0.44-2.94],0.79448329948841
Chapter II Neoplasms,Carcinoma in situ of breast,PLB1,"Phospholipase B1, membrane-associated",7945,46,0.85 [0.53-1.35],0.4842985827842303
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",7735,44,1.38 [0.84-2.25],0.2022829876555807
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",7945,46,0.95 [0.71-1.28],0.7583519723222135
Chapter II Neoplasms,Carcinoma in situ of breast,PLEKHO1,Pleckstrin homology domain-containing family O member 1,7945,46,0.83 [0.55-1.27],0.3896196716923628
Chapter II Neoplasms,Carcinoma in situ of breast,PLG,Plasminogen,7773,40,0.38 [0.09-1.50],0.1664939974697521
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN1,Perilipin-1,8849,49,1.42 [0.75-2.67],0.2775337356414963
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN3,Perilipin-3,9066,49,0.95 [0.52-1.73],0.8655568188413048
Chapter II Neoplasms,Carcinoma in situ of breast,PLPBP,Pyridoxal phosphate homeostasis protein,9066,49,0.73 [0.50-1.08],0.1138211646708796
Chapter II Neoplasms,Carcinoma in situ of breast,PLSCR3,Phospholipid scramblase 3,7928,46,0.84 [0.52-1.36],0.4710935325608847
Chapter II Neoplasms,Carcinoma in situ of breast,PLTP,Phospholipid transfer protein,9147,49,1.35 [0.64-2.85],0.433150106720051
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC1,Plexin domain-containing protein 1,8869,47,0.66 [0.26-1.72],0.3969616938709198
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC2,Plexin domain-containing protein 2,7945,46,1.62 [0.67-3.92],0.2838397684694481
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNA4,Plexin-A4,9043,49,1.02 [0.75-1.39],0.9054348363875012
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB2,Plexin-B2,9140,49,1.30 [0.45-3.74],0.6260873043533758
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB3,Plexin-B3,9043,49,0.84 [0.48-1.46],0.535185488143284
Chapter II Neoplasms,Carcinoma in situ of breast,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,9019,49,1.14 [0.98-1.33],0.0986083536734583
Chapter II Neoplasms,Carcinoma in situ of breast,PMCH,Pro-MCH,7710,44,1.12 [0.85-1.47],0.4213946687849884
Chapter II Neoplasms,Carcinoma in situ of breast,PMM2,Phosphomannomutase 2,7710,44,0.88 [0.54-1.45],0.6264508942912342
Chapter II Neoplasms,Carcinoma in situ of breast,PMS1,PMS1 protein homolog 1,7742,44,0.58 [0.30-1.12],0.1020885467285051
Chapter II Neoplasms,Carcinoma in situ of breast,PMVK,Phosphomevalonate kinase,8831,49,0.92 [0.74-1.15],0.4747257670580002
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIP,Pancreatic triacylglycerol lipase,7955,44,0.68 [0.43-1.09],0.1074460205959818
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP1,Inactive pancreatic lipase-related protein 1,7945,46,0.87 [0.60-1.25],0.4508135649659656
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP2,Pancreatic lipase-related protein 2,9065,50,1.02 [0.93-1.11],0.7346427488396561
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA1,Paraneoplastic antigen Ma1,7776,44,0.89 [0.51-1.53],0.6668711184812446
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA2,Paraneoplastic antigen Ma2,7686,45,0.61 [0.30-1.24],0.1689673017404003
Chapter II Neoplasms,Carcinoma in situ of breast,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",8903,49,0.99 [0.79-1.24],0.9344097927025804
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL,Podocalyxin,9033,51,0.41 [0.08-2.06],0.2811797358357405
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL2,Podocalyxin-like protein 2,9106,50,2.01 [0.85-4.76],0.1134571754782044
Chapter II Neoplasms,Carcinoma in situ of breast,POF1B,Protein POF1B,7735,44,1.00 [0.53-1.91],0.9907892006107708
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2A,DNA-directed RNA polymerase II subunit RPB1,7735,44,1.37 [0.58-3.21],0.4725861718597796
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",9033,51,1.58 [0.92-2.73],0.10018826969626
Chapter II Neoplasms,Carcinoma in situ of breast,POMC,Pro-opiomelanocortin,7776,44,0.82 [0.54-1.26],0.3667479773035887
Chapter II Neoplasms,Carcinoma in situ of breast,PON1,Serum paraoxonase/arylesterase 1,7955,44,1.06 [0.36-3.15],0.9094562149324508
Chapter II Neoplasms,Carcinoma in situ of breast,PON2,Serum paraoxonase/arylesterase 2,8895,49,0.60 [0.29-1.23],0.1610697973442832
Chapter II Neoplasms,Carcinoma in situ of breast,PON3,Serum paraoxonase/lactonase 3,9112,50,1.98 [0.72-5.48],0.1884049050436691
Chapter II Neoplasms,Carcinoma in situ of breast,POSTN,Periostin,7965,46,1.25 [0.59-2.66],0.5672693293853472
Chapter II Neoplasms,Carcinoma in situ of breast,PPBP,Platelet basic protein,7917,40,0.84 [0.59-1.20],0.3421604427734482
Chapter II Neoplasms,Carcinoma in situ of breast,PPCDC,Phosphopantothenoylcysteine decarboxylase,9138,49,0.80 [0.46-1.40],0.4391333222882781
Chapter II Neoplasms,Carcinoma in situ of breast,PPIB,Peptidyl-prolyl cis-trans isomerase B,9090,48,0.82 [0.63-1.08],0.1632275277680833
Chapter II Neoplasms,Carcinoma in situ of breast,PPIE,Peptidyl-prolyl cis-trans isomerase E,7824,45,1.09 [0.73-1.63],0.6741830125482385
Chapter II Neoplasms,Carcinoma in situ of breast,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",7965,46,1.04 [0.68-1.61],0.8438791600550541
Chapter II Neoplasms,Carcinoma in situ of breast,PPL,Periplakin,7735,44,1.32 [0.60-2.88],0.4903023394478942
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1A,Protein phosphatase 1A,8869,47,1.11 [0.51-2.40],0.796491372605434
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1B,Protein phosphatase 1B,7735,44,0.91 [0.53-1.54],0.7195667561834151
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1F,Protein phosphatase 1F,7948,45,0.85 [0.48-1.49],0.5697323168765749
Chapter II Neoplasms,Carcinoma in situ of breast,PPME1,Protein phosphatase methylesterase 1,9033,51,0.75 [0.50-1.12],0.1565101864239722
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,7924,45,0.85 [0.60-1.22],0.3823870350431805
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,9106,50,0.87 [0.67-1.14],0.3148649386101938
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,7824,45,0.74 [0.45-1.21],0.2312838809605643
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,7937,45,1.12 [0.80-1.57],0.4949273957304351
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,7937,45,0.93 [0.43-2.00],0.8469749505635553
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R2,Protein phosphatase inhibitor 2,9066,49,0.83 [0.60-1.16],0.2738682700876449
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R9B,Neurabin-2,9160,50,0.84 [0.64-1.10],0.212418774470063
Chapter II Neoplasms,Carcinoma in situ of breast,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,7914,45,0.94 [0.73-1.21],0.6534139567307107
Chapter II Neoplasms,Carcinoma in situ of breast,PPP3R1,Calcineurin subunit B type 1,9005,49,1.71 [0.94-3.12],0.0805108335399515
Chapter II Neoplasms,Carcinoma in situ of breast,PPT1,Palmitoyl-protein thioesterase 1,7742,44,0.81 [0.50-1.32],0.3954171696241216
Chapter II Neoplasms,Carcinoma in situ of breast,PPY,Pancreatic prohormone,9079,50,0.98 [0.76-1.24],0.8388090272632096
Chapter II Neoplasms,Carcinoma in situ of breast,PQBP1,Polyglutamine-binding protein 1,8869,47,0.95 [0.58-1.55],0.8253070645575042
Chapter II Neoplasms,Carcinoma in situ of breast,PRAME,Melanoma antigen preferentially expressed in tumors,7678,44,0.49 [0.15-1.59],0.2351657978424214
Chapter II Neoplasms,Carcinoma in situ of breast,PRAP1,Proline-rich acidic protein 1,7965,46,0.70 [0.36-1.35],0.2829294166800176
Chapter II Neoplasms,Carcinoma in situ of breast,PRC1,Protein regulator of cytokinesis 1,7924,45,1.63 [1.31-2.04],1.5566900686294698e-05
Chapter II Neoplasms,Carcinoma in situ of breast,PRCP,Lysosomal Pro-X carboxypeptidase,9135,47,0.79 [0.34-1.82],0.5763699745147164
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX1,Peroxiredoxin-1,8822,48,1.02 [0.75-1.37],0.9165382025789608
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX2,Peroxiredoxin-2,7814,43,0.71 [0.44-1.15],0.1680410322439898
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",8903,49,0.87 [0.61-1.26],0.4734725019136768
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX5,"Peroxiredoxin-5, mitochondrial",9160,50,0.86 [0.60-1.23],0.3983807053835875
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX6,Peroxiredoxin-6,9145,50,1.01 [0.66-1.54],0.9699727389484426
Chapter II Neoplasms,Carcinoma in situ of breast,PREB,Prolactin regulatory element-binding protein,8903,49,1.88 [1.01-3.51],0.0463880664279591
Chapter II Neoplasms,Carcinoma in situ of breast,PRELP,Prolargin,9065,50,1.27 [0.45-3.60],0.655691214104366
Chapter II Neoplasms,Carcinoma in situ of breast,PRG2,Bone marrow proteoglycan,7965,46,1.18 [0.70-1.99],0.528918357615051
Chapter II Neoplasms,Carcinoma in situ of breast,PRG3,Proteoglycan 3,7965,46,0.83 [0.47-1.45],0.5089915471095494
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,8903,49,0.80 [0.48-1.33],0.3826593426065616
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,7742,44,1.23 [0.56-2.73],0.6047924186751774
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,9066,49,0.91 [0.67-1.23],0.5410416926347921
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,7929,46,0.97 [0.68-1.37],0.8540678341099704
Chapter II Neoplasms,Carcinoma in situ of breast,PRKCQ,Protein kinase C theta type,8903,49,1.01 [0.57-1.78],0.978018906870582
Chapter II Neoplasms,Carcinoma in situ of breast,PRKD2,Serine/threonine-protein kinase D2,7710,44,0.52 [0.21-1.25],0.141494955250646
Chapter II Neoplasms,Carcinoma in situ of breast,PRKG1,cGMP-dependent protein kinase 1,7807,44,0.95 [0.75-1.20],0.6837263765120335
Chapter II Neoplasms,Carcinoma in situ of breast,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,8869,47,1.04 [0.70-1.53],0.8472540108835575
Chapter II Neoplasms,Carcinoma in situ of breast,PRL,Prolactin,9138,49,1.23 [0.90-1.68],0.1961660022716732
Chapter II Neoplasms,Carcinoma in situ of breast,PRND,Prion-like protein doppel,7945,46,0.76 [0.44-1.29],0.306803253989163
Chapter II Neoplasms,Carcinoma in situ of breast,PROC,Vitamin K-dependent protein C,9101,50,2.15 [0.77-6.01],0.1459046093252502
Chapter II Neoplasms,Carcinoma in situ of breast,PROCR,Endothelial protein C receptor,7710,44,0.93 [0.42-2.06],0.8648652729260372
Chapter II Neoplasms,Carcinoma in situ of breast,PROK1,Prokineticin-1,9043,49,1.47 [1.01-2.15],0.0462542685082942
Chapter II Neoplasms,Carcinoma in situ of breast,PROS1,Vitamin K-dependent protein S,7968,42,0.70 [0.21-2.33],0.5579181859639533
Chapter II Neoplasms,Carcinoma in situ of breast,PRR4,Proline-rich protein 4,7739,43,0.96 [0.63-1.46],0.8342731480981628
Chapter II Neoplasms,Carcinoma in situ of breast,PRR5,Proline-rich protein 5,7735,44,1.45 [0.92-2.29],0.1108062105763565
Chapter II Neoplasms,Carcinoma in situ of breast,PRRT3,Proline-rich transmembrane protein 3,7776,44,1.68 [0.82-3.42],0.1537550339122876
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS2,Trypsin-2,9120,50,0.79 [0.48-1.30],0.3475747622227995
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS22,Brain-specific serine protease 4,7735,44,0.80 [0.32-1.98],0.6302391814939594
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS27,Serine protease 27,9049,49,0.86 [0.46-1.60],0.6360143820850508
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS53,Serine protease 53,7945,46,0.72 [0.34-1.54],0.3968053907957081
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS8,Prostasin,9048,50,1.19 [0.65-2.16],0.5805004710631017
Chapter II Neoplasms,Carcinoma in situ of breast,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,8849,49,0.92 [0.73-1.16],0.4786768449774083
Chapter II Neoplasms,Carcinoma in situ of breast,PRTG,Protogenin,9145,50,1.83 [0.69-4.85],0.2254132267158895
Chapter II Neoplasms,Carcinoma in situ of breast,PRTN3,Myeloblastin,8842,48,0.91 [0.53-1.58],0.7434537267751959
Chapter II Neoplasms,Carcinoma in situ of breast,PRUNE2,Protein prune homolog 2,7824,45,1.11 [0.46-2.65],0.8173830341461406
Chapter II Neoplasms,Carcinoma in situ of breast,PSAP,Prosaposin,7883,46,0.91 [0.33-2.49],0.8477230579457196
Chapter II Neoplasms,Carcinoma in situ of breast,PSAPL1,Proactivator polypeptide-like 1,7914,45,1.95 [1.15-3.29],0.012727606881136
Chapter II Neoplasms,Carcinoma in situ of breast,PSCA,Prostate stem cell antigen,7914,45,0.93 [0.84-1.04],0.1949674158912024
Chapter II Neoplasms,Carcinoma in situ of breast,PSG1,Pregnancy-specific beta-1-glycoprotein 1,9005,49,1.10 [0.87-1.38],0.4257453067890145
Chapter II Neoplasms,Carcinoma in situ of breast,PSIP1,PC4 and SFRS1-interacting protein,9043,49,1.02 [0.68-1.51],0.9358685391834066
Chapter II Neoplasms,Carcinoma in situ of breast,PSMA1,Proteasome subunit alpha type-1,8869,47,0.73 [0.39-1.38],0.3370260192501174
Chapter II Neoplasms,Carcinoma in situ of breast,PSMC3,26S proteasome regulatory subunit 6A,7678,44,0.76 [0.29-1.96],0.5647305909692866
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD1,26S proteasome non-ATPase regulatory subunit 1,7937,45,0.85 [0.46-1.54],0.5844442237914294
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD5,26S proteasome non-ATPase regulatory subunit 5,7742,44,1.03 [0.62-1.69],0.9217675127870806
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD9,26S proteasome non-ATPase regulatory subunit 9,9033,51,0.82 [0.52-1.31],0.4064986271479399
Chapter II Neoplasms,Carcinoma in situ of breast,PSME1,Proteasome activator complex subunit 1,8993,49,0.62 [0.31-1.25],0.1812720410037074
Chapter II Neoplasms,Carcinoma in situ of breast,PSME2,Proteasome activator complex subunit 2,8958,49,0.79 [0.39-1.60],0.5151863490270925
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG3,Proteasome assembly chaperone 3,9043,49,0.75 [0.46-1.24],0.2647744424116248
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG4,Proteasome assembly chaperone 4,7735,44,0.75 [0.43-1.29],0.2923951360730228
Chapter II Neoplasms,Carcinoma in situ of breast,PSPN,Persephin,9043,49,1.27 [0.99-1.63],0.0567933858375594
Chapter II Neoplasms,Carcinoma in situ of breast,PSRC1,Proline/serine-rich coiled-coil protein 1,8869,47,0.88 [0.55-1.40],0.5929248990289457
Chapter II Neoplasms,Carcinoma in situ of breast,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,7554,41,0.89 [0.68-1.18],0.429096143596916
Chapter II Neoplasms,Carcinoma in situ of breast,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",8849,49,0.83 [0.35-1.95],0.6739215234367106
Chapter II Neoplasms,Carcinoma in situ of breast,PTGDS,Prostaglandin-H2 D-isomerase,9010,50,2.34 [1.27-4.30],0.0064748022473275
Chapter II Neoplasms,Carcinoma in situ of breast,PTGES2,Prostaglandin E synthase 2,7673,44,1.10 [0.65-1.87],0.7131708047298344
Chapter II Neoplasms,Carcinoma in situ of breast,PTGR1,Prostaglandin reductase 1,7948,45,1.04 [0.74-1.47],0.8101490037547356
Chapter II Neoplasms,Carcinoma in situ of breast,PTH,Parathyroid hormone,7742,44,0.85 [0.58-1.24],0.404110046444642
Chapter II Neoplasms,Carcinoma in situ of breast,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,9043,49,0.66 [0.39-1.11],0.1141043272419866
Chapter II Neoplasms,Carcinoma in situ of breast,PTK7,Inactive tyrosine-protein kinase 7,8849,49,1.53 [0.79-2.96],0.2049102424091964
Chapter II Neoplasms,Carcinoma in situ of breast,PTN,Pleiotrophin,8895,49,0.96 [0.57-1.62],0.8690570992647209
Chapter II Neoplasms,Carcinoma in situ of breast,PTP4A3,Protein tyrosine phosphatase type IVA 3,7735,44,0.79 [0.42-1.46],0.4516303941067316
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,9005,49,1.04 [0.75-1.43],0.8230431238878086
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,9094,50,0.90 [0.68-1.18],0.4520927277025347
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,7723,44,1.65 [0.87-3.14],0.1238666389991368
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRB,Receptor-type tyrosine-protein phosphatase beta,7948,45,1.21 [0.44-3.33],0.7144020980851256
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRC,Receptor-type tyrosine-protein phosphatase C,7965,46,0.96 [0.27-3.46],0.9523894193080888
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRF,Receptor-type tyrosine-protein phosphatase F,9177,49,3.33 [1.38-8.03],0.0075173199274715
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRH,Receptor-type tyrosine-protein phosphatase H,7914,45,1.13 [0.62-2.06],0.6948466919519789
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,7914,45,0.93 [0.26-3.32],0.909354800883903
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRM,Receptor-type tyrosine-protein phosphatase mu,9032,49,1.01 [0.36-2.85],0.9800787501313556
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,8978,49,1.90 [0.90-4.03],0.0922954800454325
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRR,Receptor-type tyrosine-protein phosphatase R,7945,46,1.69 [0.77-3.71],0.1883830202060529
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRS,Receptor-type tyrosine-protein phosphatase S,9177,49,2.05 [0.72-5.84],0.1775803502313838
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,7948,45,0.99 [0.41-2.39],0.9733147441949824
Chapter II Neoplasms,Carcinoma in situ of breast,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,7807,44,0.73 [0.45-1.18],0.1994006332412998
Chapter II Neoplasms,Carcinoma in situ of breast,PTS,6-pyruvoyl tetrahydrobiopterin synthase,8815,47,0.83 [0.51-1.33],0.4333284332161464
Chapter II Neoplasms,Carcinoma in situ of breast,PTTG1,Securin,7824,45,1.09 [0.57-2.09],0.7900067769559178
Chapter II Neoplasms,Carcinoma in situ of breast,PTX3,Pentraxin-related protein PTX3,9043,49,1.26 [0.71-2.23],0.4235338323087033
Chapter II Neoplasms,Carcinoma in situ of breast,PVALB,Parvalbumin alpha,9090,50,0.97 [0.78-1.21],0.7876430802601053
Chapter II Neoplasms,Carcinoma in situ of breast,PVR,Poliovirus receptor,9138,49,0.93 [0.46-1.87],0.8350114248062922
Chapter II Neoplasms,Carcinoma in situ of breast,PXDNL,Peroxidasin-like protein,7924,45,1.44 [1.09-1.91],0.0103744374177835
Chapter II Neoplasms,Carcinoma in situ of breast,PXN,Paxillin,8849,49,0.97 [0.58-1.62],0.909578557565782
Chapter II Neoplasms,Carcinoma in situ of breast,PYDC1,Pyrin domain-containing protein 1,7776,44,1.84 [1.24-2.72],0.0023529067615275
Chapter II Neoplasms,Carcinoma in situ of breast,PYY,Peptide YY,7710,44,1.13 [0.85-1.50],0.3967735237037028
Chapter II Neoplasms,Carcinoma in situ of breast,PZP,Pregnancy zone protein,7968,42,1.12 [0.70-1.80],0.6414014460095536
Chapter II Neoplasms,Carcinoma in situ of breast,QDPR,Dihydropteridine reductase,9024,49,0.85 [0.47-1.55],0.6019374800749243
Chapter II Neoplasms,Carcinoma in situ of breast,QPCT,Glutaminyl-peptide cyclotransferase,9107,47,0.81 [0.31-2.12],0.6690809700529603
Chapter II Neoplasms,Carcinoma in situ of breast,QSOX1,Sulfhydryl oxidase 1,7814,41,0.47 [0.15-1.50],0.2046380667304597
Chapter II Neoplasms,Carcinoma in situ of breast,RAB10,Ras-related protein Rab-10,7948,45,0.88 [0.51-1.51],0.6473931498016978
Chapter II Neoplasms,Carcinoma in situ of breast,RAB11FIP3,Rab11 family-interacting protein 3,7948,45,0.90 [0.69-1.17],0.4223717636936704
Chapter II Neoplasms,Carcinoma in situ of breast,RAB27B,Ras-related protein Rab-27B,7948,45,0.81 [0.58-1.14],0.2330867354844674
Chapter II Neoplasms,Carcinoma in situ of breast,RAB2B,Ras-related protein Rab-2B,7924,45,0.73 [0.45-1.18],0.1981610756397764
Chapter II Neoplasms,Carcinoma in situ of breast,RAB33A,Ras-related protein Rab-33A,7710,44,0.94 [0.60-1.48],0.8006886068906542
Chapter II Neoplasms,Carcinoma in situ of breast,RAB37,Ras-related protein Rab-37,8903,49,0.99 [0.72-1.36],0.9635539954271974
Chapter II Neoplasms,Carcinoma in situ of breast,RAB39B,Ras-related protein Rab-39B,7710,44,0.98 [0.69-1.38],0.8868227234622621
Chapter II Neoplasms,Carcinoma in situ of breast,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,7686,45,0.89 [0.51-1.54],0.6704634366309672
Chapter II Neoplasms,Carcinoma in situ of breast,RAB44,Ras-related protein Rab-44,7924,45,1.38 [0.88-2.14],0.1593245185370798
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6A,Ras-related protein Rab-6A,9043,49,1.94 [1.33-2.83],0.0005589998487105
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6B,Ras-related protein Rab-6B,8849,49,0.75 [0.42-1.34],0.3338904054643579
Chapter II Neoplasms,Carcinoma in situ of breast,RABEP1,Rab GTPase-binding effector protein 1,7807,44,0.82 [0.56-1.20],0.3100663617496875
Chapter II Neoplasms,Carcinoma in situ of breast,RABEPK,Rab9 effector protein with kelch motifs,8869,47,1.01 [0.64-1.59],0.9693208506320564
Chapter II Neoplasms,Carcinoma in situ of breast,RABGAP1L,Rab GTPase-activating protein 1-like,8903,49,0.80 [0.51-1.24],0.3103947221897249
Chapter II Neoplasms,Carcinoma in situ of breast,RAC3,Ras-related C3 botulinum toxin substrate 3,7742,44,0.47 [0.23-0.97],0.0408371811477881
Chapter II Neoplasms,Carcinoma in situ of breast,RAD23B,UV excision repair protein RAD23 homolog B,8869,47,0.93 [0.53-1.64],0.8077464456338942
Chapter II Neoplasms,Carcinoma in situ of breast,RAD51,DNA repair protein RAD51 homolog 1,7824,45,1.01 [0.61-1.70],0.9558855067926382
Chapter II Neoplasms,Carcinoma in situ of breast,RALB,Ras-related protein Ral-B,7735,44,2.30 [1.27-4.16],0.0061437784379382
Chapter II Neoplasms,Carcinoma in situ of breast,RALY,RNA-binding protein Raly,7924,45,1.45 [0.94-2.24],0.0910226246805909
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP1,Ran-specific GTPase-activating protein,7776,44,0.68 [0.39-1.17],0.1642898761207512
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP2,E3 SUMO-protein ligase RanBP2,7686,45,2.03 [1.00-4.11],0.0496598658607099
Chapter II Neoplasms,Carcinoma in situ of breast,RANGAP1,Ran GTPase-activating protein 1,8869,47,0.75 [0.40-1.42],0.3785655783183157
Chapter II Neoplasms,Carcinoma in situ of breast,RAP1A,Ras-related protein Rap-1A,7735,44,1.02 [0.69-1.50],0.9356721908933467
Chapter II Neoplasms,Carcinoma in situ of breast,RAPGEF2,Rap guanine nucleotide exchange factor 2,7824,45,0.84 [0.47-1.48],0.543814916780395
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES1,Retinoic acid receptor responder protein 1,8869,47,1.22 [0.64-2.33],0.547336333641445
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES2,Retinoic acid receptor responder protein 2,9134,50,0.85 [0.49-1.48],0.5624158656544399
Chapter II Neoplasms,Carcinoma in situ of breast,RASA1,Ras GTPase-activating protein 1,8849,49,0.91 [0.41-2.01],0.8210866303537243
Chapter II Neoplasms,Carcinoma in situ of breast,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,7678,44,0.84 [0.43-1.64],0.6133769543943752
Chapter II Neoplasms,Carcinoma in situ of breast,RASSF2,Ras association domain-containing protein 2,8869,47,0.73 [0.42-1.26],0.2526872878914032
Chapter II Neoplasms,Carcinoma in situ of breast,RBFOX3,RNA binding protein fox-1 homolog 3,7937,45,0.77 [0.34-1.77],0.5405946967430014
Chapter II Neoplasms,Carcinoma in situ of breast,RBKS,Ribokinase,8854,48,0.87 [0.55-1.40],0.5775479276051827
Chapter II Neoplasms,Carcinoma in situ of breast,RBM17,Splicing factor 45,7937,45,0.90 [0.61-1.33],0.5939861221701617
Chapter II Neoplasms,Carcinoma in situ of breast,RBM19,Probable RNA-binding protein 19,7710,44,0.94 [0.50-1.75],0.8422538730569563
Chapter II Neoplasms,Carcinoma in situ of breast,RBM25,RNA-binding protein 25,7678,44,1.18 [0.65-2.15],0.5790304222489268
Chapter II Neoplasms,Carcinoma in situ of breast,RBP1,Retinol-binding protein 1,7742,44,0.84 [0.50-1.41],0.5077965820390575
Chapter II Neoplasms,Carcinoma in situ of breast,RBP2,Retinol-binding protein 2,9033,51,1.25 [0.91-1.73],0.1729940937241117
Chapter II Neoplasms,Carcinoma in situ of breast,RBP5,Retinol-binding protein 5,9033,51,0.83 [0.53-1.31],0.4338112660102305
Chapter II Neoplasms,Carcinoma in situ of breast,RBP7,Retinoid-binding protein 7,7914,45,1.05 [0.66-1.68],0.8309403838503356
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS,RNA-binding protein with multiple splicing,7735,44,1.12 [0.78-1.63],0.5350738867470954
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS2,RNA-binding protein with multiple splicing 2,7776,44,0.85 [0.64-1.14],0.2808932158582411
Chapter II Neoplasms,Carcinoma in situ of breast,RCC1,Regulator of chromosome condensation,7924,45,1.36 [0.92-2.01],0.1181444250088744
Chapter II Neoplasms,Carcinoma in situ of breast,RCOR1,REST corepressor 1,8895,49,1.14 [0.70-1.85],0.5951577368404632
Chapter II Neoplasms,Carcinoma in situ of breast,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,7776,44,1.45 [0.34-6.20],0.6157097679796031
Chapter II Neoplasms,Carcinoma in situ of breast,REEP4,Receptor expression-enhancing protein 4,7937,45,0.86 [0.53-1.41],0.5580375675756899
Chapter II Neoplasms,Carcinoma in situ of breast,REG1A,Lithostathine-1-alpha,9015,50,1.20 [0.75-1.92],0.4507257197878747
Chapter II Neoplasms,Carcinoma in situ of breast,REG1B,Lithostathine-1-beta,9177,49,0.82 [0.51-1.32],0.4108531969449004
Chapter II Neoplasms,Carcinoma in situ of breast,REG3A,Regenerating islet-derived protein 3-alpha,9177,49,0.87 [0.57-1.33],0.5276056529421158
Chapter II Neoplasms,Carcinoma in situ of breast,REG3G,Regenerating islet-derived protein 3-gamma,7924,45,0.78 [0.37-1.64],0.5102288153282861
Chapter II Neoplasms,Carcinoma in situ of breast,REG4,Regenerating islet-derived protein 4,9082,50,1.29 [0.79-2.11],0.3016082857777546
Chapter II Neoplasms,Carcinoma in situ of breast,RELB,Transcription factor RelB,7735,44,0.98 [0.56-1.74],0.956942263692134
Chapter II Neoplasms,Carcinoma in situ of breast,RELT,Tumor necrosis factor receptor superfamily member 19L,9075,49,1.44 [0.59-3.49],0.4200250546770855
Chapter II Neoplasms,Carcinoma in situ of breast,REN,Renin,9066,49,0.74 [0.51-1.06],0.1031886899174447
Chapter II Neoplasms,Carcinoma in situ of breast,REPS1,RalBP1-associated Eps domain-containing protein 1,7735,44,1.14 [0.56-2.32],0.7141548136118075
Chapter II Neoplasms,Carcinoma in situ of breast,REST,RE1-silencing transcription factor,7678,44,0.66 [0.26-1.65],0.3714072709054864
Chapter II Neoplasms,Carcinoma in situ of breast,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,9033,51,0.84 [0.45-1.55],0.5714871893028505
Chapter II Neoplasms,Carcinoma in situ of breast,RETN,Resistin,9059,49,0.94 [0.51-1.72],0.8316564063714538
Chapter II Neoplasms,Carcinoma in situ of breast,REXO2,"Oligoribonuclease, mitochondrial",7710,44,0.74 [0.37-1.51],0.4105395782401235
Chapter II Neoplasms,Carcinoma in situ of breast,RFC4,Replication factor C subunit 4,7924,45,1.56 [0.43-5.62],0.4987061219386006
Chapter II Neoplasms,Carcinoma in situ of breast,RGCC,Regulator of cell cycle RGCC,7937,45,0.93 [0.64-1.37],0.725954628607214
Chapter II Neoplasms,Carcinoma in situ of breast,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,7824,45,1.07 [0.71-1.63],0.7422076887971893
Chapter II Neoplasms,Carcinoma in situ of breast,RGMA,Repulsive guidance molecule A,9138,49,0.69 [0.31-1.56],0.3749122249431442
Chapter II Neoplasms,Carcinoma in situ of breast,RGMB,RGM domain family member B,9138,49,1.73 [0.72-4.17],0.2234803513097999
Chapter II Neoplasms,Carcinoma in situ of breast,RGS10,Regulator of G-protein signaling 10,7937,45,0.89 [0.54-1.46],0.6408916229392396
Chapter II Neoplasms,Carcinoma in situ of breast,RGS8,Regulator of G-protein signaling 8,8903,49,1.02 [0.69-1.50],0.9393650990628324
Chapter II Neoplasms,Carcinoma in situ of breast,RHOC,Rho-related GTP-binding protein RhoC,8946,49,0.99 [0.80-1.24],0.9508651106913892
Chapter II Neoplasms,Carcinoma in situ of breast,RICTOR,Rapamycin-insensitive companion of mTOR,7735,44,0.76 [0.37-1.57],0.4584598320382652
Chapter II Neoplasms,Carcinoma in situ of breast,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,7807,44,0.63 [0.34-1.18],0.1481287217635846
Chapter II Neoplasms,Carcinoma in situ of breast,RILP,Rab-interacting lysosomal protein,9110,50,0.63 [0.42-0.97],0.0347461191507508
Chapter II Neoplasms,Carcinoma in situ of breast,RILPL2,RILP-like protein 2,7948,45,0.95 [0.71-1.28],0.7553493172045067
Chapter II Neoplasms,Carcinoma in situ of breast,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,7710,44,1.14 [0.81-1.61],0.4427236294008659
Chapter II Neoplasms,Carcinoma in situ of breast,RLN1,Prorelaxin H1,7937,45,1.20 [0.77-1.87],0.4137356914665216
Chapter II Neoplasms,Carcinoma in situ of breast,RLN2,Prorelaxin H2,7787,44,1.48 [0.93-2.38],0.1005052160545108
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE1,Ribonuclease pancreatic,7955,44,0.94 [0.30-2.92],0.9115065062164316
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE10,Inactive ribonuclease-like protein 10,7776,44,0.94 [0.52-1.68],0.8251125580273274
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE3,Eosinophil cationic protein,9032,49,1.11 [0.90-1.37],0.3323870605219117
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE4,Ribonuclease 4,7685,41,1.21 [0.41-3.54],0.7271063060142595
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE6,Ribonuclease K6,7892,44,0.81 [0.30-2.19],0.6802855171019497
Chapter II Neoplasms,Carcinoma in situ of breast,RNASEH2A,Ribonuclease H2 subunit A,7937,45,0.97 [0.53-1.75],0.9137002598826192
Chapter II Neoplasms,Carcinoma in situ of breast,RNASET2,Ribonuclease T2,9145,47,0.58 [0.21-1.59],0.2903754882021084
Chapter II Neoplasms,Carcinoma in situ of breast,RNF149,E3 ubiquitin-protein ligase RNF149,7776,44,1.13 [0.45-2.84],0.794101704631939
Chapter II Neoplasms,Carcinoma in situ of breast,RNF168,E3 ubiquitin-protein ligase RNF168,7735,44,0.74 [0.33-1.68],0.4764942390013434
Chapter II Neoplasms,Carcinoma in situ of breast,RNF31,E3 ubiquitin-protein ligase RNF31,7735,44,0.99 [0.43-2.24],0.976821231554716
Chapter II Neoplasms,Carcinoma in situ of breast,RNF4,E3 ubiquitin-protein ligase RNF4,7824,45,1.39 [1.01-1.90],0.0419987886944212
Chapter II Neoplasms,Carcinoma in situ of breast,RNF41,E3 ubiquitin-protein ligase NRDP1,8869,47,0.69 [0.46-1.05],0.082451993603376
Chapter II Neoplasms,Carcinoma in situ of breast,RNF43,E3 ubiquitin-protein ligase RNF43,7824,45,1.03 [0.63-1.68],0.9152168633037044
Chapter II Neoplasms,Carcinoma in situ of breast,RNF5,E3 ubiquitin-protein ligase RNF5,7776,44,1.02 [0.68-1.53],0.9381445347732588
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO1,Roundabout homolog 1,9082,50,1.08 [0.40-2.90],0.8795252814953958
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO2,Roundabout homolog 2,9138,49,0.91 [0.31-2.70],0.8718243868600943
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO4,Roundabout homolog 4,7776,44,3.01 [0.62-14.62],0.1720349610341102
Chapter II Neoplasms,Carcinoma in situ of breast,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,9066,49,1.69 [0.77-3.72],0.1903524320496595
Chapter II Neoplasms,Carcinoma in situ of breast,RP2,Protein XRP2,9033,51,0.91 [0.50-1.68],0.7742513456818001
Chapter II Neoplasms,Carcinoma in situ of breast,RPA2,Replication protein A 32 kDa subunit,7735,44,1.19 [0.52-2.74],0.6829084755140711
Chapter II Neoplasms,Carcinoma in situ of breast,RPE,Ribulose-phosphate 3-epimerase,7824,45,0.74 [0.46-1.17],0.1923701433997094
Chapter II Neoplasms,Carcinoma in situ of breast,RPGR,X-linked retinitis pigmentosa GTPase regulator,7742,44,0.61 [0.27-1.38],0.2390935658447624
Chapter II Neoplasms,Carcinoma in situ of breast,RPL14,60S ribosomal protein L14,7776,44,1.00 [0.48-2.09],0.9955479386493352
Chapter II Neoplasms,Carcinoma in situ of breast,RPS10,40S ribosomal protein S10,7710,44,0.76 [0.34-1.70],0.5105068549244096
Chapter II Neoplasms,Carcinoma in situ of breast,RRAS,Ras-related protein R-Ras,7742,44,0.98 [0.79-1.23],0.8889796871679597
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2,Ribonucleoside-diphosphate reductase subunit M2,8869,47,1.14 [0.74-1.74],0.5535294217827692
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,8869,47,0.89 [0.60-1.32],0.5666131114033076
Chapter II Neoplasms,Carcinoma in situ of breast,RRP15,RRP15-like protein,7686,45,1.20 [0.92-1.58],0.1831226891014268
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO1,R-spondin-1,9005,49,0.97 [0.45-2.12],0.9488983186146484
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO3,R-spondin-3,9145,50,0.69 [0.28-1.72],0.4274152818896325
Chapter II Neoplasms,Carcinoma in situ of breast,RTBDN,Retbindin,9033,51,0.76 [0.31-1.86],0.546577651985442
Chapter II Neoplasms,Carcinoma in situ of breast,RTKN2,Rhotekin-2,7710,44,0.89 [0.48-1.65],0.7118551229708144
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",7937,45,0.92 [0.67-1.26],0.6003092267209951
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4R,Reticulon-4 receptor,9145,50,1.20 [0.59-2.47],0.6146043703673375
Chapter II Neoplasms,Carcinoma in situ of breast,RUVBL1,RuvB-like 1,8869,47,1.19 [0.98-1.45],0.0813119221921511
Chapter II Neoplasms,Carcinoma in situ of breast,RWDD1,RWD domain-containing protein 1,9138,49,0.83 [0.56-1.24],0.3751830021808431
Chapter II Neoplasms,Carcinoma in situ of breast,RYR1,Ryanodine receptor 1,7710,44,0.71 [0.27-1.85],0.4873155466739696
Chapter II Neoplasms,Carcinoma in situ of breast,S100A11,Protein S100-A11,8998,48,1.03 [0.60-1.76],0.917277452505818
Chapter II Neoplasms,Carcinoma in situ of breast,S100A12,Protein S100-A12,8947,51,0.97 [0.70-1.35],0.8515583838531189
Chapter II Neoplasms,Carcinoma in situ of breast,S100A13,Protein S100-A13,7735,44,0.97 [0.42-2.26],0.9519290060163133
Chapter II Neoplasms,Carcinoma in situ of breast,S100A14,Protein S100-A14,7937,45,0.95 [0.57-1.59],0.8405685457793872
Chapter II Neoplasms,Carcinoma in situ of breast,S100A16,Protein S100-A16,8838,49,1.39 [0.99-1.95],0.0603290857765348
Chapter II Neoplasms,Carcinoma in situ of breast,S100A3,Protein S100-A3,7924,45,0.75 [0.33-1.69],0.4894790062119712
Chapter II Neoplasms,Carcinoma in situ of breast,S100A4,Protein S100-A4,9106,50,0.72 [0.47-1.12],0.14362703583342
Chapter II Neoplasms,Carcinoma in situ of breast,S100G,Protein S100-G,7937,45,1.19 [0.64-2.23],0.5849033579503728
Chapter II Neoplasms,Carcinoma in situ of breast,S100P,Protein S100-P,8895,49,1.41 [0.97-2.04],0.0692069213063071
Chapter II Neoplasms,Carcinoma in situ of breast,SAA4,Serum amyloid A-4 protein,7968,42,0.53 [0.09-2.99],0.4728522496374276
Chapter II Neoplasms,Carcinoma in situ of breast,SAFB2,Scaffold attachment factor B2,7937,45,1.01 [0.37-2.78],0.981928670340976
Chapter II Neoplasms,Carcinoma in situ of breast,SAG,S-arrestin,7686,45,1.12 [0.68-1.84],0.670089699425743
Chapter II Neoplasms,Carcinoma in situ of breast,SAMD9L,Sterile alpha motif domain-containing protein 9-like,9043,49,1.06 [0.75-1.50],0.7483176444543231
Chapter II Neoplasms,Carcinoma in situ of breast,SAP18,Histone deacetylase complex subunit SAP18,7824,45,0.87 [0.56-1.34],0.5192279422408907
Chapter II Neoplasms,Carcinoma in situ of breast,SARG,Specifically androgen-regulated gene protein,7913,45,0.94 [0.72-1.22],0.6526228125483335
Chapter II Neoplasms,Carcinoma in situ of breast,SART1,U4/U6.U5 tri-snRNP-associated protein 1,7710,44,0.98 [0.43-2.20],0.954174655106412
Chapter II Neoplasms,Carcinoma in situ of breast,SAT1,Diamine acetyltransferase 1,7710,44,1.04 [0.60-1.82],0.8835068092766704
Chapter II Neoplasms,Carcinoma in situ of breast,SAT2,Thialysine N-epsilon-acetyltransferase,7824,45,1.02 [0.67-1.55],0.9193708182137226
Chapter II Neoplasms,Carcinoma in situ of breast,SATB1,DNA-binding protein SATB1,7937,45,1.76 [0.90-3.44],0.0963128697246139
Chapter II Neoplasms,Carcinoma in situ of breast,SBSN,Suprabasin,7951,46,0.98 [0.43-2.25],0.963607360341846
Chapter II Neoplasms,Carcinoma in situ of breast,SCAMP3,Secretory carrier-associated membrane protein 3,9033,51,0.80 [0.59-1.08],0.139913499111597
Chapter II Neoplasms,Carcinoma in situ of breast,SCARA5,Scavenger receptor class A member 5,9138,49,0.98 [0.42-2.33],0.9696255400953876
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB1,Scavenger receptor class B member 1,8849,49,1.44 [1.13-1.85],0.0038299918774599
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB2,Lysosome membrane protein 2,8836,48,1.36 [0.61-3.02],0.4560256662276193
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF1,Scavenger receptor class F member 1,9177,49,0.83 [0.45-1.53],0.5453576166417199
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF2,Scavenger receptor class F member 2,9138,49,1.08 [0.46-2.52],0.8599424243172374
Chapter II Neoplasms,Carcinoma in situ of breast,SCG2,Secretogranin-2,9094,50,1.43 [0.67-3.09],0.3564049959030068
Chapter II Neoplasms,Carcinoma in situ of breast,SCG3,Secretogranin-3,9082,50,1.39 [0.67-2.90],0.3782255709817307
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB1A1,Uteroglobin,9074,49,0.90 [0.57-1.41],0.645044494704113
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB2A2,Mammaglobin-A,7710,44,1.09 [0.45-2.63],0.8428584605806357
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A1,Secretoglobin family 3A member 1,7807,44,2.78 [0.93-8.27],0.066948356255639
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A2,Secretoglobin family 3A member 2,9094,50,1.09 [0.85-1.38],0.503563393493107
Chapter II Neoplasms,Carcinoma in situ of breast,SCGN,Secretagogin,8903,49,1.38 [0.80-2.39],0.2497546600194271
Chapter II Neoplasms,Carcinoma in situ of breast,SCIN,Adseverin,7686,45,1.20 [0.85-1.70],0.2904788437483779
Chapter II Neoplasms,Carcinoma in situ of breast,SCLY,Selenocysteine lyase,9110,50,0.83 [0.48-1.42],0.4983616868368183
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2A,Sodium channel protein type 2 subunit alpha,7686,45,0.76 [0.38-1.51],0.426073440838653
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2B,Sodium channel subunit beta-2,7742,44,0.93 [0.34-2.55],0.8893835874475684
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3A,Sodium channel protein type 3 subunit alpha,7742,44,1.49 [0.80-2.79],0.2096207098213645
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3B,Sodium channel subunit beta-3,7686,45,1.36 [0.87-2.13],0.1810591523745041
Chapter II Neoplasms,Carcinoma in situ of breast,SCN4B,Sodium channel subunit beta-4,7776,44,0.86 [0.43-1.72],0.674679396108568
Chapter II Neoplasms,Carcinoma in situ of breast,SCP2,Non-specific lipid-transfer protein,8869,47,0.81 [0.53-1.22],0.3127232319341105
Chapter II Neoplasms,Carcinoma in situ of breast,SCPEP1,Retinoid-inducible serine carboxypeptidase,7743,44,0.94 [0.50-1.74],0.8321146040232814
Chapter II Neoplasms,Carcinoma in situ of breast,SCRG1,Scrapie-responsive protein 1,7948,45,0.45 [0.16-1.31],0.1423243719025385
Chapter II Neoplasms,Carcinoma in situ of breast,SCRIB,Protein scribble homolog,7776,44,0.92 [0.65-1.28],0.6139097343422123
Chapter II Neoplasms,Carcinoma in situ of breast,SCRN1,Secernin-1,9043,49,1.00 [0.63-1.58],0.9961840108640097
Chapter II Neoplasms,Carcinoma in situ of breast,SCT,Secretin,7742,44,1.50 [0.83-2.70],0.1823776601054041
Chapter II Neoplasms,Carcinoma in situ of breast,SDC1,Syndecan-1,9066,49,0.81 [0.42-1.59],0.5448897929806786
Chapter II Neoplasms,Carcinoma in situ of breast,SDC4,Syndecan-4,9066,49,0.83 [0.47-1.45],0.5059216615196034
Chapter II Neoplasms,Carcinoma in situ of breast,SDCCAG8,Serologically defined colon cancer antigen 8,7924,45,0.84 [0.65-1.09],0.1852883036425182
Chapter II Neoplasms,Carcinoma in situ of breast,SDHB,Succinate dehydrogenase,7914,45,1.09 [0.73-1.63],0.6708492868427347
Chapter II Neoplasms,Carcinoma in situ of breast,SDK2,Protein sidekick-2,7807,44,1.09 [0.53-2.23],0.8140002433435101
Chapter II Neoplasms,Carcinoma in situ of breast,SEC31A,Protein transport protein Sec31A,7776,44,0.97 [0.66-1.42],0.8564133940012699
Chapter II Neoplasms,Carcinoma in situ of breast,SEL1L,Protein sel-1 homolog 1,7776,44,1.49 [0.75-2.96],0.2528257270879687
Chapter II Neoplasms,Carcinoma in situ of breast,SELE,E-selectin,9177,49,0.76 [0.47-1.24],0.2737711135977504
Chapter II Neoplasms,Carcinoma in situ of breast,SELENOP,Selenoprotein P,7968,42,0.84 [0.22-3.16],0.797201742261218
Chapter II Neoplasms,Carcinoma in situ of breast,SELL,L-selectin,7968,42,0.69 [0.20-2.41],0.5589563053658558
Chapter II Neoplasms,Carcinoma in situ of breast,SELP,P-selectin,9120,50,1.00 [0.65-1.56],0.9827402272682756
Chapter II Neoplasms,Carcinoma in situ of breast,SELPLG,P-selectin glycoprotein ligand 1,9043,49,0.53 [0.23-1.19],0.124702290199106
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3F,Semaphorin-3F,9066,49,1.25 [0.48-3.31],0.6470657380894027
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3G,Semaphorin-3G,7807,44,1.00 [0.50-1.97],0.9955367795884554
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4C,Semaphorin-4C,9033,51,0.95 [0.37-2.44],0.9167463277496704
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4D,Semaphorin-4D,9138,49,0.67 [0.29-1.57],0.3579986018468877
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA6C,Semaphorin-6C,7735,44,1.46 [0.54-3.96],0.4597907602505283
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA7A,Semaphorin-7A,9159,49,0.78 [0.29-2.07],0.6151721979440845
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN3,Neuronal-specific septin-3,7937,45,1.02 [0.70-1.50],0.9116634676602304
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN7,Septin-7,7824,45,1.11 [0.70-1.77],0.6468050364968443
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN8,Septin-8,7932,46,0.46 [0.17-1.23],0.1224965356759783
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN9,Septin-9,9033,51,0.79 [0.32-1.97],0.6161893202969158
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA1,Alpha-1-antitrypsin,7808,41,2.83 [0.07-112.73],0.580338875589213
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA11,Serpin A11,9177,49,1.08 [0.58-2.04],0.802392187430008
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA12,Serpin A12,8785,49,1.15 [0.95-1.39],0.1606403422197478
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA3,Alpha-1-antichymotrypsin,7928,42,0.46 [0.06-3.60],0.4583759970801229
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA4,Kallistatin,7820,41,0.63 [0.18-2.21],0.4674875361423437
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA5,Plasma serine protease inhibitor,7848,41,1.29 [0.56-2.98],0.5451617356479137
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA6,Corticosteroid-binding globulin,7968,42,0.35 [0.05-2.25],0.2677932829732037
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA7,Thyroxine-binding globulin,7968,42,1.80 [0.36-8.94],0.4711495109056812
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA9,Serpin A9,8982,51,0.88 [0.62-1.25],0.4838842281392753
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB1,Leukocyte elastase inhibitor,9046,49,1.03 [0.78-1.37],0.8302352649205103
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB5,Serpin B5,8895,49,0.75 [0.47-1.20],0.2228497278769726
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB6,Serpin B6,9109,49,0.92 [0.60-1.42],0.7052658273205944
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB8,Serpin B8,9160,50,1.37 [1.00-1.86],0.0492052078592054
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB9,Serpin B9,9005,49,1.30 [0.63-2.72],0.4780885795560494
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINC1,Antithrombin-III,7951,41,0.50 [0.12-2.06],0.3371107258479472
Chapter II Neoplasms,Carcinoma in situ of breast,SERPIND1,Heparin cofactor 2,7951,41,0.78 [0.26-2.34],0.6540543736094939
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE1,Plasminogen activator inhibitor 1,9177,49,0.81 [0.56-1.17],0.2599447055275203
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE2,Glia-derived nexin,7948,45,0.73 [0.46-1.17],0.1895307111208061
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF1,Pigment epithelium-derived factor,7839,40,0.52 [0.16-1.63],0.2592601121233316
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF2,Alpha-2-antiplasmin,7814,40,0.39 [0.05-3.38],0.3935153109020868
Chapter II Neoplasms,Carcinoma in situ of breast,SERPING1,Plasma protease C1 inhibitor,7951,41,1.83 [0.35-9.42],0.4715407278191954
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINH1,Serpin H1,7824,45,0.87 [0.69-1.08],0.2136759966453059
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI1,Neuroserpin,7793,44,2.30 [1.08-4.92],0.0316636501875692
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI2,Serpin I2,7914,45,0.75 [0.44-1.29],0.2995390205730412
Chapter II Neoplasms,Carcinoma in situ of breast,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,8849,49,0.84 [0.56-1.28],0.4194176090680748
Chapter II Neoplasms,Carcinoma in situ of breast,SETMAR,Histone-lysine N-methyltransferase SETMAR,8978,47,2.10 [1.02-4.31],0.0435067765713186
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6,Seizure protein 6 homolog,7742,44,1.51 [0.62-3.68],0.3634323852614745
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L,Seizure 6-like protein,9106,50,1.74 [0.72-4.16],0.2168192677240886
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L2,Seizure 6-like protein 2,9033,51,1.40 [0.50-3.94],0.5218624521249449
Chapter II Neoplasms,Carcinoma in situ of breast,SF3B4,Splicing factor 3B subunit 4,9033,51,0.78 [0.55-1.11],0.1641316808086809
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP1,Secreted frizzled-related protein 1,8983,49,1.00 [0.55-1.80],0.987326243819215
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP4,Secreted frizzled-related protein 4,7807,44,0.88 [0.43-1.80],0.7167085674070073
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA1,Pulmonary surfactant-associated protein A1,8869,47,0.83 [0.49-1.40],0.4854683717622818
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA2,Pulmonary surfactant-associated protein A2,8869,47,0.90 [0.53-1.53],0.6871253218652991
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPD,Pulmonary surfactant-associated protein D,9066,49,1.24 [0.86-1.81],0.2528016777604085
Chapter II Neoplasms,Carcinoma in situ of breast,SGSH,N-sulphoglucosamine sulphohydrolase,7788,45,1.23 [0.77-1.96],0.3792976348521555
Chapter II Neoplasms,Carcinoma in situ of breast,SH2B3,SH2B adapter protein 3,8869,47,0.82 [0.63-1.07],0.1498211399538707
Chapter II Neoplasms,Carcinoma in situ of breast,SH2D1A,SH2 domain-containing protein 1A,9043,49,0.92 [0.57-1.48],0.7223254425594482
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,7686,45,1.17 [0.79-1.74],0.4301789871342023
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BP1,SH3 domain-binding protein 1,7914,45,1.15 [0.66-2.00],0.6212816039011638
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GL3,Endophilin-A3,7780,45,0.88 [0.62-1.23],0.4526252286723327
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GLB2,Endophilin-B2,7945,46,0.70 [0.46-1.07],0.0993480872238941
Chapter II Neoplasms,Carcinoma in situ of breast,SHBG,Sex hormone-binding globulin,7955,44,0.90 [0.53-1.52],0.6829124190760778
Chapter II Neoplasms,Carcinoma in situ of breast,SHC1,SHC-transforming protein 1,7678,44,0.85 [0.64-1.12],0.2474329832196647
Chapter II Neoplasms,Carcinoma in situ of breast,SHD,SH2 domain-containing adapter protein D,7691,44,1.06 [0.78-1.44],0.696680639836162
Chapter II Neoplasms,Carcinoma in situ of breast,SHH,Sonic hedgehog protein,7735,44,0.88 [0.45-1.74],0.7156980222370544
Chapter II Neoplasms,Carcinoma in situ of breast,SHISA5,Protein shisa-5,7965,46,1.50 [0.61-3.65],0.3765587953794123
Chapter II Neoplasms,Carcinoma in situ of breast,SHMT1,"Serine hydroxymethyltransferase, cytosolic",9094,50,0.68 [0.50-0.91],0.0094917091749701
Chapter II Neoplasms,Carcinoma in situ of breast,SHPK,Sedoheptulokinase,7824,45,0.83 [0.39-1.78],0.6343714746681859
Chapter II Neoplasms,Carcinoma in situ of breast,SIAE,Sialate O-acetylesterase,9093,50,0.73 [0.42-1.28],0.2698679147440594
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC1,Sialoadhesin,9112,50,1.74 [1.00-3.03],0.0513893345170317
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC10,Sialic acid-binding Ig-like lectin 10,9043,49,0.91 [0.42-1.98],0.8104711665958676
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC15,Sialic acid-binding Ig-like lectin 15,8849,49,0.94 [0.67-1.33],0.7335252423657399
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC5,Sialic acid-binding Ig-like lectin 5,9075,49,1.14 [0.89-1.45],0.2947341914686709
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC6,Sialic acid-binding Ig-like lectin 6,9145,50,1.10 [0.51-2.39],0.8122335823363764
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC7,Sialic acid-binding Ig-like lectin 7,9066,49,1.65 [0.66-4.16],0.2846333216551787
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC8,Sialic acid-binding Ig-like lectin 8,7776,44,1.12 [0.58-2.16],0.7447489493719123
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC9,Sialic acid-binding Ig-like lectin 9,9128,50,0.83 [0.35-1.94],0.662950243137897
Chapter II Neoplasms,Carcinoma in situ of breast,SIL1,Nucleotide exchange factor SIL1,7776,44,1.08 [0.45-2.57],0.8669935120745456
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,9099,49,0.93 [0.61-1.44],0.7620642706316715
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPB1,Signal-regulatory protein beta-1,9059,50,1.59 [0.93-2.73],0.0881051203376885
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT1,NAD-dependent protein deacetylase sirtuin-1,7735,44,0.88 [0.58-1.35],0.5589581792826627
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT2,NAD-dependent protein deacetylase sirtuin-2,9033,51,0.85 [0.64-1.12],0.2519399019101311
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",8849,49,0.66 [0.38-1.16],0.1526084595309561
Chapter II Neoplasms,Carcinoma in situ of breast,SIT1,Signaling threshold-regulating transmembrane adapter 1,8903,49,1.11 [0.70-1.75],0.6495769022635447
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP1,Src kinase-associated phosphoprotein 1,8986,49,1.08 [0.76-1.53],0.6614925384653212
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP2,Src kinase-associated phosphoprotein 2,9112,50,0.85 [0.67-1.09],0.1970504269010602
Chapter II Neoplasms,Carcinoma in situ of breast,SKIV2L,Helicase SKI2W,7710,44,1.11 [0.55-2.25],0.776449179891608
Chapter II Neoplasms,Carcinoma in situ of breast,SLA2,Src-like-adapter 2,7937,45,1.02 [0.77-1.35],0.8967636241699128
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF1,Signaling lymphocytic activation molecule,8903,49,1.07 [0.69-1.66],0.7766019681497847
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF6,SLAM family member 6,8869,47,1.28 [0.64-2.54],0.4821247306792063
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF7,SLAM family member 7,9043,49,1.35 [0.88-2.07],0.1748818195198228
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF8,SLAM family member 8,8869,47,0.78 [0.49-1.25],0.3094742960229553
Chapter II Neoplasms,Carcinoma in situ of breast,SLC12A2,Solute carrier family 12 member 2,7710,44,0.69 [0.21-2.22],0.5319374581346854
Chapter II Neoplasms,Carcinoma in situ of breast,SLC13A1,Solute carrier family 13 member 1,7924,45,0.70 [0.36-1.35],0.2818404093760277
Chapter II Neoplasms,Carcinoma in situ of breast,SLC16A1,Monocarboxylate transporter 1,8849,49,0.83 [0.51-1.37],0.4717539554948171
Chapter II Neoplasms,Carcinoma in situ of breast,SLC1A4,Neutral amino acid transporter A,7742,44,1.05 [0.60-1.82],0.8663337894659764
Chapter II Neoplasms,Carcinoma in situ of breast,SLC27A4,Long-chain fatty acid transport protein 4,8849,49,1.18 [0.83-1.69],0.3523441398361336
Chapter II Neoplasms,Carcinoma in situ of breast,SLC28A1,Sodium/nucleoside cotransporter 1,7678,44,0.77 [0.43-1.39],0.3938832977148351
Chapter II Neoplasms,Carcinoma in situ of breast,SLC34A3,Sodium-dependent phosphate transport protein 2C,7678,44,0.69 [0.33-1.44],0.3274912808920777
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A14,Zinc transporter ZIP14,8849,49,1.49 [0.86-2.59],0.1544827349834419
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A5,Zinc transporter ZIP5,9043,49,1.25 [0.88-1.77],0.2220703945789076
Chapter II Neoplasms,Carcinoma in situ of breast,SLC44A4,Choline transporter-like protein 4,7742,44,0.76 [0.45-1.29],0.3131724006584189
Chapter II Neoplasms,Carcinoma in situ of breast,SLC4A1,Band 3 anion transport protein,7965,46,1.25 [0.70-2.23],0.454826445213676
Chapter II Neoplasms,Carcinoma in situ of breast,SLC51B,Organic solute transporter subunit beta,7710,44,1.28 [0.94-1.75],0.1164327446294419
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,7807,44,0.99 [0.70-1.40],0.9503154386847784
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,7914,45,0.80 [0.41-1.56],0.5178749101923135
Chapter II Neoplasms,Carcinoma in situ of breast,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",7678,44,1.03 [0.64-1.67],0.8953281642597378
Chapter II Neoplasms,Carcinoma in situ of breast,SLIT2,Slit homolog 2 protein,8849,49,0.93 [0.55-1.56],0.7793658576672892
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK1,SLIT and NTRK-like protein 1,7735,44,1.44 [0.57-3.65],0.4407569142178227
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK2,SLIT and NTRK-like protein 2,9145,50,0.98 [0.50-1.90],0.9475481237443276
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK6,SLIT and NTRK-like protein 6,8895,49,1.50 [0.75-2.98],0.2473862687663869
Chapter II Neoplasms,Carcinoma in situ of breast,SLK,STE20-like serine/threonine-protein kinase,7824,45,1.19 [0.91-1.56],0.2036384850685467
Chapter II Neoplasms,Carcinoma in situ of breast,SLMAP,Sarcolemmal membrane-associated protein,7914,45,0.78 [0.54-1.12],0.1764950530229813
Chapter II Neoplasms,Carcinoma in situ of breast,SLURP1,Secreted Ly-6/uPAR-related protein 1,7899,46,1.10 [0.55-2.20],0.7852151756590453
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD1,Mothers against decapentaplegic homolog 1,8869,47,0.84 [0.60-1.17],0.2992867840336412
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD2,Mothers against decapentaplegic homolog 2,7924,45,0.80 [0.52-1.24],0.3176779771255404
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD3,Mothers against decapentaplegic homolog 3,7924,45,0.67 [0.37-1.21],0.1840540613095107
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD5,Mothers against decapentaplegic homolog 5,9033,51,0.33 [0.11-0.98],0.0463030479193055
Chapter II Neoplasms,Carcinoma in situ of breast,SMARCA2,Probable global transcription activator SNF2L2,8849,49,1.02 [0.70-1.46],0.9324257958231884
Chapter II Neoplasms,Carcinoma in situ of breast,SMC3,Structural maintenance of chromosomes protein 3,7678,44,0.69 [0.37-1.29],0.2435962777208296
Chapter II Neoplasms,Carcinoma in situ of breast,SMNDC1,Survival of motor neuron-related-splicing factor 30,7914,45,1.12 [0.73-1.72],0.6089565193159563
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC1,SPARC-related modular calcium-binding protein 1,9145,50,0.87 [0.40-1.87],0.7220020212889484
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC2,SPARC-related modular calcium-binding protein 2,9112,50,0.81 [0.41-1.61],0.5429994877126557
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD1,Sphingomyelin phosphodiesterase,9091,49,0.90 [0.52-1.56],0.7078245078205165
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD3,Sphingomyelin phosphodiesterase 3,7735,44,0.55 [0.24-1.27],0.1605386099245299
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,9106,50,0.75 [0.52-1.09],0.1310291954163809
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,7924,45,0.79 [0.49-1.27],0.3233549385735481
Chapter II Neoplasms,Carcinoma in situ of breast,SMS,Spermine synthase,7686,45,1.23 [0.85-1.78],0.2761956318223904
Chapter II Neoplasms,Carcinoma in situ of breast,SMTN,Smoothelin,7939,46,0.83 [0.60-1.14],0.2527364268231493
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP23,Synaptosomal-associated protein 23,9066,49,0.83 [0.62-1.09],0.183112240674812
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP25,Synaptosomal-associated protein 25,7686,45,1.20 [0.65-2.22],0.5586575283928579
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP29,Synaptosomal-associated protein 29,9106,50,0.82 [0.62-1.08],0.1630802970687681
Chapter II Neoplasms,Carcinoma in situ of breast,SNAPIN,SNARE-associated protein Snapin,7937,45,0.95 [0.57-1.58],0.8528434425273079
Chapter II Neoplasms,Carcinoma in situ of breast,SNCA,Alpha-synuclein,7807,44,0.87 [0.67-1.13],0.2927891465633709
Chapter II Neoplasms,Carcinoma in situ of breast,SNCG,Gamma-synuclein,9005,49,1.74 [1.19-2.54],0.0045253257815772
Chapter II Neoplasms,Carcinoma in situ of breast,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",7776,44,0.79 [0.32-1.98],0.6215791008454638
Chapter II Neoplasms,Carcinoma in situ of breast,SNRPB2,U2 small nuclear ribonucleoprotein B'',7945,46,1.34 [0.89-2.04],0.1637943962275724
Chapter II Neoplasms,Carcinoma in situ of breast,SNU13,NHP2-like protein 1,7710,44,1.04 [0.65-1.65],0.8783788417051509
Chapter II Neoplasms,Carcinoma in situ of breast,SNX15,Sorting nexin-15,7807,44,0.73 [0.42-1.26],0.2643288952959657
Chapter II Neoplasms,Carcinoma in situ of breast,SNX18,Sorting nexin-18,7914,45,0.87 [0.43-1.73],0.6821622811536026
Chapter II Neoplasms,Carcinoma in situ of breast,SNX2,Sorting nexin-2,7924,45,0.89 [0.61-1.29],0.5293329088762124
Chapter II Neoplasms,Carcinoma in situ of breast,SNX5,Sorting nexin-5,7776,44,1.39 [0.58-3.33],0.4629571781502359
Chapter II Neoplasms,Carcinoma in situ of breast,SNX9,Sorting nexin-9,9066,49,0.78 [0.53-1.16],0.2180037102502746
Chapter II Neoplasms,Carcinoma in situ of breast,SOD1,Superoxide dismutase [Cu-Zn],8912,49,0.70 [0.40-1.20],0.1923465827785017
Chapter II Neoplasms,Carcinoma in situ of breast,SOD2,"Superoxide dismutase [Mn], mitochondrial",9075,49,1.19 [0.62-2.27],0.601100457525246
Chapter II Neoplasms,Carcinoma in situ of breast,SOD3,Extracellular superoxide dismutase,7955,44,0.95 [0.55-1.62],0.8427968064259794
Chapter II Neoplasms,Carcinoma in situ of breast,SORBS1,Sorbin and SH3 domain-containing protein 1,7937,45,0.92 [0.44-1.91],0.8142979242027547
Chapter II Neoplasms,Carcinoma in situ of breast,SORCS2,VPS10 domain-containing receptor SorCS2,8869,47,1.14 [0.56-2.33],0.7202939786515774
Chapter II Neoplasms,Carcinoma in situ of breast,SORD,Sorbitol dehydrogenase,9099,50,0.78 [0.55-1.10],0.1536018626651292
Chapter II Neoplasms,Carcinoma in situ of breast,SORT1,Sortilin,9050,49,0.61 [0.30-1.25],0.1787804293942363
Chapter II Neoplasms,Carcinoma in situ of breast,SOST,Sclerostin,9050,49,0.75 [0.38-1.46],0.3911501254180868
Chapter II Neoplasms,Carcinoma in situ of breast,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,7742,44,1.15 [0.68-1.93],0.6034000504829953
Chapter II Neoplasms,Carcinoma in situ of breast,SOX2,Transcription factor SOX-2,7924,45,0.45 [0.13-1.63],0.2245615085504467
Chapter II Neoplasms,Carcinoma in situ of breast,SOX9,Transcription factor SOX-9,7742,44,0.55 [0.19-1.61],0.2719202166319016
Chapter II Neoplasms,Carcinoma in situ of breast,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,7937,45,0.44 [0.14-1.33],0.1460875679813122
Chapter II Neoplasms,Carcinoma in situ of breast,SPAG1,Sperm-associated antigen 1,7937,45,1.22 [0.78-1.91],0.375125445321231
Chapter II Neoplasms,Carcinoma in situ of breast,SPARC,SPARC,9106,50,0.87 [0.61-1.23],0.4311977063623614
Chapter II Neoplasms,Carcinoma in situ of breast,SPARCL1,SPARC-like protein 1,9090,50,2.55 [1.63-3.98],3.987857586213779e-05
Chapter II Neoplasms,Carcinoma in situ of breast,SPART,Spartin,7807,44,0.86 [0.58-1.27],0.4546879364378374
Chapter II Neoplasms,Carcinoma in situ of breast,SPESP1,Sperm equatorial segment protein 1,7948,45,0.79 [0.28-2.17],0.6411421575582303
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK1,Serine protease inhibitor Kazal-type 1,9075,49,0.93 [0.51-1.68],0.8073483620096797
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK2,Serine protease inhibitor Kazal-type 2,7807,44,1.06 [0.50-2.22],0.8845165474996667
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK4,Serine protease inhibitor Kazal-type 4,9043,49,0.88 [0.59-1.29],0.50530733604323
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK5,Serine protease inhibitor Kazal-type 5,9075,49,2.04 [0.96-4.34],0.0632821558104488
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK6,Serine protease inhibitor Kazal-type 6,9145,50,1.34 [0.83-2.16],0.2246185920668832
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK8,Serine protease inhibitor Kazal-type 8,7710,44,1.11 [0.60-2.04],0.7423870666052242
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT1,Kunitz-type protease inhibitor 1,9055,49,1.57 [0.57-4.32],0.3799158703903386
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT2,Kunitz-type protease inhibitor 2,9112,50,0.60 [0.36-1.01],0.0558792664176123
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT3,Kunitz-type protease inhibitor 3,7914,45,0.96 [0.78-1.20],0.7383187850992923
Chapter II Neoplasms,Carcinoma in situ of breast,SPOCK1,Testican-1,9005,49,0.96 [0.35-2.65],0.9364904878212036
Chapter II Neoplasms,Carcinoma in situ of breast,SPON1,Spondin-1,9082,50,0.99 [0.45-2.19],0.9860719446030234
Chapter II Neoplasms,Carcinoma in situ of breast,SPON2,Spondin-2,9028,49,1.73 [0.85-3.53],0.1323726740982614
Chapter II Neoplasms,Carcinoma in situ of breast,SPP1,Osteopontin,9166,49,0.60 [0.37-0.98],0.0393223525975223
Chapter II Neoplasms,Carcinoma in situ of breast,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",7735,44,0.74 [0.35-1.58],0.4409206489823529
Chapter II Neoplasms,Carcinoma in situ of breast,SPRING1,SREBP regulating gene protein,7678,44,0.56 [0.27-1.16],0.1174240376278841
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR1B,Cornifin-B,7824,45,0.76 [0.48-1.19],0.225455383110323
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR3,Small proline-rich protein 3,7945,46,1.00 [0.68-1.46],0.9950529949849368
Chapter II Neoplasms,Carcinoma in situ of breast,SPRY2,Protein sprouty homolog 2,8903,49,0.92 [0.69-1.22],0.5467352499368978
Chapter II Neoplasms,Carcinoma in situ of breast,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",7686,45,1.32 [0.59-2.94],0.5038455468903587
Chapter II Neoplasms,Carcinoma in situ of breast,SPTLC1,Serine palmitoyltransferase 1,7945,46,1.35 [0.74-2.46],0.3304037710654953
Chapter II Neoplasms,Carcinoma in situ of breast,SRC,Proto-oncogene tyrosine-protein kinase Src,9090,50,0.90 [0.73-1.11],0.3263681731648492
Chapter II Neoplasms,Carcinoma in situ of breast,SRP14,Signal recognition particle 14 kDa protein,9033,51,1.02 [0.67-1.54],0.9330777989352368
Chapter II Neoplasms,Carcinoma in situ of breast,SRPK2,SRSF protein kinase 2,9043,49,0.91 [0.67-1.25],0.5670740738384517
Chapter II Neoplasms,Carcinoma in situ of breast,SRPX,Sushi repeat-containing protein SRPX,7948,45,1.15 [0.48-2.73],0.759518685391408
Chapter II Neoplasms,Carcinoma in situ of breast,SSB,Lupus La protein,8849,49,1.06 [0.68-1.64],0.8018672021538849
Chapter II Neoplasms,Carcinoma in situ of breast,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",7735,44,1.65 [0.98-2.77],0.060327152877384
Chapter II Neoplasms,Carcinoma in situ of breast,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,9050,49,0.90 [0.71-1.15],0.3989636394910553
Chapter II Neoplasms,Carcinoma in situ of breast,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,9120,50,0.96 [0.52-1.75],0.8918702286336537
Chapter II Neoplasms,Carcinoma in situ of breast,SSH3,Protein phosphatase Slingshot homolog 3,7678,44,0.85 [0.30-2.39],0.7535085407398077
Chapter II Neoplasms,Carcinoma in situ of breast,SSNA1,Sjoegren syndrome nuclear autoantigen 1,7914,45,0.71 [0.40-1.27],0.2481379428975336
Chapter II Neoplasms,Carcinoma in situ of breast,ST13,Hsc70-interacting protein,7807,44,0.71 [0.43-1.19],0.1915765155167906
Chapter II Neoplasms,Carcinoma in situ of breast,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",9033,51,1.36 [0.79-2.34],0.2686376874180406
Chapter II Neoplasms,Carcinoma in situ of breast,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",9177,49,1.36 [0.57-3.25],0.484224851127716
Chapter II Neoplasms,Carcinoma in situ of breast,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",7735,44,0.73 [0.33-1.65],0.4514395303309019
Chapter II Neoplasms,Carcinoma in situ of breast,STAB2,Stabilin-2,7965,46,0.82 [0.32-2.13],0.6902284433041787
Chapter II Neoplasms,Carcinoma in situ of breast,STAM,Signal transducing adapter molecule 1,7924,45,0.50 [0.21-1.20],0.1214731137041224
Chapter II Neoplasms,Carcinoma in situ of breast,STAMBP,STAM-binding protein,8986,49,0.87 [0.58-1.31],0.5119903005234323
Chapter II Neoplasms,Carcinoma in situ of breast,STAT2,Signal transducer and activator of transcription 2,7735,44,0.88 [0.59-1.30],0.51241900924229
Chapter II Neoplasms,Carcinoma in situ of breast,STAT5B,Signal transducer and activator of transcription 5B,9033,51,0.87 [0.73-1.04],0.1348141278222695
Chapter II Neoplasms,Carcinoma in situ of breast,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,7678,44,0.84 [0.51-1.38],0.4836225053908831
Chapter II Neoplasms,Carcinoma in situ of breast,STC1,Stanniocalcin-1,9138,49,0.89 [0.48-1.66],0.709904249678227
Chapter II Neoplasms,Carcinoma in situ of breast,STC2,Stanniocalcin-2,9065,49,1.66 [0.58-4.77],0.344427991577889
Chapter II Neoplasms,Carcinoma in situ of breast,STEAP4,Metalloreductase STEAP4,7686,45,1.21 [0.90-1.62],0.2018399754707088
Chapter II Neoplasms,Carcinoma in situ of breast,STIP1,Stress-induced-phosphoprotein 1,9066,49,0.83 [0.56-1.23],0.3502275405602622
Chapter II Neoplasms,Carcinoma in situ of breast,STK11,Serine/threonine-protein kinase STK11,8895,49,0.77 [0.54-1.11],0.1622165002623533
Chapter II Neoplasms,Carcinoma in situ of breast,STK24,Serine/threonine-protein kinase 24,8849,49,0.82 [0.54-1.25],0.3647665974595779
Chapter II Neoplasms,Carcinoma in situ of breast,STK4,Serine/threonine-protein kinase 4,9066,49,0.89 [0.66-1.20],0.4536601427810069
Chapter II Neoplasms,Carcinoma in situ of breast,STOML2,"Stomatin-like protein 2, mitochondrial",7678,44,0.91 [0.64-1.29],0.5930586658788871
Chapter II Neoplasms,Carcinoma in situ of breast,STX16,Syntaxin-16,8869,47,0.91 [0.57-1.45],0.6975829218591741
Chapter II Neoplasms,Carcinoma in situ of breast,STX1B,Syntaxin-1B,7742,44,0.96 [0.46-2.02],0.9127174622201188
Chapter II Neoplasms,Carcinoma in situ of breast,STX3,Syntaxin-3,7945,46,1.14 [0.57-2.28],0.705944614232628
Chapter II Neoplasms,Carcinoma in situ of breast,STX4,Syntaxin-4,9033,51,1.19 [0.81-1.73],0.3748315850274417
Chapter II Neoplasms,Carcinoma in situ of breast,STX5,Syntaxin-5,7735,44,1.19 [0.66-2.14],0.5654235720311758
Chapter II Neoplasms,Carcinoma in situ of breast,STX6,Syntaxin-6,8869,47,0.73 [0.46-1.16],0.1888819074424049
Chapter II Neoplasms,Carcinoma in situ of breast,STX7,Syntaxin-7,7735,44,0.99 [0.55-1.78],0.9646296717386176
Chapter II Neoplasms,Carcinoma in situ of breast,STX8,Syntaxin-8,9043,49,0.76 [0.43-1.32],0.3287825035794428
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP1,Syntaxin-binding protein 1,7937,45,0.94 [0.65-1.37],0.7622849820799401
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP3,Syntaxin-binding protein 3,8869,47,0.67 [0.34-1.31],0.2423247127177447
Chapter II Neoplasms,Carcinoma in situ of breast,SUGP1,SURP and G-patch domain-containing protein 1,7914,45,0.91 [0.45-1.88],0.8076306059752932
Chapter II Neoplasms,Carcinoma in situ of breast,SUGT1,Protein SGT1 homolog,8869,47,0.84 [0.61-1.17],0.3069204192979009
Chapter II Neoplasms,Carcinoma in situ of breast,SULT1A1,Sulfotransferase 1A1,9138,49,1.00 [0.82-1.21],0.9608837671990728
Chapter II Neoplasms,Carcinoma in situ of breast,SULT2A1,Bile salt sulfotransferase,9043,49,1.17 [0.79-1.74],0.4276855362144003
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF1,Formylglycine-generating enzyme,7735,44,0.84 [0.49-1.46],0.5359418500667927
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,9138,49,0.90 [0.56-1.45],0.6747372176521301
Chapter II Neoplasms,Carcinoma in situ of breast,SUOX,"Sulfite oxidase, mitochondrial",7937,45,1.25 [0.84-1.88],0.273298512627259
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD1,Sushi domain-containing protein 1,8895,49,0.97 [0.57-1.65],0.9105122992134004
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD2,Sushi domain-containing protein 2,9075,49,1.89 [1.02-3.48],0.0422915878895749
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD4,Sushi domain-containing protein 4,7924,45,1.14 [0.62-2.09],0.6765582494652789
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD5,Sushi domain-containing protein 5,7759,44,2.45 [1.07-5.60],0.0342557826200562
Chapter II Neoplasms,Carcinoma in situ of breast,SV2A,Synaptic vesicle glycoprotein 2A,7742,44,0.70 [0.40-1.20],0.191254340976394
Chapter II Neoplasms,Carcinoma in situ of breast,SWAP70,Switch-associated protein 70,7914,45,1.07 [0.47-2.44],0.8708069757237196
Chapter II Neoplasms,Carcinoma in situ of breast,SYAP1,Synapse-associated protein 1,7807,44,0.96 [0.57-1.62],0.8834376653627561
Chapter II Neoplasms,Carcinoma in situ of breast,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,7686,45,0.87 [0.51-1.49],0.610709818162083
Chapter II Neoplasms,Carcinoma in situ of breast,SYT1,Synaptotagmin-1,7945,46,1.55 [0.98-2.47],0.0633682775080611
Chapter II Neoplasms,Carcinoma in situ of breast,SYTL4,Synaptotagmin-like protein 4,7948,45,0.81 [0.54-1.23],0.3231376807942855
Chapter II Neoplasms,Carcinoma in situ of breast,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,7824,45,0.87 [0.66-1.15],0.3295843622603666
Chapter II Neoplasms,Carcinoma in situ of breast,TACC3,Transforming acidic coiled-coil-containing protein 3,9033,51,0.92 [0.75-1.14],0.4682643471010562
Chapter II Neoplasms,Carcinoma in situ of breast,TACSTD2,Tumor-associated calcium signal transducer 2,8078,44,1.70 [0.75-3.83],0.2033400376873283
Chapter II Neoplasms,Carcinoma in situ of breast,TADA3,Transcriptional adapter 3,7924,45,0.75 [0.35-1.59],0.4539136628732914
Chapter II Neoplasms,Carcinoma in situ of breast,TAFA5,Chemokine-like protein TAFA-5,9033,51,0.87 [0.44-1.75],0.7049562723008048
Chapter II Neoplasms,Carcinoma in situ of breast,TAGLN3,Transgelin-3,7678,44,1.01 [0.62-1.63],0.9724327640714944
Chapter II Neoplasms,Carcinoma in situ of breast,TALDO1,Transaldolase,7923,46,1.03 [0.55-1.96],0.9193938286255314
Chapter II Neoplasms,Carcinoma in situ of breast,TANK,TRAF family member-associated NF-kappa-B activator,8903,49,0.77 [0.53-1.13],0.1839170863649961
Chapter II Neoplasms,Carcinoma in situ of breast,TAP1,Antigen peptide transporter 1,7824,45,0.53 [0.27-1.07],0.0747669037357546
Chapter II Neoplasms,Carcinoma in situ of breast,TARBP2,RISC-loading complex subunit TARBP2,8849,49,0.77 [0.55-1.08],0.1322982286537373
Chapter II Neoplasms,Carcinoma in situ of breast,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",7742,44,1.10 [0.80-1.53],0.5509087756052792
Chapter II Neoplasms,Carcinoma in situ of breast,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",7924,45,1.09 [0.53-2.26],0.8067707101866429
Chapter II Neoplasms,Carcinoma in situ of breast,TAX1BP1,Tax1-binding protein 1,7945,46,0.82 [0.52-1.31],0.4150902894386565
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D17,TBC1 domain family member 17,8849,49,0.63 [0.33-1.19],0.1550752492539066
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D23,TBC1 domain family member 23,9033,51,0.84 [0.63-1.12],0.2372564943218268
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D5,TBC1 domain family member 5,9043,49,0.99 [0.72-1.37],0.970358216275888
Chapter II Neoplasms,Carcinoma in situ of breast,TBCA,Tubulin-specific chaperone A,7807,44,0.82 [0.58-1.16],0.261925991299532
Chapter II Neoplasms,Carcinoma in situ of breast,TBCB,Tubulin-folding cofactor B,9005,49,0.94 [0.73-1.21],0.6428121747718952
Chapter II Neoplasms,Carcinoma in situ of breast,TBCC,Tubulin-specific chaperone C,9005,49,0.88 [0.64-1.21],0.4439945899767965
Chapter II Neoplasms,Carcinoma in situ of breast,TBL1X,F-box-like/WD repeat-containing protein TBL1X,8869,47,0.89 [0.66-1.22],0.4752290013334113
Chapter II Neoplasms,Carcinoma in situ of breast,TBR1,T-box brain protein 1,7742,44,0.52 [0.21-1.28],0.1568159208855408
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1A,T-cell leukemia/lymphoma protein 1A,8993,49,1.11 [0.85-1.44],0.4371904029478655
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1B,T-cell leukemia/lymphoma protein 1B,8895,49,1.19 [0.93-1.53],0.1597530193667456
Chapter II Neoplasms,Carcinoma in situ of breast,TCN1,Transcobalamin-1,7786,41,0.53 [0.21-1.31],0.1667746512455766
Chapter II Neoplasms,Carcinoma in situ of breast,TCN2,Transcobalamin-2,9166,49,0.68 [0.29-1.62],0.3858262178132362
Chapter II Neoplasms,Carcinoma in situ of breast,TCOF1,Treacle protein,7948,45,1.23 [0.52-2.91],0.6382914515974258
Chapter II Neoplasms,Carcinoma in situ of breast,TCP11,T-complex protein 11 homolog,7824,45,1.12 [0.71-1.78],0.618629855619146
Chapter II Neoplasms,Carcinoma in situ of breast,TCTN3,Tectonic-3,7948,45,0.96 [0.36-2.56],0.9312646672793826
Chapter II Neoplasms,Carcinoma in situ of breast,TDGF1,Teratocarcinoma-derived growth factor 1,8849,49,1.03 [0.87-1.23],0.7147610423350523
Chapter II Neoplasms,Carcinoma in situ of breast,TDO2,"Tryptophan 2,3-dioxygenase",7742,44,0.61 [0.25-1.51],0.2858990535275653
Chapter II Neoplasms,Carcinoma in situ of breast,TDP1,Tyrosyl-DNA phosphodiesterase 1,7924,45,1.09 [0.75-1.60],0.6441062797126877
Chapter II Neoplasms,Carcinoma in situ of breast,TDRKH,Tudor and KH domain-containing protein,8849,49,0.84 [0.61-1.16],0.285226150448849
Chapter II Neoplasms,Carcinoma in situ of breast,TEF,Thyrotroph embryonic factor,7710,44,1.18 [0.65-2.16],0.587181489362488
Chapter II Neoplasms,Carcinoma in situ of breast,TEK,Angiopoietin-1 receptor,9106,50,1.81 [0.57-5.75],0.3119885006473744
Chapter II Neoplasms,Carcinoma in situ of breast,TERF1,Telomeric repeat-binding factor 1,7735,44,2.08 [1.09-3.97],0.0268922829641797
Chapter II Neoplasms,Carcinoma in situ of breast,TET2,Methylcytosine dioxygenase TET2,7804,44,1.25 [1.01-1.54],0.0439627341501455
Chapter II Neoplasms,Carcinoma in situ of breast,TEX101,Testis-expressed protein 101,7742,44,0.92 [0.43-1.95],0.8184825516181375
Chapter II Neoplasms,Carcinoma in situ of breast,TEX33,Testis-expressed protein 33,7824,45,0.84 [0.37-1.88],0.6689310789532028
Chapter II Neoplasms,Carcinoma in situ of breast,TF,Serotransferrin,7968,42,0.47 [0.12-1.88],0.2887313465929897
Chapter II Neoplasms,Carcinoma in situ of breast,TFAP2A,Transcription factor AP-2-alpha,7686,45,1.43 [1.02-2.01],0.0384230524913828
Chapter II Neoplasms,Carcinoma in situ of breast,TFF1,Trefoil factor 1,9032,49,0.93 [0.67-1.29],0.6437958522071301
Chapter II Neoplasms,Carcinoma in situ of breast,TFF2,Trefoil factor 2,9094,50,0.77 [0.49-1.23],0.2805314797438034
Chapter II Neoplasms,Carcinoma in situ of breast,TFF3,Trefoil factor 3,9071,50,1.63 [1.13-2.35],0.0089736341508736
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI,Tissue factor pathway inhibitor,9064,50,1.52 [0.70-3.27],0.286149545938144
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI2,Tissue factor pathway inhibitor 2,9084,50,1.42 [0.78-2.56],0.2475305490964649
Chapter II Neoplasms,Carcinoma in situ of breast,TFRC,Transferrin receptor protein 1,9119,50,1.04 [0.54-2.02],0.9047867040295888
Chapter II Neoplasms,Carcinoma in situ of breast,TG,Thyroglobulin,7924,45,1.05 [0.83-1.31],0.6945702000892494
Chapter II Neoplasms,Carcinoma in situ of breast,TGFA,Protransforming growth factor alpha,9043,49,0.90 [0.52-1.56],0.7083864646673332
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB1,Transforming growth factor beta-1 proprotein,9147,50,0.96 [0.49-1.87],0.9048743037018594
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB2,Transforming growth factor beta-2 proprotein,7924,45,1.32 [0.88-1.98],0.1730653635189832
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBI,Transforming growth factor-beta-induced protein ig-h3,9026,50,1.25 [0.49-3.14],0.6417207732861994
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR1,TGF-beta receptor type-1,7735,44,1.45 [0.47-4.49],0.5176370630847024
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR2,TGF-beta receptor type-2,9106,50,1.93 [1.02-3.66],0.0439369686305229
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR3,Transforming growth factor beta receptor type 3,9177,49,1.30 [0.59-2.84],0.5189310559049821
Chapter II Neoplasms,Carcinoma in situ of breast,TGM2,Protein-glutamine gamma-glutamyltransferase 2,9057,49,0.83 [0.60-1.15],0.2710408211929168
Chapter II Neoplasms,Carcinoma in situ of breast,TGOLN2,Trans-Golgi network integral membrane protein 2,7955,44,0.91 [0.31-2.72],0.8684918693765066
Chapter II Neoplasms,Carcinoma in situ of breast,THAP12,52 kDa repressor of the inhibitor of the protein kinase,7663,44,0.93 [0.66-1.33],0.705642183350045
Chapter II Neoplasms,Carcinoma in situ of breast,THBD,Thrombomodulin,9066,49,2.64 [1.16-6.04],0.021093009657166
Chapter II Neoplasms,Carcinoma in situ of breast,THBS2,Thrombospondin-2,9075,49,1.55 [0.84-2.85],0.1635847879198269
Chapter II Neoplasms,Carcinoma in situ of breast,THBS4,Thrombospondin-4,9082,50,1.62 [0.93-2.82],0.0855555238050424
Chapter II Neoplasms,Carcinoma in situ of breast,THOP1,Thimet oligopeptidase,9013,48,0.64 [0.27-1.49],0.2969255299428048
Chapter II Neoplasms,Carcinoma in situ of breast,THPO,Thrombopoietin,8895,49,1.38 [0.72-2.65],0.3315319284992193
Chapter II Neoplasms,Carcinoma in situ of breast,THRAP3,Thyroid hormone receptor-associated protein 3,7710,44,1.07 [0.85-1.34],0.5870108930773843
Chapter II Neoplasms,Carcinoma in situ of breast,THSD1,Thrombospondin type-1 domain-containing protein 1,7674,44,1.13 [0.48-2.66],0.7742202954178058
Chapter II Neoplasms,Carcinoma in situ of breast,THTPA,Thiamine-triphosphatase,7913,45,0.81 [0.58-1.13],0.2094345943086805
Chapter II Neoplasms,Carcinoma in situ of breast,THY1,Thy-1 membrane glycoprotein,9138,49,2.01 [0.91-4.46],0.0839170223235243
Chapter II Neoplasms,Carcinoma in situ of breast,TIA1,Nucleolysin TIA-1 isoform p40,8795,48,0.90 [0.72-1.12],0.353350699089756
Chapter II Neoplasms,Carcinoma in situ of breast,TIE1,Tyrosine-protein kinase receptor Tie-1,9177,49,0.93 [0.51-1.69],0.8184377974509713
Chapter II Neoplasms,Carcinoma in situ of breast,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",8830,49,1.16 [0.67-2.00],0.598448429059772
Chapter II Neoplasms,Carcinoma in situ of breast,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,7824,45,0.41 [0.17-1.02],0.0544092568545165
Chapter II Neoplasms,Carcinoma in situ of breast,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,9120,50,2.22 [1.30-3.78],0.0034896893844945
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,7948,45,0.94 [0.46-1.93],0.8685352712398584
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,7945,46,1.01 [0.72-1.41],0.95915992157887
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP1,Metalloproteinase inhibitor 1,8993,50,2.07 [0.91-4.67],0.0811926285275747
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP2,Metalloproteinase inhibitor 2,7948,45,0.79 [0.23-2.80],0.7203596242396939
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP3,Metalloproteinase inhibitor 3,9112,50,0.89 [0.73-1.07],0.2159575126113058
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP4,Metalloproteinase inhibitor 4,9075,49,1.59 [0.91-2.80],0.1039192285744188
Chapter II Neoplasms,Carcinoma in situ of breast,TINAGL1,Tubulointerstitial nephritis antigen-like,9036,49,1.50 [0.48-4.69],0.4859998052053378
Chapter II Neoplasms,Carcinoma in situ of breast,TJAP1,Tight junction-associated protein 1,9106,50,0.80 [0.58-1.09],0.1525652622071292
Chapter II Neoplasms,Carcinoma in situ of breast,TJP3,Tight junction protein ZO-3,7686,45,0.81 [0.39-1.70],0.5788177802154792
Chapter II Neoplasms,Carcinoma in situ of breast,TK1,"Thymidine kinase, cytosolic",7824,45,0.91 [0.46-1.79],0.7879615113689017
Chapter II Neoplasms,Carcinoma in situ of breast,TLR1,Toll-like receptor 1,7735,44,0.98 [0.33-2.95],0.9730986274250844
Chapter II Neoplasms,Carcinoma in situ of breast,TLR2,Toll-like receptor 2,7824,45,1.79 [0.52-6.21],0.3580612726136444
Chapter II Neoplasms,Carcinoma in situ of breast,TLR3,Toll-like receptor 3,9160,50,0.87 [0.58-1.29],0.4893973089322587
Chapter II Neoplasms,Carcinoma in situ of breast,TLR4,Toll-like receptor 4,7735,44,0.57 [0.20-1.63],0.2926013000020075
Chapter II Neoplasms,Carcinoma in situ of breast,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,7742,44,1.11 [0.68-1.82],0.6695138788087279
Chapter II Neoplasms,Carcinoma in situ of breast,TMED1,Transmembrane emp24 domain-containing protein 1,7824,45,1.40 [0.94-2.08],0.1004961591957094
Chapter II Neoplasms,Carcinoma in situ of breast,TMED10,Transmembrane emp24 domain-containing protein 10,7710,44,0.78 [0.36-1.70],0.5367666548558814
Chapter II Neoplasms,Carcinoma in situ of breast,TMED4,Transmembrane emp24 domain-containing protein 4,7710,44,0.98 [0.57-1.68],0.9416943254287036
Chapter II Neoplasms,Carcinoma in situ of breast,TMED8,Protein TMED8,7914,45,0.90 [0.68-1.20],0.4801112506703003
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM106A,Transmembrane protein 106A,7924,45,0.85 [0.56-1.31],0.4672358607598551
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM132A,Transmembrane protein 132A,7776,44,1.82 [1.27-2.61],0.0010515918720967
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM25,Transmembrane protein 25,7937,45,1.09 [0.62-1.90],0.7696670495658617
Chapter II Neoplasms,Carcinoma in situ of breast,TMOD4,Tropomodulin-4,7678,44,0.68 [0.32-1.44],0.3112350332913103
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11B,Transmembrane protease serine 11B,7686,45,1.13 [0.83-1.56],0.4391897580128078
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11D,Transmembrane protease serine 11D,7932,46,1.18 [0.57-2.41],0.6554890693704003
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS15,Enteropeptidase,9033,51,1.00 [0.76-1.31],0.9746266177197184
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS5,Transmembrane protease serine 5,8965,49,1.59 [0.80-3.15],0.1838841811346657
Chapter II Neoplasms,Carcinoma in situ of breast,TMSB10,Thymosin beta-10,9075,49,1.07 [0.75-1.51],0.7213632322692993
Chapter II Neoplasms,Carcinoma in situ of breast,TNC,Tenascin,9120,50,1.73 [1.05-2.84],0.031978080653401
Chapter II Neoplasms,Carcinoma in situ of breast,TNF,Tumor necrosis factor,8874,49,1.07 [0.57-2.02],0.823378440834778
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,7914,45,1.10 [0.60-2.00],0.7634455316233056
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,8903,49,1.18 [0.61-2.27],0.6242097119377212
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,7807,44,0.99 [0.62-1.58],0.9678537613345654
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,9005,49,0.94 [0.42-2.11],0.8818648524121522
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,9005,49,0.68 [0.28-1.67],0.4001471378682967
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,9094,49,0.89 [0.54-1.48],0.650406933243675
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,9160,50,1.27 [0.67-2.38],0.4628498448461985
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,9065,50,1.62 [0.68-3.87],0.27535250422953
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,9106,50,2.06 [1.08-3.95],0.028647156547071
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,9082,50,1.09 [0.48-2.43],0.8416805075074731
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,8903,49,1.04 [0.55-1.95],0.9010258845883006
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,9082,50,1.02 [0.44-2.37],0.9593454318422876
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,7807,44,0.96 [0.47-1.96],0.9038392584665756
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,9145,50,1.11 [0.50-2.45],0.7953094566074009
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,9075,49,1.38 [0.59-3.20],0.4581160304136491
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,9075,49,1.33 [0.77-2.28],0.3082252509326325
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,9138,49,2.60 [1.16-5.80],0.0199466446806883
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,9147,50,1.10 [0.58-2.08],0.7789091884979471
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,9005,49,1.16 [0.75-1.78],0.5081944073720767
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,9138,49,1.37 [0.83-2.25],0.2172208157752024
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,9005,49,1.03 [0.54-1.95],0.9358797925170984
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF10,Tumor necrosis factor ligand superfamily member 10,9160,50,1.86 [0.69-5.04],0.22355036025442
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF11,Tumor necrosis factor ligand superfamily member 11,9043,49,0.97 [0.63-1.48],0.8819181528452287
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF12,Tumor necrosis factor ligand superfamily member 12,9160,50,0.53 [0.22-1.30],0.164409955484936
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13,Tumor necrosis factor ligand superfamily member 13,9112,50,0.94 [0.36-2.41],0.8939183106200457
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,9168,49,1.23 [0.51-2.96],0.6471755274223864
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF14,Tumor necrosis factor ligand superfamily member 14,9005,49,1.00 [0.64-1.57],0.9855895791763074
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF8,Tumor necrosis factor ligand superfamily member 8,7965,46,1.10 [0.50-2.43],0.8144136894740803
Chapter II Neoplasms,Carcinoma in situ of breast,TNIP1,TNFAIP3-interacting protein 1,7945,46,0.89 [0.64-1.23],0.4677548092499601
Chapter II Neoplasms,Carcinoma in situ of breast,TNN,Tenascin-N,7965,46,0.78 [0.41-1.49],0.453838642147449
Chapter II Neoplasms,Carcinoma in situ of breast,TNNI3,"Troponin I, cardiac muscle",8895,49,0.93 [0.70-1.23],0.6191160659425505
Chapter II Neoplasms,Carcinoma in situ of breast,TNPO1,Transportin-1,7824,45,1.30 [0.69-2.44],0.4194182607775861
Chapter II Neoplasms,Carcinoma in situ of breast,TNR,Tenascin-R,9005,49,1.97 [1.13-3.43],0.0166773988683687
Chapter II Neoplasms,Carcinoma in situ of breast,TNXB,Tenascin-X,9075,49,1.58 [0.59-4.25],0.3624683600836301
Chapter II Neoplasms,Carcinoma in situ of breast,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,7948,45,0.79 [0.54-1.17],0.2462485367414563
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1,DNA topoisomerase 1,7914,45,1.22 [0.94-1.59],0.1369486601245864
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1MT,"DNA topoisomerase I, mitochondrial",7678,44,0.39 [0.18-0.83],0.0145242705267978
Chapter II Neoplasms,Carcinoma in situ of breast,TOP2B,DNA topoisomerase 2-beta,7735,44,0.94 [0.65-1.38],0.7658100071111049
Chapter II Neoplasms,Carcinoma in situ of breast,TOR1AIP1,Torsin-1A-interacting protein 1,7776,44,1.14 [0.68-1.89],0.6259064525643261
Chapter II Neoplasms,Carcinoma in situ of breast,TP53,Cellular tumor antigen p53,8869,47,0.63 [0.34-1.18],0.1486441047553339
Chapter II Neoplasms,Carcinoma in situ of breast,TP53BP1,TP53-binding protein 1,7735,44,0.99 [0.71-1.37],0.9315910058369314
Chapter II Neoplasms,Carcinoma in situ of breast,TP53I3,Quinone oxidoreductase PIG3,7643,44,0.69 [0.39-1.22],0.2011253784895278
Chapter II Neoplasms,Carcinoma in situ of breast,TP53INP1,Tumor protein p53-inducible nuclear protein 1,8895,49,1.13 [0.60-2.14],0.7117438451049835
Chapter II Neoplasms,Carcinoma in situ of breast,TP73,Tumor protein p73,7742,44,1.63 [0.72-3.66],0.2402328886982423
Chapter II Neoplasms,Carcinoma in situ of breast,TPBGL,Trophoblast glycoprotein-like,7742,44,0.99 [0.49-1.97],0.973305642735906
Chapter II Neoplasms,Carcinoma in situ of breast,TPD52L2,Tumor protein D54,7807,44,0.91 [0.70-1.19],0.4990025103114109
Chapter II Neoplasms,Carcinoma in situ of breast,TPK1,Thiamin pyrophosphokinase 1,7948,45,1.92 [0.67-5.55],0.2271130487871423
Chapter II Neoplasms,Carcinoma in situ of breast,TPM3,Tropomyosin alpha-3 chain,7710,44,1.15 [0.59-2.24],0.6865031144708299
Chapter II Neoplasms,Carcinoma in situ of breast,TPMT,Thiopurine S-methyltransferase,8869,47,0.83 [0.57-1.21],0.3339157473239966
Chapter II Neoplasms,Carcinoma in situ of breast,TPP1,Tripeptidyl-peptidase 1,9001,49,0.98 [0.54-1.78],0.9366370576789964
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP2,Tubulin polymerization-promoting protein family member 2,7824,45,1.08 [0.77-1.50],0.6564408354873923
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP3,Tubulin polymerization-promoting protein family member 3,8849,49,1.33 [0.82-2.17],0.2479200831228997
Chapter II Neoplasms,Carcinoma in situ of breast,TPR,Nucleoprotein TPR,7710,44,1.13 [0.68-1.89],0.632518189229456
Chapter II Neoplasms,Carcinoma in situ of breast,TPRKB,EKC/KEOPS complex subunit TPRKB,7678,44,1.05 [0.68-1.62],0.8247311482838618
Chapter II Neoplasms,Carcinoma in situ of breast,TPSAB1,Tryptase alpha/beta-1,9146,49,1.12 [0.69-1.81],0.6575326838677937
Chapter II Neoplasms,Carcinoma in situ of breast,TPSD1,Tryptase delta,7937,45,0.75 [0.32-1.80],0.5250484168317264
Chapter II Neoplasms,Carcinoma in situ of breast,TPSG1,Tryptase gamma,7735,44,1.54 [0.60-3.94],0.3649357831959465
Chapter II Neoplasms,Carcinoma in situ of breast,TPT1,Translationally-controlled tumor protein,8903,49,0.90 [0.58-1.39],0.6367794627440391
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF2,TNF receptor-associated factor 2,9043,49,0.95 [0.66-1.36],0.7765549531751007
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3,"TNF receptor-associated factor 3, Isoform 2",7735,44,1.14 [0.53-2.47],0.7354772779447617
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,7710,44,1.02 [0.58-1.80],0.9321327820538248
Chapter II Neoplasms,Carcinoma in situ of breast,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,7824,45,1.06 [0.77-1.46],0.728204707182913
Chapter II Neoplasms,Carcinoma in situ of breast,TREH,Trehalase,7965,46,1.03 [0.70-1.52],0.8674176230914361
Chapter II Neoplasms,Carcinoma in situ of breast,TREM2,Triggering receptor expressed on myeloid cells 2,9065,50,0.95 [0.58-1.54],0.8309734224879053
Chapter II Neoplasms,Carcinoma in situ of breast,TREML1,Trem-like transcript 1 protein,7955,44,0.63 [0.35-1.12],0.1165224472208356
Chapter II Neoplasms,Carcinoma in situ of breast,TREML2,Trem-like transcript 2 protein,9075,49,0.82 [0.37-1.80],0.6193430887340037
Chapter II Neoplasms,Carcinoma in situ of breast,TRIAP1,TP53-regulated inhibitor of apoptosis 1,9145,50,0.90 [0.59-1.36],0.6148146541963238
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM21,E3 ubiquitin-protein ligase TRIM21,9043,49,0.98 [0.72-1.33],0.8938815328106271
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM24,Transcription intermediary factor 1-alpha,7807,45,0.91 [0.58-1.43],0.6757054671853424
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,7914,45,0.85 [0.65-1.11],0.2398921021139221
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM26,Tripartite motif-containing protein 26,7678,44,1.08 [0.66-1.76],0.7607960285552574
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM40,E3 ubiquitin ligase TRIM40,7742,44,0.81 [0.53-1.24],0.3352137348610631
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM5,Tripartite motif-containing protein 5,9043,49,1.03 [0.77-1.39],0.8243040657275911
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM58,E3 ubiquitin-protein ligase TRIM58,7924,45,0.79 [0.57-1.11],0.1746998667608198
Chapter II Neoplasms,Carcinoma in situ of breast,TRPV3,Transient receptor potential cation channel subfamily V member 3,7710,44,0.95 [0.51-1.78],0.8847157837023532
Chapter II Neoplasms,Carcinoma in situ of breast,TSC1,Hamartin,7735,44,0.59 [0.32-1.11],0.1015691670523767
Chapter II Neoplasms,Carcinoma in situ of breast,TSC22D1,TSC22 domain family protein 1,7937,45,1.02 [0.67-1.56],0.9254654440751152
Chapter II Neoplasms,Carcinoma in situ of breast,TSHB,Thyrotropin subunit beta,9066,49,0.79 [0.60-1.05],0.102899720124301
Chapter II Neoplasms,Carcinoma in situ of breast,TSLP,Thymic stromal lymphopoietin,8895,49,0.87 [0.55-1.38],0.5511388415455635
Chapter II Neoplasms,Carcinoma in situ of breast,TSNAX,Translin-associated protein X,7710,44,0.88 [0.42-1.86],0.7442992283900469
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN1,Tetraspanin-1,8895,49,0.78 [0.27-2.23],0.6423937996075124
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN15,Tetraspanin-15,7710,44,1.09 [0.64-1.87],0.7487031013887427
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN7,Tetraspanin-7,7686,45,1.02 [0.75-1.39],0.9116465971821446
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN8,Tetraspanin-8,7914,45,0.96 [0.73-1.25],0.742179347556402
Chapter II Neoplasms,Carcinoma in situ of breast,TSPYL1,Testis-specific Y-encoded-like protein 1,7735,44,0.77 [0.37-1.63],0.4997515927531147
Chapter II Neoplasms,Carcinoma in situ of breast,TST,Thiosulfate sulfurtransferase,8827,48,0.94 [0.67-1.34],0.7440718623815363
Chapter II Neoplasms,Carcinoma in situ of breast,TTF2,Transcription termination factor 2,7742,44,0.68 [0.36-1.29],0.2369404436937149
Chapter II Neoplasms,Carcinoma in situ of breast,TTN,Titin,7710,44,1.16 [0.79-1.71],0.4393248616179614
Chapter II Neoplasms,Carcinoma in situ of breast,TTR,Transthyretin,7878,41,0.46 [0.14-1.47],0.190285178851873
Chapter II Neoplasms,Carcinoma in situ of breast,TUBB3,Tubulin beta-3 chain,7686,45,1.26 [0.47-3.39],0.6514634906711889
Chapter II Neoplasms,Carcinoma in situ of breast,TWF2,Twinfilin-2,7965,46,0.92 [0.65-1.30],0.6308632124208877
Chapter II Neoplasms,Carcinoma in situ of breast,TXK,Tyrosine-protein kinase TXK,7824,45,0.56 [0.31-1.00],0.0511844657654776
Chapter II Neoplasms,Carcinoma in situ of breast,TXLNA,Alpha-taxilin,9005,49,0.85 [0.64-1.14],0.2831659057318695
Chapter II Neoplasms,Carcinoma in situ of breast,TXN,Thioredoxin,7824,43,0.51 [0.23-1.11],0.0903829704982054
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC15,Thioredoxin domain-containing protein 15,9106,50,1.85 [0.77-4.46],0.1718115012623565
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC5,Thioredoxin domain-containing protein 5,9138,49,0.85 [0.58-1.26],0.4271653396986055
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC9,Thioredoxin domain-containing protein 9,7945,46,1.00 [0.59-1.69],0.9877775910504736
Chapter II Neoplasms,Carcinoma in situ of breast,TXNL1,Thioredoxin-like protein 1,7671,45,1.03 [0.78-1.36],0.8394523748664744
Chapter II Neoplasms,Carcinoma in situ of breast,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",9075,49,0.70 [0.39-1.24],0.2233716304304162
Chapter II Neoplasms,Carcinoma in situ of breast,TYMP,Thymidine phosphorylase,8997,46,0.92 [0.62-1.38],0.7012923777388556
Chapter II Neoplasms,Carcinoma in situ of breast,TYRO3,Tyrosine-protein kinase receptor TYRO3,9066,49,1.10 [0.44-2.71],0.843980175688255
Chapter II Neoplasms,Carcinoma in situ of breast,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",7735,44,1.22 [0.77-1.93],0.3973782374787009
Chapter II Neoplasms,Carcinoma in situ of breast,UBAC1,Ubiquitin-associated domain-containing protein 1,9033,51,0.81 [0.41-1.63],0.558091881242071
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2B,Ubiquitin-conjugating enzyme E2 B,7924,45,0.42 [0.14-1.23],0.1148435699050286
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,7948,45,0.85 [0.52-1.38],0.5031213002435178
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,7735,44,0.66 [0.36-1.22],0.1889964322603353
Chapter II Neoplasms,Carcinoma in situ of breast,UBQLN3,Ubiquilin-3,7710,44,1.33 [0.80-2.21],0.2689407051780045
Chapter II Neoplasms,Carcinoma in situ of breast,UBXN1,UBX domain-containing protein 1,7807,44,0.71 [0.46-1.12],0.1416559389634559
Chapter II Neoplasms,Carcinoma in situ of breast,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,7914,45,0.97 [0.79-1.19],0.761221628339662
Chapter II Neoplasms,Carcinoma in situ of breast,UGDH,UDP-glucose 6-dehydrogenase,7710,44,1.07 [0.82-1.41],0.6146257462863453
Chapter II Neoplasms,Carcinoma in situ of breast,UHRF2,E3 ubiquitin-protein ligase UHRF2,7710,44,0.98 [0.44-2.16],0.9559639040231896
Chapter II Neoplasms,Carcinoma in situ of breast,ULBP2,UL16-binding protein 2,9005,49,1.01 [0.52-1.96],0.97910894639973
Chapter II Neoplasms,Carcinoma in situ of breast,UMOD,Uromodulin,9155,49,1.32 [0.80-2.16],0.2750872816416242
Chapter II Neoplasms,Carcinoma in situ of breast,UNC5D,Netrin receptor UNC5D,7735,44,1.10 [0.36-3.36],0.8671392677806377
Chapter II Neoplasms,Carcinoma in situ of breast,UNC79,Protein unc-79 homolog,7678,44,0.69 [0.39-1.21],0.1948803814700136
Chapter II Neoplasms,Carcinoma in situ of breast,UNG,Uracil-DNA glycosylase,7924,45,0.91 [0.38-2.17],0.8258214389512538
Chapter II Neoplasms,Carcinoma in situ of breast,UPB1,Beta-ureidopropionase,7948,45,0.88 [0.64-1.20],0.4233602197385027
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3A,Uroplakin-3a,7686,45,1.19 [0.70-2.03],0.5092212989355278
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3BL1,Uroplakin-3b-like protein 1,7810,45,0.84 [0.45-1.56],0.5798837504766925
Chapter II Neoplasms,Carcinoma in situ of breast,UROD,Uroporphyrinogen decarboxylase,7807,44,0.77 [0.51-1.17],0.2232800638280528
Chapter II Neoplasms,Carcinoma in situ of breast,UROS,Uroporphyrinogen-III synthase,7742,44,0.49 [0.29-0.82],0.0074069738227762
Chapter II Neoplasms,Carcinoma in situ of breast,USO1,General vesicular transport factor p115,9033,51,0.85 [0.65-1.12],0.244001631406667
Chapter II Neoplasms,Carcinoma in situ of breast,USP25,Ubiquitin carboxyl-terminal hydrolase 25,7924,45,0.82 [0.55-1.24],0.3540554792172657
Chapter II Neoplasms,Carcinoma in situ of breast,USP28,Ubiquitin carboxyl-terminal hydrolase 28,7945,46,1.55 [0.88-2.74],0.1311538529241416
Chapter II Neoplasms,Carcinoma in situ of breast,USP47,Ubiquitin carboxyl-terminal hydrolase 47,7710,44,0.95 [0.67-1.36],0.7921850691652692
Chapter II Neoplasms,Carcinoma in situ of breast,USP8,Ubiquitin carboxyl-terminal hydrolase 8,8895,49,0.85 [0.64-1.12],0.2391326344893578
Chapter II Neoplasms,Carcinoma in situ of breast,UXS1,UDP-glucuronic acid decarboxylase 1,8869,47,0.57 [0.34-0.94],0.0271122480587394
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP5,Vesicle-associated membrane protein 5,8895,49,1.22 [0.84-1.76],0.2974999930256829
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP8,Vesicle-associated membrane protein 8,7735,44,1.00 [0.71-1.39],0.9766124794854132
Chapter II Neoplasms,Carcinoma in situ of breast,VASH1,Tubulinyl-Tyr carboxypeptidase 1,9043,49,1.02 [0.75-1.39],0.9041787026140682
Chapter II Neoplasms,Carcinoma in situ of breast,VASN,Vasorin,8935,50,3.64 [1.83-7.26],0.0002419481030153
Chapter II Neoplasms,Carcinoma in situ of breast,VASP,Vasodilator-stimulated phosphoprotein,7955,44,0.88 [0.59-1.32],0.5437716631756767
Chapter II Neoplasms,Carcinoma in situ of breast,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,9033,51,2.22 [0.67-7.38],0.192064281207057
Chapter II Neoplasms,Carcinoma in situ of breast,VAV3,Guanine nucleotide exchange factor VAV3,7686,45,0.98 [0.73-1.32],0.913369105454906
Chapter II Neoplasms,Carcinoma in situ of breast,VCAM1,Vascular cell adhesion protein 1,9101,50,2.40 [1.03-5.59],0.0416942013714946
Chapter II Neoplasms,Carcinoma in situ of breast,VCAN,Versican core protein,9138,49,1.15 [0.50-2.62],0.7399211842061941
Chapter II Neoplasms,Carcinoma in situ of breast,VCPKMT,Protein-lysine methyltransferase METTL21D,7678,44,1.18 [0.88-1.58],0.2624281344245755
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFA,Vascular endothelial growth factor A,9132,50,0.89 [0.58-1.38],0.6118716290481326
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFB,Vascular endothelial growth factor B,7735,44,1.15 [0.42-3.19],0.7862547000219601
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFC,Vascular endothelial growth factor C,9106,50,0.72 [0.46-1.12],0.147354315323733
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFD,Vascular endothelial growth factor D,9141,50,2.68 [1.34-5.35],0.0053100583232542
Chapter II Neoplasms,Carcinoma in situ of breast,VGF,Neurosecretory protein VGF,7937,45,2.07 [0.84-5.09],0.113098125508094
Chapter II Neoplasms,Carcinoma in situ of breast,VIM,Vimentin,8895,49,1.45 [1.16-1.80],0.0009168915615954
Chapter II Neoplasms,Carcinoma in situ of breast,VIPR1,Vasoactive intestinal polypeptide receptor 1,7776,44,1.40 [0.47-4.18],0.548515069061325
Chapter II Neoplasms,Carcinoma in situ of breast,VIT,Vitrin,7948,45,0.75 [0.35-1.60],0.4528733699521979
Chapter II Neoplasms,Carcinoma in situ of breast,VMO1,Vitelline membrane outer layer protein 1 homolog,9033,51,0.87 [0.63-1.20],0.396955580598804
Chapter II Neoplasms,Carcinoma in situ of breast,VNN1,Pantetheinase,7955,44,0.86 [0.59-1.27],0.4532646662765338
Chapter II Neoplasms,Carcinoma in situ of breast,VNN2,Vascular non-inflammatory molecule 2,9033,51,1.35 [0.76-2.41],0.299916914361554
Chapter II Neoplasms,Carcinoma in situ of breast,VPS28,Vacuolar protein sorting-associated protein 28 homolog,7824,45,0.78 [0.49-1.24],0.298372980754795
Chapter II Neoplasms,Carcinoma in situ of breast,VPS37A,Vacuolar protein sorting-associated protein 37A,9033,51,0.91 [0.66-1.25],0.5553667268396741
Chapter II Neoplasms,Carcinoma in situ of breast,VPS4B,Vacuolar protein sorting-associated protein 4B,7924,45,0.99 [0.73-1.35],0.973635535575958
Chapter II Neoplasms,Carcinoma in situ of breast,VPS53,Vacuolar protein sorting-associated protein 53 homolog,9033,51,0.83 [0.60-1.16],0.2839673489529882
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10,V-set and immunoglobulin domain-containing protein 10,7924,45,0.89 [0.37-2.13],0.7859987144542973
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,7710,44,1.08 [0.45-2.58],0.8617334995932595
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG2,V-set and immunoglobulin domain-containing protein 2,7924,45,0.83 [0.50-1.35],0.4471445151048954
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG4,V-set and immunoglobulin domain-containing protein 4,9065,49,1.84 [1.04-3.27],0.0368970964491626
Chapter II Neoplasms,Carcinoma in situ of breast,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,9049,49,0.87 [0.57-1.34],0.5323708926684068
Chapter II Neoplasms,Carcinoma in situ of breast,VSNL1,Visinin-like protein 1,7945,46,0.82 [0.38-1.75],0.6028241110238051
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM1,V-set and transmembrane domain-containing protein 1,8849,49,0.73 [0.43-1.25],0.2573559734615219
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2B,V-set and transmembrane domain-containing protein 2B,7824,45,1.15 [0.64-2.07],0.6393957268435665
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,8895,49,1.18 [0.81-1.72],0.3805785076792147
Chapter II Neoplasms,Carcinoma in situ of breast,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,9138,49,0.83 [0.58-1.19],0.3130549511889148
Chapter II Neoplasms,Carcinoma in situ of breast,VTCN1,V-set domain-containing T-cell activation inhibitor 1,8869,47,0.72 [0.31-1.70],0.4523329397252024
Chapter II Neoplasms,Carcinoma in situ of breast,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,7807,44,1.06 [0.65-1.74],0.8159452386117428
Chapter II Neoplasms,Carcinoma in situ of breast,VWA1,von Willebrand factor A domain-containing protein 1,9127,50,1.62 [0.90-2.93],0.1086223856275391
Chapter II Neoplasms,Carcinoma in situ of breast,VWA5A,von Willebrand factor A domain-containing protein 5A,7678,44,1.08 [0.78-1.50],0.6536574814340594
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2,Brorin,8972,49,1.21 [0.63-2.34],0.5694496376855189
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2L,von Willebrand factor C domain-containing protein 2-like,7937,45,1.42 [0.96-2.11],0.0798549570517666
Chapter II Neoplasms,Carcinoma in situ of breast,VWF,von Willebrand factor,9177,49,1.24 [0.88-1.74],0.2235013323555723
Chapter II Neoplasms,Carcinoma in situ of breast,WARS,"Tryptophan--tRNA ligase, cytoplasmic",9075,49,1.41 [0.73-2.74],0.310091775611254
Chapter II Neoplasms,Carcinoma in situ of breast,WAS,Wiskott-Aldrich syndrome protein,8903,49,1.22 [0.86-1.72],0.2635256901399994
Chapter II Neoplasms,Carcinoma in situ of breast,WASF1,Wiskott-Aldrich syndrome protein family member 1,8895,49,0.84 [0.63-1.12],0.244263859310302
Chapter II Neoplasms,Carcinoma in situ of breast,WASF3,Wiskott-Aldrich syndrome protein family member 3,8849,49,0.89 [0.66-1.20],0.4485460066114062
Chapter II Neoplasms,Carcinoma in situ of breast,WASHC3,WASH complex subunit 3,7945,46,1.10 [0.76-1.58],0.6118472583267809
Chapter II Neoplasms,Carcinoma in situ of breast,WASL,Neural Wiskott-Aldrich syndrome protein,7735,44,1.28 [0.87-1.87],0.2045145736886088
Chapter II Neoplasms,Carcinoma in situ of breast,WDR46,WD repeat-containing protein 46,7924,45,0.90 [0.38-2.11],0.8083719526907966
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC1,WAP four-disulfide core domain protein 1,7751,45,0.74 [0.39-1.42],0.3669950068571366
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC12,WAP four-disulfide core domain protein 12,9136,50,1.37 [0.95-1.97],0.0943763183760202
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC2,WAP four-disulfide core domain protein 2,8628,47,1.61 [0.88-2.96],0.1240411563426246
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",8978,47,1.23 [0.65-2.32],0.532000996856322
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",9082,50,1.29 [0.63-2.64],0.4908770763266281
Chapter II Neoplasms,Carcinoma in situ of breast,WIF1,Wnt inhibitory factor 1,9145,50,0.66 [0.32-1.35],0.2541796759290303
Chapter II Neoplasms,Carcinoma in situ of breast,WNT9A,Protein Wnt-9a,8903,49,1.29 [0.54-3.09],0.5648686186171651
Chapter II Neoplasms,Carcinoma in situ of breast,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,9005,49,1.08 [0.68-1.73],0.7414585423166382
Chapter II Neoplasms,Carcinoma in situ of breast,XCL1,Lymphotactin,9145,50,1.14 [0.77-1.70],0.5086069080273912
Chapter II Neoplasms,Carcinoma in situ of breast,XG,Glycoprotein Xg,9135,47,1.32 [0.58-3.04],0.5079224735063774
Chapter II Neoplasms,Carcinoma in situ of breast,XIAP,E3 ubiquitin-protein ligase XIAP,7735,44,0.86 [0.51-1.46],0.5764663164627075
Chapter II Neoplasms,Carcinoma in situ of breast,XPNPEP2,Xaa-Pro aminopeptidase 2,9106,50,1.12 [0.84-1.50],0.4356965062740815
Chapter II Neoplasms,Carcinoma in situ of breast,XRCC4,DNA repair protein XRCC4,8849,49,0.88 [0.43-1.79],0.7220967106612572
Chapter II Neoplasms,Carcinoma in situ of breast,YAP1,Transcriptional coactivator YAP1,7945,46,1.84 [0.69-4.93],0.2242180318955908
Chapter II Neoplasms,Carcinoma in situ of breast,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",7914,45,0.95 [0.78-1.15],0.577253535960107
Chapter II Neoplasms,Carcinoma in situ of breast,YES1,Tyrosine-protein kinase Yes,9033,51,0.87 [0.70-1.08],0.2020711850311309
Chapter II Neoplasms,Carcinoma in situ of breast,YJU2,Splicing factor YJU2,7924,45,0.59 [0.23-1.53],0.2793391190867629
Chapter II Neoplasms,Carcinoma in situ of breast,YOD1,Ubiquitin thioesterase OTU1,7710,44,0.77 [0.49-1.22],0.2695799457405327
Chapter II Neoplasms,Carcinoma in situ of breast,YTHDF3,YTH domain-containing family protein 3,8903,49,0.99 [0.73-1.35],0.95989945781088
Chapter II Neoplasms,Carcinoma in situ of breast,YWHAQ,14-3-3 protein theta,7807,44,0.90 [0.60-1.34],0.6014301110623241
Chapter II Neoplasms,Carcinoma in situ of breast,YY1,Transcriptional repressor protein YY1,7735,44,0.70 [0.24-2.05],0.5150770346654163
Chapter II Neoplasms,Carcinoma in situ of breast,ZBP1,Z-DNA-binding protein 1,7735,44,0.84 [0.37-1.90],0.6828432492309133
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB16,Zinc finger and BTB domain-containing protein 16,8869,47,0.90 [0.62-1.32],0.5961559432377181
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB17,Zinc finger and BTB domain-containing protein 17,8895,49,1.20 [0.69-2.10],0.5214772675162375
Chapter II Neoplasms,Carcinoma in situ of breast,ZCCHC8,Zinc finger CCHC domain-containing protein 8,7710,44,1.17 [0.81-1.71],0.4068276352618611
Chapter II Neoplasms,Carcinoma in situ of breast,ZFYVE19,Abscission/NoCut checkpoint regulator,7914,45,0.85 [0.62-1.18],0.3322675731683852
Chapter II Neoplasms,Carcinoma in situ of breast,ZHX2,Zinc fingers and homeoboxes protein 2,7945,46,1.31 [0.67-2.57],0.4336095478922329
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF174,Zinc finger protein 174,7735,44,1.36 [0.76-2.41],0.2968169387102161
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF75D,Zinc finger protein 75D,7824,45,1.01 [0.64-1.59],0.9709583769878408
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF830,Zinc finger protein 830,7924,45,0.97 [0.66-1.41],0.8600589584455957
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRD2,Protein ZNRD2,7914,45,0.60 [0.38-0.94],0.0269611657526874
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,7924,45,0.70 [0.40-1.25],0.2325675887871495
Chapter II Neoplasms,Carcinoma in situ of breast,ZP3,Zona pellucida sperm-binding protein 3,7776,44,1.04 [0.93-1.16],0.5019520756865937
Chapter II Neoplasms,Carcinoma in situ of breast,ZP4,Zona pellucida sperm-binding protein 4,7678,44,0.70 [0.24-2.03],0.5091178089665493
Chapter II Neoplasms,Carcinoma in situ of breast,ZPR1,Zinc finger protein ZPR1,7686,45,1.05 [0.80-1.37],0.7362326021772577
